Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Previous issues

Page Path
HOME > Browse articles > Previous issues
30 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 50(2); April 2018
Prev issue Next issue
Special Articles
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018
DOI: https://doi.org/10.4143/crt.2018.143
AbstractAbstract PDFPubReaderePub
Purpose
This study presents the 2015 nationwide cancer statistics in Korea, including the incidence, survival, prevalence, and mortality.
Materials and Methods
Cancer incidence data from 1999 to 2015 was obtained from the Korea National Cancer Incidence Database and followed until December 31, 2016. Mortality data from 1983 to 2015 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2016, among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality and prevalence and 5-year relative survivals were also calculated.
Results
Herein, 214,701 and 76,855 Koreans were newly diagnosed and died from cancer in 2015, respectively. The ASRs for cancer incidence and mortality in 2015 were 258.9 and 82.0 per 100,000, respectively. The overall cancer incidence rate has increased significantly by 3.4% annually from 1999 to 2012, and started to decrease after 2012 (2012-2015, annual percent change, –6.1%). However, the overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2011 and 2015 was 70.7%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995.
Conclusion
Age-standardized cancer incidence rates have decreased since 2012 and mortality rates have declined since 2002; however, the 5-year survival rates have improved remarkably from 1993-1995 to 2011-2015 in Korea.

Citations

Citations to this article as recorded by  
  • Sensitivity, Specificity, and Cost–Benefit Effect Between Primary Human Papillomavirus Testing, Primary Liquid‐Based Cytology, and Co‐Testing Algorithms for Cervical Lesions
    Chang Gok Woo, Seung‐Myoung Son, Hye‐Kyung Hwang, Jung‐Sil Bae, Ok‐Jun Lee, Ho‐Chang Lee
    Diagnostic Cytopathology.2025; 53(1): 35.     CrossRef
  • Multistage deep learning for classification of Helicobacter pylori infection status using endoscopic images
    Guang Li, Ren Togo, Katsuhiro Mabe, Shunpei Nishida, Yoshihiro Tomoda, Fumiyuki Shiratani, Masashi Hirota, Takahiro Ogawa, Miki Haseyama
    Journal of Gastroenterology.2025; 60(4): 408.     CrossRef
  • Recent 5‑year trends in biliary tract cancer survival rates: An analytical big data survey
    Ji Yoon Lee, Ju Won Kim
    Medicine International.2025;[Epub]     CrossRef
  • Research Progress in ESD Treatment of Early Gastric Cancer
    亭 贺
    Advances in Clinical Medicine.2024; 14(02): 4201.     CrossRef
  • Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study
    Yoon Young Choi, Myeongjee Lee, Eun Hwa Kim, Jae Eun Lee, Inkyung Jung, Jae-Ho Cheong
    JMIR Public Health and Surveillance.2024; 10: e48380.     CrossRef
  • Nature and Determinants of Fear of Cancer Recurrence After Endoscopic Submucosal Dissection for Early Gastric Cancer
    Nian Song, Xiaotao Zhang, Jie Su, Lu Chen, Qianhong Jin, Chengcheng Liu, Zhengxiang Dai
    Gastroenterology Nursing.2024; 47(5): 358.     CrossRef
  • The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
    Ruoyi Yang, Teng Li, Sicheng Zhang, Chunyan Shui, Hong Ma, Chao Li
    BMC Cancer.2024;[Epub]     CrossRef
  • Contrasting income-based inequalities in incidence and mortality of breast cancer in Korea, 2006-2015
    Jinwook Bahk, Hee-Yeon Kang, Young-Ho Khang, Kyunghee Jung-Choi
    Epidemiology and Health.2024; 46: e2024074.     CrossRef
  • Anticancer activity of herbal formula Jisilhaebaekgyeji-Tang against human breast cancer cells and its mechanism
    Sang Kyu Jeon, Su Mi Park, Jung Yun Ahn, Ok Hyeon Kim, Young Woo Kim, Kwang-Il Park, Sun-Dong Park, Ju-Hee Lee
    Molecular & Cellular Toxicology.2023; 19(3): 437.     CrossRef
  • Endoscopy-assisted latissimus dorsi muscle flap harvesting technique for immediate breast reconstruction
    Y. Cha, S. Lee
    Annales de Chirurgie Plastique Esthétique.2023; 68(4): 308.     CrossRef
  • RGO-PANI composite Au microelectrodes for sensitive ECIS analysis of human gastric (MKN-1) cancer cells
    Ajay Kumar Yagati, Sachin Ganpat Chavan, Changyoon Baek, Donghyun Lee, Min-Ho Lee, Junhong Min
    Bioelectrochemistry.2023; 150: 108347.     CrossRef
  • Updated epidemiology of gastrointestinal cancers in East Asia
    Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
    Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271.     CrossRef
  • Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
    Si Won Lee, Jung Hye Kwon, Seung-hoon Beom, Sang Joon Shin, Hyo Song Kim, Sun Young Rha, Minkyu Jung, Joo Hyuk Sohn, Joong-Bae Ahn, Hyun Cheol Chung, Gun Min Kim, Hye Ryun Kim, Beodeul Kang, Youn Jung Hu, Hye Jin Choi
    Palliative Medicine Reports.2023; 4(1): 9.     CrossRef
  • Gold nanoparticles combined baker’s yeast as a successful approach for breast cancer treatment
    Amany Elwakkad, Amina A. Gamal el Din, Hisham A. Saleh, Noha E. Ibrahim, Mohamed A. Hebishy, Hagar H. Mourad, Mahitab I. El-Kassaby, Howida Sayed Abou-Seif, Ghada M. Elqattan
    Journal of Genetic Engineering and Biotechnology.2023; 21(1): 27.     CrossRef
  • Updates on global epidemiology, risk and prognostic factors of gastric cancer
    Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu, Jing Lv
    World Journal of Gastroenterology.2023; 29(16): 2452.     CrossRef
  • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
    Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
    Endocrine.2023; 82(2): 237.     CrossRef
  • Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
    Su Bee Park, Min Seob Kwak, Jin Young Yoon, Jae Myung Cha
    Gut and Liver.2023; 17(3): 449.     CrossRef
  • Harmful effect of repetitive intravenous iodinated contrast media administration on the long-term renal function of patients with early gastric cancer
    Ja Ho Koo, Myeongjee Lee, Eun Hwa Kim, Hyung Jung Oh, Joon Seok Lim, Woo Jin Hyung, Hong In Yoon, Inkyung Jung, Yong Eun Chung
    Scientific Reports.2023;[Epub]     CrossRef
  • Clinical and Biological Profile of Metastatic Colorectal Cancers Treated at the Bejaia University Hospital Center. About a Series of 93 Patients
    Chahira Mazouzi, Rachida Aftis, Radia Benyahia, Kamel Hail, Nabil Blik
    European Journal of Medical and Health Research.2023; 1(1): 34.     CrossRef
  • Applications of competing risks analysis in public health
    Hyunsoon Cho, Dahhay Lee, Sanghee Lee, Sangbum Choi
    Journal of the Korean Statistical Society.2022; 51(1): 1.     CrossRef
  • Coffee Intake Interacted with the Bcl-2 rs1944420, rs7236090, and rs2849382 Haplotype to Influence Breast Cancer Risk in Middle-Aged Women
    Meiling Liu, Sang Shin Song, Sunmin Park
    Nutrition and Cancer.2022; 74(1): 131.     CrossRef
  • Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients
    H.-K. Park, M.-H. Ryu, D.-S. Hwang, G.-C. Kim, M.-A. Jang, U.-K. Kim
    International Journal of Oral and Maxillofacial Surgery.2022; 51(6): 713.     CrossRef
  • Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison
    Joon Yeul Nam, Hyung Jin Chung, Kyu Sung Choi, Hyuk Lee, Tae Jun Kim, Hosim Soh, Eun Ae Kang, Soo-Jeong Cho, Jong Chul Ye, Jong Pil Im, Sang Gyun Kim, Joo Sung Kim, Hyunsoo Chung, Jeong-Hoon Lee
    Gastrointestinal Endoscopy.2022; 95(2): 258.     CrossRef
  • Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea
    Diego Novick, Jae Min Cho, Sam Colman, Agota Szende
    Drugs - Real World Outcomes.2022; 9(2): 263.     CrossRef
  • The diagnostic value of digital breast tomosynthesis with complementary ultrasound in comparison with magnetic resonance imaging in assessment of postoperative changes and locoregional recurrence of breast cancer
    Mai M. K. Barakat, Eman K. A. E. Mohamed, Lobna A. E. Habib, Mortada Elsayed Ahmed
    Egyptian Journal of Radiology and Nuclear Medicine.2022;[Epub]     CrossRef
  • Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
    Kyung-Lak Son, Dooyoung Jung, Kwang-Min Lee, Chan-Woo Yeom, Gyu Han Oh, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, David Spiegel, Bong-Jin Hahm
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer
    Xinwei Qiao, Feng Zhao
    Bioengineered.2022; 13(4): 9264.     CrossRef
  • Quality of life changes in elderly patients after gastrectomy: perspective of an aged Asian society in the 2010s
    Ji Hyun Jung, Seung Soo Lee, Ho Young Chung
    Annals of Surgical Treatment and Research.2022; 102(4): 214.     CrossRef
  • Deep-Learning-Based Automatic Detection and Segmentation of Brain Metastases with Small Volume for Stereotactic Ablative Radiotherapy
    Sang Kyun Yoo, Tae Hyung Kim, Jaehee Chun, Byong Su Choi, Hojin Kim, Sejung Yang, Hong In Yoon, Jin Sung Kim
    Cancers.2022; 14(10): 2555.     CrossRef
  • PD-L1 Expression and Overall Survival in Asian and Western Patients with Gastric Cancer
    Sun Young Rha, Geoffrey Y Ku, Hyo Song Kim, Hyun Cheol Chung, Fatemeh Ghazanfari Amlashi, Dipen Maheshbhai Maru, Carly A Fein, Laura H Tang, Wei Zhou, Ting Wu, Senaka A Peter, David P Kelsen, Jaffer A Ajani
    Future Oncology.2022; 18(21): 2623.     CrossRef
  • Lung Cancer Patients’ Characteristics and Comorbidities Using the Korean National Hospital Discharge In-depth Injury Survey Data
    Kyunghee Lee, Sunghong Kang, Jieun Hwang
    Journal of Epidemiology and Global Health.2022; 12(3): 258.     CrossRef
  • Estimation of Utility Weights for Prostate-related Health States in Korea
    Seon-Ha Kim, Minsu Ock, Min-Woo Jo, Sungchan Park
    Journal of Preventive Medicine and Public Health.2022; 55(3): 243.     CrossRef
  • Induction of the BRAFV600E Mutation in Thyroid Cells Leads to Frequent Hypermethylation
    Jin Wook Yi, Seong Yun Ha, Hyeon-Gun Jee, Kwangsoo Kim, Su-jin Kim, Young Jun Chai, June Young Choi, Kyu Eun Lee
    Clinical and Experimental Otorhinolaryngology.2022; 15(3): 273.     CrossRef
  • Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness
    Moamen Shalkamy Abdelgawaad Shalkamy, Jung Hoon Bae, Chul Seung Lee, Seung Rim Han, Ji Hoon Kim, Bong-Hyeon Kye, In Kyu Lee, Yoon Suk Lee
    Journal of Minimally Invasive Surgery.2022; 25(2): 53.     CrossRef
  • Relationship between Health Behaviors and Metabolic Syndrome in Cancer Survivors in Korea: Korean National Health and Nutrition Examination Survey, 2013–2018
    Nayoung Kim, Seohwan Kim, Bong Gyu Choi, Yong Uk Ko, Kyoung ah Park
    Korean Journal of Family Practice.2022; 12(3): 144.     CrossRef
  • Clinicopathologic characteristics and survival of patients with double primary malignancies: breast and colorectal cancer
    Hyundo Lee, Hae Won Lee, Eun Jung Park, Jeonghyun Kang, Seung Hyuk Baik
    Annals of Coloproctology.2022; 38(3): 197.     CrossRef
  • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
    Juhee Park, Kyeongjun Moon, Dong-Sook Kim
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea
    Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman
    Journal of Drug Assessment.2022; 11(1): 12.     CrossRef
  • MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression
    Shihyun Kim, Suyeon Park, Ji-Hyeon Oh, Sang Shin Lee, Yoon Lee, Jongho Choi
    BMC Oral Health.2022;[Epub]     CrossRef
  • Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
    Song Yi Park, Koung Jin Suh, Dae-Won Lee, Han Suk Ryu, Miso Kim, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Jee Hyun Kim, In Ae Park, Seock-Ah Im
    Breast Cancer Research and Treatment.2022; 196(1): 121.     CrossRef
  • The Role of Serum CD26 in the Diagnosis of Gastric Cancer
    Ju Yup Lee, Mae-Ja Park
    International Journal of General Medicine.2022; Volume 15: 7179.     CrossRef
  • Radiomics Nomogram: Prediction of 2-Year Disease-Free Survival in Young Age Breast Cancer
    Jeongmin Lee, Sung Hun Kim, Yelin Kim, Jaewoo Park, Ga Eun Park, Bong Joo Kang
    Cancers.2022; 14(18): 4461.     CrossRef
  • Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target
    Hyeok Ahn, Kyungchan Min, Eulgi Lee, Hyun Kim, Sujeong Kim, Yunjae Kim, Gihyeon Kim, Beomki Cho, Chanyeong Jeong, Yeongmin Kim, Hansoo Park
    Microorganisms.2022; 10(10): 1896.     CrossRef
  • Validity and reproducibility of a food frequency questionnaire for breast cancer survivors in Korea
    Sang-Eun Moon, Woo-kyoung Shin, Sihan Song, Dahye Koh, Jeong Sun Ahn, Youngbum Yoo, Minji Kang, Jung Eun Lee
    Nutrition Research and Practice.2022; 16(6): 789.     CrossRef
  • Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
    Sujeong Shin, Dong Wook Shin, In Young Cho, Su-Min Jeong, Hyein Jung
    European Journal of Preventive Cardiology.2021; 28(8): 864.     CrossRef
  • Development of all-in-one phantom dosimeter to measure multidimensional dose distribution for 60Co radiotherapy unit
    Hyun Young Shin, Jin Ho Kim, Si Won Song, Jinhong Kim, Bongsoo Lee, Joohyun Moon, Cheol Ho Pyeon
    Journal of the Korean Physical Society.2021; 78(9): 829.     CrossRef
  • Korean college students’ attitudes and health behaviour regarding human papillomavirus vaccination
    Sun Young Kim, Ju Won Seo, Eunjung Ryu
    Collegian.2021; 28(1): 57.     CrossRef
  • Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study
    Byung-Woo Yoo, Sang-Won Lee, Jason Jungsik Song, Yong-Beom Park, Seung Min Jung
    Clinical Rheumatology.2021; 40(4): 1423.     CrossRef
  • Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis
    Sang Mee Hwang, Haejin Ahn, Seungah Jeon, Jun Park, Yunye Chang, Hyungsuk Kim
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases
    Yihao Liu, Fenghua Lai, Jianyan Long, Sui Peng, Haibo Wang, Qian Zhou, Bin Li, Lei Su, Lanxia Gan, Ying Shi, Weiming Lv, Yanbing Li, Karkeung Cheng, Haipeng Xiao
    International Journal of Cancer.2021; 148(5): 1106.     CrossRef
  • Diagnostic Performance of Ultrasound Computer-Aided Diagnosis Software Compared with That of Radiologists with Different Levels of Expertise for Thyroid Malignancy: A Multicenter Prospective Study
    Feng-Ying Ye, Guo-Rong Lyu, Shang-Qing Li, Jian-Hong You, Kang-Jian Wang, Ming-Li Cai, Qi-Chen Su
    Ultrasound in Medicine & Biology.2021; 47(1): 114.     CrossRef
  • Cancer frequency among the patients with myotonic dystrophy in the South Korean population using the national health insurance database
    Jin-Sung Park, Donghwi Park, Jin-Mo Park
    Journal of the Neurological Sciences.2021; 420: 117212.     CrossRef
  • Sarcopenic obesity and 10‐year cardiovascular disease risk scores in cancer survivors and non‐cancer participants using a nationwide survey
    Kayoung Lee
    European Journal of Cancer Care.2021;[Epub]     CrossRef
  • The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer
    Yeon Joo Kim, Su Ssan Kim, Seung Do Ahn, Jinhong Jung, Sei‐Hyun Ahn, Byung Ho Son, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko, Sung‐Bae Kim, Kyung Hae Jung, Jin‐Hee Ahn, Jeong Eun Kim, Eun Kyung Choi
    Asia-Pacific Journal of Clinical Oncology.2021; 17(6): 495.     CrossRef
  • p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
    Hyun Joo Bae, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Sejung Park, Tae Soo Kim, Kyoo Hyun Kim, Hyunki Kim, Hei-Cheul Jeong, Hyun Cheol Chung, Sun Young Rha
    Biochemical Pharmacology.2021; 183: 114320.     CrossRef
  • Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
    Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo
    The World Journal of Men's Health.2021; 39(1): 158.     CrossRef
  • Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis
    Seung Wook Hong, Won-Mook Choi, Ha Won Hwang, Dae Sung Kim, Jiyoung Yoon, Jin Wook Lee, Ju Hyun Shim, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Digestive Diseases and Sciences.2021; 66(11): 3715.     CrossRef
  • Translation and validation of the Korean version of the clinical frailty scale in older patients
    Ryoung-Eun Ko, Seong Mi Moon, Danbee Kang, Juhee Cho, Chi Ryang Chung, Yunhwan Lee, Yun Soo Hong, So Hee Lee, Jung Hee Lee, Gee Young Suh
    BMC Geriatrics.2021;[Epub]     CrossRef
  • Dehydroabietic acid inhibits the gastric cancer cell growth via induced apoptosis and cell cycle arrest
    Won-Jin Kim, Hyeon-Gu Kang, Seok-Jun Kim
    Molecular & Cellular Toxicology.2021; 17(2): 133.     CrossRef
  • Factors Associated with the Quality of Life of Patients with Cancer Undergoing Radiotherapy
    Ki Ho Seol, Su Hyun Bong, Dae Hun Kang, Jun Won Kim
    Psychiatry Investigation.2021; 18(1): 80.     CrossRef
  • Diagnostic value of combining tumor and inflammatory biomarkers in detecting common cancers in Korea
    Young Sun Kim, Kyung Nam Kang, Yong Sung Shin, Ji Eun Lee, Ji Young Jang, Chul Woo Kim
    Clinica Chimica Acta.2021; 516: 169.     CrossRef
  • Physical activity of Korean cancer survivors is associated with age and sex
    Jae Hyeon Park, Jung Soo Lee, Yoon Ho Ko, Yeo Hyung Kim
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S225.     CrossRef
  • Risk factors of advanced metachronous neoplasms in surveillance after colon cancer resection
    Kwangwoo Nam, Jeong Eun Shin
    The Korean Journal of Internal Medicine.2021; 36(2): 305.     CrossRef
  • Sex difference in bowel preparation quality and colonoscopy time
    Young-Jae Hwang, Dong Woo Shin, Nayoung Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee
    The Korean Journal of Internal Medicine.2021; 36(2): 322.     CrossRef
  • The negative correlation between miR-140-3-p and Metadherin gene in estrogen and progesterone receptor positive–breast cancer
    Mai Mohamed Nabil, Maha Imam Ahmed, Muneera Al-Sheeha, Walaa Ahmed Yousry, Dalia Abdel Wahab Mohamed
    Gene Reports.2021; 23: 101068.     CrossRef
  • Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
    Wonkyo Shin, Sanghee Lee, Myong Cheol Lim, Jipmin Jung, Hak Jin Kim, Hyunsoon Cho
    Cancer Medicine.2021; 10(6): 2045.     CrossRef
  • Adherence to follow-up examination after positive fecal occult blood test results affects colorectal cancer mortality: A Korea population-based cohort study
    Yu Jin Kim, Jeong-Im Shim, Eunjung Park, Minjoo Kang, Sinhee Kang, Jessie Lee, Ha Jin Tchoe, Kyeong Ae Kong, Duk Hwan Kim, Byung Chang Kim, Kui Son Choi, Chang Mo Moon
    Digestive and Liver Disease.2021; 53(5): 631.     CrossRef
  • Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer
    Eun Jung Jung, Ju-Yeon Kim, Jae-Myung Kim, Han Shin Lee, Seung-Jin Kwag, Ji-Ho Park, Taejin Park, Sang-Ho Jeong, Chi-Young Jeong, Young-Tae Ju, Young-Joon Lee, Soon-Chang Hong
    Medicine.2021; 100(11): e25000.     CrossRef
  • Diagnosis and Clinical Management of Esophageal Squamous Dysplasia
    Gwang Ha Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 4.     CrossRef
  • The Effects of Simultaneous Pulmonary Rehabilitation during Thoracic Radiotherapy in the Treatment of Malignant Diseases
    Myeong Geun Choi, Hyang Yi Lee, Si Yeol Song, Su Ssan Kim, Seung Hak Lee, Won Kim, Chang-Min Choi, Sei Won Lee
    Tuberculosis and Respiratory Diseases.2021; 84(2): 148.     CrossRef
  • Outcomes of extracorporeal membrane oxygenation in adults with active hematologic and nonhematologic malignancy
    Chul Park, Ui Won Ko, Ryoung‐Eun Ko, Soo Jin Na, Jeong Hoon Yang, Kyeongman Jeon, Gee Young Suh, Kiick Sung, Yang Hyun Cho
    Artificial Organs.2021;[Epub]     CrossRef
  • Comparison of CT Volumetry and RECIST to Predict the Treatment Response and Overall Survival in Gastric Cancer Liver Metastases
    Sung Hyun Yu, Seung Joon Choi, HeeYeon Noh, In seon Lee, So Hyun Park, Se Jong Kim
    Journal of the Korean Society of Radiology.2021; 82(4): 876.     CrossRef
  • Disparities in Liver Cancer Surveillance Among People With Disabilities
    Jae Youn Seo, Dong Wook Shin, Su Jong Yu, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
    Journal of Clinical Gastroenterology.2021; 55(5): 439.     CrossRef
  • Population Attributable Fraction of Established Modifiable Risk Factors on Colorectal Cancer in Korea
    Sooyoung Cho, Aesun Shin
    Cancer Research and Treatment.2021; 53(2): 480.     CrossRef
  • Recent Trends in Opioid Prescription in Cancer Patients in Korea
    Jihyun Yoon, Hyeong-Seop Kim, Jae-Woo Lee, Joungyoun Kim, Hee-Taik Kang
    Korean Journal of Family Practice.2021; 11(2): 142.     CrossRef
  • Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
    Young-Il Kim, Young Ae Kim, Hak Jin Kim, Su-Hyun Kim, Yul Hwangbo, Jae Gyu Kim, Jae J. Kim, Il Ju Choi
    The Korean Journal of Internal Medicine.2021; 36(3): 584.     CrossRef
  • Worldwide trend in human papillomavirus–attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030
    Jie Wu, Fenqiang Xiao, Yang Zheng, Yushi Lin, Hong‐Liang Wang
    Cancer.2021; 127(17): 3172.     CrossRef
  • Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
    Myunhee Lee, Woo‐Baek Chung, Ji‐eun Lee, Chan‐Seok Park, Woo‐Chan Park, Byung‐Joo Song, Ho‐Joong Youn
    Cancer Medicine.2021; 10(12): 3964.     CrossRef
  • Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
    Yun-Suk Choi, Seong-Woon Choi, Jin-Wook Yi
    Journal of Clinical Medicine.2021; 10(10): 2179.     CrossRef
  • Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
    Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
    Disability and Health Journal.2021; 14(4): 101125.     CrossRef
  • Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines
    Koeun Lee, Kyung Won Kim, Yousun Ko, Ho Young Park, Eun Jin Chae, Jeong Hyun Lee, Jin-Sook Ryu, Hye Won Chung
    Korean Journal of Radiology.2021; 22(9): 1497.     CrossRef
  • Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program
    Cam Nhung Bui, Seri Hong, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi
    Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
  • Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea
    Young Ae Kim, Min Soo Yang, Minae Park, Min Gee Choi, So Young Kim, Yeon-Joo Kim
    Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
  • Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
    Yujun Park, An Na Seo, Jiwon Koh, Soo Kyoung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
    OncoImmunology.2021;[Epub]     CrossRef
  • Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
    Hyun Jin Roh, Hyung Joon Yoon, Dae Hoon Jeong, Tae Hwa Lee, Byung Su Kwon, Dong Soo Suh, Ki Hyung Kim
    Journal of Research in Medical Sciences.2021; 26(1): 48.     CrossRef
  • Descriptive epidemiology of cancer of unknown primary in South Korea, 1999–2017
    Yoo-Kyung Boo, Dayeon Park, Jiwon Lim, Hyun-Sook Lim, Young-Joo Won
    Cancer Epidemiology.2021; 74: 102000.     CrossRef
  • Survival and Death Causes in Thyroid Cancer in Taiwan: A Nationwide Case–Control Cohort Study
    Yu-Ling Lu, Shu-Fu Lin, Ming-Hsien Wu, Yi-Yin Lee, Pai-Wei Lee, Shang-Hung Chang, Yu-Tung Huang
    Cancers.2021; 13(16): 3955.     CrossRef
  • Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
    Hye Yeon Koo, Su-Min Jeong, Mi Hee Cho, Sohyun Chun, Dong Wook Shin, Jinsung Park
    Scientific Reports.2021;[Epub]     CrossRef
  • Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study
    Kwang-Sig Lee, Jin-Young Jang, Young-Dong Yu, Jin Seok Heo, Ho-Seong Han, Yoo-Seok Yoon, Chang Moo Kang, Ho Kyoung Hwang, Sunghwa Kang
    International Journal of Surgery.2021; 93: 106050.     CrossRef
  • Increasing Mortality in Korean Patients With Breast Cancer: High Mortality Rate in Elderly Breast Cancer Population Due to Suboptimal Treatment and Other Diseases
    Hyangsuk Choi, Hany Noh, Kwang-Min Kim, In-Jeong Cho, Seungtaek Lim, Airi Han
    Cancer Control.2021;[Epub]     CrossRef
  • Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial
    Kenshi Suzuki, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Hirohiko Shibayama, Po-Shen Ko, Shang-Yi Huang, Sin-Syue Li, Bifeng Ding, Monica Khurana, Shinsuke Iida
    International Journal of Hematology.2021; 114(6): 653.     CrossRef
  • Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
    Sung Eun Oh, Mi Yun Oh, Ji Yeong An, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Min-Gew Choi, Kyoung-Mee Kim
    Pathology and Oncology Research.2021;[Epub]     CrossRef
  • Clinical impact of follow‐up imaging on mortality in Korean breast cancer patients: A national cohort study
    So‐Youn Jung, Young Ae Kim, Dong‐Eun Lee, Jungnam Joo, Joung Hwan Back, Sun‐Young Kong, Eun Sook Lee
    Cancer Medicine.2021; 10(18): 6480.     CrossRef
  • Development of Population-Based Cancer Indicators and a Measurement of Cancer Care Continuum Using a Modified Delphi Method
    Vasuki Rajaguru, Jieun Jang, JaeHyun Kim, JeoungA Kwon, Oyeon Cho, SeungYeun Chung, MiSun Ahn, JinHee Park, YoungJoo Won, KyuWon Jung, Jaeyong Shin, Mison Chun
    Cancers.2021; 13(19): 4826.     CrossRef
  • JAK2 regulates paclitaxel resistance in triple negative breast cancers
    Jongmin Han, Jihui Yun, Mingji Quan, Wonyoung Kang, Ji-Gwang Jung, Woohang Heo, Songbin Li, Kyu Jin Lee, Hye-Youn Son, Ju Hee Kim, Jaeyong Choi, Dong-Young Noh, Deukchae Na, Han Suk Ryu, Charles Lee, Jong-Il Kim, Hyeong-Gon Moon
    Journal of Molecular Medicine.2021; 99(12): 1783.     CrossRef
  • Evaluation of a Targeted Next-generation Sequencing Assay for BRCA Mutation Screening in Clinical Samples
    Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
    Laboratory Medicine Online.2021; 11(4): 283.     CrossRef
  • Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection
    Hye-Sol Jung, Seung-Bum Ryoo, Han-Ki Lim, Min Jung Kim, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    Cancers.2021; 13(21): 5294.     CrossRef
  • Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor
    Tjahjadi Robert Tedjasaputra, Mochammad Hatta, Muh Nasrum Massi, Rosdiana Natzir, Agussalim Bukhari, Rina Masadah, Muh Lutfi Parewangi, Prihantono Prihantono, Rinda Nariswati, Vincent Tedjasaputra
    World Journal of Gastrointestinal Pathophysiology.2021; 12(6): 130.     CrossRef
  • Extended application of a CT-based artificial intelligence prognostication model in patients with primary lung cancer undergoing stereotactic ablative radiotherapy
    Hyungjin Kim, Joo Ho Lee, Hak Jae Kim, Chang Min Park, Hong-Gyun Wu, Jin Mo Goo
    Radiotherapy and Oncology.2021; 165: 166.     CrossRef
  • Prediction of hereditary nonpolyposis colorectal cancer using mRNA MSH2 quantitative and the correlation with nonmodifiable factor
    Tjahjadi Robert Tedjasaputra, Mochammad Hatta, Muh Nasrum Massi, Rosdiana Natzir, Agussalim Bukhari, Rina Masadah, Muh Lutfi Parewangi, Prihantono Prihantono, Rinda Nariswati, Vincent Tedjasaputra
    World Journal of Gastrointestinal Pathophysiology.2021; 12(6): 134.     CrossRef
  • Interplay of Threat, Efficacy, and Uncertainty in Cancer News Coverage: Analysis of News Content and Effects in South Korea
    Minsun Shim, Yong-Chan Kim, Keeho Park
    Asian Communication Research.2021; 18(3): 131.     CrossRef
  • Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
    Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
    Cancer Control.2021;[Epub]     CrossRef
  • Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
    Kyungchan Min, Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae Gyun Kwon, Sung Kwang Chung, Masatoshi Tanaka, Shin Egawa, Takahiro Kimura, Seock Hwan Choi
    The World Journal of Men's Health.2020; 38(2): 226.     CrossRef
  • Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer
    Kyung-Lak Son, Dooyoung Jung, Kwang-Min Lee, Heesung Hwang, JooYoung Lee, Tae-Yong Kim, Seock-Ah Im, Kyung-Hun Lee, David Spiegel, Bong-Jin Hahm
    Supportive Care in Cancer.2020; 28(3): 1351.     CrossRef
  • Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
    Dong-Hoe Koo, Kyung-Do Han, Hong Joo Kim, Cheol-Young Park
    Acta Diabetologica.2020; 57(2): 197.     CrossRef
  • Coping style at diagnosis and its association with subsequent health-related quality of life in women with breast cancer: A 3-year follow-up study
    Young Up Cho, Bo Gyeong Lee, Soo Hyun Kim
    European Journal of Oncology Nursing.2020; 45: 101726.     CrossRef
  • Disease-Specific Mortality and Prevalence Trends in Korea, 2002–2015
    Yoonhee Shin, Bomi Park, Hye Ah Lee, Bohyun Park, Hyejin Han, Eun Jeong Choi, Nam-eun Kim, Hyesook Park
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • The association between predicted inflammatory status and colorectal adenoma
    Sejin Kim, Sihan Song, Young Sun Kim, Sun Young Yang, Jung Eun Lee
    Scientific Reports.2020;[Epub]     CrossRef
  • Comparative Glycoproteomic Profiling of Human Body Fluid between Healthy Controls and Patients with Papillary Thyroid Carcinoma
    Yong Zhang, Wanjun Zhao, Yang Zhao, Yonghong Mao, Tao Su, Yi Zhong, Shisheng Wang, Rui Zhai, Jingqiu Cheng, Xiang Fang, Jingqiang Zhu, Hao Yang
    Journal of Proteome Research.2020; 19(7): 2539.     CrossRef
  • Nineteen-year trends in fermented food consumption and sodium intake from fermented foods for Korean adults from 1998 to 2016
    Sang Young Kim, Jeanne H Freeland-Graves, Hyun Ja Kim
    Public Health Nutrition.2020; 23(3): 515.     CrossRef
  • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
    Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
    Annals of Global Health.2020; 86(1): 2.     CrossRef
  • Effect of Digital Mammography for Breast Cancer Screening: A Comparative Study of More than 8 Million Korean Women
    Seri Hong, Soo Yeon Song, Boyoung Park, Mina Suh, Kui Son Choi, Seung Eun Jung, Min Jung Kim, Eun Hye Lee, Chan Wha Lee, Jae Kwan Jun
    Radiology.2020; 294(2): 247.     CrossRef
  • Practice patterns of multidisciplinary team meetings in Korean cancer care and patient satisfaction with this approach
    Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Seungtaek Lim, Bong-Seog Kim, Do Yeun Kim
    The Korean Journal of Internal Medicine.2020; 35(1): 205.     CrossRef
  • Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea
    Dong Wook Shin, Jonghan Yu, Juhee Cho, Se Kyung Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Jung Eun Yoo, Kyoung Eun Yeob, Yeon Yong Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
    Cancer.2020; 126(7): 1522.     CrossRef
  • Factors influencing supportive care needs of multiple myeloma patients treated with chemotherapy
    Yoo-Rin Cho, Yang-Sook Yoo
    Supportive Care in Cancer.2020; 28(4): 1783.     CrossRef
  • Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
    YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
    Gastric Cancer.2020; 23(3): 497.     CrossRef
  • Identification of Korean cancer survivors’ unmet needs and desired psychosocial assistance: A focus group study
    Joo Young Kim, Mison Chun, Sang-Won Kim, Joonsup Song, Rosemary Frey
    PLOS ONE.2020; 15(1): e0228054.     CrossRef
  • Prospective evaluation of clinical symptoms of chemotherapy‐induced oral mucositis in adult patients with acute leukemia: A preliminary study
    Yeon‐Hee Lee, Junshik Hong, Inho Kim, Youngnim Choi, Hee‐Kyung Park
    Clinical and Experimental Dental Research.2020; 6(1): 90.     CrossRef
  • Analysis of Prognosis according to Type of Health Insurance in Five Major Gastrointestinal Cancer Patients in Public Hospitals: Single-institution Retrospective Study
    Dong Seok Lee, Jaekyung Lee, Ji Won Kim, Kook Lae Lee, Byeong Gwan Kim, Su Hwan Kim, Yong Jin Jung
    The Korean Journal of Gastroenterology.2020; 75(1): 17.     CrossRef
  • Prognostic Performance of Preoperative Staging: Assessed by Using Multidetector Computed Tomography—Between the New Clinical Classification and the Pathological Classification in the Eighth American Joint Committee on Cancer Classification for Gastric Car
    Oh Jeong, Mi Ran Jung, Ji Hoon Kang, Seong Yeob Ryu
    Annals of Surgical Oncology.2020; 27(2): 545.     CrossRef
  • Endoscopic submucosal dissection for superficial esophageal neoplasms in elderly patients: A single‐center, large‐scale, retrospective study
    Jin Hee Noh, Eun Jeong Gong, Do Hoon Kim, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung
    Geriatrics & Gerontology International.2020; 20(5): 430.     CrossRef
  • National screening programs for cervical cancer in Asian countries
    Eiko Saitoh Aoki, Rutie Yin, Kemin Li, Neerja Bhatla, Seema Singhal, Dwiana Ocviyanti, Kumiko Saika, Mina Suh, Miseon Kim, Wichai Termrungruanglert
    Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
  • Trends in Influenza Vaccination Coverage Rates among Korean Cancer Survivors: Analysis of the Korea National Health and Nutrition Examination Survey III–VI
    Ye-Seul Kim, Jae-woo Lee, Hee-Taik Kang, Yonghwan Kim, Hyo-Sun You
    Korean Journal of Family Medicine.2020; 41(1): 45.     CrossRef
  • Descriptive analysis of prevalence and medical expenses of cancer, cardio-cerebrovascular disease, psychiatric disease, and musculoskeletal disease in Korean firefighters
    Jeehee Min, Yangwoo Kim, Hye Sim Kim, Jiyoung Han, Inah Kim, Jaechul Song, Sang-Baek Koh, Tae-Won Jang
    Annals of Occupational and Environmental Medicine.2020;[Epub]     CrossRef
  • Dietary mercury intake and colorectal cancer risk: A case-control study
    Hyejin Kim, Jeonghee Lee, Hae Dong Woo, Dong Woo Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Clinical Nutrition.2020; 39(7): 2106.     CrossRef
  • The association of physical function and quality of life on physical activity for non-small cell lung cancer survivors
    Ji Sung Yoo, Hee Chul Yang, Jong Mog Lee, Moon Soo Kim, Eun-Cheol Park, Seung Hyun Chung
    Supportive Care in Cancer.2020; 28(10): 4847.     CrossRef
  • Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism
    Jooyeon Lee, Namki Hong, Byung Moon Kim, Dong Joon Kim, Mijin Yun, Jong Ju Jeong, Yumie Rhee
    Journal of Bone and Mineral Metabolism.2020; 38(4): 570.     CrossRef
  • Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors
    Naru Kim, In Woong Han, Youngju Ryu, Dae Wook Hwang, Jin Seok Heo, Dong Wook Choi, Sang Hyun Shin
    Cancers.2020; 12(1): 137.     CrossRef
  • Unexpected Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: a Contraindication to Resection?
    Ji Su Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
    Journal of Gastrointestinal Surgery.2020; 24(12): 2789.     CrossRef
  • Comparison of liquid-based cytology with conventional smear cytology for EUS-guided FNA of solid pancreatic masses: a prospective randomized noninferiority study
    Jung Won Chun, Kyoungbun Lee, Sang Hyub Lee, Haeryoung Kim, Min Su You, Yoon Jung Hwang, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
    Gastrointestinal Endoscopy.2020; 91(4): 837.     CrossRef
  • Thyroid cancer: incidence and mortality trends in China, 2005–2015
    Junyi Wang, Fangfang Yu, Yanna Shang, Zhiguang Ping, Li Liu
    Endocrine.2020; 68(1): 163.     CrossRef
  • High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
    Tae-Wook Kong, Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong
    Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
  • Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component
    Hyungjin Kim, Jin Mo Goo, Young Tae Kim, Chang Min Park
    Journal of Thoracic Oncology.2020; 15(4): 580.     CrossRef
  • The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study
    Jihyun Kwon, So Young Kim, Kyoung Eun Yeob, Hye Sook Han, Ki Hyeong Lee, Dong Wook Shin, Yeon-Yong Kim, Jong Heon Park, Jong Hyock Park
    Cancer Research and Treatment.2020; 52(1): 1.     CrossRef
  • Trajectories of health-related quality of life in breast cancer patients
    Jin-Hee Park, Yong Sik Jung, Ji Young Kim, Yujung Jo, Sun Hyoung Bae
    Supportive Care in Cancer.2020; 28(7): 3381.     CrossRef
  • Family History of Gastric Cancer and Helicobacter pylori Treatment
    Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Young-Il Kim, Myeong-Cherl Kook, Boram Park, Jungnam Joo
    New England Journal of Medicine.2020; 382(5): 427.     CrossRef
  • Long-term Oncologic Outcome and Its Relevant Factors in Anal Cancer in Korea: A Nationwide Data Analysis
    Hyuk Hur, Kyu-Won Jung, Byung-Woo Kim, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
    Annals of Coloproctology.2020; 36(1): 35.     CrossRef
  • Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea
    Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jongchan Lee, Young Soo Park, Nayoung Kim
    Hepatobiliary & Pancreatic Diseases International.2020; 19(6): 575.     CrossRef
  • Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
    Sun Tae Hwang, Jae-Young Um, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Kwang Seok Ahn
    Molecules.2020; 25(6): 1320.     CrossRef
  • Epstein–Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas
    Chan Jin Yoon, Mee Soo Chang, Dong Ha Kim, Won Kim, Bo Kyung Koo, Sung-Cheol Yun, Sung Han Kim, Yang Soo Kim, Jun Hee Woo
    Gastric Cancer.2020; 23(5): 780.     CrossRef
  • Korean National Lung Cancer Screening
    Seung Hun Jang
    The Korean Journal of Medicine.2020; 95(2): 95.     CrossRef
  • Minimally invasive complete mesocolic excision for right colon cancer
    Hyunmi Park, Tae‐Hoon Lee, Seon‐Hahn Kim
    Annals of Gastroenterological Surgery.2020; 4(3): 234.     CrossRef
  • Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk


    Jang Hee Hong, Eun-Heui Jin, In Ae Chang, Hyojin Kang, Sang-Il Lee, Jae Kyu Sung
    Pharmacogenomics and Personalized Medicine.2020; Volume 13: 121.     CrossRef
  • Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients
    Hye-Kyung Jung, Chung Hyun Tae, Hye-Ah Lee, Hyuk Lee, Kee Don Choi, Jun Chul Park, Joong Goo Kwon, Yoon Jin Choi, Su Jin Hong, Jaekyu Sung, Woo Chul Chung, Ki Bae Kim, Seung Young Kim, Kyung Ho Song, Kyung Sik Park, Seong Woo Jeon, Byung-Wook Kim, Han Seu
    PLOS ONE.2020; 15(4): e0231456.     CrossRef
  • Impact of Onset of Psychiatric Disorders and Psychiatric Treatment on Mortality Among Patients with Cancer
    Sang Ah Lee, Chung Mo Nam, Young Hoon Kim, Tae Hyun Kim, Sung-In Jang, Eun-Cheol Park
    The Oncologist.2020; 25(4): e733.     CrossRef
  • Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
    Jeong Il Yu, Hee Chul Park, Jeeyun Lee, Changhoon Choi, Won Ki Kang, Se Hoon Park, Seung Tae Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Kyoung-Mee Kim, Heewon Han, Kyunga Kim, Sung Kim, Do Hoon Lim
    Cancers.2020; 12(4): 943.     CrossRef
  • Comparison of subjective quality of life after endoscopic submucosal resection or surgery for early gastric cancer
    Chung Hyun Tae, Ki-Nam Shim, Byung-Wook Kim, Jie-Hyun Kim, Su Jin Hong, Gwang Ho Baik, Hyun Joo Song, Yong Sung Kim, Seung-Ho Jang, Hye-Kyung Jung
    Scientific Reports.2020;[Epub]     CrossRef
  • Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors
    Sun Geun Yun, Yeong Yi An, Sung Hun Kim, Bong Joo Kang
    Journal of the Korean Society of Radiology.2020; 81(2): 395.     CrossRef
  • Establishment and characterization of 18 human colorectal cancer cell lines
    Soon-Chan Kim, Hyun-Soo Kim, Jae Hyeon Kim, Nahyun Jeong, Young-Kyoung Shin, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Ja-Lok Ku
    Scientific Reports.2020;[Epub]     CrossRef
  • Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
    Melina Arnold, Jin Young Park, M Constanza Camargo, Nuno Lunet, David Forman, Isabelle Soerjomataram
    Gut.2020; 69(5): 823.     CrossRef
  • Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases
    Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee
    Journal of Cancer Research and Clinical Oncology.2020; 146(9): 2399.     CrossRef
  • Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters
    Jeongmin Lee, Sung Hun Kim, Bong Joo Kang
    Scientific Reports.2020;[Epub]     CrossRef
  • Recent Advances in Combinatorial Cancer Therapy Via Multifunctionalized Gold Nanoparticles
    Touqeer Ahmad, Rizwana Sarwar, Ayesha Iqbal, Uzma Bashir, Umar Farooq, Sobia Ahsan Halim, Ajmal Khan, Ahmed Al-Harrasi
    Nanomedicine.2020; 15(12): 1221.     CrossRef
  • Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017
    Lixia Lou, Linyan Wang, Yaoyi Zhang, Guofeng Chen, Lele Lin, Xiaoli Jin, Yi Huang, Jian Chen
    BMJ Open.2020; 10(1): e033323.     CrossRef
  • Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?
    Huapyong Kang, Seung-seob Kim, Min Je Sung, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Mi-Suk Park, Seungmin Bang
    Pancreatology.2020; 20(5): 952.     CrossRef
  • Differences in Factors Affecting the Quality of Life Over Time After the Gastrectomy in Patients With Stage I Gastric Cancer
    Kyung Eun Lee, Kyung Hee Lim
    Gastroenterology Nursing.2020; 43(3): 241.     CrossRef
  • Age-Standardized Breast Cancer Detection Rates of Breast Cancer Screening Program by Age Group in Korea; Comparison with Age-Standardized Incidence Rates from the Korea Central Cancer Registry
    Miye Kim, Hyeongsu Kim, Heejung Choi, MiSeon Son, Kun-Sei Lee, Tae-Hwa Han, Sollip Kim
    Healthcare.2020; 8(2): 132.     CrossRef
  • Robotics Total Mesorectal Excision Up To the Minute
    Homoud Alawfi, Ho Seung Kim, Seung Yoon Yang, Nam Kyu Kim
    Indian Journal of Surgical Oncology.2020; 11(4): 552.     CrossRef
  • Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging
    Sung Eun Oh, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae
    European Journal of Surgical Oncology.2020; 46(12): 2236.     CrossRef
  • The Incidence and Management Trends of Metastatic Spinal Tumors in South Korea
    Sung Hoon Choi, Ja Wook Koo, DaeHyun Choe, Chang-Nam Kang
    Spine.2020; 45(14): E856.     CrossRef
  • The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning
    Jin-ah Sim, Young Ae Kim, Ju Han Kim, Jong Mog Lee, Moon Soo Kim, Young Mog Shim, Jae Ill Zo, Young Ho Yun
    Scientific Reports.2020;[Epub]     CrossRef
  • Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans
    Jung Hyun Kwak, Jean Kyung Paik
    Nutrients.2020; 12(7): 2004.     CrossRef
  • Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea
    Jungho Kim, Sunyoung Park, Dasom Hwang, Seung Il Kim, Hyeyoung Lee
    Medicina.2020; 56(7): 340.     CrossRef
  • Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
    Jee Suk Chang, Nalee Kim, Ji-Ye Kim, Sung-Im Do, Yeona Cho, Hyun-Soo Kim, Yong Bae Kim
    Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
  • Analysis of Tumor Size between Imaging of Preoperative Ultrasound, MRI and Pathologic Measurements in Early Breast Carcinoma
    Eun Hyeok Kim, Chan Gyun Park, Eun Hye Choi, Ye Jeong Kim, Mi Jin Kim, Kyu Dam Han, Young Sam Park, Cheol Seung Kim, Kyun Hui No, Eun Ae Yu, Gyeong Gyun Na
    Journal of Breast Disease.2020; 8(1): 19.     CrossRef
  • Operation Experiences of Women with Breast Cancer
    Hyeon-Young Kim, Sun Hwa Shin
    Journal of Korean Academy of Fundamentals of Nursing.2020; 27(2): 129.     CrossRef
  • Public Attitudes towards Cancer Survivors among Korean Adults
    Su Yeon Kye, Hyun Jeong Lee, Yeonseung Lee, Young Ae Kim
    Cancer Research and Treatment.2020; 52(3): 722.     CrossRef
  • Cancer Mortality Trends in Spain (2000–2016): Differences between Immigrant and Native Populations
    Adriana Oliva-Arocas, Pamela Pereyra-Zamora, José M. Copete, Andreu Nolasco
    International Journal of Environmental Research and Public Health.2020; 17(14): 5127.     CrossRef
  • The Health Impact of, and access to, New Drugs in Korea
    Frank R. Lichtenberg
    East Asian Economic Review.2020; 24(2): 127.     CrossRef
  • Estimating the disease burden of lung cancer attributable to residential radon exposure in Korea during 2006–2015: A socio-economic approach
    Juhwan Noh, Heeseon Jang, Jaelim Cho, Dae Ryong Kang, Tae Hyun Kim, Dong Chun Shin, Changsoo Kim
    Science of The Total Environment.2020; 749: 141573.     CrossRef
  • Squamous cell carcinoma of head and neck: what internists should know
    Kyungsuk Jung, Manpreet Narwal, Seon Young Min, Bhumsuk Keam, Hyunseok Kang
    The Korean Journal of Internal Medicine.2020; 35(5): 1031.     CrossRef
  • FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
    Changhoon Yoo, Inhwan Hwang, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jae Ho Byun, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-pyo Kim, Song Che
    Therapeutic Advances in Medical Oncology.2020;[Epub]     CrossRef
  • Rhus verniciflua Stokes extract suppresses migration and invasion in human gastric adenocarcinoma AGS cells
    Hyun Sook Lee, Jae In Jung, Kyeong-Hee Kim, Sang Jae Park, Eun Ji Kim
    Nutrition Research and Practice.2020; 14(5): 463.     CrossRef
  • Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial


    A-Ra Cho, Won-Jun Choi, Yu-Jin Kwon, Hye Sun Lee, Sung Gwe Ahn, Ji-Won Lee
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3325.     CrossRef
  • Ultrasonographic evaluation of chronic shoulder pain after breast cancer surgery: single center, cross-sectional study
    Jung Hun Kim, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, So Young Yoon, Jung-Hyun Yang, Young Bum Yoo, Kyoung Sik Park, Sang Eun Nam, Semie Hong, Hong Ki Min
    Scientific Reports.2020;[Epub]     CrossRef
  • Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
    Hyoung Woo Kim, Dong Wook Shin, Kyoung Eun Yeob, In Young Cho, So Young Kim, Seon Mee Park, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
    Clinical and Translational Gastroenterology.2020; 11(10): e00242.     CrossRef
  • Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancer
    Jae W. Chung, Sang W. Kim, Ho W. Kang, Yun S. Ha, Seock H. Choi, Jun N. Lee, Bum S. Kim, Hyun T. Kim, Tae H. Kim, Ghil S. Yoon, Tae G. Kwon, Sung K. Chung, Eun S. Yoo
    Minerva Urologica e Nefrologica.2020;[Epub]     CrossRef
  • Personality Types as Predictors of Breast Cancer Screening Compliance in Korean Patients: A Mixed-Method Approach
    Kyungmin Kim, Eunhee Sohn, Hyo-Deog Rim, Seoyoung Jang, Jungmin Woo
    Psychiatry Investigation.2020; 17(11): 1079.     CrossRef
  • Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell Lines
    Wonjun Ji, Yun Jung Choi, Myoung-Hee Kang, Ki Jung Sung, Dong Ha Kim, Sangyong Jung, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho
    Cells.2020; 9(12): 2596.     CrossRef
  • Long-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric cancer-mimicking advanced gastric cancer
    Sung Eun Oh, Ji Yeong An, Min-Gew Choi, Tae Sung Sohn, Jae Moon Bae, Jun Ho Lee
    Medicine.2020; 99(49): e23441.     CrossRef
  • Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor–Immune Microenvironment in Colorectal Cancers
    Seung-Yeon Yoo, Hye Eun Park, Jung Ho Kim, Xianyu Wen, Seorin Jeong, Nam-Yun Cho, Hwang Gwan Gwon, Kwangsoo Kim, Hye Seung Lee, Seung-Yong Jeong, Kyu Joo Park, Sae-Won Han, Tae-You Kim, Jeong Mo Bae, Gyeong Hoon Kang
    Clinical Cancer Research.2020; 26(4): 870.     CrossRef
  • Obesity Has a Stronger Relationship with Colorectal Cancer in Postmenopausal Women than Premenopausal Women
    Ji Won Chang, Dong Wook Shin, Kyung Do Han, Keun Hye Jeon, Jung Eun Yoo, In Young Cho, Yun Jin Choi, Jung Yong Hong
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(11): 2277.     CrossRef
  • Sex Difference and Smoking Effect of Lung Cancer Incidence in Asian Population
    Boyoung Park, Yeol Kim, Jaeho Lee, Nayoung Lee, Seung Hun Jang
    Cancers.2020; 13(1): 113.     CrossRef
  • The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China
    Baojing Li, Hong Tang, Zilu Cheng, Yuxiao Zhang, Hao Xiang
    Frontiers in Public Health.2020;[Epub]     CrossRef
  • A New Strategy for Elimination of Human Paplloma Virus-related Disease after Human Papillomavirus Vaccines Introduction
    Yoo-Jin Park, Tae-Hee Kim, Hae-Hyeog Lee, Jun-Mo Kim
    Urogenital Tract Infection.2020; 15(3): 63.     CrossRef
  • Overview of Malignancy in Pregnancy
    Yung-Taek Ouh, Geum Joon Cho, Sunghun Na
    Perinatology.2020; 31(4): 161.     CrossRef
  • Comparison of survival outcomes according of patients with metastatic gastric cancer receiving trastuzumab with systemic chemotherapy
    Gi-Young Ha, Sung-Hyun Yang, Hye-Jin Kang, Hyo-Lak Lee, Jin Kim, Yun-Ju Kim, Hang-Jong Yu, Jong-Inn Lee, Sung-Ho Jin
    Korean Journal of Clinical Oncology.2020; 16(2): 63.     CrossRef
  • Association between perception of care coordination and health outcomes in Korean cancer survivors
    Jinyoung Shin, Dong Wook Shin, Jungkwon Lee, Ji Hye Hwang, Jung Eun Yoo, Hyeonyoung Ko, Yun-Mi Song
    Health and Quality of Life Outcomes.2020;[Epub]     CrossRef
  • The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression
    Jaebeom Cho, Hyo-Jong Lee, Su Jung Hwang, Hye-Young Min, Han Na Kang, A-Young Park, Seung Yeob Hyun, Jeong Yeon Sim, Ho Jin Lee, Hyun-Ji Jang, Young-Ah Suh, Sungyoul Hong, Young Kee Shin, Hye Ryun Kim, Ho-Young Lee
    Cancer Research.2020; 80(11): 2257.     CrossRef
  • Tumor Identification in Colorectal Histology Images Using a Convolutional Neural Network
    Hongjun Yoon, Joohyung Lee, Ji Eun Oh, Hong Rae Kim, Seonhye Lee, Hee Jin Chang, Dae Kyung Sohn
    Journal of Digital Imaging.2019; 32(1): 131.     CrossRef
  • Significance of 18F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non–small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
    Eunji Kim, Hong-Gyun Wu, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Jin Chul Paeng, Hak Jae Kim, Ji Hyun Chang
    Clinical Lung Cancer.2019; 20(1): e9.     CrossRef
  • Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores
    Inhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, Jae Ho Jeong, Kyu-pyo Kim, Heung-Moon Chang, Changhoon Yoo, Baek-Yeol Ryoo
    Investigational New Drugs.2019; 37(3): 584.     CrossRef
  • Pathologic differential diagnosis of metastatic carcinoma in the liver
    Jeong Hwan Park, Jung Ho Kim
    Clinical and Molecular Hepatology.2019; 25(1): 12.     CrossRef
  • Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility
    Seon Woo Lee, Do Youn Park, Mi-Young Kim, Changwon Kang
    Gastric Cancer.2019; 22(3): 640.     CrossRef
  • Association between dietary cadmium intake and early gastric cancer risk in a Korean population: a case–control study
    Hyejin Kim, Jeonghee Lee, Hae Dong Woo, Dong Woo Kim, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Nutrition.2019; 58(8): 3255.     CrossRef
  • High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service–Health Screening Cohort
    Yu-Jin Kwon, Na-Young You, Jae-Woo Lee, Joungyoun Kim, Hee-Taik Kang
    Clinical Lung Cancer.2019; 20(2): e177.     CrossRef
  • Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
    Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
    Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer
    Su Hyun Chae, Seung-Hyuk Shim, Sun Joo Lee, Ji Young Lee, Soo-Nyung Kim, Soon-Beom Kang
    International Journal of Gynecological Cancer.2019; 29(1): 77.     CrossRef
  • The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis
    Hwajeong Lee
    Yonsei Medical Journal.2019; 60(2): 223.     CrossRef
  • Clinical Applications of Automated Breast Ultrasound: Screening for Breast Cancer
    Sun Mi Kim, Bo La Yun, Mijung Jang
    Journal of the Korean Society of Radiology.2019; 80(1): 32.     CrossRef
  • Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells
    Jong Won Lee, Jae Sook Sung, Young Soo Park, Seok Chung, Yeul Hong Kim
    Gastric Cancer.2019; 22(5): 967.     CrossRef
  • Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study
    Yoon Park, Tae-Jin Kim, Chang-Sun Hwang, Chi Heum Cho, Dae Hoon Jeong, Seok Ju Seong, Jae-Kwan Lee, Sooyoung Hur, Mee-Kyung Kee, Jaehyun Seong, Moran Ki
    Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis
    Hyeong Su Kim, Jung Han Kim, Boram Han, Dae Ro Choi
    Medicina.2019; 55(2): 41.     CrossRef
  • Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015
    Bang Wool Eom, Kyu-Won Jung, Young-Joo Won, Young-Woo Kim
    Journal of Gastric Cancer.2019; 19(1): 92.     CrossRef
  • Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols
    Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Su Jin Lee, Sung Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Heejin Yoo, Kyunga Kim
    Cancer Research and Treatment.2019; 51(3): 876.     CrossRef
  • Thyroid cancer risks among medical radiation workers in South Korea, 1996–2015
    Won Jin Lee, Dale L. Preston, Eun Shil Cha, Seulki Ko, Hyeyeun Lim
    Environmental Health.2019;[Epub]     CrossRef
  • The role of surgical resection before palliative chemotherapy in advanced gastric cancer
    Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Sang-Yong Son, Hoon Hur, Sang-Uk Han, Seung Soo Sheen
    Scientific Reports.2019;[Epub]     CrossRef
  • How to Achieve a Higher Pathologic Complete Response in Patients With Locally Advanced Rectal Cancer Who Receive Preoperative Chemoradiation Therapy
    Suk-Hwan Lee
    Annals of Coloproctology.2019; 35(1): 3.     CrossRef
  • Cancer Survivors and Returning to Work Perspectives from Occupational Health Physicians in Korea
    Hye Young Shim, Choong Won Lee, Eun Seung Yu, Bo Young Park, Eun Joo Yang
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Risk Factors for Delayed Isolation of Patients with Active Pulmonary Tuberculosis in an Acute-care Hospital
    Jaijun Han, Bo Da Nam, Se Yoon Park, Jebyung Park, Eunyoung Lee, Eun Jung Lee, Jung Hwa Hwang, Tae Hyong Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis
    Yoon Jin Cha, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang, Aamir Ahmad
    PLOS ONE.2019; 14(3): e0214415.     CrossRef
  • Trends and Updated Statistics of Lung Cancer in Korea
    Chan Kwon Park, Seung Joon Kim
    Tuberculosis and Respiratory Diseases.2019; 82(2): 175.     CrossRef
  • Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach

    Journal of Gastric Cancer.2019; 19(1): 1.     CrossRef
  • The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population
    Young Jae Kwon, Nayoung Kim, Sung Min Baek, Hye Seung Lee, Jaebong Lee, Young Jae Hwang, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Jin‐Wook Kim, Dong Ho Lee
    Helicobacter.2019;[Epub]     CrossRef
  • For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
    Won Tae Kim, Seok Joong Yun, Wun-Jae Kim
    International Neurourology Journal.2019; 23(1): 5.     CrossRef
  • Prediagnostic Smoking and Alcohol Drinking and Gastric Cancer Survival: A Korean Prospective Cohort Study
    Shin Ah Kim, Bo Youl Choi, Kyu Sang Song, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Hyun Ja Kim
    The Korean Journal of Gastroenterology.2019; 73(3): 141.     CrossRef
  • Role of Upper Gastrointestinal Endoscopy in Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy
    Jin Suk Kang, Sun Hee Lee, Shinwon Lee, Gwang Ha Kim, Young Joo Park, In Sub Han, Jeong Eun Lee, Soon Ok Lee, Chisook Moon
    Infection & Chemotherapy.2019; 51(1): 35.     CrossRef
  • Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells
    Yoonseon Jeong, Joo Weon Lim, Hyeyoung Kim
    Nutrients.2019; 11(4): 762.     CrossRef
  • ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
    Sunyoung Park, Suji Lee, Jungho Kim, Geehyuk Kim, Kwang Hwa Park, Tae Ue Kim, Dawn Chung, Hyeyoung Lee, Hiromu Suzuki
    PLOS ONE.2019; 14(4): e0214867.     CrossRef
  • A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
    Jung Ho Kim, Jinnam Kim, Woon Ji Lee, Hye Seong, Heun Choi, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Taeil Son, Hyoung-Il Kim, Sang Hoon Han, Jun Yong Choi, Joon-Sup Yeom, Woo Jin Hyung, Young Goo Song, Sung Hoon Noh
    Journal of Clinical Medicine.2019; 8(4): 494.     CrossRef
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Research and Treatment.2019; 51(2): 417.     CrossRef
  • Prediction of Cancer Incidence and Mortality in Korea, 2019
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Research and Treatment.2019; 51(2): 431.     CrossRef
  • Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
    Ji Soo Park, Beodeul Kang, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Minkyu Jung, Seung Hoon Beom, Sang Joon Shin, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Joong Bae Ahn, Nam Kyu Kim, Tae Il Kim
    Journal of Cancer Prevention.2019; 24(1): 48.     CrossRef
  • Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients
    Jung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, Ahrum Min, Han Suk Ryu, Han-Byoel Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im, Sukil Kim
    Breast Cancer Research and Treatment.2019; 176(2): 453.     CrossRef
  • Sex and Gender Medicine in Pancreatobiliary Diseases
    Seon Mee Park
    The Korean Journal of Pancreas and Biliary Tract.2019; 24(2): 55.     CrossRef
  • Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
    Ho Won Kang, Hongyong Park, Sung Pil Seo, Young Joon Byun, Xuan-Mei Piao, Sung Min Kim, Won Tae Kim, Seok-Joong Yun, Wooyeong Jang, Ho Sun Shon, Keun Ho Ryu, Sang-Cheol Lee, Wun-Jae Kim, Yong-June Kim
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
    Min Jung Kim, Seung-Yong Jeong, Ji Won Park, Seung-Bum Ryoo, Sang Sik Cho, Ki Young Lee, Kyu Joo Park
    Annals of Coloproctology.2019; 35(2): 83.     CrossRef
  • Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
    Tong Zhou, Yao Wang, Xue Zhao, Yang Liu, Ying-Xuan Wang, Xiao-Kun Gang, Gui-Xia Wang
    World Journal of Clinical Cases.2019; 7(10): 1213.     CrossRef
  • Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement
    Tae Ryong Chung, Jie-Hyun Kim, Ik Jae Lee, Yeona Cho, Jun Won Kim, Chang Geol Lee, Da Hyun Jung, Jae Jun Park, Young Hoon Youn, Hyojin Park
    Digestive and Liver Disease.2019; 51(11): 1610.     CrossRef
  • Incidence and Clinical Characteristics of Ischemic Stroke Patients with Underlying Cancer
    Soon Woo Kwon, Won Jun Meng, Hae in Lee, Doo Young Kim, Sung-Bom Pyun
    Brain & Neurorehabilitation.2019;[Epub]     CrossRef
  • Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study
    Jin-Kyoung Oh, Hwa Young Choi, Minji Han, Jae-Kwan Lee, Kyung-Jin Min, Moran Ki
    Sexually Transmitted Infections.2019; 95(4): 292.     CrossRef
  • Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine
    Wonryeon Cho, Ji Hye Kim, Miseon Jeong, Myeong-Sun Kim, Jinwook Lee, Hyoungwoo Son, Chunhoo Cheon, Sunju Park, Seong-Gyu Ko
    Medicine.2019; 98(24): e16035.     CrossRef
  • Comparison of Postoperative Pain in Laparoscopy-Assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy by Location of Mini-Laparotomy Site
    Jaepak Yi, Yoona Chung, Sang Hyun Kim, Sung Il Choi
    The Journal of Minimally Invasive Surgery.2019; 22(2): 75.     CrossRef
  • Value of Computer Software for Assisting Sonographers in the Diagnosis of Thyroid Imaging Reporting and Data System Grade 3 and 4 Thyroid Space‐Occupying Lesions
    Yuanyuan Lu, Xian Quan Shi, Xiaohui Zhao, Danfei Song, Junlai Li
    Journal of Ultrasound in Medicine.2019; 38(12): 3291.     CrossRef
  • Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma
    Hyunsung Kim, Yumin Chung, Seung Sam Paik, Kiseok Jang, Su-Jin Shin
    Medicine.2019; 98(26): e16207.     CrossRef
  • Cigarette smoking, alcohol consumption, and risk of colorectal cancer in South Korea: A case-control study
    Sanghee Lee, Hyeongtaek Woo, Jeeyoo Lee, Jae-Hwan Oh, Jeongseon Kim, Aesun Shin
    Alcohol.2019; 76: 15.     CrossRef
  • The economic burden of cancers attributable to smoking in Korea, 2014
    Thi Nguyen, Minji Han, Jin-Kyoung Oh
    Tobacco Induced Diseases.2019;[Epub]     CrossRef
  • Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia
    Sang Mee Hwang, Sung-Min Kim, Youngwon Nam, Jinhyun Kim, Sungsik Kim, Yong-Oon Ahn, Yong Park, Sung-Soo Yoon, Sue Shin, Sunghoon Kwon, Dong Soon Lee
    Leukemia Research.2019; 84: 106190.     CrossRef
  • The Health Burden of Cancer Attributable to Obesity in Korea: A Population-Based Cohort Study
    Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun-Cheol Park
    Cancer Research and Treatment.2019; 51(3): 933.     CrossRef
  • Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
    Jung Hye Kwon, Sang-Cheol Lee, Myung Ah Lee, Yu Jung Kim, Jung Hun Kang, Jin Young Kim, Hyo Jin Lee, Woo Kyun Bae, Mi-Jung Kim, Eui Kyu Chie, Jin Kim, Yeul Hong Kim, Hyun Cheol Chung, Sun Young Rha
    Cancer Research and Treatment.2019; 51(3): 851.     CrossRef
  • Menopausal Symptoms and Quality of Life Among Breast Cancer Patients with Chemotherapy-induced Amenorrhea
    Jin-Hee Park, Yong-Sik Jung, Ji Young Kim, Sun Hyoung Bae, Yujung Jo
    Asian Oncology Nursing.2019; 19(2): 90.     CrossRef
  • Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
    Won-Il Choi, Jiah Choi, Mi-Ae Kim, Gyumin Lee, Jihyeon Jeong, Choong Won Lee
    Cancer Research and Treatment.2019; 51(3): 1241.     CrossRef
  • Prevalence and risk factors of colorectal cancer in Asia
    Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang
    Intestinal Research.2019; 17(3): 317.     CrossRef
  • Effects of Acupressure on Fatigue in Patients with Cancer Who Underwent Chemotherapy
    Atefeh Ghanbari Khanghah, Moloud Sharifi Rizi, Bahram Naderi Nabi, Masoumeh Adib, Ehsan Kazem Nejad Leili
    Journal of Acupuncture and Meridian Studies.2019; 12(4): 103.     CrossRef
  • Risk of malignancy in patients with psoriasis: a 15‐year nationwide population‐based prospective cohort study in Korea
    J.W. Lee, K.J. Jung, T.G. Kim, M. Lee, J. Oh, S.H. Jee, M.G. Lee
    Journal of the European Academy of Dermatology and Venereology.2019; 33(12): 2296.     CrossRef
  • Malignancy risk in Korean male patients with ankylosing spondylitis
    Bora Nam, Hyoungyoung Kim, Eun Jin Jang, Soo-Kyung Cho, Yoon-Kyoung Sung, Tae-Hwan Kim
    Rheumatology International.2019; 39(10): 1741.     CrossRef
  • Clinical Implementation of Precision Medicine in Gastric Cancer
    Jaewook Jeon, Jae-Ho Cheong
    Journal of Gastric Cancer.2019; 19(3): 235.     CrossRef
  • Platyphylloside Isolated from Betula platyphylla is Antiproliferative and Induces Apoptosis in Colon Cancer and Leukemic Cells
    Joo-Eun Lee, Nguyen Thi Thanh Thuy, Jina Lee, Namki Cho, Hee Min Yoo
    Molecules.2019; 24(16): 2960.     CrossRef
  • Risk of comorbid cardiovascular disease in Korean long‐term cancer survivors
    Jinyoung Shin, Hyeonyoung Ko, Yoon‐Ho Choi, Inyoung Choi, Yun‐Mi Song
    European Journal of Cancer Care.2019;[Epub]     CrossRef
  • Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
    Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
    Cancer Research and Treatment.2019; 51(4): 1392.     CrossRef
  • Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
    Jongmoo Park, Jae Won Park, Min Kyu Kang
    Yeungnam University Journal of Medicine.2019; 36(3): 192.     CrossRef
  • Anesthetics and long-term survival after cancer surgery—total intravenous versus volatile anesthesia: a retrospective study
    Boohwi Hong, Sunyeul Lee, Yeojung Kim, Minhee Lee, Ann Misun Youn, Hyun Rhim, Seok-Hwan Hong, Yoon-Hee Kim, Seok-Hwa Yoon, Chaeseong Lim
    BMC Anesthesiology.2019;[Epub]     CrossRef
  • Development and Effectiveness of an Oncology Nursing Standardized Patient Simulation Program for Nursing Students
    Kie In Jang, Yang Sook Yoo, Young Sook Roh
    Korean Journal of Adult Nursing.2019; 31(6): 595.     CrossRef
  • The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems
    Hyun-Soo Zhang, Eun-Kyung Lee, Yuh-Seog Jung, Byung-Ho Nam, Boyoung Park
    Cancer Epidemiology.2019; 63: 101589.     CrossRef
  • Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic Cancer
    Dong Uk Kim
    Gut and Liver.2019; 13(6): 587.     CrossRef
  • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
    Sunghwan Suh, Kwang-Won Kim
    Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
  • Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
    Won Kyung Cho, Doo Ho Choi, Won Park, Haeyoung Kim, Seonwoo Kim, Myung-Hee Shin, Hyejung Cha
    Journal of Breast Cancer.2019; 22(3): 464.     CrossRef
  • The Association between Cancer Screening and Cancer History among Korean Adults: The 2010–2012 Korea National Health and Nutrition Examination Survey
    Ye-Seul Kim, Hee-Taik Kang, Jae-Woo Lee
    Korean Journal of Family Medicine.2019; 40(5): 307.     CrossRef
  • Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study
    Hye-Mi Jo, Eun Hye Lee, Kyungran Ko, Bong Joo Kang, Joo Hee Cha, Ann Yi, Hae Kyoung Jung, Jae Kwan Jun
    Cancer Research and Treatment.2019; 51(4): 1295.     CrossRef
  • Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
    Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
    Medicine.2019; 98(45): e17641.     CrossRef
  • Milk Consumption Decreases Risk for Breast Cancer in Korean Women under 50 Years of Age: Results from the Health Examinees Study
    Woo-Kyoung Shin, Hwi-Won Lee, Aesun Shin, Jong-koo Lee, Daehee Kang
    Nutrients.2019; 12(1): 32.     CrossRef
  • Aerobic capacity correlates with health‐related quality of life after breast cancer surgery
    Doo Young Kim, Jae‐Hyung Kim, Si‐Woon Park
    European Journal of Cancer Care.2019;[Epub]     CrossRef
  • Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison
    Yoonsun Chung, Jeong Il Yu, Won Park, Doo Ho Choi
    Cancer Research and Treatment.2019; 51(4): 1370.     CrossRef
  • Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
    Pyung Jung, Eung-Ho Cho, Sang-Bum Kim, Ryoung-Go Kim
    Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(4): 319.     CrossRef
  • Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells
    Qi Wang, Melisa Gun, Xing-yu Hong
    Scientific Reports.2019;[Epub]     CrossRef
  • Evaluation of Commercial Complementary DNA Synthesis Kits for Detecting Human Papillomavirus
    Kwangmin Yu, Sunyoung Park, Yunhee Chang, Dasom Hwang, Geehyuk Kim, Jungho Kim, Sunghyun Kim, Eun-Joong Kim, Dongsup Lee
    The Korean Journal of Clinical Laboratory Science.2019; 51(3): 309.     CrossRef
  • The epidemiology of hepatitis B virus infection in Korea
    Sun Young Yim, Ji Hoon Kim
    The Korean Journal of Internal Medicine.2019; 34(5): 945.     CrossRef
  • Production and Performance Evaluation of External Quality Assessment Materials for Human Epididymis Protein 4 Assay
    Anna Lee, Hee-Jung Kim
    Journal of Laboratory Medicine and Quality Assurance.2019; 41(3): 153.     CrossRef
  • Clinical Implications of Microsatellite Instability in Early Gastric Cancer
    Dong Gyu Kim, Ji Yeong An, Hyunki Kim, Su-Jin Shin, Seohee Choi, Won Jun Seo, Chul Kyu Roh, Minah Cho, Taeil Son, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Yoon Young Choi
    Journal of Gastric Cancer.2019; 19(4): 427.     CrossRef
  • Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT
    Hye Ryeong Kwon, Kisoo Pahk, Sungsoo Park, Hyun Woo Kwon, Sungeun Kim
    Nuclear Medicine and Molecular Imaging.2019; 53(6): 386.     CrossRef
  • Comparison of radiotherapy infrastructure between Korea and Japan
    Seung Jae Huh, Tetsuo Nishimura, Won Park, Katsumasa Nakamura
    Japanese Journal of Clinical Oncology.2019; 49(11): 1024.     CrossRef
  • Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
    Chang-Min Choi, Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Yoo-Duk Choi, Yang-Gun Suh, Jung-Eun Kim, Boram Lee, Young-Joo Won, Young-Chul Kim
    Cancer Research and Treatment.2019; 51(4): 1400.     CrossRef
  • Stage 1A Pancreatic Cancer Initially Manifesting as Clinical Acute Pancreatitis
    Dong Ryeol Yoo, Jihun Kim, Seung-Ho Baek, Jiwoo Lee, So Hye Nam, Se Hee Lee, Myung-Hwan Kim
    The Korean Journal of Medicine.2019; 94(6): 519.     CrossRef
  • A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
    Yumi Kim, Un-Beom Kang, Sungsoo Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh
    Journal of Breast Cancer.2019; 22(4): 579.     CrossRef
  • Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program
    Jaeho Lee, Juntae Lim, Yeol Kim, Hyae Young Kim, Jin Mo Goo, Choon-Taek Lee, Seung Hun Jang, Won-Chul Lee, Chan Wha Lee, Jin Young An, Ki Dong Ko, Min Ki Lee, Kui Son Choi, Boyoung Park, Duk Hyoung Lee
    Cancer Research and Treatment.2019; 51(4): 1285.     CrossRef
  • Relief of Cancer Pain in Patients with Pancreatic Cancer
    Jung Wan Choe, Jong Jin Hyun
    The Korean Journal of Gastroenterology.2019; 74(2): 81.     CrossRef
  • Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea
    Jae Kwang Yun, Han Pil Lee, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
    Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Seung-Hyun Ko, Yong Gyu Park
    Clinical and Translational Gastroenterology.2019; 10(10): e00090.     CrossRef
  • Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea
    Dong Wook Shin, Beomseok Suh, Hyunsun Lim, Yun-Suhk Suh, Yoon Jin Choi, Su-Min Jeong, Jae Moon Yun, Sun Ok Song, Youngmin Park
    American Journal of Gastroenterology.2019; 114(11): 1735.     CrossRef
  • Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
    Heon Ha, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Ghil Suk Yoon, Tae Gyun Kwon, Sung Kwang Chung, Eun Sang Yoo
    Investigative and Clinical Urology.2019; 60(6): 447.     CrossRef
  • Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors
    Hyejin Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Nutrients.2019; 11(11): 2612.     CrossRef
  • Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study
    Jihoon Kang, Yoosoo Chang, Jiin Ahn, Sukjoong Oh, Dong‐Hoe Koo, Yun‐Gyoo Lee, Hocheol Shin, Seungho Ryu
    International Journal of Cancer.2019; 145(12): 3267.     CrossRef
  • Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study
    Madhawa Neranjan Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Yongju Ahn, Chanhyeok Park, Jeongseon Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Epidemiology of and Risk Factors for Esophageal Cancer in Korea
    Hye-Kyung Jung
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(3): 145.     CrossRef
  • Validation of an automated adenoma detection rate calculating system for quality improvement of colonoscopy
    Dae Kyung Sohn, Il Won Shin, Jeonghwa Yeon, Jin Yoo, Byung Chang Kim, Bun Kim, Chang Won Hong, Kyung Su Han
    Annals of Surgical Treatment and Research.2019; 97(6): 319.     CrossRef
  • Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer
    Eun Sook Ryu, Seung Jun Chang, Jungsuk An, Jun-Young Yang, Jun-Won Chung, Yoon Jae Kim, Kyoung Oh Kim, Dong Kyun Park, Kwang An Kwon, Seungyoon Nam, Woon Kee Lee, Jung Ho Kim, Masaru Katoh
    PLOS ONE.2019; 14(10): e0224019.     CrossRef
  • Knowledge and Anxiety Related to Hereditary Ovarian Cancer in Serous Ovarian Cancer Patients
    Sang Hee Lee, Hyangkyu Lee, Myong Cheol Lim, Sue Kim
    Korean Journal of Women Health Nursing.2019; 25(4): 365.     CrossRef
  • Alcohol consumption and gastric cancer risk in Korea: a case-control study
    Mi Hui Kim, Shin Ah Kim, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
    Nutrition Research and Practice.2019; 13(5): 425.     CrossRef
  • Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer
    Yujun Park, Jiwon Koh, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    Cancer Immunology, Immunotherapy.2019; 68(11): 1779.     CrossRef
  • Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016
    Ha Na Cho, Eunji Choi, Da Hea Seo, Boyoung Park, Sohee Park, Juhee Cho, Sue Kim, Yeong-Ran Park, Yumie Rhee, Kui Son Choi
    BMJ Open.2019; 9(4): e026366.     CrossRef
  • Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic Types: Evidence from the Korean Nationwide Registry
    So-Youn Jung, Kyu-Won Jung, Johyun Ha, Young-Joo Won, Young Ae Kim, Youngmee Kwon, Sun-Young Kong, Eun Sook Lee
    Cancer Epidemiology, Biomarkers & Prevention.2019; 28(7): 1169.     CrossRef
  • Cancer Incidence Trend in the Hebei Spirit Oil Spill Area, from 1999 to 2014: An Ecological Study
    Kyung-Hwa Choi, Myung-Sook Park, Mina Ha, Jong-Il Hur, Hae-Kwan Cheong
    International Journal of Environmental Research and Public Health.2018; 15(5): 1006.     CrossRef
  • Updates on Cancer Epidemiology in Korea, 2018
    Sun-Seog Kweon
    Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
  • Avoiding “curiosity killed the cat”: personalized surveillance in post-resection colorectal cancer patients
    Hyunkyung Park, Joohan Lim
    The Korean Journal of Internal Medicine.2018; 33(4): 693.     CrossRef
  • Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer
    Heesung Hwang, Kwang-Min Lee, Kyung-Lak Son, Dooyoung Jung, Won-Hyoung Kim, Joo-Young Lee, Seong-Ho Kong, Yun-Suhk Suh, Hyuk-Joon Lee, Han-Kwang Yang, Bong-Jin Hahm
    BMC Cancer.2018;[Epub]     CrossRef
  • Dietary Carotenoids Intake and the Risk of Gastric Cancer: A Case—Control Study in Korea
    Ji Hyun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Oran Kwon, Hyesook Kim, Jeongseon Kim
    Nutrients.2018; 10(8): 1031.     CrossRef
  • Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
    Hyeong Su Kim, Jung Han Kim, Hyun Joo Jang, Boram Han, Dae Young Zang
    International Journal of Molecular Sciences.2018; 19(9): 2529.     CrossRef
  • Immune checkpoint inhibitors for urothelial carcinoma
    Hyung Suk Kim, Ho Kyung Seo
    Investigative and Clinical Urology.2018; 59(5): 285.     CrossRef
  • Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data
    Hyuk Hur, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
    Annals of Coloproctology.2018; 34(4): 212.     CrossRef
  • Patterns of Practice in Radiotherapy for Breast Cancer in Korea
    Hae Jin Park, Do Hoon Oh, Kyung Hwan Shin, Jin Ho Kim, Doo Ho Choi, Won Park, Chang-Ok Suh, Yong Bae Kim, Seung Do Ahn, Su Ssan Kim
    Journal of Breast Cancer.2018; 21(3): 244.     CrossRef
  • Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
    Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong
    Obstetrics & Gynecology Science.2018; 61(5): 542.     CrossRef
  • Cause-of-death statistics in 2016 in the Republic of Korea
    Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
  • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
    Il Yong Chung, Jihyoun Lee, Suyeon Park, Jong Won Lee, Hyun Jo Youn, Jung Hwa Hong, Ho Hur
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Physical Activity and Gastric Cancer Risk in Patients with and without Helicobacter pylori Infection in A Korean Population: A Hospital-Based Case-Control Study
    Madhawa Neranjan Gunathilake, Jeonghee Lee, Aelee Jang, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Cancers.2018; 10(10): 369.     CrossRef
  • Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females
    Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
    Chang Hyun Kim
    Annals of Coloproctology.2018; 34(5): 227.     CrossRef
  • Evaluation of the Association between Gestational Diabetes Mellitus at First Pregnancy and Cancer within 10 Years Postpartum Using National Health Insurance Data in South Korea
    Kyu-Tae Han, Geum Joon Cho, Eui Hyeok Kim
    International Journal of Environmental Research and Public Health.2018; 15(12): 2646.     CrossRef
  • Helicobacter pylori Eradication Therapy and Gastric Cancer Prevention
    Il Ju Choi
    The Korean Journal of Gastroenterology.2018; 72(5): 245.     CrossRef
  • Projected lifetime cancer risks from occupational radiation exposure among diagnostic medical radiation workers in South Korea
    Won Jin Lee, Yeongchull Choi, Seulki Ko, Eun Shil Cha, Jaeyoung Kim, Young Min Kim, Kyoung Ae Kong, Songwon Seo, Ye Jin Bang, Yae Won Ha
    BMC Cancer.2018;[Epub]     CrossRef
  • The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea
    Joonki Lee, Sunho Choe, Ji Won Park, Seung-Yong Jeong, Aesun Shin
    Journal of Preventive Medicine and Public Health.2018; 51(6): 281.     CrossRef
  • Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials
    Young-Jae Hwang, Nayoung Kim, Sung Eun Kim, Gwang Ho Baik, Ju Yup Lee, Kyung Sik Park, Young-Eun Joo, Dae-Seong Myung, Hyeon Ju Kim, Hyun Joo Song, Heung Up Kim, Kwangwoo Nam, Jeong Eun Shin, Hyun Jin Kim, Gwang Ha Kim, Jongchan Lee, Seon Hee Lim, Geom Se
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(4): 247.     CrossRef
  • MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells
    Jung Yoon Jang, Yong Jung Kang, Bokyung Sung, Min Jeong Kim, Chaeun Park, Dongwan Kang, Hyung Ryong Moon, Hae Young Chung, Nam Deuk Kim
    Molecules.2018; 24(1): 96.     CrossRef
  • Factors Affecting Cognitive Function in Patients with Stomach Cancer
    Yeoung Ji Yu, Seung Hee Ahn, Yong Ae Cho, Eunjung Ryu, Eun-Ju Kim
    Asian Oncology Nursing.2018; 18(4): 241.     CrossRef
  • Mouse models of breast cancer in preclinical research
    Mi Kyung Park, Chang Hoon Lee, Ho Lee
    Laboratory Animal Research.2018; 34(4): 160.     CrossRef
  • Treatment of Patients with Cancer in a Secondary Hospital in Korea
    Myoung Kyun Son
    The Korean Journal of Hospice and Palliative Care.2018; 21(3): 84.     CrossRef
  • Influence of Insurance Status on Survival of Surgically Treated Esophageal Cancer Patients
    Yoohwa Hwang, Se-Jin Oh, Jae-Sung Choi, Ji Won Kim, Jeong Sang Lee, Hyun Jong Moon
    The Korean Journal of Gastroenterology.2018; 72(1): 15.     CrossRef
  • Potential Epigenetic Biomarkers for Prostate Cancer Screening
    Jong-Myon Bae
    International Neurourology Journal.2018; 22(2): 142.     CrossRef
  • Induction of apoptosis and G1 phase cell cycle arrest by Aster�incises in AGS gastric adenocarcinoma cells
    Daniel Ngabire, Yeong-Ae Seong, Maheshkumar Prakash Patil, Irvine Niyonizigiye, Yong Bae Seo, Gun-Do Kim
    International Journal of Oncology.2018;[Epub]     CrossRef
  • 35,627 View
  • 1,368 Download
  • 310 Web of Science
  • 318 Crossref
Close layer
Prediction of Cancer Incidence and Mortality in Korea, 2018
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
Cancer Res Treat. 2018;50(2):317-323.   Published online March 21, 2018
DOI: https://doi.org/10.4143/crt.2018.142
AbstractAbstract PDFPubReaderePub
Purpose
This study aimed to report on cancer incidence and mortality for the year 2018 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2015 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2016 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly, we only used the data of the latest trend.
Results
A total of 204,909 new cancer cases and 82,155 cancer deaths are expected to occur in Korea in 2018. The most common cancer sites were lung, followed by stomach, colorectal, breast and liver. These five cancers represent half of the overall burden of cancer in Korea. For mortality, the most common sites were lung cancer, followed by liver, colorectal, stomach and pancreas.
Conclusion
The incidence rate of all cancer in Korea are estimated to decrease gradually, mainly due to decrease of thyroid cancer. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluation of cancer-control programs.

Citations

Citations to this article as recorded by  
  • Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Robot Assisted Laparoscopic Surgery in Gynaecology: An Evolving Assistive Technology
    Siwen Xie, Thomas Charles Wood, Prokar Dasgupta, Abdullatif Aydin
    Surgical Innovation.2024; 31(3): 324.     CrossRef
  • Cancer mortality trends in Luxembourg: A 24-year descriptive study (1998–2021)
    Allini Mafra, Jérôme Weiss, Stéphanie Saleh, Guy Weber, Claudine Backes
    Cancer Epidemiology.2024; 93: 102648.     CrossRef
  • Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea
    Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Suyog Jain, Steve Olsen, Byoung Chul Cho
    Cancer Treatment and Research Communications.2023; 36: 100715.     CrossRef
  • Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Mammographic Breast Density and Risk of Ovarian Cancer in Korean Women
    Thi Xuan Mai Tran, Soyeoun Kim, Boyoung Park
    Cancer Epidemiology, Biomarkers & Prevention.2023; 32(12): 1690.     CrossRef
  • Characteristics of Patients Undergoing Surgical Treatment for Spinal Metastases From Colorectal Cancer
    Se-Jun Park, Jin-Sung Park, Yunjin Nam, Chong-Suh Lee
    Clinical Spine Surgery: A Spine Publication.2022; 35(1): E187.     CrossRef
  • Assessment of risks for breast cancer in a flight attendant exposed to night shift work and cosmic ionizing radiation: a case report
    Dong Joon Park, Sungkyun Park, Seong Won Ma, Hoekyeong Seo, Sang Gil Lee, Kyung-Eun Lee
    Annals of Occupational and Environmental Medicine.2022;[Epub]     CrossRef
  • Cancer Statistics over Time in Northwestern São Paulo State, Brazil: Incidence and Mortality
    Allini Mafra da Costa, Isabela Campos Pereira Hernandes, Elisabete Weiderpass, Isabelle Soerjomataram, José Humberto Tavares Guerreiro Fregnani
    Cancer Epidemiology, Biomarkers & Prevention.2022; 31(4): 707.     CrossRef
  • Characteristics and outcomes of colorectal cancer surgery by age in a tertiary center in Korea: a retrospective review
    Tae-Hoon Lee, Jeong Min Choo, Jeong Sub Kim, Seon Hui Shin, Ji-Seon Kim, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim
    Annals of Coloproctology.2022; 38(3): 244.     CrossRef
  • Additive interaction of diabetes mellitus and chronic kidney disease in cancer patient mortality risk
    Seohyun Kim, Gyuri Kim, Jae Hyeon Kim
    Scientific Reports.2022;[Epub]     CrossRef
  • CD47 Expression Predicts Unfavorable Prognosis in Clear Cell Renal Cell Carcinoma after Curative Resection
    Hosub Park, Seungyun Jee, Seongsik Bang, Hwangkyu Son, Hyebin Cha, Jaekyung Myung, Jongmin Sim, Yeseul Kim, Seungsam Paik, Hyunsung Kim
    Diagnostics.2022; 12(10): 2291.     CrossRef
  • Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
    Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo
    The World Journal of Men's Health.2021; 39(1): 158.     CrossRef
  • Implementation effect of institutional policy of EGD observation time on neoplasm detection
    Jae Myung Park, Sang Yoon Kim, Ga-Yeong Shin, Younghee Choe, Hyun Sun Cho, Chul-Hyun Lim, Yu Kyung Cho, Myung-Gyu Choi
    Gastrointestinal Endoscopy.2021; 93(5): 1152.     CrossRef
  • Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
    Wonkyo Shin, Sanghee Lee, Myong Cheol Lim, Jipmin Jung, Hak Jin Kim, Hyunsoon Cho
    Cancer Medicine.2021; 10(6): 2045.     CrossRef
  • Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
    Yeong Hak Bang, Jeong Eun Kim, Ji Sung Lee, Sun Young Kim, Kyu-Pyo Kim, Tae Won Kim, Yong Sang Hong
    Scientific Reports.2021;[Epub]     CrossRef
  • Clinical Practice Guidelines for the Treatment of Functional Dyspepsia in Korea
    Jung Hwan Oh, Joong Goo Kwon, Hye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, Seung Joo Kang, Sung Eun Kim, Kyoungwon Jung, Joon Sung Kim, Jong Kyu Park, Ki Bae Bang, Jeong Eun Shin, Myong Ki Baeg, Cheol Min Shin, Ju Yup Lee, Hyun Chul Lim
    The Korean Journal of Medicine.2021; 96(2): 116.     CrossRef
  • Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells
    Jeongshin An, Jong Bin Kim, Eun Yeol Yang, Hye Ok Kim, Won-Hee Lee, Jinho Yang, Hyungju Kwon, Nam Sun Paik, Woosung Lim, Yoon-Keun Kim, Byung-In Moon
    Medicine.2021; 100(18): e25835.     CrossRef
  • Consent for withholding life-sustaining treatment in cancer patients: a retrospective comparative analysis before and after the enforcement of the Life Extension Medical Decision law
    Yu Jin Chung, Incheol Park, Junho Cho, Jin Ho Beom, Ji Eun Lee
    BMC Medical Ethics.2021;[Epub]     CrossRef
  • Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea
    Taeyun Kim, Tae Won Jang, Chang Min Choi, Mi‐Hyun Kim, Sung Yong Lee, Cheol‐Kyu Park, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon
    Cancer Medicine.2021; 10(17): 5809.     CrossRef
  • Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
    Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
    Cancer Research and Treatment.2021; 53(3): 650.     CrossRef
  • Associations Between Kidney Function, Proteinuria, and the Risk of Kidney Cancer: A Nationwide Cohort Study Involving 10 Million Participants
    Jinsung Park, Dong Wook Shin, Kyungdo Han, Dahye Kim, Sohyun Chun, Hye Ryoun Jang
    American Journal of Epidemiology.2021; 190(10): 2042.     CrossRef
  • Evaluation of a Targeted Next-generation Sequencing Assay for BRCA Mutation Screening in Clinical Samples
    Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
    Laboratory Medicine Online.2021; 11(4): 283.     CrossRef
  • Clinical Practice Guidelines for Functional Dyspepsia in Korea
    Jung Hwan Oh, Joong Goo Kwon, Hye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, Seung Joo Kang, Sung Eun Kim, Kyoungwon Jung, Joon Sung Kim, Jong Kyu Park, Ki Bae Bang, Myong Ki Baeg, Jeong Eun Shin, Cheol Min Shin, Ju Yup Lee, Hyun Chul Lim
    Journal of Neurogastroenterology and Motility.2020; 26(1): 29.     CrossRef
  • Pancreatic Cancer in a Young Male in His Twenties
    Seung-Ho Baek, Seung Soo Lee, Ji Hoon Kim, So Hyun Kim, Jihye Lim, Joune Seup Lee, Myung-Hwan Kim
    The Korean Journal of Medicine.2020; 95(1): 50.     CrossRef
  • Role of Cervical Cancer Radiotherapy in the Expression of EGFR and p53 Gene
    Yan Cheng, Kuntian Lan, Xiaoxia Yang, Dongxia Liang, Li Xia, Jinquan Cui
    Current Proteomics.2020; 17(1): 23.     CrossRef
  • Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
    Jii Bum Lee, Han Sang Kim, Inkyung Jung, Sang Joon Shin, Seung Hoon Beom, Jee Suk Chang, Woong Sub Koom, Tae Il Kim, Hyuk Hur, Byung Soh Min, Nam Kyu Kim, Sohee Park, Seung-Yong Jeong, Jeong-Heum Baek, Seon Hahn Kim, Joon Seok Lim, Kang Young Lee, Joong B
    Trials.2020;[Epub]     CrossRef
  • Prognosis factors of advanced gastric cancer according to sex and age
    Abdulaziz Alshehri, Hussain Alanezi, Beom Su Kim
    World Journal of Clinical Cases.2020; 8(9): 1608.     CrossRef
  • Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea
    Inseon Choi, Donghwan Lee, Kyung-Bok Son, SeungJin Bae
    BMC Public Health.2020;[Epub]     CrossRef
  • Econazole Induces p53-Dependent Apoptosis and Decreases Metastasis Ability in Gastric Cancer Cells
    Eun Kyoung Choi, Eun Jung Park, Tien Thuy Phan, Hea Dong Kim, Kwang-Lae Hoe, Dong-Uk Kim
    Biomolecules & Therapeutics.2020; 28(4): 370.     CrossRef
  • Anti-cancer effect of farrerol induced apoptosis through activating p38 MAPK in Human breast cancer MCF-7 cells
    Jongbeom Chae, Seul Gi Lee, Ju-Ock Nam
    Journal of Applied Biological Chemistry.2020; 63(2): 147.     CrossRef
  • Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea
    Hye Lee, Dae Hwang, Hye Han
    Oncology Letters.2020; 20(1): 655.     CrossRef
  • Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
    Jaehoon Shin, Seungbeom Shin, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Hyoung Jung Kim, Jae Ho Byun, HyungJun Cho, Song Cheol Kim, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2020; 54(5): 387.     CrossRef
  • Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects
    Jooyoung Lee, Su Jin Chung, Ji Min Choi, Yoo Min Han, Joo Sung Kim, Greger Lindberg
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patterns According to Tumor Location
    Sung Hoon Choi, Ha Yan Kim, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee
    Pancreas.2020; 49(10): 1290.     CrossRef
  • Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
    Junyoung Shin, Laura D. Wood, Ralph H. Hruban, Seung-Mo Hong, Francisco X. Real
    PLOS ONE.2020; 15(11): e0242571.     CrossRef
  • Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
    Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
    Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1–IIA2 cervical cancer
    Se Ik Kim, Jae Hyun Cho, Aeran Seol, Young Im Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
    Gynecologic Oncology.2019; 153(1): 3.     CrossRef
  • Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors
    Mi Jung Kwon, Ho Suk Kang, Hyeon Tae Kim, Jin Woo Choo, Bo Hyun Lee, Sung Eun Hong, Kun Ha Park, Dong Min Jung, Hyun Lim, Jae Seung Soh, Sung Hoon Moon, Jong Hyeok Kim, Hye-Rim Park, Soo Kee Min, Jin won Seo, Ji-Young Choe
    World Journal of Gastroenterology.2019; 25(4): 469.     CrossRef
  • HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer
    Mi Jung Kwon, Jae Seung Soh, Sang-Woo Lim, Ho Suk Kang, Hyun Lim
    Pathology - Research and Practice.2019; 215(5): 910.     CrossRef
  • Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
    Hyun-Woong Cho, Yung-Taek Ouh, Jae Kwan Lee, Jin Hwa Hong
    Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
  • Clinicopathologic characteristics of early gastric cancer according to specific intragastric location
    Kyungeun Kim, Younghye Cho, Jin Hee Sohn, Dong-Hoon Kim, In Gu Do, Hyun Joo Lee, Sung-Im Do, Sangjeong Ahn, Hyoun Wook Lee, Seoung Wan Chae
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • Dietary Lutein Plus Zeaxanthin Intake and DICER1 rs3742330 A > G Polymorphism Relative to Colorectal Cancer Risk
    Jimi Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Oran Kwon, Aesun Shin, Jeongseon Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
    Heejung Chae, Dok Hyun Yoon
    The Korean Journal of Medicine.2019; 94(2): 152.     CrossRef
  • Correlations between Genetic Polymorphisms in Long Non-Coding RNA PRNCR1 and Gastric Cancer Risk in a Korean Population
    Jang Hee Hong, Eun-Heui Jin, Hyojin Kang, In Ae Chang, Sang-Il Lee, Jae Kyu Sung
    International Journal of Molecular Sciences.2019; 20(13): 3355.     CrossRef
  • Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
    Hyejeong Hue, Kidong Kim, HyoJin Kim, Dong Hoon Suh, Jae Hong No, Yong Beom Kim
    Obstetrics & Gynecology Science.2019; 62(4): 285.     CrossRef
  • Clinical Implementation of Precision Medicine in Gastric Cancer
    Jaewook Jeon, Jae-Ho Cheong
    Journal of Gastric Cancer.2019; 19(3): 235.     CrossRef
  • Comparison of radiotherapy infrastructure between Korea and Japan
    Seung Jae Huh, Tetsuo Nishimura, Won Park, Katsumasa Nakamura
    Japanese Journal of Clinical Oncology.2019; 49(11): 1024.     CrossRef
  • Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer
    Gyuseo Jung, Seok-Hyun Kim, Tae Gyu Kim, Young Zoon Kim
    Brain Tumor Research and Treatment.2019; 7(2): 112.     CrossRef
  • Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion
    Pedro Weslley Rosario, Laura Sterian Ward, Hans Graf, Fernanda Vaisman, Gabriela Franco Mourão, Mario Vaisman
    Archives of Endocrinology and Metabolism.2019;[Epub]     CrossRef
  • Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study
    Madhawa Neranjan Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Yongju Ahn, Chanhyeok Park, Jeongseon Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study
    Hye-Mi Jo, Eun Hye Lee, Kyungran Ko, Bong Joo Kang, Joo Hee Cha, Ann Yi, Hae Kyoung Jung, Jae Kwan Jun
    Cancer Research and Treatment.2019; 51(4): 1295.     CrossRef
  • Clinical usefulness of fluorodeoxyglucose-positron emission tomography/computed tomography and carbohydrate antigen 19-9 in patients with periampullary tumors
    Jeong Eon Kim, Min Ho Shin, Nam Kyu Choi
    Korean Journal of Clinical Oncology.2019; 15(2): 56.     CrossRef
  • Contemporary Debates in Adult Papillary Thyroid Cancer Management
    Donald S A McLeod, Ling Zhang, Cosimo Durante, David S Cooper
    Endocrine Reviews.2019; 40(6): 1481.     CrossRef
  • Are shape morphologies associated with survival? A potential shape-based biomarker predicting survival in lung cancer
    Maliazurina Saad, Ik Hyun Lee, Tae-Sun Choi
    Journal of Cancer Research and Clinical Oncology.2019; 145(12): 2937.     CrossRef
  • Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
    Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
    Medicine.2019; 98(45): e17641.     CrossRef
  • Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer
    Mihong Choi, Jiyeon Han, Bo Ram Yang, Myoung-jin Jang, Miso Kim, Tae-Yong Kim, Seock-Ah Im, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Kyung-Hun Lee
    The Oncologist.2019; 24(12): e1268.     CrossRef
  • Sex‑biased differences in the correlation between epithelial‑to‑mesenchymal transition‑associated genes in cancer cell lines
    Sun Kim, Seungeun Lee, Eunhye Lee, Hyesol Lim, Ji Shin, Joohee Jung, Sang Kim, Aree Moon
    Oncology Letters.2019;[Epub]     CrossRef
  • Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
    Hyun-Ji Lee, Sun Min Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(3): 168.     CrossRef
  • Physical Activity and Gastric Cancer Risk in Patients with and without Helicobacter pylori Infection in A Korean Population: A Hospital-Based Case-Control Study
    Madhawa Neranjan Gunathilake, Jeonghee Lee, Aelee Jang, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Cancers.2018; 10(10): 369.     CrossRef
  • 14,250 View
  • 524 Download
  • 63 Web of Science
  • 60 Crossref
Close layer
Original Articles
A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry
Jia-Wei Lv, Xiao-Dan Huang, Yu-Pei Chen, Guan-Qun Zhou, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Ai-Hua Lin, Jun Ma, Ying Sun
Cancer Res Treat. 2018;50(2):324-334.   Published online April 19, 2017
DOI: https://doi.org/10.4143/crt.2016.544
AbstractAbstract PDFPubReaderePub
Purpose
Conditional survival (CS) provides important information on survival for a period of time after diagnosis. Currently, information on CS patterns of patients with nasopharyngeal carcinoma (NPC) is lacking. We aimed to analyze survival rate over time and estimate CS for NPC patients using a national population-based registry.
Materials and Methods
Patients diagnosed with NPC between 1973 and 2007 with at least 5-year follow-up were identified from the Surveillance Epidemiology End Results registry. Traditional survival rates and crude CS estimateswere calculated using Kaplan-Meier analysis. Risk-adjusted survival curves were plotted from the proportional hazards model using the correct group prognosis method.
Results
For 7,713 patients analyzed, adjusted baseline 5-year overall survival improved significantly from 36.0% in patients diagnosed in 1973-1979, 41.7% in 1980-1989, 46.6% in 1990- 1999, to 54.7% in 2000-2007 (p < 0.01). CS analysis demonstrated that for every additional year survived, adjusted probability of surviving the next 5 years increased from 66.7% (localized), 54.0% (regional), and 35.3% (distant) at the time of diagnosis, to 83.7% (localized), 75.0% (regional), and 62.2% (distant) for patients who had survived 5 years. Adjusted 5-year CS differed among age, sex, tumor histology, ethnicity, and stage subgroups initially, but converged with time.
Conclusion
Treatment outcomes of NPC patients have greatly improved over the decades. Increases in CS become more prominent in patients with distant disease than in those with localized or regional disease as patients survive longer. CS provides more dynamic prognostic information for patients who have survived a period of time after diagnosis.

Citations

Citations to this article as recorded by  
  • A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
    Anna Spreafico, Eric Winquist, Cheryl Ho, Brian O’Sullivan, Nathaniel Bouganim, Neil Chua, Sarah Doucette, Lillian L. Siu, Desiree Hao
    Current Oncology.2025; 32(1): 48.     CrossRef
  • Role of combined surgical and radiotherapy treatment in nonmetastatic WHO I nasopharyngeal carcinoma patients
    Zi-meng Wang, Si-yu Zhu, Qin Wang, Chong-yang Duan, Si-han Liu, Rui You, Ming-Yuan Chen, Pei-Yu Huang
    Acta Oto-Laryngologica.2024; 144(4): 325.     CrossRef
  • Health and Well-Being Needs Among Head and Neck Cancer Caregivers – A Systematic Review
    Sarah Benyo, Chandat Phan, Neerav Goyal
    Annals of Otology, Rhinology & Laryngology.2023; 132(4): 449.     CrossRef
  • Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach
    Tianzhu Lu, Hanchuan Xu, Wanfang Huang, Jingfeng Zong, Caizhu Pan, Chaobin Huang, Youping Xiao, Bijuan Chen, Jingao Li, Jianji Pan, Shaojun Lin, Fang Guo, Qiaojuan Guo
    Radiotherapy and Oncology.2023; 185: 109716.     CrossRef
  • Conditional survival nomogram for monitoring real-time survival of young non-metastatic nasopharyngeal cancer survivors
    Jianing Luo, Xiaonan Hu, Xiaofeng Ge
    Journal of Cancer Research and Clinical Oncology.2023; 149(12): 10181.     CrossRef
  • Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma
    James C. H. Chow, Wah Cheuk, William C. S. Cho, Chi-Fai Wong, Dennis W. Y. Au, Anthony H. P. Tam, Rachel C. W. Wong, Jeffrey C. H. Chan, Simon C. C. Law, Roger K. C. Ngan, Kam-Hung Wong, Ka-Man Cheung
    JAMA Network Open.2023; 6(7): e2323890.     CrossRef
  • Analysis of conditional survival for primary hepatocellular carcinoma with narrow-margin hepatectomy: a large-sample, dual-center, retrospective study
    Jie Kong, Tingfeng Huang, Jianxi Zhang, Shichuan Tang, Hongzhi Liu, Jingfeng Liu, Yongyi Zeng
    HPB.2022;[Epub]     CrossRef
  • Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
    Oren Shechter, Daniel G. Sausen, Elisa S. Gallo, Harel Dahari, Ronen Borenstein
    International Journal of Molecular Sciences.2022; 23(22): 14389.     CrossRef
  • Health literacy impacts self-management, quality of life and fear of recurrence in head and neck cancer survivors
    Nicholas Clarke, Simon Dunne, Laura Coffey, Linda Sharp, Deirdre Desmond, Jean O’Conner, Eleanor O’Sullivan, Conrad Timon, Claire Cullen, Pamela Gallagher
    Journal of Cancer Survivorship.2021; 15(6): 855.     CrossRef
  • Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases
    Chen‐Fei Wu, Jia‐Wei Lv, Li Lin, Yan‐Ping Mao, Bin Deng, Wei‐Hong Zheng, Dan‐Wan Wen, Yue Chen, Jia Kou, Fo‐Ping Chen, Xing‐Li Yang, Zi‐Qi Zheng, Zhi‐Xuan Li, Si‐Si Xu, Jun Ma, Ying Sun
    Cancer Communications.2021; 41(1): 37.     CrossRef
  • Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study
    Susanna Hilda Hutajulu, Daniel Howdon, Kartika Widayati Taroeno-Hariadi, Mardiah Suci Hardianti, Ibnu Purwanto, Sagung Rai Indrasari, Camelia Herdini, Bambang Hariwiyanto, Ahmad Ghozali, Henry Kusumo, Wigati Dhamiyati, Sri Retna Dwidanarti, I. Bing Tan, J
    PLOS ONE.2021; 16(2): e0246638.     CrossRef
  • Prognostic models for 1-year survival of NPC after radiotherapy in different ages
    Qu-xia Zhang, Lv-ping Zhuang, Zhong-yang Lin
    European Archives of Oto-Rhino-Laryngology.2021; 278(12): 4955.     CrossRef
  • Characteristics of Early Death in Patients With Localized Nasopharyngeal Cancer: A Population-Based SEER Analysis
    Haiyan Chen, Zhiheng Huang, Liubo Chen, Yanlin Li, Tiehong Zhao, Qichun Wei
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Stage‐dependent conditional survival and failure hazard of non‐metastatic nasopharyngeal carcinoma after intensity‐modulated radiation therapy: Clinical implications for treatment strategies and surveillance
    Jingbo Wang, Xiaodong Huang, Shiran Sun, Kai Wang, Yuan Qu, Xuesong Chen, Runye Wu, Ye Zhang, Qingfeng Liu, Jianghu Zhang, Jingwei Luo, Jianping Xiao, Li Gao, Guozhen Xu, Chen Hu, Ye‐Xiong Li, Junlin Yi
    Cancer Medicine.2021; 10(11): 3613.     CrossRef
  • Effects of radiotherapy in patients with nasopharyngeal carcinoma under continuous-discrete mixed mathematical model and comparison on the fungal and pathogen infection indexes before and after nutritional supplementation
    Yi Li, Xuan Li, Sahar Issa, Khairi Mohamed Omar
    Results in Physics.2021; 26: 104355.     CrossRef
  • Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients
    Xing‐Xi Pan, Ya‐Jie Liu, Wen Yang, Yong‐Fa Chen, Wu‐Bing Tang, Chu‐Rong Li
    The Laryngoscope.2020;[Epub]     CrossRef
  • Association of Ambient Air Pollution with Nasopharyngeal Carcinoma Incidence in Ten Large Chinese Cities, 2006–2013
    Tianan Yang, Yexin Liu, Weigang Zhao, Zhenjiao Chen, Jianwei Deng
    International Journal of Environmental Research and Public Health.2020; 17(6): 1824.     CrossRef
  • Increasing incidence and improving survival of oral tongue squamous cell carcinoma
    Yi-Jun Kim, Jin Ho Kim
    Scientific Reports.2020;[Epub]     CrossRef
  • Identification of differentially expressed circular RNAs in human nasopharyngeal carcinoma
    Hanwei Wu, Yuchen Liu, Hongfang Duan, Xiaoqin Fan, Yujie Wang, Jian Song, Jinghong Han, Ming Yang, Lu Lu, Guohui Nie
    Cancer Biomarkers.2020; 29(4): 483.     CrossRef
  • PP‐22 promotes autophagy and apoptosis in the nasopharyngeal carcinoma cell line CNE‐2 by inducing endoplasmic reticulum stress, downregulating STAT3 signaling, and modulating the MAPK pathway
    Gui‐Xiang Tan, Xin‐Ning Wang, Yun‐Yun Tang, Wan‐Jing Cen, Zhen‐Hua Li, Guo‐Cai Wang, Jian‐Wei Jiang, Xi‐Cheng Wang
    Journal of Cellular Physiology.2019; 234(3): 2618.     CrossRef
  • microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells
    Zheqing Cui, Yulin Zhao
    BMC Cancer.2019;[Epub]     CrossRef
  • Changing odds of survival over time among patients undergoing surgical resection of extremity soft tissue sarcoma
    Yongsung Kim, Han‐Soo Kim, Hwan Seong Cho, Ilkyu Han
    Journal of Surgical Oncology.2019; 120(2): 193.     CrossRef
  • Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma
    Elaine Johanna Limkin, Pierre Blanchard
    The British Journal of Radiology.2019;[Epub]     CrossRef
  • Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma
    Wen Wen, Shi-Juan Mai, Huan-Xin Lin, Mei-Yin Zhang, Jia-Ling Huang, Xin Hua, Chao Lin, Zhi-Qing Long, Zi-Jian Lu, Xiao-Qing Sun, Sai-Lan Liu, Qi Yang, Qian Zhu, Hui-Yun Wang, Ling Guo
    Journal of Translational Medicine.2019;[Epub]     CrossRef
  • Utility of Serum EB Virus Zta Antibody in the Diagnostic of Nasopharyngeal Carcinoma: Evidences From 2,126 Cases and 15,644 Controls
    Guangying Zhang, Zhanzhan Li, Qin Zhou
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Impact of age on survival of locoregional nasopharyngeal carcinoma: An analysis of the Surveillance, Epidemiology, and End Results program database, 2004‐2013
    S.‐J. Huang, Y.‐Y. Tang, H.‐M. Liu, G.‐X. Tan, X. Wang, H. Zhang, F. Yang, S. Yang
    Clinical Otolaryngology.2018; 43(5): 1209.     CrossRef
  • Conditional survival in patients with gallbladder cancer
    Yi-Jun Kim, Kyubo Kim
    Chinese Journal of Cancer.2017;[Epub]     CrossRef
  • 24,094 View
  • 319 Download
  • 29 Web of Science
  • 27 Crossref
Close layer
Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea
Tae Wan Kim, Euncheol Choi, Jeonghoon Park, Dong-ho Shin, Su Kyung Jung, Susie Seok, Kwan Ho Cho, Joo-Young Kim, Dae Yong Kim, Tae Hyun Kim, Yang Kwon Suh, Yeon Joo Kim, Sung Ho Moon
Cancer Res Treat. 2018;50(2):335-344.   Published online April 19, 2017
DOI: https://doi.org/10.4143/crt.2017.070
AbstractAbstract PDFPubReaderePub
Purpose
This study retrospectively evaluated the clinical outcomes and complications of proton beam therapy (PBT) in a single institution in Korea and quantitatively analyzed the change in tumor volume after PBT using magnetic resonance imaging (MRI).
Materials and Methods
Twenty-four treatment-naïve patients who underwent PBT for choroidal melanoma between 2009 and 2015 were reviewed. Dose fractionation was 60-70 cobalt gray equivalents over 5 fractions. Orbital MRIs were taken at baseline and 3, 6, and 12 months after PBT and annually thereafter. The tumor volume was reconstructed and evaluated by stacking the tumor boundary in each thin-sliced axial T1-weighted image using MIM software.
Results
The median follow-up duration was 36.5 months (range, 9 to 82 months). One patient had suspicious local progression and two patients had distant metastasis. The 3-year local progression-free survival, distant metastasis-free survival, and overall survival rates were 95.8%, 95.8%, and 100%,respectively. Five Common Terminology Criteria for Adverse Event ver. 4.03 grade 3-4 toxicities were observed in four patients (16.7%), including one with neovascular glaucoma. The mean tumor volume at the baseline MRI was 0.565±0.084 mL (range, 0.074 to 1.610 mL), and the ratios of the mean volume at 3, 6, and 12 months to that at baseline were 81.8%, 67.3%, and 60.4%, respectively.
Conclusion
The local controlrate and complication profile after PBT in patientswith choroidal melanoma in Korea were comparable with those reported in a previous PBT series. The change in tumor volume after PBT exhibited a gradual regression pattern on MRI.

Citations

Citations to this article as recorded by  
  • Efficacy and safety of proton radiotherapy in treating choroidal melanoma: a systematic review and meta-analysis
    Yuxin Miao, Tingwei Zheng, Qiuning Zhang, Meixuan Li, Qihang Lei, Qin Liu, Hongtao Luo, Huiling Bai
    Radiation Oncology.2025;[Epub]     CrossRef
  • Monte Carlo simulation of polymer phantoms in proton therapy for eye tumor treatment
    Engin Aşlar, Fatih Ekinci
    The European Physical Journal Plus.2025;[Epub]     CrossRef
  • Opportunities and challenges of upright patient positioning in radiotherapy
    Lennart Volz, James Korte, Maria Chiara Martire, Ye Zhang, Nicholas Hardcastle, Marco Durante, Tomas Kron, Christian Graeff
    Physics in Medicine & Biology.2024; 69(18): 18TR02.     CrossRef
  • Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective
    Myriam G. Jaarsma-Coes, Lisa Klaassen, Marina Marinkovic, Gregorius P. M. Luyten, T. H. Khanh Vu, Teresa A. Ferreira, Jan-Willem M. Beenakker
    Cancers.2023; 15(11): 2995.     CrossRef
  • When Is the Optimum Radiological Response to Proton Beam Therapy in Uveal Melanoma?
    Matthew Gillam, Glenn Ace Fenech, Oliver Chadwick, Jonathan Nairn, Vikas Chadha, Julie Connolly, Oliver Cram, Wilma Kincaid, Paul Cauchi
    Ocular Oncology and Pathology.2023; 9(5-6): 130.     CrossRef
  • Optimization of proton therapy eye-treatment systems toward improved clinical performances
    Eustache Gnacadja, Cédric Hernalsteens, Stewart Boogert, Quentin Flandroy, Carolina Fuentes, Laurence J. Nevay, Nicolas Pauly, Eliott Ramoisiaux, William Shields, Robin Tesse, Raphael Van Roermund, Marion Vanwelde
    Physical Review Research.2022;[Epub]     CrossRef
  • Who Will Benefit from Charged-Particle Therapy?
    Kyung Su Kim, Hong-Gyun Wu
    Cancer Research and Treatment.2021; 53(3): 621.     CrossRef
  • Uveal Melanoma: A Review of the Literature and Personal Experiences
    Yong Joon Kim, Christopher Seungkyu Lee, Sung Chul Lee
    Journal of Retina.2021; 6(2): 65.     CrossRef
  • Carbon Fiducial Markers for Tumor Localization in Stereotactic Irradiation of Uveal Melanoma
    Timothy T. Xu, Jose S. Pulido, Ian F. Parney, Cristiane M. Ida, Lauren A. Dalvin, Timothy W. Olsen
    Ocular Oncology and Pathology.2021; 7(5): 368.     CrossRef
  • Uveal Melanoma in Asians: A Review
    Pradeep Manchegowda, Arun D. Singh, Carol Shields, Swathi Kaliki, Parag Shah, Lingam Gopal, Pukhraj Rishi
    Ocular Oncology and Pathology.2021; 7(3): 159.     CrossRef
  • Preliminary Dosimetric Study of Proton Minibeam Radiation Therapy for the Treatment of Choroidal Melanoma
    Myeongsoo Kim, Sang Soo Kim, Haksoo Kim, Sung Ho Moon, Young Kyung Lim, Ui-Jung Hwang, Sang Hyoun Choi
    Journal of the Korean Physical Society.2020; 77(5): 447.     CrossRef
  • Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea
    Su-Kyung Jung, Young-Hoon Park, Dong-ho Shin, Hak-Soo Kim, Jong-Hwi Jung, Tae-Hyun Kim, Sung Ho Moon, Vikas Khetan
    PLOS ONE.2020; 15(12): e0242966.     CrossRef
  • 12,169 View
  • 271 Download
  • 12 Web of Science
  • 12 Crossref
Close layer
The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015
Young-Seok Seo, Mi-Sook Kim, Jin-Kyu Kang, Won-Il Jang, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Jae Sun Yoon
Cancer Res Treat. 2018;50(2):345-355.   Published online April 25, 2017
DOI: https://doi.org/10.4143/crt.2017.096
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2011 and 2015.
Materials and Methods
We analyzed the claims data from the Health Insurance Review and Assessment Service to estimate the clinical utilization of RT. The source population consisted of all patients who had any of the International Classification of Diseases 10th revision cancer diagnoses (C00-C97) and those with diagnostic codes D00-D48, who were also associated with at least one of the procedure codes related to RT.
Results
The total number of patients who received RT in 2011, 2012, 2013, 2014, and 2015 were 54,810, 59,435, 61,839, 64,062, and 66,183, respectively. Among them, the total numbers of male and female patients were 24,946/29,864 in 2011, 27,211/32,224 in 2012, 28,111/33,728 in 2013, 29,312/34,750 in 2014, and 30,266/35,917 in 2015. The utilization rate of RT in cancer patients has also increased steadily over the same period from 25% to 30%. The five cancers that were most frequently treated with RT between 2011 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. More than half of cancer patients (64%) were treated with RT in the capital area (Seoul, Gyeonggi, and Incheon).
Conclusion
The total number of patients who underwent RT increased steadily from 2011 to 2015 in Korea. The utilization rate of RT in cancer patients is also increasing.

Citations

Citations to this article as recorded by  
  • An Analysis of Radiotherapy Machine Requirements in India: Impact of the Pandemic and Regional Disparities
    Rohit Singh Chauhan, Anusheel Munshi, Anirudh Pradhan
    Journal of Medical Physics.2024; 49(3): 370.     CrossRef
  • Efficacy of Auricular Acupressure Combined With Positive Psychological Techniques on Sleep Quality in Cancer Patients Undergoing Radiotherapy
    Liuna Bi, Wenjuan Gao, Qian Zhang, Na Li, Xian Zhang, Jing Han
    Cancer Nursing.2024;[Epub]     CrossRef
  • Recent trends in radiotherapy use for major cancers in Korea
    Kyungmi Yang, Jeong Eun Lee, Won Park, Yong Chan Ahn, Seung Jae Huh
    Japanese Journal of Clinical Oncology.2023; 53(12): 1177.     CrossRef
  • An Investigation of the Effect of Virtual Reality on Alleviating Anxiety in Patients With Breast Cancer Undergoing Radiation Therapy: A Randomized Controlled Trial
    Jaeyong Shin, Jee Suk Chang, Jin Sung Kim, Ji-Yeon An, Seung Yeun Chung, So-Yeon Yoon, Yong Bae Kim
    International Journal of Radiation Oncology*Biology*Physics.2023; 117(5): 1191.     CrossRef
  • Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
    Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
    Radiation Oncology Journal.2022; 40(1): 53.     CrossRef
  • Clinical utilization of radiation therapy in Korea between 2017 and 2019
    Eunji Kim, Won Il Jang, Kwangmo Yang, Mi-Sook Kim, Hyung Jun Yoo, Eun Kyung Paik, Heejin Kim, Jaesun Yoon
    Radiation Oncology Journal.2022; 40(4): 251.     CrossRef
  • The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High‐Income Countries: Canada, Korea, and Italy
    Jinyao Wang, Zhiqiang Bai, Xudong Gao, Nianping Zhang, Zhenkun Wang, Zhongjie Shi
    BioMed Research International.2021;[Epub]     CrossRef
  • Variation of heart and lung radiation doses according to setup uncertainty in left breast cancer
    Sunmin Park, Chai Hong Rim, Won Sup Yoon
    Radiation Oncology.2021;[Epub]     CrossRef
  • Who Will Benefit from Charged-Particle Therapy?
    Kyung Su Kim, Hong-Gyun Wu
    Cancer Research and Treatment.2021; 53(3): 621.     CrossRef
  • Current status and comparison of national health insurance systems for advanced radiation technologies in Korea and Japan
    Seung Jae Huh, Tetsuo Nishimura, Won Park, Hiroshi Onishi, Yong Chan Ahn, Katsumasa Nakamura
    Radiation Oncology Journal.2020; 38(3): 170.     CrossRef
  • External beam radiation therapy in a centenarian with primary liver cancer
    Zhen Meng, Feifei Gao, Chang Liu, Shengcai Huang, Kai Hu, Rensheng Wang
    Medicine.2020; 99(47): e22473.     CrossRef
  • Comparison of radiotherapy infrastructure between Korea and Japan
    Seung Jae Huh, Tetsuo Nishimura, Won Park, Katsumasa Nakamura
    Japanese Journal of Clinical Oncology.2019; 49(11): 1024.     CrossRef
  • Recent trends in intensity-modulated radiation therapy use in Korea
    Seung Jae Huh, Won Park, Do Ho Choi
    Radiation Oncology Journal.2019; 37(4): 249.     CrossRef
  • Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta‐analyses
    Chai Hong Rim, Hyung Joon Yim, Sunmin Park, Jinsil Seong
    Journal of Medical Imaging and Radiation Oncology.2019; 63(6): 812.     CrossRef
  • Second re-irradiation: a narrative review of the available clinical data
    Carsten Nieder, Johannes A. Langendijk, Matthias Guckenberger, Anca L. Grosu
    Acta Oncologica.2018; 57(3): 305.     CrossRef
  • 10,634 View
  • 274 Download
  • 19 Web of Science
  • 15 Crossref
Close layer
Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine
Margherita Baldassarri, Chiara Fallerini, Francesco Cetta, Marco Ghisalberti, Cristiana Bellan, Simone Furini, Ottavia Spiga, Sergio Crispino, Giuseppe Gotti, Francesca Ariani, Piero Paladini, Alessandra Renieri, Elisa Frullanti
Cancer Res Treat. 2018;50(2):356-365.   Published online May 26, 2017
DOI: https://doi.org/10.4143/crt.2017.125
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Lung cancer is strongly associated to tobacco smoking. However, global statistics estimate that in females the proportion of lung cancer cases that is unrelated to tobacco smoking reaches fifty percent, making questionable the etiology of the disease.
Materials and Methods
A never-smoker female with primary EGFR/KRAS/ALK-negative squamous cell carcinoma of the lung and their normal sibswere subjected to a novel integrative “omic” approach using a pedigree-based model for discovering genetic factors leading to cancer in the absence of well-known environmental trigger. A first-stepwhole-exome sequencing on tumor and normal tissue did not identify mutations in known driver genes. Building on the idea of a germline oligogenic origin of lung cancer, we performed whole-exome sequencing of DNA from patients’ peripheral blood and their unaffected sibs. Finally, RNA-sequencing analysis in tumoral and matched non-tumoral tissues was carried out in order to investigate the clonal profile and the pathogenic role of the identified variants.
Results
Filtering for rare variants with Combined Annotation Dependent Depletion (CADD) > 25 and potentially damaging effect, we identified rare/private germline deleterious variants in 11 cancer-associated genes, none ofwhich, except one, sharedwith the healthy sib, pinpointing to a “private” oligogenic germline signature. Noteworthy, among these, two mutated genes, namely ACACA and DEPTOR, turned to be potential targets for therapy because related to known drivers, such as BRCA1 and EGFR.
Conclusion
In the era of precision medicine, this report emphasizes the importance of an “omic” approach to uncover oligogenic germline signature underlying cancer development and to identify suitable therapeutic targets as well.

Citations

Citations to this article as recorded by  
  • Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
    Yingxi Mo, Jun Zhao, Ran Zhao, Yiying Huang, Ziyuan Liang, Xiaoying Zhou, Jiemei Chu, Xinli Pan, Siyu Duan, Shiman Chen, Liufang Mo, Bizhou Huang, Zhaozhang Huang, Jiale Wei, Qian Zheng, Wenqi Luo
    Open Life Sciences.2023;[Epub]     CrossRef
  • The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma
    Ahmed El-Azony, Mohammad Abd Alkhalik Basha, Yassir Edrees Almalki, Bader Abdelmaksoud, Nabila Hefzi, Ahmed A. Alnagar, Sheren Mahdey, Ismail Mohamed Ali, Ibrahim Nasr, Ahmed A. El-Hamid M. Abdalla, Hala Y. Yousef, Mohamed M. A. Zaitoun, Saeed Bakry Elsay
    European Radiology.2023; 34(4): 2500.     CrossRef
  • MicroRNA‑15a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression
    Po Xu, Ying Wang, Zhe Deng, Zhibo Tan, Xiaojuan Pei
    Oncology Letters.2022;[Epub]     CrossRef
  • Prognostic Value of Dual-Time-Point [18F]FDG PET/CT for Predicting Distant Metastasis after Treatment in Patients with Non-Small Cell Lung Cancer
    Sang Mi Lee, Jeong Won Lee, Ji-Hyun Lee, In Young Jo, Su Jin Jang
    Journal of Personalized Medicine.2022; 12(4): 592.     CrossRef
  • Management of Fournier’s gangrene during the Covid-19 pandemic era: make a virtue out of necessity
    Alessio Paladini, Giovanni Cochetti, Angelica Tancredi, Matteo Mearini, Andrea Vitale, Francesca Pastore, Paolo Mangione, Ettore Mearini
    Basic and Clinical Andrology.2022;[Epub]     CrossRef
  • Welding Fume Instillation in Isolated Perfused Mouse Lungs—Effects of Zinc- and Copper-Containing Welding Fumes
    Julia Krabbe, Thomas Kraus, Hanif Krabbe, Christian Martin, Patrick Ziegler
    International Journal of Molecular Sciences.2022; 23(16): 9052.     CrossRef
  • The Challenges of Patient Selection for Prostate Cancer Focal Therapy: A Retrospective Observational Multicentre Study
    Alessio Paladini, Giovanni Cochetti, Alexandre Colau, Martin Mouton, Sara Ciarletti, Graziano Felici, Giuseppe Maiolino, Federica Balzarini, Philippe Sèbe, Ettore Mearini
    Current Oncology.2022; 29(10): 6826.     CrossRef
  • Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
    Tao Feng, Chunyu Song, Zhiyong Wu, Ke Zhao, Shenglan Ye
    Open Medicine.2022; 17(1): 1528.     CrossRef
  • lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
    Wenjun Mao, Shengfei Wang, Ruo Chen, Yijun He, Rongguo Lu, Mingfeng Zheng
    Open Medicine.2022; 17(1): 1538.     CrossRef
  • Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis
    Qingfeng Ye, Jundan Wang, Da Xu, Yu Liu, Dimei Zhang, Jufeng Ye, Hua Li
    Expert Review of Anticancer Therapy.2022; 22(12): 1357.     CrossRef
  • lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
    Shuangqin Peng, Yanjun Luo, Lijuan Chen, Kang Dai, Qin Wang
    Open Medicine.2022; 17(1): 1999.     CrossRef
  • Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer
    Zhuo Li, La-Xiu Li, Yan-Jun Diao, Juan Wang, Yun Ye, Xiao-Ke Hao
    Cancer Management and Research.2021; Volume 13: 25.     CrossRef
  • Metastatic renal Ewing’s sarcoma in adult woman: Case report and review of the literature
    Giovanni Cochetti, Alessio Paladini, Jacopo Adolfo Rossi de Vermandois, Sonia Fatigoni, Magda Zanelli, Stefano Ascani, Ettore Mearini
    Open Medicine.2021; 16(1): 397.     CrossRef
  • Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
    Pawel Rajwa, Nicolai A. Huebner, Dadjar I. Hostermann, Nico C. Grossmann, Victor M. Schuettfort, Stephan Korn, Fahad Quhal, Frederik König, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Takafumi Yanagisawa, Abdulmajeed Aydh, Piot
    Journal of Personalized Medicine.2021; 11(11): 1231.     CrossRef
  • Age and Clinical Presentation for Primary Spontaneous Pneumothorax
    Marco Ghisalberti, Francesco Guerrera, Andrea De Vico, Luca Bertolaccini, Angela De Palma, Alfonso Fiorelli, Piero Paladini, Enrico Ruffini, Roberto Crisci, Mario Nosotti, Paolo Mendogni
    Heart, Lung and Circulation.2020; 29(11): 1648.     CrossRef
  • Fatty acid synthesis and cancer: Aberrant expression of the ACACA and ACACB genes increases the risk for cancer
    Kasturi Bhattacharjee, Moumita Nath, Yashmin Choudhury
    Meta Gene.2020; 26: 100798.     CrossRef
  • Non-Smoking-Associated Lung Cancer: A distinct Entity in Terms of Tumor Biology, Patient Characteristics and Impact of Hereditary Cancer Predisposition
    Elisabeth Smolle, Martin Pichler
    Cancers.2019; 11(2): 204.     CrossRef
  • Germline mutations in lung cancer and personalized medicine
    Francesco Cetta, Alessandra Renieri, Elisa Frullanti
    Familial Cancer.2018; 17(3): 429.     CrossRef
  • DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways
    Naoki Katase, Shin‑Ichiro Nishimatsu, Akira Yamauchi, Masahiro Yamamura, Shuichi Fujita
    International Journal of Oncology.2018;[Epub]     CrossRef
  • 9,464 View
  • 270 Download
  • 20 Web of Science
  • 19 Crossref
Close layer
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
Jeong-Ju Yoo, Goh Eun Chung, Jeong-Hoon Lee, Joon Yeul Nam, Young Chang, Jeong Min Lee, Dong Ho Lee, Hwi Young Kim, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Seoul Liver Group
Cancer Res Treat. 2018;50(2):366-373.   Published online May 15, 2017
DOI: https://doi.org/10.4143/crt.2017.126
AbstractAbstract PDFPubReaderePub
Purpose
Advanced hepatocellular carcinoma (HCC) is associated with various clinical conditions including major vessel invasion, metastasis, and poor performance status. The aim of this study was to establish a prognostic scoring system and to propose a sub-classification of the Barcelona-Clinic Liver Cancer (BCLC) stage C.
Materials and Methods
This retrospective study included consecutive patientswho received sorafenib for BCLC stage C HCC at a single tertiary hospital in Korea. A Cox proportional hazard model was used to develop a scoring system, and internal validationwas performed by a 5-fold cross-validation. The performance of the model in predicting risk was assessed by the area under the curve and the Hosmer-Lemeshow test.
Results
A total of 612 BCLC stage C HCC patients were sub- classified into strata depending on their performance status. Five independent prognostic factors (Child-Pugh score, α-fetoprotein, tumor type, extrahepatic metastasis, and portal vein invasion) were identified and used in the prognostic scoring system. This scoring system showed good discrimination (area under the receiver operating characteristic curve, 0.734 to 0.818) and calibration functions (both p < 0.05 by the Hosmer-Lemeshow test at 1 month and 12 months, respectively). The differences in survival among the different risk groups classified by the total score were significant (p < 0.001 by the log-rank test in both the Eastern Cooperative Oncology Group 0 and 1 strata).
Conclusion
The heterogeneity of patientswith BCLC stage C HCC requires sub-classification of advanced HCC. A prognostic scoring system with five independent factors is useful in predicting the survival of patients with BCLC stage C HCC.

Citations

Citations to this article as recorded by  
  • Tumor burden affects the progression pattern on the prognosis in patients treated with sorafenib
    Jun Sun, Dongdong Xia, Wei Bai, Xiaomei Li, Enxing Wang, ZhanXin Yin, Guohong Han
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
    Ji W. Han, Soon K. Lee, Jung H. Kwon, Soon W. Nam, Hyun Yang, Si H. Bae, Ji H. Kim, Heechul Nam, Chang W. Kim, Hae L. Lee, Hee Y. Kim, Sung W. Lee, Ahlim Lee, U I. Chang, Do S. Song, Seok-Hwan Kim, Myeong J. Song, Pil S. Sung, Jong Y. Choi, Seung K. Yoon,
    Clinical Cancer Research.2024; 30(13): 2812.     CrossRef
  • Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
    Sujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
    Journal of Liver Cancer.2023; 23(1): 177.     CrossRef
  • Development and validation of web‐based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database
    Guizhong Huang, Qiaohong Lin, Pengfei Yin, Kai Mao, Jianlong Zhang
    Cancer Medicine.2023; 12(12): 13167.     CrossRef
  • Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma
    Xiaomi Li, Xiaoyan Ding, Mei Liu, Jingyan Wang, Wei Li, Jinglong Chen
    The Oncologist.2023; 28(10): e942.     CrossRef
  • Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal
    Li Li, Xiaomi Li, Wendong Li, Xiaoyan Ding, Yongchao Zhang, Jinglong Chen, Wei Li
    BMC Cancer.2022;[Epub]     CrossRef
  • Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
    Min Chen, Guang-Bo Wu, Shan Hua, Zhi-Feng Zhao, Hong-Jie Li, Meng Luo
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy
    Jian-Xu Li, Mei-Ling He, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Jian-Hong Zhong, Rui-Jun Zhang, Chun-Feng Liang, Ya-Dan Pang, Jun-Kun He, Qian-Qian Chen, Jin-Xia Weng, Shi-Xiong Liang, Bang-De Xiang
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
    Giovanni Marasco, Francesco Poggioli, Antonio Colecchia, Giuseppe Cabibbo, Filippo Pelizzaro, Edoardo Giannini, Sara Marinelli, Gian Rapaccini, Eugenio Caturelli, Mariella Di Marco, Elisabetta Biasini, Fabio Marra, Filomena Morisco, Francesco Foschi, Marc
    Cancers.2021; 13(11): 2677.     CrossRef
  • Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study
    Young Youn Cho, Su Jong Yu, Hye Won Lee, Do Young Kim, Wonseok Kang, Yong-Han Paik, Pil Soo Sung, Si Hyun Bae, Su Cheol Park, Young Seok Doh, Kang Mo Kim, Eun Sun Jang, In Hee Kim, Won Kim, Yoon Jun Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 613.     CrossRef
  • Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
    Chen Jin, Rui Li, Tuo Deng, Jialiang Li, Yan Yang, Haoqi Li, Kaiyu Chen, Huihua Xiong, Gang Chen, Yi Wang
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • Construction and validation of an N6‑methyladenosine‑associated prognostic signature in hepatocellular carcinoma
    Peng Zhu, Qianqian Ren, Nan He, Cheng Zhou, Qianna Jin, Zhao Gong
    Oncology Letters.2021;[Epub]     CrossRef
  • Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
    Tim A. Labeur, Sarah Berhane, Julien Edeline, Jean‐Frederic Blanc, Dominik Bettinger, Tim Meyer, Jeroen L. A. Van Vugt, David W. G. Ten Cate, Robert A. De Man, Ferry A. L. M. Eskens, Alessandro Cucchetti, Laura J. Bonnett, Otto M. Van Delden, Heinz‐Josef
    Liver International.2020; 40(1): 215.     CrossRef
  • A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients
    Tingting Zhang, Zhe Liu, Xiangqian Zhao, Zhiyuan Mao, Li Bai
    Artificial Cells, Nanomedicine, and Biotechnology.2019; 47(1): 2246.     CrossRef
  • Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C
    Yeon Joo Kim, Jinhong Jung, Ji Hyeon Joo, So Yeon Kim, Jin Hyoung Kim, Young-Suk Lim, Han Chu Lee, Jong Hoon Kim, Sang Min Yoon
    Radiotherapy and Oncology.2019; 141: 95.     CrossRef
  • Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Bo Hyun Kim, Joong-Won Park
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • 9,651 View
  • 308 Download
  • 18 Web of Science
  • 16 Crossref
Close layer
Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study
Won-Il Choi, Sun Hyo Park, Byeong Ju Park, Choong Won Lee
Cancer Res Treat. 2018;50(2):374-381.   Published online May 8, 2017
DOI: https://doi.org/10.4143/crt.2017.119
AbstractAbstract PDFPubReaderePub
Purpose
In this nationwide 5-year longitudinal population-based study, we aimed at investigating the incidence of lung cancer among patients with interstitial lung disease.
Materials and Methods
Data was collected from the Korean National Health Insurance Research Database from 49,773,195 Korean residents in 2009. Thirteen thousand six hundred and sixty-six patients with interstitial lung disease diagnosed January-December 2009. The end of follow-up was June 30, 2014. Up to four matching chronic obstructive pulmonary disease controls were selected to compare the lung cancer high-risk group based on age, sex, diagnosis date (within 30 days), and hospital size. The number of patients with newly developed lung cancer was determined.
Results
The incidences of lung cancer were 126.98, 156.62, and 370.38 cases per 10,000 person-years (2,732, 809, and 967 cases of cancer, respectively) in the chronic obstructive pulmonary disease, interstitial lung disease, and chronic obstructive pulmonary disease with interstitial lung disease groups, respectively. Of the 879 patients with idiopathic pulmonary fibrosis, 112 developed lung cancer (incidence, 381.00 cases per 10,000 personyears).
Conclusion
Incidence of lung cancer among patients with interstitial lung disease was high. Interstitial lung diseases have a high potential for developing into lung cancer, even when concurrent with chronic obstructive pulmonary disease.

Citations

Citations to this article as recorded by  
  • Air Pollution and Interstitial Lung Disease
    Yong Suk Jo, Jin Woo Song
    Tuberculosis and Respiratory Diseases.2025; 88(1): 45.     CrossRef
  • Spatial transcriptome analysis of lung squamous cell carcinoma arising from interstitial pneumonia provides insights into tumor heterogeneity
    Koto Ukon, Satoshi Nojima, Daisuke Motooka, Tsuyoshi Takashima, Masaharu Kohara, Hiroki Kiyokawa, Kenji Kimura, Eriko Fukui, Shinichiro Tahara, Kansuke Kido, Takahiro Matsui, Yasushi Shintani, Daisuke Okuzaki, Eiichi Morii
    Pathology - Research and Practice.2025; 266: 155805.     CrossRef
  • Evaluating lung cancer risk factors in adults with interstitial lung disease
    Jane Dobkin, B. Payne Stanifer, Mary Salvatore, Christina M. Eckhardt
    Lung Cancer.2025; 201: 108416.     CrossRef
  • Diagnostic du cancer pulmonaire en imagerie : pièges à connaître
    M. Dobre, S. Fawaz, C. Caramella, C. de Margerie-Mellon
    Journal d'imagerie diagnostique et interventionnelle.2025;[Epub]     CrossRef
  • The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis
    Doris Lan, Caitlin C. Fermoyle, Lauren K. Troy, Luke D. Knibbs, Tamera J. Corte
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Subsolid Nodules
    Lea Azour, Andrea S. Oh, Ashley E. Prosper, Danielle Toussie, Geraldine Villasana-Gomez, Lila Pourzand
    Clinics in Chest Medicine.2024; 45(2): 263.     CrossRef
  • Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
    Soo Jin Han, Hyeon Hwa Kim, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee, Ho Cheol Kim
    BMC Pulmonary Medicine.2024;[Epub]     CrossRef
  • High risk of lung cancer in surfactant-related gene variant carriers
    Alexandre Brudon, Marie Legendre, Arthur Mageau, Julien Bermudez, Philippe Bonniaud, Diane Bouvry, Jacques Cadranel, Aurélie Cazes, Bruno Crestani, Tristan Dégot, Céline Delestrain, Rémi Diesler, Ralph Epaud, Quentin Philippot, Nathalie Théou-Anton, Carol
    European Respiratory Journal.2024; 63(5): 2301809.     CrossRef
  • Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives
    Masaki Hanibuchi, Hirokazu Ogino, Seidai Sato, Yasuhiko Nishioka
    The Journal of Medical Investigation.2024; 71(1.2): 9.     CrossRef
  • Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
    Fotios Sampsonas, Pinelopi Bosgana, Vasiliki Bravou, Argyrios Tzouvelekis, Foteinos-Ioannis Dimitrakopoulos, Eleni Kokkotou
    Genes.2024; 15(7): 934.     CrossRef
  • Predictors for acute exacerbation of interstitial pneumonia following lung cancer surgery: a multicenter study
    Lijie Yin, Rui Xu, Xiaojian Liu, Liping Fu, Guangliang Qiang
    BMC Pulmonary Medicine.2024;[Epub]     CrossRef
  • Effects of Light-absorbing Carbons in Intraoperative Molecular Imaging–Guided Lung Cancer Resections
    Feredun Azari, Gregory Kennedy, Kevin Zhang, Elizabeth Bernstein, Ashley Chang, Bilal Nadeem, Alix Segil, Charuhas Desphande, James Delikatny, John Kucharczuk, Sunil Singhal
    Molecular Imaging and Biology.2023; 25(1): 156.     CrossRef
  • Management of Lung Cancer in the Patient with Interstitial Lung Disease
    Angela J Frank, Ibiayi Dagogo-Jack, Ioana A Dobre, Sarah Tait, Lana Schumacher, Florian J Fintelmann, Leah M Fingerman, Florence K Keane, Sydney B Montesi
    The Oncologist.2023; 28(1): 12.     CrossRef
  • Is pulmonary fibrosis a precancerous disease?
    Mahdie Hosseini, Mary Salvatore
    European Journal of Radiology.2023; 160: 110723.     CrossRef
  • Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
    Jang Ho Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Ho Cheol Kim
    BMC Pulmonary Medicine.2023;[Epub]     CrossRef
  • Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review
    Anna Stainer, Antonio Tonutti, Maria De Santis, Francesco Amati, Angela Ceribelli, Gabriele Bongiovanni, Chiara Torrisi, Antonio Iacopino, Giuseppe Mangiameli, Stefano Aliberti, Carlo Selmi
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway
    Junmei Guo, Wei Zhang, Liping Sun, Hongfang Yu, Yuzhe Wang, Li Feng, Hao Yang
    Scientific Reports.2023;[Epub]     CrossRef
  • Proteomic analysis of serum in workers exposed to diesel engine exhaust
    Mohammad L. Rahman, Bryan A. Bassig, Yufei Dai, Wei Hu, Jason Y. Y. Wong, Batel Blechter, H. Dean Hosgood, Danzhi Ren, Huawei Duan, Yong Niu, Jun Xu, Wei Fu, Kees Meliefste, Baosen Zhou, Jufang Yang, Meng Ye, Xiaowei Jia, Tao Meng, Ping Bin, Debra T. Silv
    Environmental and Molecular Mutagenesis.2022; 63(1): 18.     CrossRef
  • Two‐Stage Hybrid Approach of Deep Learning Networks for Interstitial Lung Disease Classification
    Swati P. Pawar, Sanjay N. Talbar, Fan Yang
    BioMed Research International.2022;[Epub]     CrossRef
  • Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry
    Laurie L. Carr, Debra S. Dyer, Pearlanne T. Zelarney, Elizabeth O. Kern
    JTO Clinical and Research Reports.2022; 3(3): 100297.     CrossRef
  • Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
    Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour
    ERJ Open Research.2022; 8(2): 00115-2022.     CrossRef
  • Comorbidity and life expectancy in shared decision making for lung cancer screening
    Brett Bade, Mary Gwin, Matthew Triplette, Renda Soylemez Wiener, Kristina Crothers
    Seminars in Oncology.2022; 49(3-4): 220.     CrossRef
  • Inhaled Corticosteroids and the Risk of Lung Cancer in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis
    Amare Abera Tareke, Wondwosen Debebe, Addis Alem, Nebiyou Simegnew Bayileyegn, Taddese Alemu Zerfu, Andualem Mossie Ayana, Kazuyoshi Kuwano
    Pulmonary Medicine.2022; 2022: 1.     CrossRef
  • MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review)
    Xindi Liang, Qiang Wu, Yuan Wang, Shirong Li
    Oncology Reports.2022;[Epub]     CrossRef
  • Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges
    Ahmad Abu Qubo, Jamil Numan, Juan Snijder, Maria Padilla, John H.M. Austin, Kathleen M. Capaccione, Monica Pernia, Jean Bustamante, Timothy O'Connor, Mary M. Salvatore
    Breathe.2022; 18(4): 220147.     CrossRef
  • Shades of Gray
    Lea Azour, Jane P. Ko, David P. Naidich, William H. Moore
    Chest.2021; 159(5): 2072.     CrossRef
  • Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patients
    Jeffrey A Sparks, Yinzhu Jin, Soo-Kyung Cho, Seanna Vine, Rishi Desai, Tracy J Doyle, Seoyoung C Kim
    Rheumatology.2021; 60(8): 3689.     CrossRef
  • Diagnosis and Management of Fibrotic Interstitial Lung Diseases
    Bridget F. Collins, Fabrizio Luppi
    Clinics in Chest Medicine.2021; 42(2): 321.     CrossRef
  • Idiopathic Pulmonary Comorbidities and Mechanisms
    Maricica Pacurari, Amal Mitra, Timothy Turner, Jian-Dong Li
    International Journal of Inflammation.2021; 2021: 1.     CrossRef
  • Repurposing Anticancer Drugs for the Treatment of Idiopathic Pulmonary Fibrosis and Antifibrotic Drugs for the Treatment of Cancer: State of the Art
    Panagiotis Paliogiannis, Sara Solveig Fois, Alessandro Giuseppe Fois, Antonio Cossu, Giuseppe Palmieri, Gianfranco Pintus
    Current Medicinal Chemistry.2021; 28(11): 2234.     CrossRef
  • Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?
    George E Fragoulis, Katerina Chatzidionysiou
    Clinical Rheumatology.2020; 39(3): 957.     CrossRef
  • Pharmacological treatment of pulmonary fibrosis
    Won-Il Choi
    Journal of the Korean Medical Association.2020; 63(1): 47.     CrossRef
  • Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
    Paolo Cameli, Elena Bargagli, Laura Bergantini, Miriana d’Alessandro, Maria Pieroni, Giovanni A. Fontana, Piersante Sestini, Rosa Metella Refini
    International Journal of Molecular Sciences.2020; 21(17): 6187.     CrossRef
  • Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study
    Won-Il Choi, Dong Yoon Lee, Hyun-Gi Choi, Choong Won Lee
    Respiratory Research.2019;[Epub]     CrossRef
  • Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
    Osamu Kanai, Young Hak Kim, Yoshiki Demura, Makiko Kanai, Tsuyoshi Ito, Kohei Fujita, Hironori Yoshida, Masaya Akai, Tadashi Mio, Toyohiro Hirai
    Thoracic Cancer.2018; 9(7): 847.     CrossRef
  • Germline mutations in young non-smoking women with lung adenocarcinoma
    Iikki Donner, Riku Katainen, Lauri J. Sipilä, Mervi Aavikko, Eero Pukkala, Lauri A. Aaltonen
    Lung Cancer.2018; 122: 76.     CrossRef
  • Risk factors for interstitial lung disease: a 9-year Nationwide population-based study
    Won-Il Choi, Sonila Dauti, Hyun Jung Kim, Sun Hyo Park, Jae Seok Park, Choong Won Lee
    BMC Pulmonary Medicine.2018;[Epub]     CrossRef
  • Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy
    Fangjuan Li, Ziyang Zhou, Ailu Wu, Yong Cai, Hongyu Wu, Ming Chen, Shixiong Liang
    Radiation Oncology.2018;[Epub]     CrossRef
  • 13,428 View
  • 534 Download
  • 40 Web of Science
  • 38 Crossref
Close layer
Effect of Necrosis on the miRNA-mRNA Regulatory Network in CRT-MG Human Astroglioma Cells
So-Hee Ahn, Jung-Hyuck Ahn, Dong-Ryeol Ryu, Jisoo Lee, Min-Sun Cho, Youn-Hee Choi
Cancer Res Treat. 2018;50(2):382-397.   Published online May 22, 2017
DOI: https://doi.org/10.4143/crt.2016.551
AbstractAbstract PDFPubReaderePub
Purpose
Glioblastoma multiforme (GBM) is the most common adult primary intracranial tumor. The remarkable features of GBM include central necrosis. MicroRNAs (miRNAs) have been considered as diagnostic/prognostic biomarkers for many cancers, including glioblastoma. However, the effect of necrosis on the miRNA expression profile and predicted miRNA-mRNA regulatory information remain unclear. The purpose of this study is to examine the effect of necrotic cells on the modulation of miRNA and mRNA expression profiles and miRNA-mRNA network in CRT-MG cells.
Materials and Methods
We used human astroglioma cells, CRT-MG, treated with necrotic CRT-MG cells to examine the effect of necrosis on the modulation of miRNA and mRNA by next-generation sequencing. For preparation of necrotic cells, CRT-MGcellswere frozen and thawed through cycle of liquid nitrogen–water bath. The putative miRNA-mRNA regulatory relationshipwas inferred through target information, using miRDB.
Results
The necrotic cells induced dysregulation of 106 miRNAs and 887 mRNAs. Among them, 11 miRNAs that had a negative correlation value of p < 0.05 by the hypergeometric test were screened, and their target mRNAs were analyzed by Gene Ontology enrichment analysis. Using the Kyoto Encyclopedia of Genes and Genomes database, we also found several necrotic cell treatment-activated pathways that were modulated by relevant gene targets of differentially expressed miRNAs.
Conclusion
Our result demonstrated that dysregulation of miRNA and mRNA expression profiles occurs when GBM cells are exposed to necrotic cells, suggesting that several miRNAs may have the potential to be used as biomarkers for predicting GBM progression and pathogenesis.

Citations

Citations to this article as recorded by  
  • MiR-4492, a New Potential MicroRNA for Cancer Diagnosis and Treatment: A Mini Review
    Aida Alizamir, Mohammad Amin Amini, Ashkan Karbasi, Mehdi Beyrami
    Chonnam Medical Journal.2024; 60(1): 21.     CrossRef
  • The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives
    Edgar G. Ordóñez-Rubiano, Nicolás Rincón-Arias, Sebastian Espinosa, William J. Shelton, Andres F. Salazar, Alba Cómbita, Matías Baldoncini, Sabino Luzzi, César Payán-Gómez, Diego F. Gómez- Amarillo, Fernando Hakim, Javier G. Patiño-Gómez, Rafael Parra- Me
    Current Research in Pharmacology and Drug Discovery.2024; 7: 100193.     CrossRef
  • Evaluation of a Set of miRNAs in 26 Cases of Fatal Traumatic Brain Injuries
    Serena Bonin, Stefano D’Errico, Caterina Medeot, Carlo Moreschi, Solange Sorçaburu Ciglieri, Michela Peruch, Monica Concato, Eros Azzalini, Carlo Previderè, Paolo Fattorini
    International Journal of Molecular Sciences.2023; 24(13): 10836.     CrossRef
  • MiR-4461 Inhibits Tumorigenesis of Renal Cell Carcinoma by Targeting PPP1R3C
    Yuanyuan Zhao, Gang Ye, You Wang, Dan Luo
    Cancer Biotherapy and Radiopharmaceuticals.2022; 37(6): 503.     CrossRef
  • Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020
    Manuela Rocha de Menezes, Maria Eduarda Azevêdo Acioli, Ana Carolina Lemos da Trindade, Suéllen Pedrosa da Silva, Raul Emídio de Lima, Vanessa Gabryelle da Silva Teixeira, Luydson Richardson Silva Vasconcelos
    Molecular Biology Reports.2021; 48(5): 4647.     CrossRef
  • The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression
    Federica Caponnetto, Emiliano Dalla, Damiano Mangoni, Silvano Piazza, Slobodanka Radovic, Tamara Ius, Miran Skrap, Carla Di Loreto, Antonio Paolo Beltrami, Ivana Manini, Daniela Cesselli
    Biomedicines.2020; 8(12): 564.     CrossRef
  • Differential expression of miR‑4492 and IL‑10 is involved in chronic rhinosinusitis with nasal polyps
    Linge Li, Juan Feng, Dinghao Zhang, Jun Yong, Yan Wang, Jianfeng Yao, Rongfu Huang
    Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
  • Integrated Analysis of MicroRNA (miRNA) and mRNA Profiles Reveals Reduced Correlation between MicroRNA and Target Gene in Cancer
    Xingsong Li, Xiaokang Yu, Yuting He, Yuhuan Meng, Jinsheng Liang, Lizhen Huang, Hongli Du, Xueping Wang, Wanli Liu
    BioMed Research International.2018; 2018: 1.     CrossRef
  • 10,925 View
  • 201 Download
  • 7 Web of Science
  • 8 Crossref
Close layer
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study
Yung-Jue Bang, Toshimi Takano, Chia-Chi Lin, Adedigbo Fasanmade, Huyuan Yang, Hadi Danaee, Takayuki Asato, Thea Kalebic, Hui Wang, Toshihiko Doi
Cancer Res Treat. 2018;50(2):398-404.   Published online May 10, 2017
DOI: https://doi.org/10.4143/crt.2017.074
AbstractAbstract PDFPubReaderePub
Purpose
This phase 1 dose-escalation portion of the study evaluated the safety, pharmacokinetics (PK), and antitumor activity of TAK-264 in Asian patients with advanced gastrointestinal (GI) carcinoma or metastatic or recurrent gastric or gastroesophageal junction adenocarcinoma expressing guanylyl cyclase C (GCC).
Materials and Methods
Adult patients with advanced GI malignancies expressing GCC (H-score ≥ 10) received TAK-264 on day 1 of 3-week cycles as 30-minute intravenous infusions for up to 1 year or until disease progression or unacceptable toxicity. The primary objectives were to evaluate the safety profile including dose-limiting toxicities (DLTs) during cycle 1, determine the maximum tolerated dose (MTD), and characterize the PK profile of TAK-264.
Results
Twelve patients were enrolled and treated with 1.2 mg/kg (n=3), 1.5 mg/kg (n=3), or 1.8 mg/kg TAK-264 (n=6). Median number of treatment cycles received was two (range, 1 to 10). None of the patients experienced a DLT and the MTD was not determined. Ten patients (83%) experienced adverse events (AEs). The most common were neutropenia, anorexia, and nausea (each reported by four patients). Five patients (42%) experienced grade ≥ 3 AEs consisting of tumor hemorrhage and hypertension, ascites, adrenal insufficiency, neutropenia and asthenia. Serum exposure to TAK-264 increased proportionally with the dose and the median half-life was approximately 5.5-6.6 days. No patients experienced an objective response.
Conclusion
TAK-264 demonstrated a manageable safety profile with limited antitumor activity consistent with studies conducted in Western patients with advanced GI malignancies. TAK-264 exposure increased proportionally with the dose.

Citations

Citations to this article as recorded by  
  • Expanding the potential of antibody–drug conjugates in gastrointestinal malignancies: beyond HER2 targets
    P. Ntellas, A. Athauda, K. Sugiyama, M.L. Le, V. Crespi, I. Chau
    ESMO Gastrointestinal Oncology.2025; 8: 100154.     CrossRef
  • Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies
    Jia-Lin Hao, Xin-Yun Li, Yu-Tong Liu, Ji-Xuan Lang, Di-Jie Liu, Chun-Dong Zhang
    Gastric Cancer.2024; 27(5): 887.     CrossRef
  • Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo
    Karthik Venkatakrishnan, Neeraj Gupta, Patrick F. Smith, Tiffany Lin, Neil Lineberry, Tatiana Ishida, Lin Wang, Mark Rogge
    Clinical Pharmacology & Therapeutics.2023; 113(2): 298.     CrossRef
  • A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
    Richard Kim, Alexis D. Leal, Aparna Parikh, David P. Ryan, Shining Wang, Brittany Bahamon, Neeraj Gupta, Aaron Moss, Joanna Pye, Harry Miao, Haig Inguilizian, James M. Cleary
    Cancer Chemotherapy and Pharmacology.2023; 91(4): 291.     CrossRef
  • Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature
    Moein Piroozkhah, Ali Aghajani, Pooya Jalali, Arvin Shahmoradi, Mobin Piroozkhah, Younes Tadlili, Zahra Salehi
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential
    Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani
    Pharmacology & Therapeutics.2022; 236: 108106.     CrossRef
  • Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
    Na Wang, Qingyun Mei, Ziwei Wang, Lu Zhao, Dou Zhang, Dongying Liao, Jinhui Zuo, Hongxia Xie, Yingjie Jia, Fanming Kong
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development
    Davinder Singh, Divya Dheer, Abhilash Samykutty, Ravi Shankar
    Journal of Controlled Release.2021; 340: 1.     CrossRef
  • 9,765 View
  • 214 Download
  • 10 Web of Science
  • 8 Crossref
Close layer
Development and Evaluation of a Korean Version of a Thyroid-Specific Quality-of-Life Questionnaire Scale in Thyroid Cancer Patients
Chang Hwan Ryu, Boram Park, Junsun Ryu, Youn Mi Ryu, Seong Ae Jo, You Jin Lee, Eun-Kyung Lee, Yul Hwangbo, Jungnam Joo, Yuh-Seog Jung
Cancer Res Treat. 2018;50(2):405-415.   Published online May 26, 2017
DOI: https://doi.org/10.4143/crt.2017.012
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to develop a Korean version of the self-reported thyroid-specific quality of life (QoL) questionnaire for thyroid cancer patients (KT-QoL), and to evaluate its reliability and validity.
Materials and Methods
Two hundred seventy-two patients who underwent thyroidectomy from January to December 2010 were recruited in this study. The original version of the thyroid QoL was translated into Korean and evaluated for its reliability and validity. Using the developed KT-QoL, the postoperative QoL was evaluated until postoperative 1 year.
Results
At the preoperative baseline, the item internal consistency (IIC) ranged from ‒0.19 to 0.76, with low IIC values for items 2, 17, and 27. Item discriminant validity ranged from 86% to 97%. These values were similar at the postoperative periods. The internal consistency reliability (Cronbach’s α) was high for all dimensions, ranging from 0.90 to 0.95. The test-retest reliability (intraclass correlation coefficient) was acceptable (0.74-0.82). The external validity examined by the correlation between the item 1j (voice changes) of KT-QoL and the voice handicap index-30 ranged from 0.51 to 0.75. Patients’ QoL scores decreased after surgery, which demonstrated the sensitivity of the questionnaire. The QoL scores in patients with lobectomy showed best QoL scores postoperatively and those with receiving radioactive iodine still showed decreased QoL scores along the postoperative periods.
Conclusion
These results demonstrate that KT-QoL is a valid instrument for evaluating QoL of Korean patients with thyroid cancer.

Citations

Citations to this article as recorded by  
  • Laryngeal Electromyography as a Predictive Factor in the Evolution of Unilateral Recurrent Paralysis Post-Thyroidectomy
    Shirley Tarabichi, Codrut Sarafoleanu
    Journal of Clinical Medicine.2025; 14(4): 1047.     CrossRef
  • Health-Related Quality of Life in Patients with Low-Risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy
    Kathy Bach, Palvishey Ansari, Hamayail Ansari, Nicole M. Mott, Dawn M. Elfenbein, Hunter Underwood, Susan C. Pitt
    Thyroid®.2024; 34(1): 14.     CrossRef
  • Longitudinal Changes in Quality of Life Before and After Thyroidectomy in Patients With Differentiated Thyroid Cancer
    Byung Hun Kim, Soo Rack Ryu, Jin Won Lee, Chang Myeon Song, Yong Bae Ji, Seok Hyun Cho, Seung Hwan Lee, Kyung Tae
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(6): 1505.     CrossRef
  • Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)
    Ja Kyung Lee, Eu Jeong Ku, Su-jin Kim, Woochul Kim, Jae Won Cho, Kyong Yeun Jung, Hyeong Won Yu, Yea Eun Kang, Mijin Kim, Hee Kyung Kim, Junsun Ryu, June Young Choi
    Annals of Surgical Treatment and Research.2024; 106(1): 19.     CrossRef
  • Five-Year Follow-Up of Health-Related Quality of Life in Differentiated Thyroid Cancer Patients Treated with Total Thyroidectomy and Radioiodine in Sweden: A Nationwide Prospective Cohort Study
    Julia Winter, Erland Axelsson, Linda Björkhem-Bergman, Catharina Ihre Lundgren, Christel Hedman
    Thyroid®.2024; 34(6): 713.     CrossRef
  • Assessment of preoperative health-related quality of life in patients undergoing thyroidectomy based on patient-reported outcomes
    Lei Liu, Yuqing Xiang, Lujing Xiong, Chao Li, Wei Dai, Jinchuan Hu, Chunyan Shui, Yuqiu Zhou, Xu Wang, Linjie Ma, Nan Xu, Bintao Hu, Yongcong Cai
    Frontiers in Psychology.2024;[Epub]     CrossRef
  • A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma Favoring Active Surveillance Over Surgery
    Ji Ye Lee, Dong Gyu Na, Jung Suk Sim, Jin Yong Sung, Sun Wook Cho, Do Joon Park, Young Joo Park, Ji-hoon Kim
    Thyroid®.2024; 34(9): 1126.     CrossRef
  • Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort
    Min Joo Kim, Hojeong Won, Won Bae Kim, Eun Kyung Lee, Chang Yoon Lee, Sun Wook Cho, Han-Sang Baek, Yong Sang Lee, Yea Eun Kang, Sun Wook Kim, Ho-Cheol Kang, Jeongmin Lee, Mijin Kim, Min Ji Jeon, Jae Hoon Moon
    Thyroid®.2024; 34(11): 1371.     CrossRef
  • Optimizing surgical outcomes in papillary thyroid carcinoma with Hashimoto’s Thyroiditis: a retrospective comparative study of unilateral and total thyroidectomy
    Xiaoyong Wen, Shiwei Zhou, Wu Li, Hui Li, Xiaohua Song, Yu Mao, Zeyu Li, Guangji Chen, Xiaowei Peng, Peng Wu
    Scientific Reports.2024;[Epub]     CrossRef
  • Quality of life in thyroid cancer
    Torquil Watt, Thea Christoffersen, Mathilde Borring Brogaard, Jakob Bue Bjorner, Jens Bentzen, Christoffer Holst Hahn, Birte Nygaard, Ulla Feldt-Rasmussen
    Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(1): 101732.     CrossRef
  • Systematic review of health-related quality of life following thyroid cancer
    Emma G Walshaw, Mike Smith, Dae Kim, Jonathan Wadsley, Anastasios Kanatas, Simon N. Rogers
    Tumori Journal.2022; 108(4): 291.     CrossRef
  • Factors affecting the health-promoting behavior of thyroid cancer survivors: comparison by stage of cancer survivorship
    Kyung Ah Park, Sanghee Kim, Eui Geum Oh, Heejung Kim, Hang-Seok Chang, Soo Hyun Kim
    Supportive Care in Cancer.2022; 30(4): 3429.     CrossRef
  • Care and Management of Voice Change in Thyroid Surgery: Korean Society of Laryngology, Phoniatrics and Logopedics Clinical Practice Guideline
    Chang Hwan Ryu, Seung Jin Lee, Jae-Gu Cho, Ik Joon Choi, Yoon Seok Choi, Yong Tae Hong, Soo Yeon Jung, Ji Won Kim, Doh Young Lee, Dong Kun Lee, GIljoon Lee, Sang Joon Lee, Young Chan Lee, Yong Sang Lee, Inn Chul Nam, Ki Nam Park, Young Min Park, Eui-Suk S
    Clinical and Experimental Otorhinolaryngology.2022; 15(1): 24.     CrossRef
  • Health-Related Quality of Life following Total Thyroidectomy and Lobectomy for Differentiated Thyroid Carcinoma: A Systematic Review
    Vivianne Landry, Elizabeth Siciliani, Melissa Henry, Richard J. Payne
    Current Oncology.2022; 29(7): 4386.     CrossRef
  • Effect of radioiodine therapy under thyroid hormone withdrawal on health-related quality of life in patients with differentiated thyroid cancer
    Hui Ming, Hui Yu, Yangbao Liu, Lihua Yang, Yuanhao Chen
    Japanese Journal of Clinical Oncology.2022;[Epub]     CrossRef
  • Thyroid disease‐specific quality of life questionnaires ‐ A systematic review
    Verena Uslar, Caroline Becker, Dirk Weyhe, Navid Tabriz
    Endocrinology, Diabetes & Metabolism.2022;[Epub]     CrossRef
  • Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma
    Jae Hoon Moon, Chang Hwan Ryu, Sun Wook Cho, June Young Choi, Eun-Jae Chung, Jeong Hun Hah, Yul Hwangbo, Woo-Jin Jeong, Yuh-Seog Jung, Ji-hoon Kim, Min Joo Kim, Su-jin Kim, Yeo Koon Kim, Chang Yoon Lee, Eun Kyung Lee, Ji Ye Lee, Kyu Eun Lee, You Jin Lee,
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): 724.     CrossRef
  • Singing voice range profile: New objective evaluation methods for voice change after thyroidectomy
    Jungirl Seok, Youn Mi Ryu, Seong Ae Jo, Chang Yoon Lee, Yuh‐Seog Jung, Junsun Ryu, Chang Hwan Ryu
    Clinical Otolaryngology.2021; 46(2): 332.     CrossRef
  • A Propensity Score Matching Study Between Microwave Ablation and Radiofrequency Ablation in Terms of Safety and Efficacy for Benign Thyroid Nodules Treatment
    Hao Jin, Jinrui Fan, Ligong Lu, Min Cui
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Adaptation transculturelle en Français du questionnaire évaluant la qualité de vie des patients opérés d’un cancer de la thyroïde : THYCA-QoL
    Boris Scheller, Joseph Santini, Amélie Anota, Gilles Poissonnet, Y. Chateau, Renaud Schiappa, Danielle Benisvy, Olivier Dassonville, Alexandre Bozec, Emmanuel Chamorey
    Bulletin du Cancer.2021; 108(7-8): 696.     CrossRef
  • A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial
    Eun Kyung Lee, You Jin Lee, Young Joo Park, Jae Hoon Moon, Ka Hee Yi, Koon Soon Kim, Joo Hee Lee, Sun Wook Cho, Jungnam Joo, Yul Hwangbo, Sujeong Go, Do Joon Park
    Endocrinology and Metabolism.2020; 35(3): 571.     CrossRef
  • Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study
    Massimo Giusti, Stefano Gay, Lucia Conte, Francesca Cecoli, Lorenzo Mortara, Lara Vera, Eleonora Monti
    European Thyroid Journal.2020; 9(5): 247.     CrossRef
  • Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro)
    Sung Hye Kong, Junsun Ryu, Min Joo Kim, Sun Wook Cho, Young Shin Song, Ka Hee Yi, Do Joon Park, Yul Hwangbo, You Jin Lee, Kyu Eun Lee, Su-jin Kim, Woo-Jin Jeong, Eun-Jae Chung, Jeong Hun Hah, June Young Choi, Chang Hwan Ryu, Yuh-Seog Jung, Jae Hoon Moon,
    Thyroid.2019; 29(8): 1089.     CrossRef
  • Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)
    Jae Hoon Moon, Ji-hoon Kim, Eun Kyung Lee, Kyu Eun Lee, Sung Hye Kong, Yeo Koon Kim, Woo-jin Jung, Chang Yoon Lee, Roh-Eul Yoo, Yul Hwangbo, Young Shin Song, Min Joo Kim, Sun Wook Cho, Su-jin Kim, Eun Jae Jung, June Young Choi, Chang Hwan Ryu, You Jin Lee
    Endocrinology and Metabolism.2018; 33(2): 278.     CrossRef
  • 17,491 View
  • 333 Download
  • 25 Web of Science
  • 24 Crossref
Close layer
Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea
Nhung Cam Bui, Ha Na Cho, Yoon Young Lee, Mina Suh, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi
Cancer Res Treat. 2018;50(2):416-427.   Published online May 10, 2017
DOI: https://doi.org/10.4143/crt.2017.075
AbstractAbstract PDFPubReaderePub
Purpose
While colorectal cancer (CRC) is common in Asian countries, screening for CRC is not. Moreover, CRC screening behaviors in Asian populations remain largely unknown. The present study aimed to investigate the stages of adopting CRC screening in Korea according to screening modality.
Materials and Methods
Data were obtained from the 2014 Korean National Cancer Screening Survey, a cross-sectional survey that utilized nationally representative random sampling to investigate cancer screening rates. A total of 2,066 participants aged 50-74 years were included in this study. Chi-square test and multinomial logistic regressionwere applied to determine stages of adoption for fecal occult blood test (FOBT) and colonoscopy and factors associated with each stage.
Results
Of 1,593 participants included in an analysis of stage of adoption for FOBT, 36% were in action/maintenance stages, while 18%, 40%, and 6% were in precontemplation, contemplation, and relapse/relapse risk stages, respectively. Of 1,371 subjects included in an analysis of stage of adoption for colonoscopy, 48% were in action/maintenance stages, with 21% in precontemplation, 21% in contemplation, and 11% in relapse/relapse risk stages. Multinomial logistic regression highlighted sex, household income, place of residency, family history of cancer, having private cancer insurance, smoking status, alcohol use, and regular exercise as being associated with stages of adoption for FOBT and colonoscopy.
Conclusion
This study outlines the distributions of stages of adoption for CRC screening by screening modality. Interventions to improve screening rates should be tailored to individuals in particular stages of adoption for CRC screening by modality.

Citations

Citations to this article as recorded by  
  • Predictors of stages of adoption of colorectal cancer screening among adults attending primary healthcare centers in Turkey
    Elif Dönmez, Nadire Ercan Toptaner, Elvan E. Ata, Zeynep Dülger, Onur Acar
    Journal of the Egyptian Public Health Association.2025;[Epub]     CrossRef
  • Factors Affecting Adherence to National Colorectal Cancer Screening: A 12-Year Longitudinal Study Using Multi-Institutional Pooled Data in Korea
    Dae Sung Kim, Jeeyoung Hong, Kihyun Ryu, Sang Hyuk Lee, Hwanhyi Cho, Jehyeong Yu, Jieun Lee, Jong-Yeup Kim
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • A new TGF‐β risk score predicts clinical and immune landscape in colorectal cancer patients
    Bing Tang, Binggang Liu, Zhiyao Zeng
    Annals of Gastroenterological Surgery.2024; 8(5): 927.     CrossRef
  • Utilization of colorectal cancer screening tests: a systematic review and time trend analysis of nationally representative data
    Idris Ola, Rafael Cardoso, Michael Hoffmeister, Hermann Brenner
    eClinicalMedicine.2024; 75: 102783.     CrossRef
  • Role of breast cancer screening in the overdiagnosis of thyroid cancer: results from a cross-sectional nationwide survey
    Eunhye Lee, Sung Hoon Jeong, Chung Mo Nam, Jae Kwan Jun, Eun-Cheol Park
    BMC Women's Health.2023;[Epub]     CrossRef
  • Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kui Son Choi
    Epidemiology and Health.2023; 45: e2023086.     CrossRef
  • The risk of developing colorectal cancer in individuals aged 50-70 years and behavioral changes in high-risk individuals regarding a fecal occult blood test
    Renginar ÖZTÜRK DÖNMEZ, Süheyla ÖZSOY, Melek ARDAHAN
    Journal of Surgery and Medicine.2022; 6(1): 14.     CrossRef
  • Using Decision Tree Aggregation with Random Forest Model to Identify Gut Microbes Associated with Colorectal Cancer
    Dongmei Ai, Hongfei Pan, Rongbao Han, Xiaoxin Li, Gang Liu, Li C. Xia
    Genes.2019; 10(2): 112.     CrossRef
  • Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis
    Rafael Cardoso, Tobias Niedermaier, Chen Chen, Michael Hoffmeister, Hermann Brenner
    Cancer Prevention Research.2019; 12(9): 617.     CrossRef
  • Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea
    Hye Young Shin, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi
    BMC Cancer.2017;[Epub]     CrossRef
  • 8,760 View
  • 180 Download
  • 7 Web of Science
  • 10 Crossref
Close layer
Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study
Shu-Hui Wang, Ching-Chi Chi, Zi-Hao Zhao, Tao-Hsin Tung
Cancer Res Treat. 2018;50(2):428-435.   Published online May 10, 2017
DOI: https://doi.org/10.4143/crt.2017.110
AbstractAbstract PDFPubReaderePub
Purpose
Previous western studies have found Caucasians with skin cancer, either melanoma or nonmelanoma skin cancer (NMSC), have an elevated risk of second primary cancer. Our objective was to assess the risk of second primary cancer in Taiwanese with NMSC.
Materials and Methods
By using data from Taiwan’s National Health Insurance Research Database, we conducted a population-based cohort study to assess the risk of incident second primary cancer in Taiwanese affected by NMSC.
Results
We identified 505 subjects with NMSC and 2,020 matched controls. After adjustment for potential confounders including age, sex, urbanization, and Charlson Comorbidity Index, people who had NMSC had a 1.43-fold (95% confidence interval [CI], 1.05 to 1.96) risk for the development of second primary cancer as comparedwith control group. Menwith NMSC had a 2.99-fold (95% CI, 1.00 to 9.10) risk for second primary cancer involving the lip, oral cavity, and pharynx and a 3.51-fold (95% CI, 1.21 to 10.17) risk for second primary cancer involving the genitourinary organs when compared to the control group. By contrast, women with NMSC did not have an increased risk of second primary cancer.
Conclusion
This study revealed Asians with NMSC have an increased risk of second primary cancer. Our findings can be a useful reference for health care for people diagnosed with NMSC.

Citations

Citations to this article as recorded by  
  • Epidemiological and genetic insights into the co-occurrence of cutaneous melanoma and hematologic malignancies: A meta-analytic review
    Ashmitha Kumar, Arunan Jeyakumar, Alfred K. Lam, Vinod Gopalan
    Leukemia Research.2024; 147: 107610.     CrossRef
  • Non‐melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population‐based cohort study
    S.J. Yun, J.M. Bae, H. Kim, B.C. Park, J.S. Kim, S.H. Seo, H.H. Ahn, D.Y. Lee, Y.C. Kim, H.J. Park, K.Y. Chung
    Journal of the European Academy of Dermatology and Venereology.2020; 34(4): 746.     CrossRef
  • 10,876 View
  • 170 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys
Jin-Kyoung Oh, Bo Yoon Jeong, E Hwa Yun, Min Kyung Lim
Cancer Res Treat. 2018;50(2):436-444.   Published online May 10, 2017
DOI: https://doi.org/10.4143/crt.2017.174
AbstractAbstract PDFPubReaderePub
Purpose
Human papillomavirus (HPV) vaccination has been included in the National Immunization Program in Korea since 2016. We aimed to evaluate changes in the awareness of and attitudes toward HPV vaccination, among adults in Korea since the first introduction of the vaccines in 2007.
Materials and Methods
A nationwide population-based survey was conducted in 2016 for 1,200 nationally representative Korean men and women; the data obtained were compared with the data from the nationwide survey conducted in 2007.
Results
A significant increase in the awareness of HPV infection (35.8%) and vaccination (36.9%) was observed in 2016 from 13.3% and 8.6% in 2007, respectively. Willingness to be vaccinated against HPV decreased from 55.0% in 2007 to 25.8% in 2016, and the proportion of respondents expressing uncertainty increased from 28.3% in 2007 to 43.3% in 2016. Only 12.1% of men and 22.0% of women knew about the free national HPV vaccination program for girls, launched in June 2016. Younger women, with higher income level, awareness of the HPV vaccine, and perception of the seriousness of infections had a higher willingness to be vaccinated. A high education level, awareness of HPV infection and vaccination, and perception of the seriousness of infection were positively associated with the willingness of respondents to vaccinate their daughters.
Conclusion
Raising the awareness of HPV infection and vaccination with appropriate knowledge is necessary for the successful implementation of the national HPV vaccination program.

Citations

Citations to this article as recorded by  
  • An investigation into the human papilloma virus (HPV) vaccination among undergraduate medical students (A prospective cross-sectional KAP survey)
    Remah M Kamel, Aseel Alomari, Abeer Ismail, Rogayah Alballa, A’laa Almowallad, Laila Alsankari, Mona Sabsabi
    Obstetrics & Gynecology International Journal.2024; 15(5): 194.     CrossRef
  • Parental Factors Affecting Decision to Vaccinate Their Daughters against Human Papillomavirus
    Yoon Park, Moran Ki, Hyunju Lee, Jae-Kwan Lee, Jin-Kyoung Oh
    Cancer Prevention Research.2023; 16(3): 133.     CrossRef
  • Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey
    Yejin Ha, Kyeongmin Lee, Bomi Park, Mina Suh, Jae Kwan Jun, Kui Son Choi
    Epidemiology and Health.2023; 45: e2023076.     CrossRef
  • ARE WOMEN AWARE OF THE VACCINE AGAINST HUMAN PAPILLOMAVIRUS? A HOSPITAL-FOCUSED CROSS-SECTIONAL STUDY
    Ülkü Ayşe TÜRKER, Binali ÇATAK
    SDÜ Tıp Fakültesi Dergisi.2022; 29(2): 249.     CrossRef
  • Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020
    Hye Young Shin, Yun Yeong Lee, Soo Yeon Song, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
    Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
  • Perception of human papilloma virus (HPV) vaccination during the COVID-19 pandemic
    Ye Won Jung, Soo Youn Song, Won Kyo Shin, Su Min Chung, Ji Won Park, Heon Jong Yoo
    Medicine.2022; 101(43): e31389.     CrossRef
  • Awareness of and practice toward cancer prevention recommendations: results of the Korean National Cancer Prevention Awareness and Practice Survey in 2021
    Jin-Kyoung Oh, Eunjung Park, Byungmi Kim, Yoon-Jung Choi, E Hwa Yun, Min Kyung Lim, Jeong-Soo Im, Eun Young Park
    Epidemiology and Health.2022; 44: e2022068.     CrossRef
  • The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population
    Yuh‐Seog Jung, Jungirl Seok, Seri Hong, Chang Hwan Ryu, Junsun Ryu, Kyu‐Won Jung
    Cancer.2021; 127(10): 1638.     CrossRef
  • Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study
    Jaehyun Seong, Sangmi Ryou, JeongGyu Lee, Myeongsu Yoo, Sooyoung Hur, Byeong-Sun Choi
    Virology Journal.2021;[Epub]     CrossRef
  • Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review
    Soojung Jo, Soo-Yeon Han, Connor A. Walters
    International Journal of Environmental Research and Public Health.2021; 19(1): 51.     CrossRef
  • Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China
    Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
    Cancer Research and Treatment.2020; 52(1): 207.     CrossRef
  • Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia
    Li Ping Wong, Pooi-Fong Wong, Megat Mohamad Amirul Amzar Megat Hashim, Liyuan Han, Yulan Lin, Zhijian Hu, Qinjian Zhao, Gregory D. Zimet
    Human Vaccines & Immunotherapeutics.2020; 16(7): 1611.     CrossRef
  • Chinese Residents’ Perceptions of COVID-19 During the Pandemic: Online Cross-sectional Survey Study
    Tingting Cui, Guoping Yang, Lili Ji, Lin Zhu, Shiqi Zhen, Naiyang Shi, Yan Xu, Hui Jin
    Journal of Medical Internet Research.2020; 22(11): e21672.     CrossRef
  • Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea
    Hae Won Kim, Hyang Yuol Lee, Seong Eun Kim, Hye Young Ahn, Yeon Hee Kim, Young Jin Lee, Italo Francesco Angelillo
    PLOS ONE.2019; 14(2): e0211475.     CrossRef
  • Current knowledge of and attitudes toward human papillomavirus‐related disease prevention among Japanese: A large‐scale questionnaire study
    Yukio Suzuki, Akiko Sukegawa, Aya Nishikawa, Kazumi Kubota, Yoko Motoki, Mikiko Asai‐Sato, Yutaka Ueda, Masayuki Sekine, Takayuki Enomoto, Fumiki Hirahara, Takeharu Yamanaka, Etsuko Miyagi
    Journal of Obstetrics and Gynaecology Research.2019; 45(5): 994.     CrossRef
  • High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women
    Eun-Jeong Joo, Yoosoo Chang, Min-Jung Kwon, Ara Cho, Hae Suk Cheong, Seungho Ryu
    Circulation Research.2019; 124(5): 747.     CrossRef
  • Awareness and attitude towards human papillomavirus and its vaccine among females with and without daughter(s) who participated in cervical cancer screening in Shenzhen, China
    Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
    Tropical Medicine & International Health.2019; 24(9): 1054.     CrossRef
  • 9,170 View
  • 234 Download
  • 16 Web of Science
  • 17 Crossref
Close layer
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo, Bingfei Xu, Qi Han, Hongxia Zhou, Yun Xia, Chongwen Gong, Xiaofang Dai, Zhenyu Li, Gang Wu
Cancer Res Treat. 2018;50(2):445-460.   Published online May 10, 2017
DOI: https://doi.org/10.4143/crt.2016.572
AbstractAbstract PDFPubReaderePub
Purpose
Ferroptosis is a new mode of regulated cell death, which is completely distinct from other cell death modes based on morphological, biochemical, and genetic criteria. This study evaluated the therapeutic role of ferroptosis in classic chemotherapy drugs, including the underlying mechanism.
Materials and Methods
Cell viabilitywas detected by using the methylthiazoltetrazlium dye uptake method. RNAiwas used to knockout iron-responsive element binding protein 2, and polymerase chain reaction, western blot was used to evaluate the efficiency. Intracellular reduced glutathione level and glutathione peroxidases activitywere determined by related assay kit. Intracellularreactive oxygen species levelswere determined by flowcytometry. Electron microscopywas used to observe ultrastructure changes in cell.
Results
Among five chemotherapeutic drugs screened in this study, cisplatin was found to be an inducer for both ferroptosis and apoptosis in A549 and HCT116 cells. The depletion of reduced glutathione caused by cisplatin and the inactivation of glutathione peroxidase played the vital role in the underlying mechanism. Besides, combination therapy of cisplatin and erastin showed significant synergistic effect on their anti-tumor activity.
Conclusion
Ferroptosis had great potential to become a new approach in anti-tumor therapies and make up for some classic drugs, which open up a new way for their utility in clinic.

Citations

Citations to this article as recorded by  
  • Deciphering Ferroptosis: From Molecular Pathways to Machine Learning-Guided Therapeutic Innovation
    Megha Mete, Amiya Ojha, Priyanka Dhar, Deeplina Das
    Molecular Biotechnology.2025; 67(4): 1290.     CrossRef
  • Cell Death and Survival Mechanisms in Cholangiocarcinogenesis
    Luana D'Artista, Marco Seehawer
    The American Journal of Pathology.2025; 195(3): 470.     CrossRef
  • Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways
    Ademola C Famurewa, Nupura Manish Prabhune, Sudharshan Prabhu
    Journal of Pharmacy and Pharmacology.2025; 77(1): 1.     CrossRef
  • Illuminating cisplatin-induced ferroptosis in non-small-cell lung cancer with biothiol-activatable fluorescent/photoacoustic bimodal probes
    Li Xu, Hongwen Liu, Yi Kong, Lingyun Li, Jia Li, Kang Li, Shuzhi Liang, Bolin Chen
    Journal of Materials Chemistry B.2025; 13(1): 239.     CrossRef
  • EMC2 suppresses ferroptosis via regulating TFRC in nasopharyngeal carcinoma
    Xianghui Chen, Xiaoyan Wang, Yuxia Zou, Yan Wang, Tingting Duan, Zijie Zhou, Yi Huang, Qing Ye
    Translational Oncology.2025; 52: 102251.     CrossRef
  • Synergistic effects of dihydroartemisinin and cisplatin on inducing ferroptosis in gastric cancer through GPX4 inhibition
    Huina Wang, Chanchan Lu, Haihua Zhou, Xiaojun Zhao, Chuanjiang Huang, Zhiyi Cheng, Guiyuan Liu, Xiaolan You
    Gastric Cancer.2025; 28(2): 187.     CrossRef
  • Research progress on gene mutations and drug resistance in leukemia
    Xiangyu Ma, Jiamin Xu, Yanan Wang, Joshua S. Fleishman, Hao Bing, Boran Yu, Yanming Li, Letao Bo, Shaolong Zhang, Zhe-Sheng Chen, Libo Zhao
    Drug Resistance Updates.2025; 79: 101195.     CrossRef
  • Reconnoitering the role of Lipid Metabolites in Ferroptosis
    Manikandan Vani Raju, Meenakshi Kaniyur Chandrasekaran, Rathi Muthaiyan Ahalliya, Gopalakrishnan Velliyur Kanniappan
    Advances in Redox Research.2025; 14: 100117.     CrossRef
  • DLBCL cells with ferroptosis morphology can be detected with a deep convolutional neural network
    Pyry Kotkaranta, Mikko Chan, Tero Vuolio, Ilkka Miinalainen, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Hanna-Riikka Teppo, Outi Kuittinen, Milla E.L. Kuusisto
    Biomedicine & Pharmacotherapy.2025; 182: 117785.     CrossRef
  • Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer
    Emily N. Devericks, Bennett H. Brosnan, Alyssa N. Ho, Elaine M. Glenny, Hannah M. Malian, Dorothy Teegarden, Michael K. Wendt, Michael F. Coleman, Stephen D. Hursting
    Cancer & Metabolism.2025;[Epub]     CrossRef
  • Transferrin Receptor 2 in Canine Testicular Tumors: An Emerging Key Role in Seminomas
    Rebecca Leandri, Sara Buonocore, Karen Power
    Animals.2025; 15(2): 264.     CrossRef
  • Construction of a ferroptosis-based prediction model for the prognosis of MYCN-amplified neuroblastoma and screening and verification of target sites
    Linjun Tan, Guoqian He, Chengqi Shen, Sijia He, Yan Chen, Xia Guo
    Hereditas.2025;[Epub]     CrossRef
  • Targeting ferroptosis in gastrointestinal tumors: Interplay of iron-dependent cell death and autophagy
    Mohamad Hosein Safari, Payman Rahimzadeh, Elmira Alaei, Mina Alimohammadi, Negin Esfandiari, Salman Daneshi, Neda Malgard, Najma Farahani, Afshin Taheriazam, Mehrdad Hashemi
    Molecular and Cellular Probes.2025; 79: 102013.     CrossRef
  • Investigating the interaction between calcium signaling and ferroptosis for novel cancer treatment
    Hao-xin Yan, Yi-zhong Zhang, Yu-qing Niu, Yu-wei Wang, Li-hua Liu, Yu-ping Tang, Ju-min Huang, Elaine Lai-Han Leung
    Phytomedicine.2025; 137: 156377.     CrossRef
  • A systematical review on traditional Chinese medicine treating chronic diseases via regulating ferroptosis from the perspective of experimental evidence and clinical application
    Yuanyuan Zhang, Fazhi Su, Enlin Zhu, Yanping Sun, Haixue Kuang, Qiuhong Wang
    Chinese Herbal Medicines.2025; 17(2): 246.     CrossRef
  • RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
    Jialin Yuan, Cong Liu, Chengwei Jiang, Ning Liu, Zhaoying Yang, Hua Xing
    Scientific Reports.2025;[Epub]     CrossRef
  • Design, synthesis, and biological evaluation of quinolinyl-ureido-phenyl-hydrazide derivatives and quinolinyl-hydrazide derivatives as anticancer agents targeting Nur77-mediated ferroptosis
    Yan-fang Gao, Yi-jing Yang, Jing-bo Qin, Ming-yue Yu, Sheng-wei Hu, Hao-fan Zhang, Fan-hong Lin, Hong-yu Hu, Mei-juan Fang, Jin-Zhang Zeng
    European Journal of Medicinal Chemistry.2025; 291: 117559.     CrossRef
  • Ferroptosis: a novel perspective on tumor immunotherapy
    Yuan Xu, Mingpai Ge, Yuqing Xu, Kai Yin
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • HPV E6/E7‐Induced Acetylation of a Peptide Encoded by a Long Non‐Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer
    Xiaoyu Qi, Jing Zhou, Xinyue Wang, Yan Shen, Yuxun Cao, Liangzi Jiang, Miaomiao Shen, Haoran Zhang, Tianjiao Wang, Pengjun Wei, Ruoqi Xu, Yue Yang, Xiangya Ding, Cong Wang, Xuemei Jia, Qin Yan, Wan Li, Chun Lu
    Advanced Science.2025;[Epub]     CrossRef
  • The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
    Wenhua Xia, Yuanhao Lv, Yan Zou, Zhanting Kang, Zhaoyi Li, Jiaqi Tian, Hongyan Zhou, Wei Su, Jiateng Zhong
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Harnessing ferroptosis for precision oncology: challenges and prospects
    Roberto Fernández-Acosta, Iuliana Vintea, Ine Koeken, Behrouz Hassannia, Tom Vanden Berghe
    BMC Biology.2025;[Epub]     CrossRef
  • Research Progress on Iron Overload and Lung Diseases
    星愿 王
    Advances in Clinical Medicine.2025; 15(01): 1331.     CrossRef
  • STX1A regulates ferroptosis and chemoresistance in gastric cancer through mitochondrial function modulation
    Yan Niu, Chunyu Liu, Lizhou Jia, Fangxin Zhao, Yixiao Wang, Lu Wang, Weiyi Chen, Yanzi Gan, Yongjun Wen
    Human Cell.2025;[Epub]     CrossRef
  • Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to lung cancer
    Feifei Yao, Feng Guo, Chuanzhong Sun, Erdong Wang, Hang Wang, Na Li
    Frontiers in Genetics.2025;[Epub]     CrossRef
  • Half‐Sandwich Organometallic Ir(III) and Ru(II) Compounds and their Interactions with Biomolecules
    Sandra Kozieł, Daria Wojtala, Magdalena Szmitka, Monika Lesiów, Aleksandra Ziółkowska, Jacek Sawka, Edgar Del Carpio, Debbie C. Crans, Urszula K. Komarnicka
    ChemPlusChem.2025;[Epub]     CrossRef
  • Regulation and therapy: the role of ferroptosis in DLBCL
    Yifan Wang, Zhengmei He, Xinyu Dong, Yiming Yao, Qiuni Chen, Yuye Shi, Yuan Deng, Quane Zhang, Liang Yu, Chunling Wang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Epithelial-mesenchymal transition promotes metabolic reprogramming to suppress ferroptosis
    Wenzheng Guo, Zhibing Duan, Jingjing Wu, Binhua P. Zhou
    Seminars in Cancer Biology.2025; 112: 20.     CrossRef
  • Spatial control of m6A deposition on enhancer and promoter RNAs through co-acetylation of METTL3 and H3K27 on chromatin
    Xiang Huang, Jie Zhang, Yixian Cun, Meijun Ye, Zhijun Ren, Wenbing Guo, Xiaojun Ma, Jiayin Liu, Weiwei Luo, Xiang Sun, Jingwen Shao, Zehong Wu, Xiaofeng Zhu, Jinkai Wang
    Molecular Cell.2025; 85(7): 1349.     CrossRef
  • Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells
    Zheng Zhang, Huaxiang Xu, Junyi He, Qiangsheng Hu, Yuxin Liu, Zijin Xu, Wenhui Lou, Wenchuan Wu, Lei Zhang, Ning Pu, Chenye Shi, Yaolin Xu, Wenquan Wang, Liang Liu
    Cell Death & Disease.2025;[Epub]     CrossRef
  • BMAL1-depletion remodels ceramide metabolism to regulate ferroptosis and sorafenib chemosensitivity in acute myeloid leukemia
    Hong Zheng, Zhi Lin, Dan Wang, Jing Zhang, Ting Zeng, Jie Shen, Jia-Da Li, Minghua Yang
    iScience.2025; 28(4): 112054.     CrossRef
  • Ferroptosis meets inflammation: A new frontier in cancer therapy
    Hu Liu, Hui Xue, Qian Guo, Xutong Xue, Lixue Yang, Kaijun Zhao, Yu'e Liu
    Cancer Letters.2025; 620: 217696.     CrossRef
  • Ferroptosis in cancer: Mechanisms, therapeutic strategies, and clinical implications
    Mina Pourhabib Mamaghani, Seyedeh Nasibeh Mousavikia, Hosein Azimian
    Pathology - Research and Practice.2025; 269: 155907.     CrossRef
  • SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells
    Xiaojuan Mao, Jingwen Xiong, Mengjiao Cai, Chao Wang, Qian He, Binxian Wang, Jing Chen, Zhengtao Xiao, Baofeng Wang, Suxia Han, Yilei Zhang
    Journal of Advanced Research.2025;[Epub]     CrossRef
  • Ferroptosis: a potential target for non-surgical treatment of laryngeal cancer
    Yang Luo, Yuzhu He, Shuang Xu, Yuxiang Chen, Fengfeng Qin, Wenjian Hu
    European Archives of Oto-Rhino-Laryngology.2025;[Epub]     CrossRef
  • Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells
    Stefano Miglietta, Manuela Sollazzo, Iacopo Gherardi, Sara Milioni, Beatrice Cavina, Lorena Marchio, Monica De Luise, Camelia Alexandra Coada, Marco Fiorillo, Anna Myriam Perrone, Ivana Kurelac, Giuseppe Gasparre, Luisa Iommarini, Anna Maria Ghelli, Anna
    Open Biology.2025;[Epub]     CrossRef
  • Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
    Weijia Wang, Behishta Hashimi, Ping Wang
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub]     CrossRef
  • CD44 variant exons induce chemoresistance by modulating cell death pathways
    Maria Yanova, Evgeniya Stepanova, Diana Maltseva, Alexander Tonevitsky
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Cepharanthine hydrochloride: a novel ferroptosis-inducing agent for prostate cancer treatment
    Jing-Song Guan, Jing Jia, Ze-Xiu Huang, Yu-Qing Zhou, Jing-Jie Zheng, Qi-Man Lin, Yi-Fei Wang, Jiang-Lin Fan, Yao Wang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway
    Wanhui Wei, Yuanyuan Lu, Qian Hu, Jinwen Yin, Youwei Wang, Heng Zhang, Qiu Zhao, Lan Liu
    Cellular Oncology.2024; 47(1): 321.     CrossRef
  • Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy
    Shutong Li, Aoxue Wang, Yongya Wu, Shengyuan He, Wen Shuai, Min Zhao, Yumeng Zhu, Xiuying Hu, Yubin Luo, Guan Wang
    Immunological Reviews.2024; 321(1): 300.     CrossRef
  • Impact of TP53‐induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma
    Katsuya Toshida, Shinji Itoh, Norifumi Iseda, Takuma Izumi, Shohei Yoshiya, Takeo Toshima, Mizuki Ninomiya, Takeshi Iwasaki, Yoshinao Oda, Tomoharu Yoshizumi
    Cancer Science.2024; 115(1): 170.     CrossRef
  • Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells
    Xue-Wei Wang, Zi-Yi Yang, Ting Li, Xin-Ran Zhao, Xiao-Zhong Li, Xiao-Xia Wang
    Molecular Biotechnology.2024; 66(9): 2558.     CrossRef
  • Heteronemin promotes iron-dependent cell death in pancreatic cancer
    Gizem Kaftan, Mümin Alper Erdoğan, Mohamed El-Shazly, Mei-Chin Lu, Shou-Ping Shih, Hung-Yu Lin, Luciano Saso, Güliz Armagan
    Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(3): 1865.     CrossRef
  • Prognostic significance of a 3-gene ferroptosis-related signature in lung cancer via LASSO analysis and cellular functions of UBE2Z
    Bin Xie, Qiong Chen, Ziyu Dai, Chen Jiang, Jingyi Sun, Anqi Guan, Xi Chen
    Computational Biology and Chemistry.2024; 113: 108192.     CrossRef
  • Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis
    Wenjie Huang, Fang Wen, Peipei Yang, Ye Li, Qiurong Li, Peng Shu
    Phytomedicine.2024; 123: 155220.     CrossRef
  • Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15
    Sheng‐Fan Wang, Yuh‐Lih Chang, Ting‐Yu Liu, Kuo‐Hung Huang, Wen‐Liang Fang, Anna Fen‐Yau Li, Tien‐Shun Yeh, Giun‐Yi Hung, Hsin‐Chen Lee
    The FEBS Journal.2024; 291(6): 1131.     CrossRef
  • Current and Potential Roles of Ferroptosis in Bladder Cancer
    Wen-xin An, Radheshyam Gupta, Kun Zhai, Ya-ru Wang, Wan-hai Xu, Yan Cui
    Current Medical Science.2024; 44(1): 51.     CrossRef
  • BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    Yizhi Cao, Xuelong Wang, Yang Liu, Pengyi Liu, Jiejie Qin, Youwei Zhu, Shuyu Zhai, Yongsheng Jiang, Yihao Liu, Lijie Han, Jiaxin Luo, Ronghao Zhang, Minmin Shi, Liwen Wang, Xiaomei Tang, Meilin Xue, Jia Liu, Weishen Wang, Chenlei Wen, Xiaxing Deng, Chengh
    Advanced Science.2024;[Epub]     CrossRef
  • Ferroptosis and its modulators: A raising target for cancer and Alzheimer’s disease
    Gourav Singh, Prashant Kesharwani, Gireesh Kumar Singh, Saroj Kumar, Anjaneyulu Putta, Gyan Modi
    Bioorganic & Medicinal Chemistry.2024; 98: 117564.     CrossRef
  • The application of nanoparticles based on ferroptosis in cancer therapy
    Yifei Li, Chen Wei, Jianqin Yan, Fashun Li, Bohan Chen, Yong Sun, Kui Luo, Bin He, Yan Liang
    Journal of Materials Chemistry B.2024; 12(2): 413.     CrossRef
  • Stability-Enhanced Cisplatin Gold Nanoparticles as Therapeutic Anticancer Agents
    Tae Joon Cho, Vytas Reipa, Justin M. Gorham, John M. Pettibone, Alessandro Tona, Aaron Johnston-Peck, Jingyu Liu, Bryant C. Nelson, Vincent A. Hackley
    ACS Applied Nano Materials.2024; 7(1): 836.     CrossRef
  • Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
    Anqi Ge, Qi He, Da Zhao, Yuwei Li, Junpeng Chen, Ying Deng, Wang Xiang, Hongqiao Fan, Shiting Wu, Yan Li, Lifang Liu, Yue Wang
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma
    Xiaodong Li, Fanguang Meng, Hankang Wang, Liwei Sun, Shulin Chang, Guijie Li, Feng Chen
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
    Na Liu, Minbin Chen
    Biomedicine & Pharmacotherapy.2024; 171: 116115.     CrossRef
  • A risk model based on 10 ferroptosis regulators and markers established by LASSO-regularized linear Cox regression has a good prognostic value for ovarian cancer patients
    Tingchuan Xiong, Yinghong Wang, Changjun Zhu
    Diagnostic Pathology.2024;[Epub]     CrossRef
  • The role of ferroptosis in cardio-oncology
    Kai Hou, Lin Liu, Zhi-Hui Fang, Wei-Xing Zong, Daqiang Sun, Zhigang Guo, Lu Cao
    Archives of Toxicology.2024; 98(3): 709.     CrossRef
  • Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application
    Oscar Claudio-Ares, Jeileen Luciano-Rodríguez, Yolmarie L. Del Valle-González, Selene L. Schiavone-Chamorro, Alex J. Pastor, Javier O. Rivera-Reyes, Carmen L. Metzler, Lizandra M. Domínguez-Orona, Brenda Lee Vargas-Pérez, Rachid Skouta, Arthur D. Tinoco
    Inorganics.2024; 12(1): 26.     CrossRef
  • Ferroptosis: a dual-edged sword in tumour growth
    Xiangye Zhao, Xiaoning Li, Yinghui Xu
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity
    Yihong Wei, Wancheng Liu, Ruiqing Wang, Yuhong Chen, Jinting Liu, Xiaodong Guo, Can Can, Xinyu Yang, Dongmei Wang, Xiang Hu, Daoxin Ma
    Free Radical Biology and Medicine.2024; 213: 36.     CrossRef
  • Programmed cell death in tumor immunity: mechanistic insights and clinical implications
    Man Wang, Fei Yu, Yuan Zhang, Peifeng Li
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy
    Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, Lingzhi Wang, Gautam Sethi, Zhaowu Ma
    Cell Death Discovery.2024;[Epub]     CrossRef
  • Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment
    Yuze Hua, Sen Yang, Yalu Zhang, Jiayi Li, Mengyi Wang, Palashate Yeerkenbieke, Quan Liao, Qiaofei Liu
    Journal of Experimental & Clinical Cancer Research.2024;[Epub]     CrossRef
  • Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer
    Kaili Deng, Hailong Tian, Tingting Zhang, Yajie Gao, Edouard C. Nice, Canhua Huang, Na Xie, Guoliang Ye, Yuping Zhou
    Journal of Controlled Release.2024; 366: 684.     CrossRef
  • Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
    Jing Yang, Zhaowei Gu
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Lysine acetyltransferase KAT2A modulates ferroptosis during colorectal cancer development
    Zhenye Xu, Xiaoyan Wang, Ping Yu, Yong Zhang, Liang Huang, Enqiang Mao, Yi Han
    Scandinavian Journal of Gastroenterology.2024; 59(4): 437.     CrossRef
  • Recent Progress in Ferroptosis Induced Tumor Cell Death by Anti‐tumor Metallic complexes
    Yong‐Chang Zhou, Tian‐Kun Zhao, Si‐Man Tao, Peng Wang, Yi‐Chen Guan, Ke‐Pei Yang, Sheng‐Qiang Chen, Xiu‐Ying Pu
    Chemistry – An Asian Journal.2024;[Epub]     CrossRef
  • Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
    Tong-Mei Shi, Xiao-Fei Chen, Huihui Ti
    Journal of Medicinal Chemistry.2024; 67(4): 2238.     CrossRef
  • Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration
    Jiayan Wei, Jinsong Wang, Xinyi Chen, Li Zhang, Min Peng
    PeerJ.2024; 12: e16819.     CrossRef
  • Edaravone-loaded poly(amino acid) nanogel inhibits ferroptosis for neuroprotection in cerebral ischemia injury
    Yunhan Zhang, Zhulin Zou, Shuang Liu, Fangfang Chen, Minglu Li, Haoyang Zou, Haiyan Liu, Jianxun Ding
    Asian Journal of Pharmaceutical Sciences.2024; 19(2): 100886.     CrossRef
  • A Pt(II) complex bearing N-heterocycle ring induced ferroptotic cell death in ovarian cancer
    Xiaomin Shen, Yue Peng, Haixia Zhou, Xiaoxia Ye, Zhong Han, Xiangchao Shi
    Journal of Inorganic Biochemistry.2024; 253: 112502.     CrossRef
  • A Smooth Muscle Cell-Based Ferroptosis Model to Evaluate Iron-Chelating Molecules for Cardiovascular Disease Treatment
    Sarah El Hajj, Laetitia Canabady-Rochelle, Isabelle Fries-Raeth, Caroline Gaucher
    Current Issues in Molecular Biology.2024; 46(2): 1348.     CrossRef
  • DTTZ suppresses ferroptosis and reverses mitochondrial dysfunction in normal tissues affected by chemotherapy
    Yuwei Yang, Yuanfang Chen, Haikang Tang, Ziqi Zhang, Xiaoliang Zhou, Wenqing Xu
    Biomedicine & Pharmacotherapy.2024; 172: 116227.     CrossRef
  • Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer
    Jun Zhao, Jijie Shen, Liang Mao, Tianli Yang, Jingyu Liu, Sun Hongbin
    Oncogene.2024; 43(27): 2104.     CrossRef
  • Iron Oxide Nanoparticles Carrying microRNA-124 Promote Ferroptosis in Treatment of Prostate Cancer
    Min Liu, Chuanbing Xu, Huichao Dong, Dongshen Jia, Dongfang Hao, Ruozen Rong, Yao Peng
    Journal of Biomedical Nanotechnology.2024; 20(2): 224.     CrossRef
  • Targeting LGR4–Wnt activates ferroptosis and reverses drug resistance in colorectal cancer

    Nature Cancer.2024; 5(4): 542.     CrossRef
  • Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects
    Shijing Yu, Lingwu Tong, Jiangwen Shen, Chenglei Li, Yongshan Hu, Keke Feng, Jingwei Shao
    European Journal of Medicinal Chemistry.2024; 269: 116290.     CrossRef
  • TRAIL predisposes non-small cell lung cancer to ferroptosis by regulating ASK-1/JNK1 pathway
    Xiaofang Liu, Huiqian Deng, Mi Huang, Wei Zhou, Yilin Yang
    Discover Oncology.2024;[Epub]     CrossRef
  • G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis
    Jiaping Chen, Rong Zhao, Yangwei Wang, Han Xiao, Wei Lin, Mingxin Diao, Shiwen He, Peiyuan Mei, Yongde Liao
    Molecular Medicine.2024;[Epub]     CrossRef
  • Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1
    Tillmann Bork, Camila Hernando-Erhard, Wei Liang, Zhejia Tian, Kosuke Yamahara, Tobias B. Huber
    International Journal of Molecular Sciences.2024; 25(5): 2560.     CrossRef
  • Ailanthone induces autophagy and ferroptosis in non‑small cell lung cancer Lewis cells
    Hongbin Yang, Xiaotong Zhang, Yanjie Lu, Xin Wang, Zhengxin Zhang, Hailan Xu, Fan Li, Qianhui Chen, Yiying Bai, Xinyu Bai, Li Zhang, Lei Liu
    Molecular and Clinical Oncology.2024;[Epub]     CrossRef
  • Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies
    Yunbin Li, Xiaosong Li, Jian Li
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Curcumin activates the JNK signaling pathway to promote ferroptosis in colon cancer cells
    Wei Xin, Yong Zhang
    Chemical Biology & Drug Design.2024;[Epub]     CrossRef
  • Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
    Qian Zhou, Yu Meng, Daishi Li, Lei Yao, Jiayuan Le, Yihuang Liu, Yuming Sun, Furong Zeng, Xiang Chen, Guangtong Deng
    Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
  • AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis
    Yuan Mi, Liying Chen, Cong Wang, Yuxin Miao, Chuntao Song, Jie Su, Lei Wang
    Heliyon.2024; 10(7): e28365.     CrossRef
  • Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
    Jing Zeng, Xianghong Zhang, Zhengjun Lin, Yu Zhang, Jing Yang, Pengcheng Dou, Tang Liu
    Experimental Hematology & Oncology.2024;[Epub]     CrossRef
  • Emerging mechanisms of ferroptosis and its implications in lung cancer
    Qian Li, Qibin Song, Huadong Pei, Yali Chen
    Chinese Medical Journal.2024; 137(7): 818.     CrossRef
  • Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer
    Shasha Xiang, Wen Yan, Xing Ren, Jianbo Feng, Xuyu Zu
    Cellular & Molecular Biology Letters.2024;[Epub]     CrossRef
  • Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis
    Yangfan Ye, Lei Xu, Liuchao Zhang, Pengzhan Zhao, Wanzhi Cai, Guoqiang Fu, Tian Wang, Zeqiang Tao, Wenqian Shi, Wei Gu, Jingming Hu, Guangyao Yuan, Yutian Wei, Ke Xu, Zhongyuan Bao, Honglu Chao, Ning Liu, Lin Zhao, Yiming Tu, Jing Ji
    Redox Biology.2024; 72: 103137.     CrossRef
  • Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades
    Xiaoke Ji, Zongpin Chen, Weifan Lin, Qifang Wu, Yu Wu, Yan Hong, Haibin Tong, Changxiong Wang, Ya Zhang
    Journal of Ethnopharmacology.2024; 328: 118139.     CrossRef
  • A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy
    Xiaokang Zhu, Li Xie, Jinming Tian, Yang Jiang, Erqun Song, Yang Song
    Acta Biomaterialia.2024; 180: 383.     CrossRef
  • Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
    Marwa M Abu-Serie
    Nanomedicine.2024; 19(11): 979.     CrossRef
  • Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
    Aurel Prosz, Pranshu Sahgal, Brandon M. Huffman, Zsofia Sztupinszki, Clare X. Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada Likasitwatanakul, Orsolya Rusz, Istvan Csabai, Michael Cecchini, Yasmine Baca, Andrew E
    npj Precision Oncology.2024;[Epub]     CrossRef
  • Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
    Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, Masoud Salavati-Niasari, Mahnaz Amiri
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis
    Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
    Oncogene.2024; 43(22): 1714.     CrossRef
  • Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression
    Rumeng Pan, Rongli Wang, Feiyan Cheng, Lihui Wang, Zhiwei Cui, Jing She, Xinyuan Yang
    Reproductive Biology and Endocrinology.2024;[Epub]     CrossRef
  • FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications
    Ran Gao, Jinge Wang, Jingjing Huang, Tong Wang, Lingfeng Guo, Wenlu Liu, Jialu Guan, Desen Liang, Qinghui Meng, Huayang Pan
    Apoptosis.2024; 29(7-8): 1019.     CrossRef
  • Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies
    Namdev Dhas, Ritu Kudarha, Ruchi Tiwari, Gaurav Tiwari, Neha Garg, Praveen Kumar, Sanjay Kulkarni, Jahnavi Kulkarni, Soji Soman, Aswathi R. Hegde, Jayvadan Patel, Atul Garkal, Anam Sami, Deepanjan Datta, Viola Colaco, Tejal Mehta, Lalitkumar Vora, Sriniva
    Life Sciences.2024; 346: 122629.     CrossRef
  • Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
    Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, Sanjanaa Senthilkumar, Pratip K. Bhattacharya, Daniel E. Frigo, Elavarasan Subramani
    Nature Reviews Urology.2024; 21(10): 615.     CrossRef
  • Disruption of lipid metabolism to induce ferroptosis using multifunctional fibrate-Pt(iv) prodrugs for cancer treatment
    Peng Sun, Jia-Qian Wang, Qiang Xie, Xuan-Lin Ren, Xin Qiao, Jing-Yuan Xu
    Inorganic Chemistry Frontiers.2024; 11(10): 2914.     CrossRef
  • Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2
    Feng Liu, Ling Tang, Huai Liu, Yanzhu Chen, Tengfei Xiao, Wangning Gu, Hongmin Yang, Hui Wang, Pan Chen
    Cell Death & Disease.2024;[Epub]     CrossRef
  • Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis
    Ke Zong, Caifeng Lin, Kai Luo, Yilei Deng, Hongfei Wang, Jianfei Hu, Shi Chen, Renfeng Li
    BMC Cancer.2024;[Epub]     CrossRef
  • Oleanolic Acid Acetate Alleviates Cisplatin-Induced Nephrotoxicity via Inhibition of Apoptosis and Necroptosis In Vitro and In Vivo
    Bori Lee, Yeon-Yong Kim, Seungwon Jeong, Seung Woong Lee, Seung-Jae Lee, Mun-Chual Rho, Sang-Hyun Kim, Soyoung Lee
    Toxics.2024; 12(4): 301.     CrossRef
  • Ferroptosis is an effective strategy for cancer therapy
    Afrasyab Khan, Yu Huo, Yilei Guo, Juanjuan Shi, Yongzhong Hou
    Medical Oncology.2024;[Epub]     CrossRef
  • Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
    Xin Jin, Wenke Jin, Linlin Tong, Jia Zhao, Lan Zhang, Na Lin
    Acta Pharmaceutica Sinica B.2024; 14(7): 2815.     CrossRef
  • Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation
    Xinyu Zhou, Duanna Zhang, Jieting Lei, Jixia Ren, Bo Yang, Zhixing Cao, Chuanjie Guo, Yuzhi Li
    Journal of Natural Medicines.2024; 78(3): 618.     CrossRef
  • Ferroptotic therapy in cancer: benefits, side effects, and risks
    Jiandong Diao, Yuanyuan Jia, Enyong Dai, Jiao Liu, Rui Kang, Daolin Tang, Leng Han, Yingjie Zhong, Lingjun Meng
    Molecular Cancer.2024;[Epub]     CrossRef
  • Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential
    Ting Zhang, Xiaoping Zeng, Erming Zeng, Hongmei Wang
    International Immunopharmacology.2024; 134: 112203.     CrossRef
  • Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling
    Zhe Li, Zhi-min Xu, Wei-peng Chen, Xiao-jing Du, Chun-xian Ou, Zi-kang Luo, Rong Wang, Chu-qing Zhang, Chao-dong Ge, Meng Han, Fudi Wang, Rong-Rong He, Wan-yang Sun, Jun Ma, Xiao-yu Liang, Zhuo-wei Liu
    Nature Chemical Biology.2024; 20(10): 1341.     CrossRef
  • Network pharmacology and molecular docking technology for exploring the effect and mechanism of high-dose vitamin c on ferroptosis of tumor cells: A review
    Jinxiu Qu, Shuai Lu, Bing Wang, Shiwan Wang, Zhenpeng Yang, Huazhen Tang, Jia He, Yuan Zhao, Xin Wang, Xiaozhu Liu, Benqiang Rao
    Medicine.2024; 103(20): e38189.     CrossRef
  • A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer
    Hua Zhou, Xiaoting Zhou, Runying Zhu, Zhongquan Zhao, Kang Yang, Zhenghai Shen, Hongwen Sun
    Discover Oncology.2024;[Epub]     CrossRef
  • CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma
    Xiang Yong, Yanling Zhang, Heng Tang, Huaiyuan Hu, Rui Song, Qiang Wu
    Anti-Cancer Drugs.2024; 35(8): 698.     CrossRef
  • Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
    Celine Kapper, Peter Oppelt, Barbara Arbeithuber, Ayberk Alp Gyunesh, Ivona Vilusic, Patrick Stelzl, Marlene Rezk-Füreder
    Life Sciences.2024; 349: 122720.     CrossRef
  • Cysteine substitutants emerge in lung cancer proteomes during arginine restriction
    Dennis J. Hsu, Sohail F. Tavazoie
    Molecular Cell.2024; 84(10): 1819.     CrossRef
  • The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review)
    Yu Feng, Xiulei Li, Bingwu Yang, Maocai Li, Yongya Du, Jing Wang, Siyu Liu, Lili Gong, Lianqing Li, Lei Gao
    Oncology Reports.2024;[Epub]     CrossRef
  • Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
    M. Kciuk, A. Gielecińska, Ż. Kałuzińska-Kołat, E.B. Yahya, R. Kontek
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2024; 1879(4): 189124.     CrossRef
  • Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis
    Tianqi Ming, Jiarong Lei, Yuhui Peng, Minmin Wang, Yuanjing Liang, Shun Tang, Qiu Tao, Muqing Wang, Xiaomeng Tang, Ziyu He, Xiaohong Liu, Haibo Xu
    Phytotherapy Research.2024; 38(8): 3954.     CrossRef
  • Ferroptosis: A double-edged sword
    Shengmei Wang, Qiuyan Guo, Lili Zhou, Xinhua Xia
    Cell Death Discovery.2024;[Epub]     CrossRef
  • Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions
    Jiaan Lu, Ru He, Yang Liu, Jinghan Zhang, Heng Xu, Tianchi Zhang, Li Chen, Guanhu Yang, Jun Zhang, Jie Liu, Hao Chi
    Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
  • Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
    Aaron T. Kao, Christian V. Cabanlong, Kendra Padilla, Xiang Xue
    Acta Pharmaceutica Sinica B.2024; 14(9): 3785.     CrossRef
  • The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
    Dinara Baiskhanova, Heiner Schäfer
    Antioxidants.2024; 13(6): 696.     CrossRef
  • Ferroptosis: principles and significance in health and disease
    Fangquan Chen, Rui Kang, Daolin Tang, Jiao Liu
    Journal of Hematology & Oncology.2024;[Epub]     CrossRef
  • Micro-PIXE reveals cisplatin uptake followed by Fe accumulation in U87 cells
    Henrique Fonteles, T. S. Klippel, Julia Marcolin, Deiverti Bauer, Daphne Torgo, Laura Boose, Karine Begnini, Eduardo Filippi-Chiela, Guido Lenz, Johnny Ferraz Dias, Pedro Luis Grande
    Journal of Analytical Atomic Spectrometry.2024; 39(8): 2087.     CrossRef
  • Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma
    Yunyi Bian, Guangyao Shan, Jiaqi Liang, Zhengyang Hu, Qihai Sui, Haochun Shi, Qun Wang, Guoshu Bi, Cheng Zhan
    Communications Biology.2024;[Epub]     CrossRef
  • TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis
    Wenjing Ji, Weibin Zhang, Xin Zhang, Yue Ke
    Cellular Signalling.2024; 121: 111268.     CrossRef
  • Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
    Yu Cao, Chang Lu, Narasimha M. Beeraka, Sergey Efetov, Mikhail Enikeev, Yu Fu, Xinyi Yang, Basappa Basappa, Mingze He, Zhi Li
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy
    Yu Tang, Ying Zhuang, Chuanxiang Zhao, Shuangshuang Gu, Junya Zhang, Shiqi Bi, Ming Wang, Lei Bao, Mei Li, Wei Zhang, Liqun Zhu
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells
    Wei Huang, Yi Guo, Yazhi Qian, Xiaoang Liu, Gaoxiang Li, Jun Wang, Xiaozhou Yang, Mo Wu, Ying Fan, Haojun Luo, Yuzhu Chen, Liangren Zhang, Nan Yang, Zhenming Liu, Yanyong Liu
    European Journal of Medicinal Chemistry.2024; 276: 116670.     CrossRef
  • The role of hydrogen sulfide regulation of ferroptosis in different diseases
    Jingwen Lian, Yuhang Chen, Yanting Zhang, Shiyun Guo, Honggang Wang
    Apoptosis.2024; 29(9-10): 1377.     CrossRef
  • Glutathione-Dependent Pathways in Cancer Cells
    Elena Kalinina
    International Journal of Molecular Sciences.2024; 25(15): 8423.     CrossRef
  • Potential therapies for HCC involving targeting the ferroptosis pathway
    Denghui Li
    American Journal of Cancer Research.2024; 14(4): 1446.     CrossRef
  • Loss of Lipocalin2 confers cisplatin vulnerability through modulating NF-ĸB mediated ferroptosis via ferroportin
    Meibao Feng
    American Journal of Cancer Research.2024; 14(5): 2088.     CrossRef
  • Ropivacaine prompts ferroptosis to enhance the cisplatin-sensitivity of human colorectal cancer through SIRT1/Nrf2 signaling pathway
    Lian Zeng, WenBo Zhao, Tiantian Han, Fangfang Qing, Zhongshi He, Qiang Zhao, Ailin Luo, Pengchao Hu, Xudong Ding, Zhen Zhang
    Chemico-Biological Interactions.2024; 400: 111163.     CrossRef
  • Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma
    Feng-Jiao Li, Li-Chen Gao, Hui-Zhi Long, Zi-Wei Zhou, Hong-Yu Luo, Shuo-Guo Xu, Shang-Ming Dai, Jin-Da Hu
    Journal of Pharmacy and Pharmacology.2024;[Epub]     CrossRef
  • Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials
    Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, Brojendra Nath Saren, Kaushik Kuche, Sanyog Jain
    Journal of Drug Delivery Science and Technology.2024; 100: 105998.     CrossRef
  • The interplay of transition metals in ferroptosis and pyroptosis
    Frantisek Vana, Zoltan Szabo, Michal Masarik, Monika Kratochvilova
    Cell Division.2024;[Epub]     CrossRef
  • SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors
    Yingshu Cui, Yi Li, Yuanyuan Xu, Xinxin Liu, Xiaofeng Kang, Junwen Zhu, Shan Long, Yuchen Han, Chunyuan Xue, Zhijia Sun, Yimeng Du, Jia Hu, Lu Pan, Feifan Zhou, Xiaojie Xu, Xiaosong Li
    Redox Biology.2024; 76: 103304.     CrossRef
  • Ellagic acid ameliorates arsenic-induced neuronal ferroptosis and cognitive impairment via Nrf2/GPX4 signaling pathway
    Xiyue Yang, Fang Chu, Zhe Jiao, Hao Yu, Wenjing Yang, Yang Li, Chunqing Lu, Hao Ma, Sheng Wang, Zhipeng Liu, Shaoxiao Qin, Hongna Sun
    Ecotoxicology and Environmental Safety.2024; 283: 116833.     CrossRef
  • Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
    Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, Weixue Wang, Fan Wu, Yumin Wang, Yu Wang
    Molecular Cancer.2024;[Epub]     CrossRef
  • Targeting ferroptosis as a potential prevention and treatment strategy for aging-related diseases
    Taiwei Jiao, Yiman Chen, Haiyan Sun, Lina Yang
    Pharmacological Research.2024; 208: 107370.     CrossRef
  • A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms
    Ayşe Hale Alkan, Mine Ensoy, Demet Cansaran-Duman
    Medical Oncology.2024;[Epub]     CrossRef
  • FOXO1‐NCOA4 Axis Contributes to Cisplatin‐Induced Cochlea Spiral Ganglion Neuron Ferroptosis via Ferritinophagy
    Xue Wang, Lei Xu, Yu Meng, Fang Chen, Jinzhu Zhuang, Man Wang, Weibin An, Yuechen Han, Bo Chu, Renjie Chai, Wenwen Liu, Haibo Wang
    Advanced Science.2024;[Epub]     CrossRef
  • Targeting Ferroptosis with Small Molecule Atranorin (ATR) as a Novel Therapeutic Strategy and Providing New Insight into the Treatment of Breast Cancer
    Mine Ensoy, Demet Cansaran-Duman
    Pharmaceuticals.2024; 17(10): 1380.     CrossRef
  • Asiatic acid induces lung cancer toxicity by triggering SRC-mediated ferroptosis
    Huizhen Li, Guixuan Fang, Wen Tian, Yinglin Liao, Jing Xiang, Yingying Hu, Lianxiang Luo
    Toxicology and Applied Pharmacology.2024; 492: 117097.     CrossRef
  • UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling
    Mei Song, Shuting Huang, Xiaoxue Wu, Ziyi Zhao, Xiaoting Liu, Chong Wu, Mengru Wang, Jialing Gao, Zunfu Ke, Xiaojing Ma, Weiling He
    Redox Biology.2024; 76: 103349.     CrossRef
  • Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
    Lijie Sun, Hongfei Cao, Yanzhe Wang, Hongquan Wang
    Biology Direct.2024;[Epub]     CrossRef
  • Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology
    Zongchao Yu, Zhongcheng Mo, Yuan Qiu, Hengzhe Lu, Biao Zheng, Longfei Liu
    Current Pharmaceutical Biotechnology.2024; 25(15): 2012.     CrossRef
  • Inorganic Nanomedicine—Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy
    Adityanarayan Mohapatra, Ayeskanta Mohanty, In-Kyu Park
    Cancers.2024; 16(18): 3210.     CrossRef
  • Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis
    Yunyi Bian, Guangyao Shan, Guoshu Bi, Jiaqi Liang, Zhengyang Hu, Qihai Sui, Haochun Shi, Zhaolin Zheng, Guangyu Yao, Qun Wang, Hong Fan, Cheng Zhan
    Redox Biology.2024; 77: 103361.     CrossRef
  • Research progress on ferroptosis in colorectal cancer
    Yuan Li, Yao Bi, Wenjing Li, Yingshi Piao, Junjie Piao, Tong Wang, Xiangshan Ren
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • A Pan-Cancer Analysis of Ferroptosis-Related Gene Arachidonic Acid 15-Lipoxygenase-1 (ALOX15): Its Prognostic and Immunotherapeutic Values
    Hua Yang
    Cytology and Genetics.2024; 58(5): 456.     CrossRef
  • Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma
    Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu, Jian Xu, Bo Zhang, Yu Hu, Chunyan Sun
    Blood Advances.2024; 8(19): 5022.     CrossRef
  • Mechanosensitive fluorescence lifetime probes for investigating the dynamic mechanism of ferroptosis
    Xing Liang, Yuping Zhao, Jun Yan, Qian Zhang, Tony D. James, Weiying Lin
    Proceedings of the National Academy of Sciences.2024;[Epub]     CrossRef
  • Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies
    Wenjie Ma, Xiaotian Jiang, Ruipeng Jia, Yang Li
    Cell Death Discovery.2024;[Epub]     CrossRef
  • The melatonin-FTO-ATF4 signaling pathway protects granulosa cells from cisplatin-induced chemotherapeutic toxicity by suppressing ferroptosis
    Rongli Wang, Jing Geng
    Journal of Assisted Reproduction and Genetics.2024; 41(12): 3503.     CrossRef
  • Therapeutic efficacy of ferroptosis in the treatment of colorectal cancer (Review)
    Zhao Guo, Haoyan Zhuang, Xuewen Shi
    Oncology Letters.2024;[Epub]     CrossRef
  • The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects
    Ming-Yuan Cao, Zhen-Dong Zhang, Xin-Rui Hou, Xiao-Ping Wang
    Anti-Cancer Agents in Medicinal Chemistry.2024; 24(16): 1182.     CrossRef
  • A herbal pair of Scutellaria barbata D. Don and Scleromitrion diffusum (Willd.) R.J. Wang induced ferroptosis in ovarian cancer A2780 cells via inducing heme catabolism and ferritinophagy
    Zhen Wang, Min Liu, Guang-xing Li, Liu Zhang, Kai-yue Ding, Si-qi Li, Bing-qing Gao, Peng Chen, Hyok-Chol Choe, Lun-yue Xia, Yu-tong Yang, Yi Liu, Xue Sui, Jun-nan Ma, Lin Zhang
    Journal of Integrative Medicine.2024; 22(6): 665.     CrossRef
  • Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies
    Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Attalla F. El-kott, Mohammed A. AlShehri, Kareem Morsy, Salama A. Salama, Mahmoud E. Youssef
    European Journal of Pharmaceutical Sciences.2024; 203: 106939.     CrossRef
  • Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies
    Wei Li, Liying Zheng, Peiyue Luo, Tao Chen, Jun Zou, Qi Chen, Le Cheng, Lifeng Gan, Fangtao Zhang, Biao Qian
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Targeting ferroptosis with polymerized platinum (IV) prodrugs nanoparticles with everolimus for enhancing therapeutic efficacy on cholangiocarcinoma
    Yang Chen, Jia Huang, Hanchen Zhang, Fuzhen Hu, Zheng Cao, Zhiying Yang, Haiqin Song, Rong Liu
    Nano Today.2024; 59: 102531.     CrossRef
  • Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy
    Jinyu Zhu, Wenyuan Zhou, Yuan Yao, Xin Zhou, Xiaokun Ma, Baohui Zhang, Zhi Yang, Bufu Tang, Hua Zhu, Nan Li
    ACS Nano.2024; 18(45): 31401.     CrossRef
  • Genetic profile of ferroptosis in non-small cell lung carcinoma and pharmaceutical options for ferroptosis induction
    Rohil Jawed, Huma Bhatti, Adnan khan
    Clinical and Translational Oncology.2024;[Epub]     CrossRef
  • Quantitative determination and subcellular mapping of Pt-based drugs in single breast tumour cells via laser ablation-ICP-mass spectrometry
    Legna Colina-Vegas, Thibaut Van Acker, Wilmer Villarreal, Olivier De Wever, Alzir Azevedo Batista, Joaquim Araújo Nóbrega, Frank Vanhaecke
    Dalton Transactions.2024; 53(47): 18880.     CrossRef
  • STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression
    Laigang Zhao, HanLin Yang, Yuanmei Wang, Shuang Yang, Qisi Jiang, Jun Tan, Xing Zhao, Dan Zi
    Communications Biology.2024;[Epub]     CrossRef
  • Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
    Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, Monica Fedele
    Biomolecules.2024; 14(11): 1443.     CrossRef
  • LncRNA MALAT1 promotes Erastin-induced ferroptosis in the HBV-infected diffuse large B-cell lymphoma
    Xiaofei Bai, Jianguo Li, Xuecong Guo, Yinghui Huang, Xu Xu, Ailing Tan, Yisha Jia, Qiaoyi Sun, Xudong Guo, Jie Chen, Jiuhong Kang
    Cell Death & Disease.2024;[Epub]     CrossRef
  • MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
    Jie Liu, Xujin Wei, Yixuan Xie, Yuxiang Yan, Sihui Xue, Xiangyu Wang, Han Chen, Qilong Pan, Sisi Yan, Xiaoling Zheng, Qingling Huang
    Cell Death & Disease.2024;[Epub]     CrossRef
  • RETRACTED ARTICLE: CKS2 induces autophagy-mediated glutathione metabolic reprogramming to facilitate ferroptosis resistance in colon cancer
    Leilei Yang, Chengfeng Fang, Jiaju Han, Yufeng Ren, Zaiping Yang, Lingyan Shen, Dinghai Luo, Ruili Zhang, Yan Chen, Shenkang Zhou
    Molecular Medicine.2024;[Epub]     CrossRef
  • Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review
    Ruchi Saxena, Craig M. Welsh, You-Wen He
    Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
  • Ferroptosis: mechanisms and therapeutic targets
    Qian Zhou, Yu Meng, Jiayuan Le, Yuming Sun, Yating Dian, Lei Yao, Yixiao Xiong, Furong Zeng, Xiang Chen, Guangtong Deng
    MedComm.2024;[Epub]     CrossRef
  • Mechanism of ferroptosis resistance in cancer cells
    Yuan Wang, Guifang Yu, Xin Chen
    Cancer Drug Resistance.2024;[Epub]     CrossRef
  • Clinicopathological characteristics of invasive stratified mucinous carcinoma of the cervix and the expression and clinical significance of SLC7A11, SLC3A2 and PD-L1
    Changyu Lu, Wei Zhu, Xiahui Han, Xiuzhen Du, Hui Zhang, Qin Yao, Ting Liu, Ce Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Infection of Helicobacter pylori contributes to the progression of gastric cancer through ferroptosis
    Yun Liu, Renjie Miao, Jinxuan Xia, Yong Zhou, Jun Yao, Shihe Shao
    Cell Death Discovery.2024;[Epub]     CrossRef
  • Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)
    Yumin Wang, Joshua Fleishman, Yulin Li, Yuwei Cao, Haidong Wei, Zhe Zhang, Jichao Chen, Mingchao Ding
    International Journal of Oncology.2024;[Epub]     CrossRef
  • Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
    Chun Zhuang, Xiaoqi Li, Linxi Yang, Xinli Ma, Yanying Shen, Chen Huang, Tao Pan, Jianzhi Cui, Bo Ni, Ming Wang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety
    Yaseen A. Al-Soud, Sadeekah O. W. Saber, Amneh Shtaiwi, Sondos O. Alsawakhneh, Kafa’ A. S. Alhelal, Qusay F. A. Salman, Luay Abu-Qatouseh, Monther A. Khanfar, Raed A. Al-Qawasmeh
    Zeitschrift für Naturforschung C.2023; 78(3-4): 93.     CrossRef
  • The role of ferroptosis in prostate cancer: a novel therapeutic strategy
    Yue Wang, Yifan Ma, Kui Jiang
    Prostate Cancer and Prostatic Diseases.2023; 26(1): 25.     CrossRef
  • Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways
    Nasrin Ghassemi-Barghi, Zeynab Ehsanfar, Omid Mohammadrezakhani, Sorour Ashari, Shamim Ghiabi, Zahra Bayrami
    Inflammation.2023; 46(1): 342.     CrossRef
  • Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
    Amir Ajoolabady, Daolin Tang, Guido Kroemer, Jun Ren
    British Journal of Cancer.2023; 128(2): 190.     CrossRef
  • Metal complexes induced ferroptosis for anticancer therapy
    Shumeng Li, Hao Yuan, Yuncong Chen, Zijian Guo
    Fundamental Research.2023; 3(4): 525.     CrossRef
  • Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
    Ke Chen, Angling Li, Jian Wang, Dongchang Li, Xiaoshan Wang, Chengwei Liu, Zhengguang Wang
    Journal of Traditional and Complementary Medicine.2023; 13(1): 72.     CrossRef
  • Research trends in ferroptosis since the origin of the concept: A bibliometric analysis
    Huimin Deng, Juan Wei, Keting Min, Hao Yang, Sheng Wang, Zhuoran Xiao, Meiyun Liu, Li Zheng, Huanping Zhou, Yuanli Chen, Wanli Zhu, Quanfu Li, Xin Lv
    Clinical and Experimental Pharmacology and Physiology.2023; 50(2): 149.     CrossRef
  • Targeting lipid metabolism for ferroptotic cancer therapy
    Minhua Luo, Jiajing Yan, Xinyu Hu, Haolong Li, Hongsheng Li, Quentin Liu, Yibing Chen, Zhengzhi Zou
    Apoptosis.2023; 28(1-2): 81.     CrossRef
  • Metal-free polymer nano-photosensitizer actuates ferroptosis in starved cancer
    Dapeng Chen, Chen Liang, Xinyu Qu, Tian Zhang, Xiaozhou Mou, Yu Cai, Wenjun Wang, Jinjun Shao, Xiaochen Dong
    Biomaterials.2023; 292: 121944.     CrossRef
  • Targeting ferroptosis: Paving new roads for drug design and discovery
    Yilin Gu, Yizhe Li, Jiaxing Wang, Lele Zhang, Jifa Zhang, Yuxi Wang
    European Journal of Medicinal Chemistry.2023; 247: 115015.     CrossRef
  • Ferroptosis: a potential therapeutic target for Alzheimer’s disease
    Lan Yang, Jianfei Nao
    Reviews in the Neurosciences.2023; 34(5): 573.     CrossRef
  • Mechanism and application of ferroptosis in colorectal cancer
    Liu Yang, Yewei Zhang, Yingyi Zhang, Zhe Fan
    Biomedicine & Pharmacotherapy.2023; 158: 114102.     CrossRef
  • Overcoming cancer chemotherapy resistance by the induction of ferroptosis
    Yumin Wang, Xiaorui Wu, Zhao Ren, Yulin Li, Wailong Zou, Jichao Chen, Hongquan Wang
    Drug Resistance Updates.2023; 66: 100916.     CrossRef
  • Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy
    Nguyen Thi Nguyen, Juho Kim, Xuan Thien Le, Woo Tak Lee, Eun Seong Lee, Kyung Taek Oh, Han-Gon Choi, Yu Seok Youn
    ACS Nano.2023; 17(1): 382.     CrossRef
  • NaErF4-Based Nanocarrier for Enhanced Ferroptosis Therapy of Cancer
    Jin-Yang Liu, Na Liu, Yue Wu, Xiao-Min Ning, Wen-Chao Zhang, Jing Qian
    ACS Applied Nano Materials.2023; 6(1): 270.     CrossRef
  • Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer
    Yang Liu, Xuebo Quan, Jie Li, Jiawei Huo, Xing Li, Zhongpu Zhao, Shumu Li, Jing Wan, Jiao Li, Shuai Liu, Tao Wang, Xing Zhang, Bo Guan, Rui Wen, Zhenwen Zhao, Chunru Wang, Chunli Bai
    National Science Review.2023;[Epub]     CrossRef
  • Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products
    Višnja Stepanić, Marta Kučerová-Chlupáčová
    Molecules.2023; 28(2): 475.     CrossRef
  • Mechanism of ferroptosis in traditional chinese medicine for clinical treatment: A review
    Jiajiao Liu, Guanyin Jiang, Pengfei He, Xing Du, Zhenming Hu, Fuxiang Li
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis
    Xing-Qiang Dong, Li-Kai Chu, Xu Cao, Qian-Wei Xiong, Yi-Ming Mao, Ching-Hsien Chen, Yun-Li Bi, Jun Liu, Xiang-Ming Yan
    Redox Report.2023;[Epub]     CrossRef
  • Review of ferroptosis in colorectal cancer: Friends or foes?
    Zheng Wu, Ze-Xuan Fang, Yan-Yu Hou, Bing-Xuan Wu, Yu Deng, Hua-Tao Wu, Jing Liu
    World Journal of Gastroenterology.2023; 29(3): 469.     CrossRef
  • Ferroptosis as a therapeutic target for inflammation-related intestinal diseases
    Xiaoli Zhang, Yiming Ma, Guoqing Lv, Hongying Wang
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Crosstalk between microwave ablation and ferroptosis: The next hot topic?
    Lu Yu, Min Cheng, Jie Liu, Xin Ye, Zhigang Wei, Jiamei Xu, Qi Xie, Jing Liang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Progress in the study of ferroptosis in cancer treatment: State-of-the-Art
    Dong Wang
    Chemico-Biological Interactions.2023; 371: 110348.     CrossRef
  • RNA methylation and cellular response to oxidative stress-promoting anticancer agents
    Marco Ponzetti, Nadia Rucci, Stefano Falone
    Cell Cycle.2023; 22(8): 870.     CrossRef
  • Open pocket and tighten holes: Inhalable lung cancer-targeted nanocomposite for enhanced ferroptosis-apoptosis synergetic therapy
    Wenhua Wang, Wenhao Wang, Shiwei Jin, Fangqin Fu, Zhengwei Huang, Ying Huang, Chuanbin Wu, Xin Pan
    Chemical Engineering Journal.2023; 458: 141487.     CrossRef
  • Iron as a therapeutic target in chronic liver disease
    Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
    World Journal of Gastroenterology.2023; 29(4): 616.     CrossRef
  • Ferroptosis in colorectal cancer: a future target?
    Hong Yan, Ronan Talty, Oladimeji Aladelokun, Marcus Bosenberg, Caroline H. Johnson
    British Journal of Cancer.2023; 128(8): 1439.     CrossRef
  • Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer
    Gang Wang, Jun-Jie Wang, Zhu Zhi-Min, Xiao-Na Xu, Feng Shi, Xing-Li Fu
    Science Progress.2023;[Epub]     CrossRef
  • Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma
    Xiangming Fang, Ting Zhang, Zhitao Chen
    International Journal of General Medicine.2023; Volume 16: 481.     CrossRef
  • Overexpression of PRDX2 in Adipose-Derived Mesenchymal Stem Cells Enhances the Therapeutic Effect in a Neurogenic Erectile Dysfunction Rat Model by Inhibiting Ferroptosis
    Peng Chen, Zehong Chen, Jiancheng Zhai, Wende Yang, Hongbo Wei, Víctor M. Mendoza-Núñez
    Oxidative Medicine and Cellular Longevity.2023; 2023: 1.     CrossRef
  • Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
    Qiaolin Liu, Yuliang Zhao, Huige Zhou, Chunying Chen
    Regenerative Biomaterials.2023;[Epub]     CrossRef
  • miR-29a-5p modulates ferroptosis by targeting ferritin heavy chain FTH1 in prostate cancer
    Guang Yang, Qi Pan, Yang Lu, Junlong Zhu, Xin Gou
    Biochemical and Biophysical Research Communications.2023; 652: 6.     CrossRef
  • Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer
    Wesley Huang, Noora Aabed, Yatrik M. Shah
    Antioxidants & Redox Signaling.2023; 39(7-9): 551.     CrossRef
  • Cell death, therapeutics, and the immune response in cancer
    Kay Hänggi, Brian Ruffell
    Trends in Cancer.2023; 9(5): 381.     CrossRef
  • Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
    Danni Yan, Zhenghong Wu, Xiaole Qi
    Saudi Pharmaceutical Journal.2023; 31(4): 554.     CrossRef
  • Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells
    Roberto Fernández-Acosta, Behrouz Hassannia, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Bruno Verstraeten, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo-Andreu
    Cells.2023; 12(5): 735.     CrossRef
  • Ferroptosis As Ultimate Target of Cancer Therapy
    Yashiro Motooka, Shinya Toyokuni
    Antioxidants & Redox Signaling.2023; 39(1-3): 206.     CrossRef
  • Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
    Federica Maccarinelli, Daniela Coltrini, Silvia Mussi, Mattia Bugatti, Marta Turati, Paola Chiodelli, Arianna Giacomini, Floriana De Cillis, Nadia Cattane, Annamaria Cattaneo, Alessia Ligresti, Michela Asperti, Maura Poli, William Vermi, Marco Presta, Rob
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Identification of cuproptosis hub genes contributing to the immune microenvironment in ulcerative colitis using bioinformatic analysis and experimental verification
    Cejun Yang, Wendi Wang, Sang Li, Zhengkang Qiao, Xiaoqian Ma, Min Yang, Juan Zhang, Lu Cao, Shanhu Yao, Zhe Yang, Wei Wang
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The unfolding story of dying tumor cells during cancer treatment
    Sijia He, Qian Huang, Jin Cheng
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Engineered exosomes from different sources for cancer-targeted therapy
    Menghui Zhang, Shengyun Hu, Lin Liu, Pengyuan Dang, Yang Liu, Zhenqiang Sun, Bingbing Qiao, Chengzeng Wang
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
    Jianxin Zhong, Xi Shen, Junjie Zhou, Heping Yu, Birong Wang, Jianbin Sun, Jing Wang, Feng Liu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
    Rong Du, Xi Cheng, Jingjing Ji, Yang Lu, Yuanyuan Xie, Weina Wang, Yanhua Xu, Yuquan Zhang
    Scientific Reports.2023;[Epub]     CrossRef
  • An anticancer Ti(IV) complex increases mitochondrial reactive oxygen species levels in relation with hypoxia and endoplasmic-reticulum stress: A distinct non DNA-related mechanism
    Zohar Shpilt, Naomi Melamed-Book, Edit Y. Tshuva
    Journal of Inorganic Biochemistry.2023; 243: 112197.     CrossRef
  • Ferroptosis: Mechanism and potential applications in cervical cancer
    Xiangyu Chang, Jinwei Miao
    Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
  • Ferroptosis in gastrointestinal cancer: from mechanisms to implications
    Ruoxi Zhang, Rui Kang, Daolin Tang
    Cancer Letters.2023; 561: 216147.     CrossRef
  • Ferroptosis Detection: From Approaches to Applications
    Fantian Zeng, Sureya Nijiati, Longguang Tang, Jinmin Ye, Zijian Zhou, Xiaoyuan Chen
    Angewandte Chemie International Edition.2023;[Epub]     CrossRef
  • Ferroptosis Detection: From Approaches to Applications
    Fantian Zeng, Sureya Nijiati, Longguang Tang, Jinmin Ye, Zijian Zhou, Xiaoyuan Chen
    Angewandte Chemie.2023;[Epub]     CrossRef
  • The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs
    Mine Ensoy, Zehra Sena Bumin, Huda Abdirizak Jama, Demet Cansaran-Duman
    Current Medicinal Chemistry.2023; 30(14): 1638.     CrossRef
  • Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
    Jingjuan Zhu, Xiao Xu, Man Jiang, Fangfang Yang, Yingying Mei, Xiaochun Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
    Nan Xing, Qinyun Du, Sa Guo, Gelin Xiang, Yi Zhang, Xianli Meng, Li Xiang, Shaohui Wang
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
    Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, Andreas Koeberle
    Medicinal Research Reviews.2023; 43(3): 614.     CrossRef
  • Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
    Mingyu Yang, Meng Li, Zhuozhen Lyu, Zhen Yang
    Cancer Management and Research.2023; Volume 15: 335.     CrossRef
  • A review of nemorosone: Chemistry and biological properties
    Osmany Cuesta-Rubio, Lianet Monzote, Roberto Fernández-Acosta, Gilberto Lázaro Pardo-Andreu, Luca Rastrelli
    Phytochemistry.2023; 210: 113674.     CrossRef
  • Ferroptosis landscape in prostate cancer from molecular and metabolic perspective
    Jiaming Liang, Yihao Liao, Pu Wang, Kun Yang, Youzhi Wang, Keke Wang, Boqiang Zhong, Diansheng Zhou, Qian Cao, Junbo Li, Yang Zhao, Ning Jiang
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells
    Chieh-Hsin Chen, Yi-Ming Huang, Louis Grillet, Yu-Chen Hsieh, Ya-Wen Yang, Kai-Yin Lo
    Cellular Oncology.2023; 46(4): 1127.     CrossRef
  • Ferroptosis regulates key signaling pathways in gastrointestinal tumors: Underlying mechanisms and therapeutic strategies
    Ravichandiran Rabitha, Sethuraman Shivani, Yahya Showket, Ganapasam Sudhandiran
    World Journal of Gastroenterology.2023; 29(16): 2433.     CrossRef
  • Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells
    Yingchao Wu, Dajin Pi, Shuyao Zhou, Zhongjia Yi, Yangyang Dong, Wuhong Wang, Huan Ye, Yiliu Chen, Qian Zuo, Mingzi Ouyang
    Acta Biochimica et Biophysica Sinica.2023; 55(4): 587.     CrossRef
  • Modulation of Ferroptosis by microRNAs in Human Cancer
    Irena Velkova, Martina Pasino, Zumama Khalid, Paola Menichini, Emanuele Martorana, Alberto Izzotti, Alessandra Pulliero
    Journal of Personalized Medicine.2023; 13(5): 719.     CrossRef
  • Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin
    Chenyuan Li, Ziqi He, Feng Yao, Shichong Liao, Kai Sun, Shengrong Sun, Zhiyu Li, Zhong Wang
    Apoptosis.2023; 28(7-8): 1154.     CrossRef
  • PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation
    Yang Luo, Yunli Zhang, Shiyu Pang, Jingxian Min, Tao Wang, Dali Wu, Chun Lin, Zebin Xiao, Qi Xiang, Qing Li, Lili Ma
    Molecular Carcinogenesis.2023; 62(7): 907.     CrossRef
  • Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
    Tianyuan Zhong, Jie Yu, Yong Pan, Ning Zhang, Yanxin Qi, Yubin Huang
    Advanced Healthcare Materials.2023;[Epub]     CrossRef
  • SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex
    Ping Huang, Han Zhao, Xiafang Pan, Jinying Li, Wentian Pan, Hua Dai, Jia Wang, Chunhua Xia, Fanglan Liu
    Biochemical Pharmacology.2023; 213: 115592.     CrossRef
  • AKT activation because of PTEN loss upregulates xCT via GSK3β/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells
    Kaitlyn M. Cahuzac, Abigail Lubin, Kaitlyn Bosch, Nicole Stokes, Sarah Mense Shoenfeld, Royce Zhou, Haddy Lemon, John Asara, Ramon E. Parsons
    Cell Reports.2023; 42(5): 112536.     CrossRef
  • CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
    Xiaoqian Zhang, Xiaocui Zheng, Xiang Ying, Weiwei Xie, Yujia Yin, Xipeng Wang
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
    Ryosuke Takahashi, Koki Kamizaki, Keitaro Yamanaka, Yoshito Terai, Yasuhiro Minami
    Oncology Reports.2023;[Epub]     CrossRef
  • Exosomal miR-17–92 derived from human mesenchymal stem cells promotes wound healing by enhancing angiogenesis and inhibiting endothelial cell ferroptosis
    Wenbo Nie, Xuemiao Huang, Lijing Zhao, Taiwei Wang, Dan Zhang, Tianxin Xu, Lin Du, Yuxiang Li, Weiyuan Zhang, Fengjun Xiao, Lisheng Wang
    Tissue and Cell.2023; 83: 102124.     CrossRef
  • Progress in the Mechanism of the Effect of Fe3O4 Nanomaterials on Ferroptosis in Tumor Cells
    Yaxuan Wang, Xiao Wu, Xiaoying Bao, Xianbo Mou
    Molecules.2023; 28(11): 4562.     CrossRef
  • Donafenib and GSK‐J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression
    Chenyang Zheng, Bo Zhang, Yunyun Li, Kejia Liu, Wei Wei, Shuhang Liang, Hongrui Guo, Kun Ma, Yao Liu, Jiabei Wang, Lianxin Liu
    Advanced Science.2023;[Epub]     CrossRef
  • Schizochytrium sp. Extracted Lipids Prevent Alopecia by Enhancing Antioxidation and Inhibiting Ferroptosis of Dermal Papilla Cells
    Zuye Zeng, Boyu Wang, Muhammad Ibrar, Ming Ying, Shuangfei Li, Xuewei Yang
    Antioxidants.2023; 12(7): 1332.     CrossRef
  • Interaction mechanisms between autophagy and ferroptosis: Potential role in colorectal cancer
    Xin-Ya Zeng, Xin-Ze Qiu, Jiang-Ni Wu, Sheng-Mei Liang, Jie-An Huang, Shi-Quan Liu
    World Journal of Gastrointestinal Oncology.2023; 15(7): 1135.     CrossRef
  • A Novel Bromophenol Compound from Leathesia nana Inhibits Breast Cancer in a Direct Tumor Killing and Immunotherapy Manner
    Ruochen Sun, Mi Zhang, Bufan Li, Shan Jiang, Wanpeng Yu, Lina Yang, Yantao Han, Zhangfeng Zhong, Wenwen Zhao
    Molecules.2023; 28(14): 5349.     CrossRef
  • “Double-Edged Sword” Effect of Reactive Oxygen Species (ROS) in Tumor Development and Carcinogenesis
    W Zhao, P Zhuang, Y Chen, Y Wu, M Zhong, Y Lun
    Physiological Research.2023;[Epub]     CrossRef
  • Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
    Xiaogang Zheng, Xiaodong Jin, Fei Ye, Xiongxiong Liu, Boyi Yu, Zheng Li, Ting Zhao, Weiqiang Chen, Xinguo Liu, Cuixia Di, Qiang Li
    Experimental Hematology & Oncology.2023;[Epub]     CrossRef
  • Integrated single-cell and bulk RNA sequencing analysis identifies a prognostic signature related to ferroptosis dependence in colorectal cancer
    Xiaochen Xu, Xinwen Zhang, Qiumei Lin, Yuling Qin, Yihao Liu, Weizhong Tang
    Scientific Reports.2023;[Epub]     CrossRef
  • Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines
    James Patrick Heiserman, Zenab Minhas, Elahe Nikpayam, Dong-Joo Cheon
    International Journal of Molecular Sciences.2023; 24(16): 12638.     CrossRef
  • A planning strategy may reduce the risk of heart diseases and radiation pneumonia: Avoiding the specific heart substructures
    AiHui Feng, YanHua Duan, ZhangRu Yang, Yan Shao, Hao Wang, Hua Chen, HengLe Gu, Ying Huang, ZhenJiong Shen, Xufei Wang, ZhiYong Xu
    Journal of Applied Clinical Medical Physics.2023;[Epub]     CrossRef
  • Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
    Yuqing Ren, Xiangrong Mao, Hui Xu, Qin Dang, Siyuan Weng, Yuyuan Zhang, Shuang Chen, Shutong Liu, Yuhao Ba, Zhaokai Zhou, Xinwei Han, Zaoqu Liu, Guojun Zhang
    Cellular and Molecular Life Sciences.2023;[Epub]     CrossRef
  • Sinularin Exerts Anti-cancer Effects by Inducing Oxidative Stress-mediated Ferroptosis, Apoptosis, and Autophagy in Prostate Cancer Cells
    ZhengPing Wu, MengQiao Su, HanWu Chen, XuZhou Chen, Chung-Yi Chen, LiJie An, ZiChen Shao, XiaoYu Liu, Yi Lin, Ai-Jun OuYang, Chi-Ming Liu
    Anti-Cancer Agents in Medicinal Chemistry.2023; 23(12): 1457.     CrossRef
  • NRF2, a Superstar of Ferroptosis
    Ruihan Yan, Bingyi Lin, Wenwei Jin, Ling Tang, Shuming Hu, Rong Cai
    Antioxidants.2023; 12(9): 1739.     CrossRef
  • SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer
    Yiding Wang, Xiaoling Pang, Yuexin Liu, Guiling Mu, Qian Wang
    Carcinogenesis.2023; 44(8-9): 708.     CrossRef
  • Ferroptosis, autophagy, tumor and immunity
    Yuyan Xie, Yang Zhou, Jiale Wang, Lijuan Du, Yuanyuan Ren, Fang Liu
    Heliyon.2023; 9(9): e19799.     CrossRef
  • Ferroptosis regulation by methylation in cancer
    Mengqiu Hao, Yixin Jiang, Yang Zhang, Xuyang Yang, Junhong Han
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(6): 188972.     CrossRef
  • FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis
    Xin Liu, Chunli Yan, Chunxiao Chang, Fansong Meng, Wenjie Shen, Song Wang, Yi Zhang
    Advanced Science.2023;[Epub]     CrossRef
  • Creation of a Rat Takotsubo Syndrome Model and Utilization of Machine Learning Algorithms for Screening Diagnostic Biomarkers
    Hongyu Huai, Junliang Li, Xiangjie Zhang, Qiang Xu, Huan Lan
    Journal of Inflammation Research.2023; Volume 16: 4833.     CrossRef
  • Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes
    Qi Li, Hengchen Liu, Yun Jin, Yuanquan Yu, Yihang Wang, Di Wu, Yinghao Guo, Longfu Xi, Dan Ye, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li
    Computers in Biology and Medicine.2023; 165: 107370.     CrossRef
  • Ferroptosis as a promising therapeutic strategy for melanoma
    Na Ta, Xiaodong Jiang, Yongchun Zhang, Hongquan Wang
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy
    Yichen Zheng, Lingqi Sun, Jiamin Guo, Ji Ma
    Cancer Communications.2023; 43(10): 1071.     CrossRef
  • Impact of ferroptosis on preeclampsia: A review
    Yuping Shan, Chengcheng Guan, Jingli Wang, Weihong Qi, Aiping Chen, Shiguo Liu
    Biomedicine & Pharmacotherapy.2023; 167: 115466.     CrossRef
  • Endogenous molecule-targeted fluorescent probes for ferroptosis visualization: Current progress and future prospects
    Wen-Jie Shu, Zhengzhi Cao, Yuxing Yan, Zhuang Cai, Fu Wang
    Coordination Chemistry Reviews.2023; 496: 215432.     CrossRef
  • Selenium intake and multiple health-related outcomes: an umbrella review of meta-analyses
    Puze Wang, Bo Chen, Yin Huang, Jin Li, Dehong Cao, Zeyu Chen, Jinze Li, Biao Ran, Jiahao Yang, Ruyi Wang, Qiang Wei, Qiang Dong, Liangren Liu
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Recent advances of ferroptosis in tumor: From biological function to clinical application
    Shunfeng Hu, Yurou Chu, Xiangxiang Zhou, Xin Wang
    Biomedicine & Pharmacotherapy.2023; 166: 115419.     CrossRef
  • Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
    Xun Chen, Lejia Zhang, Yi He, Siyuan Huang, Shangwu Chen, Wei Zhao, Dongsheng Yu
    Cell Death Discovery.2023;[Epub]     CrossRef
  • Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
    Simona D’Aprile, Simona Denaro, Anna Maria Pavone, Sebastiano Giallongo, Cesarina Giallongo, Alfio Distefano, Lucia Salvatorelli, Filippo Torrisi, Raffaella Giuffrida, Stefano Forte, Daniele Tibullo, Giovanni Li Volti, Gaetano Magro, Nunzio Vicario, Rosal
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer
    Biqing Chen, Liping Zhao, Rulin Yang, Tianmin Xu
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Implanted, Wireless, Self‐Powered Photodynamic Therapeutic Tablet Synergizes with Ferroptosis Inducer for Effective Cancer Treatment
    Pingjin Zou, Rui Lin, Zengyi Fang, Junyang Chen, Hongye Guan, Jie Yin, Zhiheng Chang, Lili Xing, Jinyi Lang, Xinyu Xue, Meihua Chen
    Advanced Science.2023;[Epub]     CrossRef
  • Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic Treatment
    Vicente Valentí, Laia Capdevila, Isabel Ruiz, Javier Ramos, Joan Badía, Susana Blázquez, Óscar Villuendas, Cristina Pérez, Laura Fernández-Sender, Mónica Córdoba, Carlos Alonso-Villaverde
    Cancer Investigation.2023; 41(10): 821.     CrossRef
  • Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence
    Min Deng, Shuang Wu, Peizheng Huang, Yun Liu, Chong Li, Ji Zheng
    Asian Journal of Pharmaceutical Sciences.2023; 18(6): 100870.     CrossRef
  • Molecular Mechanisms of Ferroptosis and Its Role in Viral Pathogenesis
    Riwei Huang, Jiang Wu, Yaodan Ma, Kai Kang
    Viruses.2023; 15(12): 2373.     CrossRef
  • Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
    Abdullah A. Osman, Emre Arslan, Mason Bartels, Chieko Michikawa, Antje Lindemann, Katarzyna Tomczak, Wangjie Yu, Vlad Sandulache, Wencai Ma, Li Shen, Jing Wang, Anand K. Singh, Mitchell J. Frederick, Nakia D. Spencer, Jeffery Kovacs, Timothy Heffernan, Wi
    Clinical Cancer Research.2023; 29(7): 1344.     CrossRef
  • Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
    Yumin Wang, Jing Hu, Shuang Wu, Joshua S. Fleishman, Yulin Li, Yinshi Xu, Wailong Zou, Jinhua Wang, Yukuan Feng, Jichao Chen, Hongquan Wang
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
    Rui Fu, Borui Zhao, Min Chen, Xiaolong Fu, Qian Zhang, Yange Cui, Xin Hu, Wei Zhou
    Medical Oncology.2023;[Epub]     CrossRef
  • ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape
    Tianyao Liu, Xinyan Xu, Jiazheng Li, Ming Bai, Wenjie Zhu, Yanqing Liu, Siyang Liu, Zihan Zhao, Tianhang Li, Ning Jiang, Yuhao Bai, Qingyang Jin, Yulin Zhang, Yufeng Zheng, Shengkai Zhou, Shoubin Zhan, Ying Sun, Gaoli Liang, Yang Luo, Xi Chen, Hongqian Gu
    Cell Death & Disease.2023;[Epub]     CrossRef
  • NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma
    Ping Huang, Wei Duan, Cao Ruan, Lingxian Wang, Rendy Hosea, Zheng Wu, Jianting Zeng, Shourong Wu, Vivi Kasim, Carmen Priolo
    PLOS Genetics.2023; 19(12): e1011098.     CrossRef
  • Ferroptosis: An emerging therapeutic opportunity for cancer
    Liyuan Wang, Xiaoguang Chen, Chunhong Yan
    Genes & Diseases.2022; 9(2): 334.     CrossRef
  • Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy
    Nasim Ebrahimi, Samaneh Adelian, Siavash Shakerian, Maral Afshinpour, Siavash Rahimian Chaleshtori, Nadi Rostami, Fatemeh Rezaei-Tazangi, Sheida Beiranvand, Michael R. Hamblin, Amir Reza Aref
    Cytokine & Growth Factor Reviews.2022; 64: 33.     CrossRef
  • Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target
    Abhijit Chakraborty, Yang Li, Chen Zhang, Yanming Li, Scott A. LeMaire, Ying H. Shen
    Journal of Molecular and Cellular Cardiology.2022; 163: 67.     CrossRef
  • Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
    Shiyao Sui, Shouping Xu, Da Pang
    Pharmacology & Therapeutics.2022; 232: 107992.     CrossRef
  • GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway
    Hua-wen Li, Mu-biao Liu, Xue Jiang, Ting Song, Shu-xian Feng, Jing-ya Wu, Peng-fei Deng, Xiao-yu Wang
    Future Oncology.2022; 18(2): 149.     CrossRef
  • Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC
    Yifan Zhang, Ruixue Guo, Jia Li, Liangming Zhu
    Naunyn-Schmiedeberg's Archives of Pharmacology.2022; 395(1): 1.     CrossRef
  • A novel mechanism linking ferroptosis and endoplasmic reticulum stress via the circPtpn14/miR-351-5p/5-LOX signaling in melatonin-mediated treatment of traumatic brain injury
    Chenrui Wu, Mengran Du, Renqiang Yu, Yuqi Cheng, Biying Wu, Jiayuanyuan Fu, Weilin Tan, Qiang Zhou, Ehab Balawi, Z.B. Liao
    Free Radical Biology and Medicine.2022; 178: 271.     CrossRef
  • The Role of Ferroptosis Signature in Overall Survival and Chemotherapy of Pancreatic Adenocarcinoma
    Wanhui Wei, Qian Hu, Wenjie Li, Mengting Li, Shouquan Dong, Yanan Peng, Jingwen Yin, Yuanyuan Lu, Lan Liu, Qiu Zhao
    DNA and Cell Biology.2022; 41(2): 116.     CrossRef
  • The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer
    Yingying Hu, Nan Guo, Ting Yang, Jianghong Yan, Wenjun Wang, Xiang Li, Julio J. Ochoa
    Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
  • Induction and application of ferroptosis in cancer therapy
    Qing Nie, Yue Hu, Xiao Yu, Xiao Li, Xuedong Fang
    Cancer Cell International.2022;[Epub]     CrossRef
  • Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates
    Fan Yang, Si-Yu Sun, Sheng Wang, Jin-Tao Guo, Xiang Liu, Nan Ge, Guo-Xin Wang
    World Journal of Gastrointestinal Oncology.2022; 14(1): 1.     CrossRef
  • Can Polyphenols Inhibit Ferroptosis?
    Marija Lesjak, Nataša Simin, Surjit K. S. Srai
    Antioxidants.2022; 11(1): 150.     CrossRef
  • Nickel oxide nanoparticles induce apoptosis and ferroptosis in airway epithelial cells via ATF3
    Fengfan Liu, Xiang Cheng, Shuang Wu, Bei Hu, Chen Yang, Shufen Deng, Qiwen Shi
    Environmental Toxicology.2022; 37(5): 1093.     CrossRef
  • Emerging Mechanisms and Disease Implications of Ferroptosis: Potential Applications of Natural Products
    Chun Ge, Sujie Zhang, Huiwen Mu, Shaojun Zheng, Zhaoyi Tan, Xintong Huang, Chen Xu, Jianjun Zou, Yubing Zhu, Dong Feng, Jiye Aa
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
    Xiangjun Shu, Zaiqi Zhang, Zhi-Yong Yao, Xiao-Liang Xing
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • Modulations of ferroptosis in lung cancer therapy
    Robert Walters, Shaker A. Mousa
    Expert Opinion on Therapeutic Targets.2022; 26(2): 133.     CrossRef
  • Epigenetic landscape of drug responses revealed through large-scale ChIP-seq data analyses
    Zhaonan Zou, Michio Iwata, Yoshihiro Yamanishi, Shinya Oki
    BMC Bioinformatics.2022;[Epub]     CrossRef
  • Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
    Jingchao Liu, Zhipeng Zhang, Wei Zhang, Lingfeng Meng, Jiawen Wang, Zhengtong Lv, Haoran Xia, Meng Wu, Yaoguang Zhang, Jianye Wang
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?
    Gong Feng, Christopher D. Byrne, Giovanni Targher, Fudi Wang, Ming‐Hua Zheng
    Liver International.2022; 42(7): 1496.     CrossRef
  • Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer
    Erva Ozkan, Filiz Bakar-Ates
    Current Medicinal Chemistry.2022; 29(1): 41.     CrossRef
  • Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer
    Junhao Wu, Jing Ye, Qiang Xie, Bo Liu, Ming Liu
    Journal of Medicinal Chemistry.2022; 65(4): 2989.     CrossRef
  • Albumin-Based Therapeutics Capable of Glutathione Consumption and Hydrogen Peroxide Generation for Synergetic Chemodynamic and Chemotherapy of Cancer
    Guangbao Yang, Dongdong Wang, Soo Zeng Fiona Phua, Anivind Kaur Bindra, Cheng Qian, Rui Zhang, Liang Cheng, Guofeng Liu, Hongwei Wu, Zhuang Liu, Yanli Zhao
    ACS Nano.2022; 16(2): 2319.     CrossRef
  • A Ferroptosis-Related lncRNA Model to Enhance the Predicted Value of Cervical Cancer
    Zhaojing Jiang, Jingyu Li, Wenqing Feng, Yujie Sun, Junguo Bu, Fu Wang
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • Ferroptosis in cancer and cancer immunotherapy
    Lei Zhao, Xiaoxue Zhou, Feng Xie, Lei Zhang, Haiyan Yan, Jun Huang, Chong Zhang, Fangfang Zhou, Jun Chen, Long Zhang
    Cancer Communications.2022; 42(2): 88.     CrossRef
  • Schisandrin B suppresses gastric cancer cell growth and enhances the efficacy of chemotherapy drug 5-FU in vitro and in vivo
    Leye He, Hao Chen, Qinqin Qi, Nan Wu, Ying Wang, Mengxia Chen, Qian Feng, Buyuan Dong, Rong Jin, Lei Jiang
    European Journal of Pharmacology.2022; 920: 174823.     CrossRef
  • Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
    Hsin-Chih Chen, Han-Hsuan Tang, Wei-Hsiang Hsu, Shan-Ying Wu, Wen-Hsing Cheng, Bao-Yuan Wang, Chun-Li Su
    Antioxidants.2022; 11(2): 298.     CrossRef
  • Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma
    Johanna Kusnick, Alix Bruneau, Frank Tacke, Linda Hammerich
    Immuno.2022; 2(1): 185.     CrossRef
  • Cyclophosphamide Induces the Ferroptosis of Tumor Cells Through Heme Oxygenase-1
    Hezhan Shi, Bo Hou, Huifeng Li, Hui Zhou, Bin Du
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
    Hong-Tao Wang, Jie Ju, Shao-Cong Wang, Yu-Hui Zhang, Cui-Yun Liu, Tao Wang, Xue Yu, Fei Wang, Xue-Ru Cheng, Kun Wang, Zhao-Yang Chen
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis
    Yiting Wei, Shilong Duan, Fanyong Gong, Qiang Li
    Biochemical and Biophysical Research Communications.2022; 603: 153.     CrossRef
  • Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism
    Jiasi Zhang, Yuxi Liu, Qun Li, Aoshuang Xu, Yu Hu, Chunyan Sun
    Biomedicine & Pharmacotherapy.2022; 148: 112747.     CrossRef
  • Metabolic regulation of ferroptosis in the tumor microenvironment
    Nneka E. Mbah, Costas A. Lyssiotis
    Journal of Biological Chemistry.2022; 298(3): 101617.     CrossRef
  • The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
    Siqi Zhao, Wubin Zheng, Chao Yu, Gaoxin Xu, Xinyi Zhang, Chao Pan, Yongheng Feng, Kunxing Yang, Jin Zhou, Yong Ma
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Potential Role of APEX1 During Ferroptosis
    Nan Guo, Yan Chen, Yuhong Zhang, Yonghao Deng, Fancai Zeng, Xiang Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
    Yue Li, Jiongshan Zhang, Kun Zhang, Yan Chen, Wei Wang, Hongjie Chen, Zengcheng Zou, Yongwei Li, Min Dai
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
    Lei Li, Buhai Wang
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model
    Jingyu Wang, Yaqing Wang, Yi Liu, Xintian Cai, Xin Huang, Wenjing Fu, Lei Wang, Lihua Qiu, Junying Li, Li Sun
    Cell Death Discovery.2022;[Epub]     CrossRef
  • Targeting ferroptosis as a vulnerability in cancer
    Guang Lei, Li Zhuang, Boyi Gan
    Nature Reviews Cancer.2022; 22(7): 381.     CrossRef
  • AXL inhibition improves BRAF-targeted treatment in melanoma
    Marta Nyakas, Karianne Giller Fleten, Mads Haugland Haugen, Nikolai Engedal, Christina Sveen, Inger Nina Farstad, Vivi Ann Flørenes, Lina Prasmickaite, Gunhild Mari Mælandsmo, Kotryna Seip
    Scientific Reports.2022;[Epub]     CrossRef
  • Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin
    Jung Yoon Jang, Bokyung Sung, Nam Deuk Kim
    International Journal of Molecular Sciences.2022; 23(7): 3757.     CrossRef
  • Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer
    Wenwen Wang, Jing Cai, Jiayi Wen, Xinyi Li, Yingjie Yu, Lingpu Zhang, Qing Han, Zheng Wei, Yujia Ma, Feiquan Ying, Xiaohan Xu, Wenhan Li, Qiang Yang, Si Sun, Xiaoqi He, Liqiong Cai, Haihua Xiao, Zehua Wang
    Nano Today.2022; 44: 101459.     CrossRef
  • A GSH-depleted platinum(IV) prodrug triggers ferroptotic cell death in breast cancer
    Dachuan Qi, Lei Xing, Lijun Shen, Wenshuang Sun, Cheng Cai, Chunhua Xue, Xuwei Song, Hua Yu, Hulin Jiang, Chengjun Li, Qingri Jin, Zhiqi Zhang
    Chinese Chemical Letters.2022; 33(10): 4595.     CrossRef
  • miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
    Guoshu Bi, Jiaqi Liang, Mengnan Zhao, Huan Zhang, Xing Jin, Tao Lu, Yuansheng Zheng, Yunyi Bian, Zhencong Chen, Yiwei Huang, Valeria Besskaya, Cheng Zhan, Qun Wang, Lijie Tan
    Molecular Therapy - Nucleic Acids.2022; 28: 366.     CrossRef
  • Non-coding RNAs and ferroptosis: potential implications for cancer therapy
    Amar Balihodzic, Felix Prinz, Michael A. Dengler, George A. Calin, Philipp J. Jost, Martin Pichler
    Cell Death & Differentiation.2022; 29(6): 1094.     CrossRef
  • SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
    Xin Cheng, Yadong Wang, Liangchao Liu, Chenggang Lv, Can Liu, Jingyun Xu
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • Molecular mechanisms of reactive oxygen species in regulated cell deaths: Impact of ferroptosis in cancer therapy
    Morteza Golbashirzadeh, Hamid Reza Heidari, Ahmad Yari Khosroushahi
    Gene Reports.2022; 27: 101614.     CrossRef
  • Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies
    Yixin Shi, Bingrun Qiu, Linyang Huang, Jie Lin, Yiling Li, Yiting Ze, Chenglong Huang, Yang Yao
    PeerJ.2022; 10: e13238.     CrossRef
  • Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells
    Lu Han, Lei Li, Geng Wu
    Molecular and Cellular Probes.2022; 64: 101821.     CrossRef
  • Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer
    Lv Yang, Tang WenTao, Zhang ZhiYuan, Lin Qi, Luo YuXiang, Zheng Peng, Li Ke, Jia XiaoNa, Pang YuZhi, Ji MeiLing, Feng QingYang, He GuoDong, Wang YueXiang, Xu JianMin
    Oncogene.2022; 41(23): 3210.     CrossRef
  • Excessive selenium affects neural development and locomotor behavior of zebrafish embryos
    Guang Zhao, Jun Hu, Meng Gao, Yuejie Zhu, Yijiang Hong
    Ecotoxicology and Environmental Safety.2022; 238: 113611.     CrossRef
  • Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy
    Tushar Date, Kaushik Kuche, Dasharath Chaudhari, Rohan Ghadi, Deepak Kumar Sahel, Deepak Chitkara, Sanyog Jain
    ACS Biomaterials Science & Engineering.2022; 8(6): 2349.     CrossRef
  • Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy
    Jing Su, Qin Zhao, Zhuangzhuang Zheng, Huanhuan Wang, Chenbin Bian, Lingbin Meng, Ying Xin, Xin Jiang
    Antioxidants.2022; 11(5): 921.     CrossRef
  • Solasonine Causes Redox Imbalance and Mitochondrial Oxidative Stress of Ferroptosis in Lung Adenocarcinoma
    Yao-Ying Zeng, Ying-Bin Luo, Xu-Dong Ju, Bo Zhang, Ya-Jing Cui, Yan-Bin Pan, Jian-Hui Tian, Wen-Jing Teng, Jianchun Wu, Yan Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
    Zhenyu Nie, Mei Chen, Yuanhui Gao, Denggao Huang, Hui Cao, Yanling Peng, Na Guo, Fei Wang, Shufang Zhang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
    Le Zhang, Ningning Hou, Bing Chen, Chengxia Kan, Fang Han, Jingwen Zhang, Xiaodong Sun
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Pharmacological Targeting of Ferroptosis in Cancer Treatment
    Mehdi Rabiee Valashedi, Amirsadegh Nikoo, Nima Najafi-Ghalehlou, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar
    Current Cancer Drug Targets.2022; 22(2): 108.     CrossRef
  • Flavonoid 4,4′-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECH
    Changmei Yang, Tianxiang Wang, Yujiao Zhao, Xianbin Meng, Wenxi Ding, Qingtao Wang, Chongdong Liu, Haiteng Deng
    Free Radical Biology and Medicine.2022; 188: 14.     CrossRef
  • Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses
    Cheng Zhang, Jiao‐jiao Yu, Chen Yang, Shuang Shang, Xiao‐xi Lv, Bing Cui, Fang Hua
    Cancer Innovation.2022; 1(1): 92.     CrossRef
  • Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
    Shaokun Wang, Wei Wei, Ning Ma, Yongliang Qu, Qiuju Liu
    Critical Reviews in Oncology/Hematology.2022; 176: 103732.     CrossRef
  • The power of heteronemin in cancers
    Kuan Wang, Yi-Fong Chen, Yu-Chen S. H. Yang, Haw-Ming Huang, Sheng-Yang Lee, Ya-Jung Shih, Zi-Lin Li, Jacqueline Whang-Peng, Hung-Yun Lin, Paul J. Davis
    Journal of Biomedical Science.2022;[Epub]     CrossRef
  • CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability
    Mehdi Rabiee Valashedi, Amaneh Mohammadi Roushandeh, Kazuo Tomita, Yoshikazu Kuwahara, Zahra Pourmohammadi-Bejarpasi, Pouya Safarzadeh Kozani, Tomoaki Sato, Mehryar Habibi Roudkenar
    Life Sciences.2022; 304: 120704.     CrossRef
  • Ana Hatları ile Ferroptozis
    Arzu GEZER, Ebru KARADAĞ SARI
    Turkish Veterinary Journal.2022; 4(1): 24.     CrossRef
  • Microwave assisted extraction, characterization of a polysaccharide from Salvia miltiorrhiza Bunge and its antioxidant effects via ferroptosis-mediated activation of the Nrf2/HO-1 pathway
    Huanhuan Meng, Jianjun Wu, Li Shen, Guangwei Chen, Liang Jin, Mengxia Yan, Haitong Wan, Yu He
    International Journal of Biological Macromolecules.2022; 215: 398.     CrossRef
  • Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
    Weitong Gao, Xueying Wang, Yang Zhou, Xueqian Wang, Yan Yu
    Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
  • Predicting prognosis and clinical features of the tumor microenvironment based on ferroptosis score in patients with breast cancer
    Lianli Yin, Yinghua Tang
    Scientific Reports.2022;[Epub]     CrossRef
  • Multifaceted Roles of Ferroptosis in Lung Diseases
    Yi Li, Ying Yang, Yongfeng Yang
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
    Yiming Zhang, Rong He, Xuan Lei, Lianghao Mao, Zhengyu Yin, Xinyu Zhong, Wenbing Cao, Qiping Zheng, Dapeng Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity
    Bartosz Wiernicki, Sophia Maschalidi, Jonathan Pinney, Sandy Adjemian, Tom Vanden Berghe, Kodi S. Ravichandran, Peter Vandenabeele
    Nature Communications.2022;[Epub]     CrossRef
  • Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature AURKA in NSCLC
    Liqiu Li, Qian Gao, Jin Wang, Ling Gu, Zhihui Li, Shiping Zhang, Cheng Hu, Menglin He, Yulin Wang, Zixuan Wang, Yongxiang Yi, Jin Fu, Xiongfei Zhang, Fei Ge, Meijuan Chen, Xu Zhang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells
    Xiaobin Wang, Xiaoyu Liu, Huihan Wang
    Cancer Gene Therapy.2022; 29(11): 1742.     CrossRef
  • Role of Heme Oxygenase in Gastrointestinal Epithelial Cells
    Reiko Akagi
    Antioxidants.2022; 11(7): 1323.     CrossRef
  • Capsaicin induces ferroptosis of NSCLC by regulating SLC7A11/GPX4 signaling in vitro
    Xiao-Yan Liu, Dong-Guang Wei, Rong-Shan Li
    Scientific Reports.2022;[Epub]     CrossRef
  • Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy
    Devangkumar Maru, Akhil Hothi, Chintan Bagariya, Anmol Kumar
    Current Cancer Drug Targets.2022; 22(3): 234.     CrossRef
  • Amorphous ferric oxide-coating selenium core–shell nanoparticles: a self-preservation Pt(iv) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis
    Zhaowei Xu, Qingdong Li, Caiyun Zhang, Peng Wang, Xiaotong Xu, Lang Ran, Li Zhang, Geng Tian, Guilong Zhang
    Nanoscale.2022; 14(32): 11600.     CrossRef
  • ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression
    Junpeng Ji, Huibing Li, Wenjun Wang, Bo Yuan, Tianyu Shen
    Human Cell.2022; 35(5): 1591.     CrossRef
  • Iron as spirit of life to share under monopoly
    Shinya Toyokuni, Yingyi Kong, Hao Zheng, Yuki Maeda, Yashiro Motooka, Shinya Akatsuka
    Journal of Clinical Biochemistry and Nutrition.2022; 71(2): 78.     CrossRef
  • Multi-platform-based characterization of ferroptosis in human colorectal cancer
    Yafang Zhong, Wei Zhang, Haiyan Yu, Liewen Lin, Xucan Gao, Jingquan He, Dandan Li, Yumei Chen, Zhipeng Zeng, Yong Xu, Donge Tang, Yong Dai
    iScience.2022; 25(8): 104750.     CrossRef
  • Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
    Yang Gao, Bin Chen, Ruru Wang, An Xu, Lijun Wu, Huayi Lu, Guoping Zhao
    Cell Death Discovery.2022;[Epub]     CrossRef
  • Revisiting “BAP1ness” in Malignant Pleural Mesothelioma
    Haitang Yang, Feng Yao, Ren-Wang Peng
    Journal of Thoracic Oncology.2022; 17(8): e67.     CrossRef
  • Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator
    Tian-Liang Ma, Jing-Xian Chen, Peng Zhu, Chao-Bin Zhang, Yong Zhou, Jia-Xi Duan
    Life Sciences.2022; 307: 120868.     CrossRef
  • The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer
    Kun Ke, Li Li, Chao Lu, Qicong Zhu, Yuanyu Wang, Yiping Mou, Huiju Wang, Weiwei Jin
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Regulated cell death (RCD) in cancer: key pathways and targeted therapies
    Fu Peng, Minru Liao, Rui Qin, Shiou Zhu, Cheng Peng, Leilei Fu, Yi Chen, Bo Han
    Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
  • Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field
    Kunming Cheng, Qiang Guo, Zefeng Shen, Weiguang Yang, Yan Zhou, Zaijie Sun, Xiuhua Yao, Haiyang Wu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach
    Heshu Chen, Chenyu Wang, Zemin Liu, Xinmiao He, Wenjie Tang, Liuqin He, Yanzhong Feng, Di Liu, Yulong Yin, Tiejun Li
    Antioxidants.2022; 11(8): 1504.     CrossRef
  • Targeting Ferroptosis in Colorectal Cancer
    Xiaojie Liang, Zhihuan You, Xinhao Chen, Jun Li
    Metabolites.2022; 12(8): 745.     CrossRef
  • Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells
    Zheng Zhang, Qiangsheng Hu, Shuang Ye, Libing Xiang
    Acta Biochimica et Biophysica Sinica.2022;[Epub]     CrossRef
  • Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer
    Qiumo Zhang, Ting Deng, Hongdian Zhang, Duo Zuo, Qihang Zhu, Ming Bai, Rui Liu, Tao Ning, Le Zhang, Zhentao Yu, Haiyang Zhang, Yi Ba
    Advanced Science.2022;[Epub]     CrossRef
  • The role of ferroptosis in esophageal cancer
    Zimin Wang, Sikai Wu, Chengchu Zhu, Jianfei Shen
    Cancer Cell International.2022;[Epub]     CrossRef
  • Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer
    Jingchao Liu, Jingyi Cui, Shuangyi Zhao, Meng Wu, Jiawen Wang, Yaoguang Zhang, Bin Jin, Jianye Wang, Lianxiang Luo
    Oxidative Medicine and Cellular Longevity.2022; 2022: 1.     CrossRef
  • Neratinib inhibits proliferation and promotes apoptosis of acute myeloid leukemia cells by activating autophagy‐dependent ferroptosis
    Hongxia Ma, Yang Liu, Zhen Miao, Shijia Cheng, Yunan Zhu, Yifan Wu, Xinxin Fan, Jing Yang, Xingang Li, Liyin Guo
    Drug Development Research.2022; 83(7): 1641.     CrossRef
  • System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
    Feng-Jiao Li, Hui-Zhi Long, Zi-Wei Zhou, Hong-Yu Luo, Shuo-Guo Xu, Li-Chen Gao
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer
    Xiao Xu, Na Zhou, Hongwei Lan, Fangfang Yang, Bowen Dong, Xiaochun Zhang
    International Journal of Molecular Sciences.2022; 23(17): 9767.     CrossRef
  • The Role of Programmed Necrosis in Colorectal Cancer
    Yu-Qiang Yu, Reyes Gamez-Belmonte, Jay V. Patankar, Eva Liebing, Christoph Becker
    Cancers.2022; 14(17): 4295.     CrossRef
  • Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
    Huan Feng, Qi Liu, Zhiyao Deng, Hao Li, Huajie Zhang, Jingyu Song, Xiaming Liu, Jihong Liu, Bo Wen, Tao Wang
    Stem Cell Research & Therapy.2022;[Epub]     CrossRef
  • Long non-coding RNA OGFRP1 regulates cell proliferation and ferroptosis by miR-299-3p/SLC38A1 axis in lung cancer
    Liang Liu, Shengtian Su, Dan Ye, Zhigao Yu, Wenjing Lu, Xiaoju Li
    Anti-Cancer Drugs.2022;[Epub]     CrossRef
  • Ferroptosis: A mixed blessing for infectious diseases
    Leyao Xiao, Huanshao Huang, Shuhao Fan, Biying Zheng, Jianguo Wu, Junai Zhang, Jiang Pi, Jun-Fa Xu
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • More than a duologue: In-depth insights into epitranscriptomics and ferroptosis
    Justin Chak Ting Cheung, Guangzheng Deng, Nathalie Wong, Yujuan Dong, Simon Siu Man Ng
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer
    Dongya Shen, Jia Luo, Ling Chen, Wenjuan Ma, Xiaoyuan Mao, Yu Zhang, Juyan Zheng, Yang Wang, Jielin Wan, Shiyu Wang, Jing Ouyang, Hanying Yi, Dongbo Liu, Weihua Huang, Wei Zhang, Zhaoqian Liu, Howard L. McLeod, Yijing He
    Cancer Letters.2022; 550: 215919.     CrossRef
  • Mechanisms and inhibitors of ferroptosis in psoriasis
    Qiao Zhou, Lijing Yang, Ting Li, Kaiwen Wang, Xiaobo Huang, Jingfen Shi, Yi Wang
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
    Yeqin Sha, Rui Jiang, Yi Miao, Shuchao Qin, Wei Wu, Yi Xia, Li Wang, Lei Fan, Hui Jin, Wei Xu, Jianyong Li, Huayuan Zhu
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice
    Yubing Zhang, Lili Li, Song Qin, Jingyi Yuan, Xiaonan Xie, Fan Wang, Shanliang Hu, Yuetao Yi, Min Chen
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • KIF20A is associated with clinical prognosis and synergistic effect of gemcitabine combined with ferroptosis inducer in lung adenocarcinoma
    Hua He, Lu Liang, Jingjing Huang, Shiyao Jiang, Yueying Liu, Xiaoyan Sun, Yi Li, Li Cong, Yiqun Jiang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives
    Chu Qiao, Haiying Wang, Qiutong Guan, Minjie Wei, Zhenhua Li
    Asian Journal of Pharmaceutical Sciences.2022; 17(5): 613.     CrossRef
  • The Relationship Between Ferroptosis and Diseases
    Jinchang Lv, Biao Hou, Jiangang Song, Yunhua Xu, Songlin Xie
    Journal of Multidisciplinary Healthcare.2022; Volume 15: 2261.     CrossRef
  • Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways
    Nang Lae Lae Phoo, Amonnat Sukhamwang, Pornngarm Dejkriengkraikul, Supachai Yodkeeree
    International Journal of Molecular Sciences.2022; 23(20): 12066.     CrossRef
  • Aberrant expression of microRNA-4443 (miR-4443) in human diseases
    Yunan Mao, Jinze Shen, Yuchen Wu, Ruan Wenjing, Feng Zhu, Shiwei Duan
    Bioengineered.2022; 13(6): 14770.     CrossRef
  • The differential usage of molecular machinery in brain cancer patients with iron-enriched glioma environments
    Lucke-Wold Brandon, Diaz Michael Joseph, Song Joanna, Batchu Sai, Root Kevin, Patel Karan, Taneja Kamil
    Journal of Surgery and Surgical Research.2022; 8(3): 030.     CrossRef
  • Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications
    Linzhou Yin, Pengyu Liu, Yue Jin, Zunxi Ning, Yiren Yang, Huiyuan Gao
    European Journal of Medicinal Chemistry.2022; 244: 114861.     CrossRef
  • Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma
    Qi Su, Qi Li, Weimin Zhang, Bingzong Li, Wenzhuo Zhuang
    Carcinogenesis.2022; 43(11): 1050.     CrossRef
  • Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy
    Jing Xu, Xiaolin Lin, Ting Han, Qingqing Zhou, Yang Su, Shuqing Jiang, Xiuying Xiao, Tengfei Liu
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • Ferroptosis in tumor immunity and therapy
    Chuandong Gong, Qiankun Ji, Miaojing Wu, Zewei Tu, Kunjian Lei, Min Luo, Junzhe Liu, Li Lin, Kuangxun Li, Jingying Li, Kai Huang, Xingen Zhu
    Journal of Cellular and Molecular Medicine.2022; 26(22): 5565.     CrossRef
  • Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity
    Tomonori Tadokoro, Masataka Ikeda, Ko Abe, Tomomi Ide, Hiroko Deguchi Miyamoto, Shun Furusawa, Kosei Ishimaru, Masatsugu Watanabe, Akihito Ishikita, Shouji Matsushima, Tomoko Koumura, Ken-ichi Yamada, Hirotaka Imai, Hiroyuki Tsutsui
    Journal of Cardiovascular Pharmacology.2022; 80(5): 690.     CrossRef
  • Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
    Qianwen Zhou, Xiaoqi Wang, Yingxue Zhang, Lie Wang, Zhijun Chen
    BMC Oral Health.2022;[Epub]     CrossRef
  • Ferroptosis: A new insight for treatment of acute kidney injury
    Shiyang Li, Rui Wang, Yixue Wang, Yong Liu, Yingjin Qiao, Peipei Li, Jingfang Chen, Shaokang Pan, Qi Feng, Zhangsuo Liu, Dongwei Liu
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Impacts of Iron Overload and Ferroptosis on Intestinal Mucosal Homeostasis and Inflammation
    Caiyun Huo, Guiping Li, Yanxin Hu, Huiling Sun
    International Journal of Molecular Sciences.2022; 23(22): 14195.     CrossRef
  • Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis
    Wei Cang, Anyue Wu, Liying Gu, Wenjing Wang, Qi Tian, Zhong Zheng, Lihua Qiu
    International Immunopharmacology.2022; 113: 109422.     CrossRef
  • A novel ferroptosis‑related gene signature for overall survival prediction and immune infiltration in patients with breast cancer
    Yan Zhang, Yiran Liang, Yajie Wang, Fangzhou Ye, Xiaoli Kong, Qifeng Yang
    International Journal of Oncology.2022;[Epub]     CrossRef
  • Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival
    Jonathan W. Villanueva, Lawrence Kwong, Teng Han, Salvador Alonso Martinez, Michael T. Shanahan, Matt Kanke, Lukas E. Dow, Charles G. Danko, Praveen Sethupathy
    BMC Genomics.2022;[Epub]     CrossRef
  • Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future
    Chang Li, Xunzhe Yin, Zuojia Liu, Jin Wang
    International Journal of Molecular Sciences.2022; 23(23): 15031.     CrossRef
  • Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
    Xuhui Tong, Rong Tang, Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Xianjun Yu, Si Shi
    Journal of Hematology & Oncology.2022;[Epub]     CrossRef
  • Ferroptosis: Reviewing CRC with the Third Eye
    Xingyu Liu, Halahati Tuerxun, Yawen Li, Yaping Li, Yuanyuan He, Yuguang Zhao
    Journal of Inflammation Research.2022; Volume 15: 6801.     CrossRef
  • Low Sulfur Amino Acid, High Polyunsaturated Fatty Acid Diet Inhibits Breast Cancer Growth
    Riccardo Turchi, Flavia Tortolici, Monica Benvenuto, Carolina Punziano, Anastasia De Luca, Stefano Rufini, Raffaella Faraonio, Roberto Bei, Daniele Lettieri-Barbato, Katia Aquilano
    International Journal of Molecular Sciences.2022; 24(1): 249.     CrossRef
  • Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis
    Yu Zhao, Pengpeng Ren, Zhiqin Yang, Lei Wang, Changhua Hu
    Oncology Reports.2022;[Epub]     CrossRef
  • Comprehensive Analysis of the Expression and Clinical Significance of a Ferroptosis-Related Genome in Ovarian Serous Cystadenocarcinoma: A Study Based on TCGA Data
    Hua Yang
    Oncologie.2022; 24(4): 835.     CrossRef
  • Cisplatin Promotes the Efficacy of ICI Therapy by Inducing Ferroptosis and Activating Neutrophils
    Ziwei Zhou, Yiming Zhao, Si Chen, Guohui Cui, Wenkui Fu, Shouying Li, Xiaorong Lin, Hai Hu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Ferroptosis a Futuristic Roadmap for Cancer and Alzheimer's Disease
    Gourav Singh, Prashant Kesharwani, Bhupendra Kumar, Indubhusan Mishra, Saroj Kumar, Gyan Modi
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
    Tianai Sun, Jen-Tsan Chi
    Genes & Diseases.2021; 8(3): 241.     CrossRef
  • Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
    Jian-Shu Lou, Li-Ping Zhao, Zhi-Hui Huang, Xia-Yin Chen, Jing-Ting Xu, William Chi-Shing TAI, Karl W.K. Tsim, Yi-Tao Chen, Tian Xie
    Phytomedicine.2021; 80: 153370.     CrossRef
  • Lipid Peroxidation, GSH Depletion, and SLC7A11 Inhibition Are Common Causes of EMT and Ferroptosis in A549 Cells, but Different in Specific Mechanisms
    Lulu Sun, Hongliang Dong, Weiqun Zhang, Nan Wang, Na Ni, Xuelian Bai, Naiguo Liu
    DNA and Cell Biology.2021; 40(2): 172.     CrossRef
  • A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways
    Wen-Tsan Chang, Yung-Ding Bow, Pei-Jung Fu, Chia-Yang Li, Chang-Yi Wu, Yi-Hua Chang, Yen-Ni Teng, Ruei-Nian Li, Mei-Chin Lu, Yi-Chang Liu, Chien-Chih Chiu, Cristina Angeloni
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Broadening horizons: the role of ferroptosis in cancer
    Xin Chen, Rui Kang, Guido Kroemer, Daolin Tang
    Nature Reviews Clinical Oncology.2021; 18(5): 280.     CrossRef
  • Elucidating the Roles of Fenton Reactants in Drug‐Treated Cells by Using a Selective Rhodamine‐Thiophenol Fluorogenic Sensor
    Zhanlong Wang, Jia Hao Yeo, Elizabeth J. New
    Analysis & Sensing.2021; 1(2): 90.     CrossRef
  • Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment
    Lesang Shen, Yunxiang Zhou, Haifei He, Wuzhen Chen, Cameron Lenahan, Xiaoyi Li, Yongchuan Deng, Anwen Shao, Jian Huang, Ding Sheng Jiang
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Targeting the tumour microenvironment in platinum-resistant ovarian cancer
    M. Cummings, C. Freer, N.M. Orsi
    Seminars in Cancer Biology.2021; 77: 3.     CrossRef
  • Cell death in head and neck cancer pathogenesis and treatment
    Martina Raudenská, Jan Balvan, Michal Masařík
    Cell Death & Disease.2021;[Epub]     CrossRef
  • Curcumin induces ferroptosis in non‐small‐cell lung cancer via activating autophagy
    Xin Tang, Hui Ding, Maoli Liang, Xing Chen, Yuxia Yan, Nansheng Wan, Qianqian Chen, Jing Zhang, Jie Cao
    Thoracic Cancer.2021; 12(8): 1219.     CrossRef
  • Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer
    Jiyan Zhang, Jie Xi, Ping Huang, Saitian Zeng
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Effect of Micelle-Incorporated Cisplatin With Sizes Ranging From 8 to 40 nm for the Therapy of Lewis Lung Carcinoma
    Zhicheng Wang, Yumin Li, Tong Zhang, Hongxia Li, Zhao Yang, Cheng Wang
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
    Ting Hong, Guang Lei, Xue Chen, He Li, Xiaoye Zhang, Nayiyuan Wu, Yu Zhao, Yilei Zhang, Jing Wang
    Redox Biology.2021; 42: 101928.     CrossRef
  • Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer
    Ali Ghoochani, En-Chi Hsu, Merve Aslan, Meghan A. Rice, Holly M. Nguyen, James D. Brooks, Eva Corey, Ramasamy Paulmurugan, Tanya Stoyanova
    Cancer Research.2021; 81(6): 1583.     CrossRef
  • The emerging role of ferroptosis in intestinal disease
    Shu Xu, Yao He, Lihui Lin, Peng Chen, Minhu Chen, Shenghong Zhang
    Cell Death & Disease.2021;[Epub]     CrossRef
  • Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
    Zhiyu Song, Gang Jia, Peizhi Ma, Shundong Cang
    Life Sciences.2021; 276: 119399.     CrossRef
  • The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis
    Chunhua Rui, Shen-nan Shi, Wenqing Ren, Xia Qin, Chunlin Zhuang, Xiaofei Chen, Gang Chen, Jianqiang Yu, Hong-yang Wang, Zhenyu Cai
    Biochemical Pharmacology.2021; 188: 114542.     CrossRef
  • Emerging mechanisms and targeted therapy of ferroptosis in cancer
    Haiyan Wang, Yan Cheng, Chao Mao, Shuang Liu, Desheng Xiao, Jun Huang, Yongguang Tao
    Molecular Therapy.2021; 29(7): 2185.     CrossRef
  • Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells
    Ching-Yuan Wu, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Ming-Shao Tsai, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu
    Biomedicine & Pharmacotherapy.2021; 139: 111585.     CrossRef
  • Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo
    Qi Cheng, Lingjie Bao, Mingqing Li, Kaikai Chang, Xiaofang Yi
    Journal of Obstetrics and Gynaecology Research.2021; 47(7): 2481.     CrossRef
  • Ferroptosis, radiotherapy, and combination therapeutic strategies
    Guang Lei, Chao Mao, Yuelong Yan, Li Zhuang, Boyi Gan
    Protein & Cell.2021; 12(11): 836.     CrossRef
  • Recent progress on targeting ferroptosis for cancer therapy
    Guangxiang Xu, Han Wang, Xiaoling Li, Riming Huang, Lianxiang Luo
    Biochemical Pharmacology.2021; 190: 114584.     CrossRef
  • Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin
    Zheng Tang, Wanli Jiang, Ming Mao, Jinping Zhao, Jiakuan Chen, Nitao Cheng
    Clinical and Translational Medicine.2021;[Epub]     CrossRef
  • Nitroimidazoles Part 9. Synthesis, molecular docking, and anticancer evaluations of piperazine-tagged imidazole derivatives
    Yaseen A. Al-Soud, Ala’a H. Al-Ahmad, Luay Abu-Qatouseh, Amneh Shtaiwi, Kafa’ A. S. Alhelal, Hossam H. Al-Suod, Sondos O. Alsawakhneh, Raed A. Al-Qawasmeh
    Zeitschrift für Naturforschung B.2021; 76(5): 293.     CrossRef
  • Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis
    David Soriano-Castell, Antonio Currais, Pamela Maher
    Free Radical Biology and Medicine.2021; 171: 219.     CrossRef
  • Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
    Jingchao Liu, Hong Ma, Lingfeng Meng, Xiaodong Liu, Zhengtong Lv, Yaoguang Zhang, Jianye Wang
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • Tetrahedral DNA Nanostructures Inhibit Ferroptosis and Apoptosis in Cisplatin-induced Renal Injury
    Jiaying Li, Liwen Wei, Yuanqing Zhang, Minhao Wu
    ACS Applied Bio Materials.2021; 4(6): 5026.     CrossRef
  • Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice
    Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Licht Miyamoto, Tasuku Hirayama, Hideko Nagasawa, Toshiaki Tamaki, Koichiro Tsuchiya
    Journal of Trace Elements in Medicine and Biology.2021; 67: 126798.     CrossRef
  • Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer
    Jie Zhu, Weikaixin Kong, Zhengwei Xie
    International Journal of Molecular Sciences.2021; 22(11): 5652.     CrossRef
  • Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling
    Dazhi Fu, Chunxiao Wang, Lei Yu, Rui Yu
    Cellular & Molecular Biology Letters.2021;[Epub]     CrossRef
  • A Promising Future of Ferroptosis in Tumor Therapy
    Hui Wang, Danfeng Lin, Qianqian Yu, Zhouqi Li, Cameron Lenahan, Ying Dong, Qichun Wei, Anwen Shao
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Role of Exosomal Non-coding RNAs in Gastric Cancer: Biological Functions and Potential Clinical Applications
    Feng Hu, Jixuan Liu, Huibo Liu, Fan Li, Minjie Wan, Manli Zhang, Yanfang Jiang, Min Rao
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs
    Yuan Zhi, Ling Gao, Baisheng Wang, Wenhao Ren, Kristina Xiao Liang, Keqian Zhi
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Opportunities for Ferroptosis in Cancer Therapy
    Kenji M. Fujihara, Bonnie Z. Zhang, Nicholas J. Clemons
    Antioxidants.2021; 10(6): 986.     CrossRef
  • Platinum drugs and taxanes: can we overcome resistance?
    Elena V. Sazonova, Gelina S. Kopeina, Evgeny N. Imyanitov, Boris Zhivotovsky
    Cell Death Discovery.2021;[Epub]     CrossRef
  • Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells
    Zhigang Liang, Weijun Zhao, Xinjian Li, Longfei Wang, Lifei Meng, Rui Yu
    Biochemical and Biophysical Research Communications.2021; 569: 79.     CrossRef
  • Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction
    Rui-Rong Ye, Bi-Chun Chen, Jun-Jian Lu, Xiu-Rong Ma, Rong-Tao Li
    Journal of Inorganic Biochemistry.2021; 223: 111537.     CrossRef
  • CPEB1 enhances erastin‐induced ferroptosis in gastric cancer cells by suppressing twist1 expression
    Jing Wang, Tao Wang, Yang Zhang, Jiaqi Liu, Jie Song, Yanlong Han, Lihong Wang, Shuang Yang, Lili Zhu, Rui Geng, Weimin Li, Xiaoguang Yu
    IUBMB Life.2021; 73(9): 1180.     CrossRef
  • DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
    Jing Du, Xu Wang, Yanchun Li, Xueying Ren, Yi Zhou, Wanye Hu, Chaoting Zhou, Qiangan Jing, Chen Yang, Luyang Wang, Huanjuan Li, Lijuan Fang, Yonglie Zhou, Xiangmin Tong, Ying Wang
    Cell Death & Disease.2021;[Epub]     CrossRef
  • Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma
    Chao Yang, Shuoyang Huang, Fengyu Cao, Yongbin Zheng
    PeerJ.2021; 9: e11745.     CrossRef
  • Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
    Huanji Xu, Di Ye, Meiling Ren, Hongying Zhang, Feng Bi
    Trends in Molecular Medicine.2021; 27(9): 856.     CrossRef
  • Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics
    Khaled S Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Saleh A Almatroodi, Mohammad O Alkurbi, Ghaiyda Talal Basfar, Arshad Husain Rahmani, Amjad Ali Khan
    International Journal of Nanomedicine.2021; Volume 16: 5065.     CrossRef
  • Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications
    Xiao-Huan Tang, Ting Guo, Xiang-Yu Gao, Xiao-Long Wu, Xiao-Fang Xing, Jia-Fu Ji, Zi-Yu Li
    Molecular Cancer.2021;[Epub]     CrossRef
  • Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology
    Maria Scuto, Angela Trovato Salinaro, Isabella Caligiuri, Maria Laura Ontario, Valentina Greco, Nello Sciuto, Roberto Crea, Edward J. Calabrese, Flavio Rizzolio, Vincenzo Canzonieri, Vittorio Calabrese
    Mechanisms of Ageing and Development.2021; 199: 111551.     CrossRef
  • Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
    Jingjing Cai, Chunyan Li, Hongsheng Li, Xiaoxiong Wang, Yongchun Zhou
    PeerJ.2021; 9: e11931.     CrossRef
  • A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
    Yilin Yan, Jinming Cai, Zhengnan Huang, Xiangqian Cao, Pengfei Tang, Zeyi Wang, Fang Zhang, Shujie Xia, Bing Shen
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • WITHDRAWN: Oroxylin A promotes therapeutic efficacy of cisplatin to suppress bladder cancer progression via inducing ferroptosis
    Qiao Tang, Jiahui Jiang, Junyi Sun, Liang Tang, Xiangyang Zhang
    Biochemical and Biophysical Research Communications.2021;[Epub]     CrossRef
  • A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer
    Yingchun Liang, Fangdie Ye, Chenyang Xu, Lujia Zou, Yun Hu, Jimeng Hu, Haowen Jiang
    BMC Cancer.2021;[Epub]     CrossRef
  • Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
    Rui Sha, Yaqian Xu, Chenwei Yuan, Xiaonan Sheng, Ziping Wu, Jing Peng, Yaohui Wang, Yanping Lin, Liheng Zhou, Shuguang Xu, Jie Zhang, Wenjin Yin, Jinsong Lu
    eBioMedicine.2021; 71: 103560.     CrossRef
  • Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
    Shengyi Long, Fang Peng, Baohui Song, Liang Wang, Jun Chen, Bingbing Shang
    International Journal of General Medicine.2021; Volume 14: 5483.     CrossRef
  • Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
    Shi Dong, Xin Li, Wenkai Jiang, Zhou Chen, Wence Zhou
    Cancer Cell International.2021;[Epub]     CrossRef
  • Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis
    Shichuan Hu, Jinhu Ma, Chao Su, Yanwei Chen, Yongheng Shu, Zhongbing Qi, Bin Zhang, Gang Shi, Yan Zhang, Yuwei Zhang, Anliang Huang, Yueting Kuang, Ping Cheng
    Acta Biomaterialia.2021;[Epub]     CrossRef
  • The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future
    Hung-Yu Lin, Hui-Wen Ho, Yen-Hsiang Chang, Chun-Jui Wei, Pei-Yi Chu
    Cancers.2021; 13(18): 4576.     CrossRef
  • Cashing in on ferroptosis against tumor cells: Usher in the next chapter
    Mehdi Rabiee Valashedi, Nima Najafi-Ghalehlou, Amirsadegh Nikoo, Chia Bamshad, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar
    Life Sciences.2021; 285: 119958.     CrossRef
  • Ferroptosis: A New Promising Target for Lung Cancer Therapy
    Rui Xiong, Ruyuan He, Bohao Liu, Wenyang Jiang, Bo Wang, Ning Li, Qing Geng, Manuela Curcio
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Glutathione peroxidase 4‐dependent glutathione high‐consumption drives acquired platinum chemoresistance in lung cancer‐derived brain metastasis
    Wenwen Liu, Yang Zhou, Wenzhe Duan, Jing Song, Song Wei, Shengkai Xia, Yingyan Wang, Xiaohui Du, Encheng Li, Caixia Ren, Wei Wang, Qimin Zhan, Qi Wang
    Clinical and Translational Medicine.2021;[Epub]     CrossRef
  • Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis‐Associated Mechanisms
    Tian-Liang Ma, Yong Zhou, Ci Wang, Lu Wang, Jing-Xian Chen, Hui-Hui Yang, Chen-Yu Zhang, Yong Zhou, Cha-Xiang Guan, Laura Bravo
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Ferroptosis is involved in the anti‑tumor effect of lycorine in renal cell carcinoma cells
    Yang Du, Hong-Chao Zhao, Heng-Cheng Zhu, Yao Jin, Lei Wang
    Oncology Letters.2021;[Epub]     CrossRef
  • Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death
    Bufu Tang, Wangting Xu, Yajie Wang, Jinyu Zhu, Hailin Wang, Jianfei Tu, Qiaoyou Weng, Chunli Kong, Yang Yang, Rongfang Qiu, Zhongwei Zhao, Min Xu, Jiansong Ji
    Clinical Immunology.2021; 232: 108872.     CrossRef
  • Ferritinophagy‐Mediated ROS Production Contributed to Proliferation Inhibition, Apoptosis, and Ferroptosis Induction in Action of Mechanism of 2‐Pyridylhydrazone Dithiocarbamate Acetate
    Longlong Li, Hao Li, Yongli Li, Jiankang Feng, Deng Guan, Yalei Zhang, Yun Fu, Shaoshan Li, Changzheng Li, Maria R. Ciriolo
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Construction and analysis of a novel ferroptosis‐related gene signature predicting prognosis in lung adenocarcinoma
    Jing Zhou, Xinyue Wang, Zhaona Li, Richeng Jiang
    FEBS Open Bio.2021; 11(11): 3005.     CrossRef
  • A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
    Wei Lu, Yihua Wu, Shengyun Huang, Dongsheng Zhang
    Frontiers in Genetics.2021;[Epub]     CrossRef
  • Baicalin suppresses autophagy-dependent ferroptosis in early brain injury after subarachnoid hemorrhage
    Bao Zheng, Xiwei Zhou, Lujun Pang, Yanjun Che, Xin Qi
    Bioengineered.2021; 12(1): 7794.     CrossRef
  • Biological protein mediated ferroptotic tumor nanotherapeutics
    Jiaoyang Tao, Chaoqun Li, Yongquan Zheng, Fengmei Wang, Meng Zhang, Xiaodong Wu, Yue Chen, Qingquan Zeng, Fengying Chen, Weidong Fei
    Journal of Materials Chemistry B.2021; 9(45): 9262.     CrossRef
  • The role of ferroptosis in lung cancer
    Sikai Wu, Chengchu Zhu, Daolin Tang, Q. Ping Dou, Jianfei Shen, Xin Chen
    Biomarker Research.2021;[Epub]     CrossRef
  • Downregulation of Cx43 reduces cisplatin-induced acute renal injury by inhibiting ferroptosis
    Meiling Yu, Zhuoheng Lin, Xiaoxue Tian, Shiyu Chen, Xinling Liang, Min Qin, Qian Zhu, Yuanyuan Wu, Shilong Zhong
    Food and Chemical Toxicology.2021; 158: 112672.     CrossRef
  • Prognostic significance of ferroptosis-related genes and their methylation in AML
    Fang Zhou, Baoan Chen
    Hematology.2021; 26(1): 919.     CrossRef
  • Research progress on the mechanism of ferroptosis and its clinical application
    Jiarui Xia, Huifang Si, Wu Yao, Chao Li, Guo Yang, Yangyang Tian, Changfu Hao
    Experimental Cell Research.2021; 409(2): 112932.     CrossRef
  • The mechanisms and therapeutic targets of ferroptosis in cancer
    Long Ye, Fengyan Jin, Shaji K. Kumar, Yun Dai
    Expert Opinion on Therapeutic Targets.2021; 25(11): 965.     CrossRef
  • Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells
    Haiyang Zhang, Meng Wang, Yi He, Ting Deng, Rui Liu, Weixue Wang, Kegan Zhu, Ming Bai, Tao Ning, Haiou Yang, Ying Liu, Junyi Wang, Yi Ba
    Cell Death & Disease.2021;[Epub]     CrossRef
  • Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
    Vickram Ramkumar, Debashree Mukherjea, Asmita Dhukhwa, Leonard P. Rybak
    Antioxidants.2021; 10(12): 1919.     CrossRef
  • Ferroptosis: The Silver Lining of Cancer Therapy
    Zhengming Tang, Zhijie Huang, Yisheng Huang, Yuanxin Chen, Mingshu Huang, Hongyu Liu, Q. Adam Ye, Jianjiang Zhao, Bo Jia
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis
    Shenshen Zhang, Ruizhe Hu, Yaping Geng, Ke Chen, Ling Wang, Mustapha Umar Imam
    Foods.2021; 10(12): 2952.     CrossRef
  • Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
    Peyman Tabnak, Zanyar HajiEsmailPoor, Soroush Soraneh
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC
    Meng Li, Yanpeng Zhang, Meng Fan, Hui Ren, Mingwei Chen, Puyu Shi
    BMC Medical Genomics.2021;[Epub]     CrossRef
  • Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It
    Jiayu Zou, Li Wang, Hailin Tang, Xiuxiu Liu, Fu Peng, Cheng Peng
    International Journal of Molecular Sciences.2021; 22(24): 13335.     CrossRef
  • The Emerging Role of Ferroptosis in Liver Diseases
    Si Chen, Jun-yao Zhu, Xin Zang, Yong-zhen Zhai
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Roles of ferroptosis in urologic malignancies
    Shankun Zhao, Peng Li, Weizhou Wu, Qinzhang Wang, Biao Qian, Xin Li, Maolei Shen
    Cancer Cell International.2021;[Epub]     CrossRef
  • Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path
    Elisabetta Iessi, Rosa Vona, Camilla Cittadini, Paola Matarrese
    Biomedicines.2021; 9(12): 1942.     CrossRef
  • Research Progress on the Mechanism of Tumor Drug Resistance
    爱敏 王
    Advances in Clinical Medicine.2021; 11(12): 6139.     CrossRef
  • miR-6077 Promotes Cisplatin/Pemetrexed Resistance in Lung Adenocarcinoma by Targeting CDKN1A/Cell Cycle Arrest and KEAP1/Ferroptosis Pathways
    Guoshu Bi, Jiaqi Liang, Mengnan Zhao, Huan Zhang, Xing Jin, Tao Lu, Yuansheng Zheng, Yunyi Bian, Zhencong Chen, Yiwei Huang, Valeria Besskaya, Cheng Zhan, Qun Wang, Lijie Tan
    SSRN Electronic Journal .2021;[Epub]     CrossRef
  • Ferroptosis and its emerging role in tumor
    Xiaoxuan Wang, Zicheng Liu, Lijuan Ma, Haijie Yu
    Biophysics Reports.2021; 7(4): 280.     CrossRef
  • Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers
    Eikan Mishima, Emiko Sato, Junya Ito, Ken-ichi Yamada, Chitose Suzuki, Yoshitsugu Oikawa, Tetsuro Matsuhashi, Koichi Kikuchi, Takafumi Toyohara, Takehiro Suzuki, Sadayoshi Ito, Kiyotaka Nakagawa, Takaaki Abe
    Journal of the American Society of Nephrology.2020; 31(2): 280.     CrossRef
  • CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
    Haiyang Zhang, Ting Deng, Rui Liu, Tao Ning, Haiou Yang, Dongying Liu, Qiumo Zhang, Dan Lin, Shaohua Ge, Ming Bai, Xinyi Wang, Le Zhang, Hongli Li, Yuchong Yang, Zhi Ji, Hailong Wang, Guoguang Ying, Yi Ba
    Molecular Cancer.2020;[Epub]     CrossRef
  • Systems biology of ferroptosis: A modeling approach
    Anna Konstorum, Lia Tesfay, Bibbin T. Paul, Frank M. Torti, Reinhard C. Laubenbacher, Suzy V. Torti
    Journal of Theoretical Biology.2020; 493: 110222.     CrossRef
  • Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases
    Yunbin Zhang, Jingjing Song, Zhongwei Zhao, Mengxuan Yang, Ming Chen, Chenglong Liu, Jiansong Ji, Di Zhu
    Cancer Letters.2020; 470: 84.     CrossRef
  • Ferroptosis: past, present and future
    Jie Li, Feng Cao, He-liang Yin, Zi-jian Huang, Zhi-tao Lin, Ning Mao, Bei Sun, Gang Wang
    Cell Death & Disease.2020;[Epub]     CrossRef
  • Functional role of ferroptosis on cancers, activation and deactivation by various therapeutic candidates-an update
    The Hong Phong Nguyen, B. Mahalakshmi, Bharath Kumar Velmurugan
    Chemico-Biological Interactions.2020; 317: 108930.     CrossRef
  • Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
    Yanwei Su, Bin Zhao, Liangfu Zhou, Zheyuan Zhang, Ying Shen, Huanhuan Lv, Luban Hamdy Hameed AlQudsy, Peng Shang
    Cancer Letters.2020; 483: 127.     CrossRef
  • Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
    Rikki A. M. Brown, Kirsty L. Richardson, Tasnuva D. Kabir, Debbie Trinder, Ruth Ganss, Peter J. Leedman
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Nonhomologous end-joining repair is likely involved in the repair of double-stranded DNA breaks induced by riluzole in melanoma cells
    Robert Cerchio, Christina Marinaro, Tzeh Keong Foo, Bing Xia, Suzie Chen
    Melanoma Research.2020; 30(3): 303.     CrossRef
  • The multifaceted role of reactive oxygen species in tumorigenesis
    Anuradha Kirtonia, Gautam Sethi, Manoj Garg
    Cellular and Molecular Life Sciences.2020; 77(22): 4459.     CrossRef
  • Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma
    Jana Lippmann, Kathrin Petri, Simone Fulda, Juliane Liese
    Translational Oncology.2020; 13(8): 100785.     CrossRef
  • The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy


    Yuechen Zhao, Yanqing Li, Ruifeng Zhang, Feng Wang, Tiejun Wang, Yan Jiao
    OncoTargets and Therapy.2020; Volume 13: 5429.     CrossRef
  • Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease
    Ningning Tao, Kang Li, Jingjing Liu
    Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
  • Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
    Anna Martina Battaglia, Roberta Chirillo, Ilenia Aversa, Alessandro Sacco, Francesco Costanzo, Flavia Biamonte
    Cells.2020; 9(6): 1505.     CrossRef
  • Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress
    Wangjie Yu, Yunyun Chen, Nagireddy Putluri, Cristian Coarfa, Matthew J. Robertson, Vasanta Putluri, Fabio Stossi, Julien Dubrulle, Michael A. Mancini, Jonathan C. Pang, Trung Nguyen, Dodge Baluya, Jeffrey N. Myers, Stephen Y. Lai, Vlad C. Sandulache
    Cancers.2020; 12(6): 1670.     CrossRef
  • Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
    Han-jie Liu, Hui-min Hu, Guan-zhang Li, Ying Zhang, Fan Wu, Xiu Liu, Kuan-yu Wang, Chuan-bao Zhang, Tao Jiang
    Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
  • The Mechanism of Ferroptosis and Applications in Tumor Treatment
    Xinyue Lin, Jieyi Ping, Yi Wen, Yan Wu
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis
    Junjun Zhang, Xi Zhang, Jie Li, Zewen Song
    Life Sciences.2020; 257: 118131.     CrossRef
  • Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
    Rong Tang, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Si Shi
    Journal of Hematology & Oncology.2020;[Epub]     CrossRef
  • Glutathione Synthesis in Cancer Cells
    E. V. Kalinina, L. A. Gavriliuk
    Biochemistry (Moscow).2020; 85(8): 895.     CrossRef
  • Sestrin2 Expression Has Regulatory Properties and Prognostic Value in Lung Cancer
    Hee Sung Chae, Minchan Gil, Subbroto Kumar Saha, Hee Jeung Kwak, Hwan-Woo Park, Balachandar Vellingiri, Ssang-Goo Cho
    Journal of Personalized Medicine.2020; 10(3): 109.     CrossRef
  • Near Infrared‐Activatable Platinum‐Decorated Gold Nanostars for Synergistic Photothermal/Ferroptotic Therapy in Combating Cancer Drug Resistance
    Andrea C. del Valle, Chih‐Kuang Yeh, Yu‐Fen Huang
    Advanced Healthcare Materials.2020;[Epub]     CrossRef
  • Ferroptosis in Cancer Treatment: Another Way to Rome
    Yinan Wu, Chengcheng Yu, Meng Luo, Chen Cen, Jili Qiu, Suzhan Zhang, Kaimin Hu
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Emerging roles of ferroptosis in liver pathophysiology
    Kyu Min Kim, Sam Seok Cho, Sung Hwan Ki
    Archives of Pharmacal Research.2020; 43(10): 985.     CrossRef
  • Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo
    Bing Hu, Yunsheng Liu, Xiaozhu Chen, Jianjun Zhao, Jinghong Han, Hongsong Dong, Qingyin Zheng, Guohui Nie
    Biochemical and Biophysical Research Communications.2020; 533(4): 1442.     CrossRef
  • Bioactive metal-containing nanomaterials for ferroptotic cancer therapy
    Weidong Fei, Yue Zhang, Yiqing Ye, Chaoqun Li, Yao Yao, Meng Zhang, Fanzhu Li, Caihong Zheng
    Journal of Materials Chemistry B.2020; 8(46): 10461.     CrossRef
  • Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma
    Hee Jeong Kwak, Minchan Gil, Hee Sung Chae, Jaekwon Seok, Nagasundarapandian Soundrarajan, Subbroto Kumar Saha, Aram Kim, Kyoung Sik Park, Chankyu Park, Ssang-Goo Cho
    Journal of Personalized Medicine.2020; 10(4): 263.     CrossRef
  • The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors
    Jinghan Zhu, Yixiao Xiong, Yuxin Zhang, Jingyuan Wen, Ning Cai, Kun Cheng, Huifang Liang, Wanguang Zhang, Xin Yi
    Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
  • Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
    Yunseo Woo, Hyo-Ji Lee, Young Mee Jung, Yu-Jin Jung
    Cells.2020; 9(12): 2709.     CrossRef
  • Nanomaterial-induced ferroptosis for cancer specific therapy
    Mei Liu, Bin Liu, Qianqian Liu, Keke Du, Zhifei Wang, Nongyue He
    Coordination Chemistry Reviews.2019; 382: 160.     CrossRef
  • Ferroptosis, a new form of cell death: opportunities and challenges in cancer
    Yanhua Mou, Jun Wang, Jinchun Wu, Dan He, Chunfang Zhang, Chaojun Duan, Bin Li
    Journal of Hematology & Oncology.2019;[Epub]     CrossRef
  • Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
    José Pedro Friedmann Angeli, Dmitri V. Krysko, Marcus Conrad
    Nature Reviews Cancer.2019; 19(7): 405.     CrossRef
  • Molecular mechanisms of ferroptosis and its role in cancer therapy
    Tao Xu, Wei Ding, Xiaoyu Ji, Xiang Ao, Ying Liu, Wanpeng Yu, Jianxun Wang
    Journal of Cellular and Molecular Medicine.2019; 23(8): 4900.     CrossRef
  • A New Approach in Cancer Treatment: Discovery of Chlorido[N,N′-disalicylidene-1,2-phenylenediamine]iron(III) Complexes as Ferroptosis Inducers
    Jessica Sagasser, Benjamin N. Ma, Daniel Baecker, Stefan Salcher, Martin Hermann, Julia Lamprecht, Stefanie Angerer, Petra Obexer, Brigitte Kircher, Ronald Gust
    Journal of Medicinal Chemistry.2019; 62(17): 8053.     CrossRef
  • Recent Progress in Ferroptosis Inducers for Cancer Therapy
    Chen Liang, Xinglin Zhang, Mengsu Yang, Xiaochen Dong
    Advanced Materials.2019;[Epub]     CrossRef
  • Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule
    Fei Deng, Isha Sharma, Yingbo Dai, Ming Yang, Yashpal S. Kanwar
    Journal of Clinical Investigation.2019; 129(11): 5033.     CrossRef
  • STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma
    Yuanyang Lai, Zhipei Zhang, Jianzhong Li, Weimiao Li, Zhao Huang, Chenxi Zhang, Xiaofei Li, Jinbo Zhao
    Biochemical and Biophysical Research Communications.2019; 519(4): 659.     CrossRef
  • Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
    Hai-Hong Zhou, Xu Chen, Lu-Ya Cai, Xing-Wei Nan, Jia-Hua Chen, Xiu-Xiu Chen, Yang Yang, Zi-Hao Xing, Meng-Ning Wei, Yao Li, Sheng-Te Wang, Kun Liu, Zhi Shi, Xiao-Jian Yan
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • The role of ferroptosis in digestive system cancer (Review)
    Yan Song, Hu Yang, Rui Lin, Kui Jiang, Bang‑Mao Wang
    Oncology Letters.2019;[Epub]     CrossRef
  • Potential mechanism of ferroptosis in pancreatic cancer (Review)
    Gang Chen, Guangqi Guo, Xiaodong Zhou, Hongxia Chen
    Oncology Letters.2019;[Epub]     CrossRef
  • Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death
    Lia Tesfay, Bibbin T. Paul, Anna Konstorum, Zhiyong Deng, Anderson O. Cox, Jingyun Lee, Cristina M. Furdui, Poornima Hegde, Frank M. Torti, Suzy V. Torti
    Cancer Research.2019; 79(20): 5355.     CrossRef
  • Interactions of Schiff base compounds and their coordination complexes with the drug cisplatin
    József Magyari, Berta Barta Holló, Ljiljana S. Vojinović-Ješić, Mirjana M. Radanović, Stevan Armaković, Sanja J. Armaković, Joseph Molnár, Annamária Kincses, Márió Gajdács, Gabriella Spengler, Katalin Mészáros Szécsényi
    New Journal of Chemistry.2018; 42(8): 5834.     CrossRef
  • Oxytosis/Ferroptosis—(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System
    Jan Lewerenz, Gamze Ates, Axel Methner, Marcus Conrad, Pamela Maher
    Frontiers in Neuroscience.2018;[Epub]     CrossRef
  • Routes to cell death in animal and plant kingdoms: from classic apoptosis to alternative ways to die—a review
    Sonia Emanuele, Elisabetta Oddo, Antonella D’Anneo, Antonietta Notaro, Giuseppe Calvaruso, Marianna Lauricella, Michela Giuliano
    Rendiconti Lincei. Scienze Fisiche e Naturali.2018; 29(2): 397.     CrossRef
  • Role of ferroptosis in hepatocellular carcinoma
    Jianhua Nie, Binlin Lin, Meng Zhou, Li Wu, Tongsen Zheng
    Journal of Cancer Research and Clinical Oncology.2018; 144(12): 2329.     CrossRef
  • Induction of reactive oxygen species: an emerging approach for cancer therapy
    Zhengzhi Zou, Haocai Chang, Haolong Li, Songmao Wang
    Apoptosis.2017; 22(11): 1321.     CrossRef
  • Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
    Brent R. Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, Ashley I. Bush, Marcus Conrad, Scott J. Dixon, Simone Fulda, Sergio Gascón, Stavroula K. Hatzios, Valerian E. Kagan, Kay Noel, Xuejun Jiang, Andreas Linkermann, Maureen E. Murphy, Michael Overh
    Cell.2017; 171(2): 273.     CrossRef
  • 26,267 View
  • 1,420 Download
  • 557 Web of Science
  • 534 Crossref
Close layer
Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
E Sun Paik, Hyun Jin Choi, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
Cancer Res Treat. 2018;50(2):461-473.   Published online May 22, 2017
DOI: https://doi.org/10.4143/crt.2017.104
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We aimed to develop molecular classifier that can predict lymphatic invasion and their clinical significance in epithelial ovarian cancer (EOC) patients.
Materials and Methods
We analyzed gene expression (mRNA, methylated DNA) in data from The Cancer Genome Atlas. To identify molecular signatures for lymphatic invasion, we found differentially expressed genes. The performance of classifier was validated by receiver operating characteristics analysis, logistic regression, linear discriminant analysis (LDA), and support vector machine (SVM). We assessed prognostic role of classifier using random survival forest (RSF) model and pathway deregulation score (PDS). For external validation,we analyzed microarray data from 26 EOC samples of Samsung Medical Center and curatedOvarianData database.
Results
We identified 21 mRNAs, and seven methylated DNAs from primary EOC tissues that predicted lymphatic invasion and created prognostic models. The classifier predicted lymphatic invasion well, which was validated by logistic regression, LDA, and SVM algorithm (C-index of 0.90, 0.71, and 0.74 for mRNA and C-index of 0.64, 0.68, and 0.69 for DNA methylation). Using RSF model, incorporating molecular data with clinical variables improved prediction of progression-free survival compared with using only clinical variables (p < 0.001 and p=0.008). Similarly, PDS enabled us to classify patients into high-risk and low-risk group, which resulted in survival difference in mRNA profiles (log-rank p-value=0.011). In external validation, gene signature was well correlated with prediction of lymphatic invasion and patients’ survival.
Conclusion
Molecular signature model predicting lymphatic invasion was well performed and also associated with survival of EOC patients.

Citations

Citations to this article as recorded by  
  • Identifying Stage II Colorectal Cancer Recurrence Associated Genes by Microarray Meta-Analysis and Building Predictive Models with Machine Learning Algorithms
    Wei Lu, Xiang Pan, Siqi Dai, Dongliang Fu, Maxwell Hwang, Yingshuang Zhu, Lina Zhang, Jingsun Wei, Xiangxing Kong, Jun Li, Qian Xiao, Kefeng Ding, Quan Cheng
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • 10,224 View
  • 249 Download
  • 5 Web of Science
  • 1 Crossref
Close layer
Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies
Yoon-Jung Choi, Seung-Kwon Myung, Ji-Ho Lee
Cancer Res Treat. 2018;50(2):474-487.   Published online May 22, 2017
DOI: https://doi.org/10.4143/crt.2017.094
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to determine whether light alcohol drinking increases the risk of cancer by using a meta-analysis of cohort studies because the newly revised 2015 European Code against Cancer fourth edition on alcohol and cancer was based on critical flaws in the interpretation and citation of the previous meta-analyses.
Materials and Methods
PubMed and EMBASE were searched in April, 2016. Two authors independently reviewed and selected cohort studies on the association between very light (≤ 0.5 drink/day), light (≤ 1 drink/day), or moderate drinking (1-2 drinks/day) and the risk of cancer incidence and mortality. A pooled relative riskwith its 95% confidence intervalwas calculated by a randomeffects meta-analysis. Main outcome measures were cancer incidence and mortality.
Results
A total of 60 cohort studies from 135 articles were included in the final analysis. Very light drinking or light drinking was not associated with the incidence of most cancers except for female breast cancer in women and male colorectal cancer. Conversely, light drinking was associated with a decreased incidence of both female and male lung cancer significantly and both female and male thyroid cancer marginally significantly. Moderate drinking significantly increased the incidence of male colorectal cancer and female breast cancer,whereas it decreased the incidence of both female and male hematologic malignancy.
Conclusion
We found that very light or light alcohol drinking was not associated with the risk of most of the common cancers except for the mild increase in the incidence of breast cancer in women and colorectal cancer in men.

Citations

Citations to this article as recorded by  
  • Lung Cancer and Lifestyle Factors
    Jeta Bunjaku, Arber Lama, Tawanda Pesanayi, Jeton Shatri, Mary Chamberlin, Ilir Hoxha
    Hematology/Oncology Clinics of North America.2024; 38(1): 171.     CrossRef
  • Breast Cancer and Lifestyle Factors
    Ilir Hoxha, Fitim Sadiku, Lot Hoxha, Midhet Nasim, Marie Anne Christine Buteau, Krenare Grezda, Mary D. Chamberlin
    Hematology/Oncology Clinics of North America.2024; 38(1): 137.     CrossRef
  • Association between lifestyle and dietary preference factors and conventional adenomas and serrated polyps
    Jue Xu, Peihan Chi, Kang Qin, Biao Li, Zhongxue Cheng, Zhecong Yu, Caixia Jiang, Yunxian Yu
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Predicting lung cancer survival prognosis based on the conditional survival bayesian network
    Lu Zhong, Fan Yang, Shanshan Sun, Lijie Wang, Hong Yu, Xiushan Nie, Ailing Liu, Ning Xu, Lanfang Zhang, Mingjuan Zhang, Yue Qi, Huaijun Ji, Guiyuan Liu, Huan Zhao, Yinan Jiang, Jingyi Li, Chengcun Song, Xin Yu, Liu Yang, Jinchao Yu, Hu Feng, Xiaolei Guo,
    BMC Medical Research Methodology.2024;[Epub]     CrossRef
  • Differential patterns of reproductive and lifestyle risk factors for breast cancer according to birth cohorts among women in China, Japan and Korea
    Salma Nabila, Ji-Yeob Choi, Sarah Krull Abe, Md Rashedul Islam, Md Shafiur Rahman, Eiko Saito, Aesun Shin, Melissa A. Merritt, Ryoko Katagiri, Xiao-Ou Shu, Norie Sawada, Akiko Tamakoshi, Ritsu Sakata, Atsushi Hozawa, Jeongseon Kim, Chisato Nagata, Sue K.
    Breast Cancer Research.2024;[Epub]     CrossRef
  • Design, synthesis, in silico, and pharmacological evaluation of novel quinoline derivatives containing substituted piperazine moieties as potential anti-breast cancer agents
    Muthiah Gnana Ruba Priya, Viswas Raja Solomon, Nagarajan Hemavathy, Jeyaraman Jeyakanthan, Dileep Kumar, Jahnavi Mahesh
    Results in Chemistry.2024; 7: 101359.     CrossRef
  • Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression
    Xinxin Wang, Shufang Pan, Liangyan Chen, Chengchen Liang, Yueyi Zhu, Ke Zhou, Xiaolan Shi
    Journal of Ethnopharmacology.2024; 329: 118115.     CrossRef
  • The Lancet Breast Cancer Commission
    Charlotte E Coles, Helena Earl, Benjamin O Anderson, Carlos H Barrios, Maya Bienz, Judith M Bliss, David A Cameron, Fatima Cardoso, Wanda Cui, Prudence A Francis, Reshma Jagsi, Felicia Marie Knaul, Stuart A McIntosh, Kelly-Anne Phillips, Lukas Radbruch, M
    The Lancet.2024; 403(10439): 1895.     CrossRef
  • The Combined Effects of Alcohol Consumption and Smoking on Cancer Risk by Exposure Level: A Systematic Review and Meta-Analysis
    Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Non-genetic factors and breast cancer: an umbrella review of meta-analyses
    Anneza Yiallourou, Katerina Pantavou, Georgios Markozannes, Antonis Pilavas, Andrea Georgiou, Andria Hadjikou, Mary Economou, Neophytos Christodoulou, Konstantinos Letsos, Elina Khattab, Chrystalleni Kossyva, Maria Constantinou, Melanie Theodoridou, Danie
    BMC Cancer.2024;[Epub]     CrossRef
  • Sex difference in alcohol consumption associated with colorectal cancer risk in Quzhou, China: A nested case-control study
    Shi-Ming Lai, Hong-Hong Zhu, Zhi-Juan Gan, Bi-Yun Zheng, Zhao-Hui Xu, Zhi-Cheng Wang, Xiao-Fang Liao
    Preventive Medicine Reports.2024; 44: 102807.     CrossRef
  • Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy
    Yanan Sun, Jiahe Hu, Rongfang Wang, Xinlian Du, Xiaoling Zhang, Jiaoting E, Shaoyue Zheng, Yuxin Zhou, Ruishu Mou, Xuedong Li, Hanbo Zhang, Ying Xu, Yuan Liao, Wenjie Jiang, Lijia Liu, Ruitao Wang, Jiuxin Zhu, Rui Xie
    Cancer Medicine.2024;[Epub]     CrossRef
  • Oncologists’ communication about tobacco and alcohol use during treatment for esophagogastric cancer: a qualitative observational study of simulated consultations
    Danique W. Bos-van den Hoek, Loïs F. van de Water, Pieter G. Vos, Meeke Hoedjes, Ruud Roodbeen, Bastiaan R. Klarenbeek, Debby Geijsen, Ellen M. A. Smets, Hanneke W. M. van Laarhoven, Inge Henselmans
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis
    Shu-Yi Dong, Shuxin Ding, Zhen Meng, Bo Zou
    Future Science OA.2024;[Epub]     CrossRef
  • Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta‐analysis of prospective cohort studies
    Ivneet Sohi, Jürgen Rehm, Marian Saab, Lavanya Virmani, Ari Franklin, Gonzalo Sánchez, Mihojana Jhumi, Ahmed Irshad, Hiya Shah, Daniela Correia, Pietro Ferrari, Carina Ferreira‐Borges, Beatrice Lauby‐Secretan, Gauden Galea, Susan Gapstur, Maria Neufeld, H
    Alcohol, Clinical and Experimental Research.2024; 48(12): 2222.     CrossRef
  • The global, regional, and national alcohol-related colorectal cancer burden and forecasted trends: results from the global burden of disease study 2021
    Jinfeng Yao, Guo Chen
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Drinking pattern and time lag of alcohol consumption with colorectal cancer risk in US men and women
    Xinyi Li, Jinhee Hur, Yin Zhang, Mingyang Song, Stephanie A Smith-Warner, Liming Liang, Kenneth J Mukamal, Eric B Rimm, Edward L Giovannucci
    JNCI: Journal of the National Cancer Institute.2024;[Epub]     CrossRef
  • Association of alcohol types, coffee and tea intake with mortality: prospective cohort study of UK Biobank participants
    Sylva M. Schaefer, Anna Kaiser, Inken Behrendt, Gerrit Eichner, Mathias Fasshauer
    British Journal of Nutrition.2023; 129(1): 115.     CrossRef
  • Magazines as contradictory spaces for alcohol messaging: a mixed method content and thematic analysis of UK women’s magazine representations of alcohol and its consumption
    A. M. Atkinson, B. R. Meadows, K. M. Ross-Houle, C. Smith, H. R. Sumnall
    Drugs: Education, Prevention and Policy.2023; 30(5): 474.     CrossRef
  • Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach
    Raul Zamora-Ros, Valerie Cayssials, Ramon Clèries, Maria Torrents, Graham Byrnes, Elisabete Weiderpass, Maria Sandström, Martin Almquist, Marie-Christine Boutron-Ruault, Anne Tjønneland, Cecilie Kyrø, Verena A. Katzke, Charlotte Le Cornet, Giovanna Masala
    European Journal of Nutrition.2023; 62(1): 105.     CrossRef
  • Designing Effective Alcohol Warnings: Consumer Reactions to Icons and Health Topics
    Anna H. Grummon, Phoebe R. Ruggles, Thomas K. Greenfield, Marissa G. Hall
    American Journal of Preventive Medicine.2023; 64(2): 157.     CrossRef
  • Reinstating apoptosis using putative Bcl-xL natural product inhibitors: Molecular docking and ADMETox profiling investigations
    Ibrahim Damilare Boyenle, Abdeen Tunde Ogunlana, Abdul-Quddus Kehinde Oyedele, Babatunde Kazeem Olokodana, Nurudeen Owolabi, Abdulmalik Salahudeen, Oluwafemi Timothy Aderenle, Taiwo Oluwafisayomi Oloyede, Temitope Isaac Adelusi
    Journal of Taibah University Medical Sciences.2023; 18(3): 461.     CrossRef
  • Cancer Risk According to Alcohol Consumption Trajectories: A Population-based Cohort Study of 2.8 Million Korean Men
    Thi Tra Bui, Minji Han, Ngoc Minh Luu, Thi Phuong Thao Tran, Min Kyung Lim, Jin-Kyoung Oh
    Journal of Epidemiology.2023; 33(12): 624.     CrossRef
  • A Brief Intervention for Improving Alcohol Literacy and Addressing Harmful Alcohol Use Among Women Attending an Australian Breast Screening Service (Health4her): Protocol for a Hybrid Effectiveness-Implementation Trial
    Jasmin Grigg, Victoria Manning, Darren Lockie, Michelle Giles, Robin Bell, Peta Stragalinos, Chloe Bernard, Isabelle Volpe, Christopher J Greenwood, Liam Smith, Peter Bragge, Dan I Lubman
    JMIR Research Protocols.2023; 12: e44867.     CrossRef
  • Moderate wine consumption and cancer risk in context
    Ursula Fradera, Claudia Hammer, P. Roca
    BIO Web of Conferences.2023; 56: 04002.     CrossRef
  • Systemic treatment for metastatic colorectal cancer
    Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana
    World Journal of Gastroenterology.2023; 29(10): 1425.     CrossRef
  • Systemic treatment for metastatic colorectal cancer
    Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana
    World Journal of Gastroenterology.2023; 29(10): 1569.     CrossRef
  • Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?
    Anna Maria Rychter, Liliana Łykowska-Szuber, Agnieszka Zawada, Aleksandra Szymczak-Tomczak, Alicja Ewa Ratajczak, Kinga Skoracka, Michalina Kolan, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak
    Journal of Clinical Medicine.2023; 12(7): 2451.     CrossRef
  • Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study
    Jasmin Grigg, Victoria Manning, Ali Cheetham, Christopher J. Greenwood, George Youssef, Darren Lockie, Robin Bell, Peta Stragalinos, Chloe Bernard, Dan I. Lubman
    Addiction.2023; 118(8): 1493.     CrossRef
  • Alcohol consumption and all-cause and cause-specific mortality among US adults: prospective cohort study
    Yalan Tian, Jiahui Liu, Yue Zhao, Nana Jiang, Xiao Liu, Gang Zhao, Xia Wang
    BMC Medicine.2023;[Epub]     CrossRef
  • A brief intervention for improving alcohol literacy and reducing harmful alcohol use by women attending a breast screening service: a randomised controlled trial
    Jasmin Grigg, Victoria Manning, Darren Lockie, Michelle Giles, Robin J Bell, Peta Stragalinos, Chloe Bernard, Christopher J Greenwood, Isabelle Volpe, Liam Smith, Peter Bragge, Dan I Lubman
    Medical Journal of Australia.2023; 218(11): 511.     CrossRef
  • Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample
    Onni Niemelä, Aini Bloigu, Risto Bloigu, Mauri Aalto, Tiina Laatikainen
    Journal of Clinical Medicine.2023; 12(13): 4276.     CrossRef
  • Gut Microbiota and Colorectal Cancer Risk Factors
    Hadi Feizi, Mohammad Ahangarzadeh Rezaee, Reza Ghotaslou, Mohammad Sadrkabir, Farhad Jadidi-Niaragh, Pourya Gholizadeh, Sepehr Taghizadeh, Khudaverdi Ghanbarov, Mehdi Yousefi, Hossein Samadi Kafil
    Current Pharmaceutical Biotechnology.2023; 24(8): 1018.     CrossRef
  • Effect of alcohol consumption on breast cancer: probabilistic bias analysis for adjustment of exposure misclassification bias and confounders
    Reza Pakzad, Saharnaz Nedjat, Hamid Salehiniya, Nasrin Mansournia, Mahyar Etminan, Maryam Nazemipour, Iraj Pakzad, Mohammad Ali Mansournia
    BMC Medical Research Methodology.2023;[Epub]     CrossRef
  • Food Intake and Colorectal Cancer
    Akshaya Kumar, Shanmugavel Chinnathambi, Magi Kumar, Ganesh N. Pandian
    Nutrition and Cancer.2023; 75(9): 1710.     CrossRef
  • Shared Lifestyle-Related Risk Factors of Cardiovascular Disease and Cancer: Evidence for Joint Prevention
    Farzad Masoudkabir, Noushin Mohammadifard, Arya Mani, Andrew Ignaszewski, Margot K. Davis, Golnaz Vaseghi, Marjan Mansourian, Christopher Franco, Carolyn Gotay, Nizal Sarrafzadegan, Francesco Giallauria
    The Scientific World Journal.2023; 2023: 1.     CrossRef
  • Alcohol and cancer: a denied association the statement of the Italian society on alcohol (Società Italiana di Alcologia—SIA)
    Gianni Testino, Emanuele Scafato, Valentino Patussi, Patrizia Balbinot, Andrea Ghiselli, Fabio Caputo
    Alcohol and Alcoholism.2023; 58(6): 683.     CrossRef
  • Diet-Wide Association, Genetic Susceptibility and Colorectal Cancer Risk: A Prospective Cohort Study
    Dongqing Jin, Ying Lu, Wei Wu, Fangyuan Jiang, Zihan Li, Liying Xu, Rongqi Zhang, Xue Li, Dong Chen
    Nutrients.2023; 15(22): 4801.     CrossRef
  • Male- and female-specific reproductive risk factors across the lifespan for dementia or cognitive decline: a systematic review and meta-analysis
    Shuang-Ling Han, De-Chun Liu, Chen-Chen Tan, Lan Tan, Wei Xu
    BMC Medicine.2023;[Epub]     CrossRef
  • Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis
    Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Eun Jeong Choi, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park
    Epidemiology and Health.2023; 45: e2023092.     CrossRef
  • ‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram
    A.M. Atkinson, B.R. Meadows, C. Emslie, A. Lyons, H.R. Sumnall
    International Journal of Drug Policy.2022; 101: 103547.     CrossRef
  • Very-light alcohol consumption suppresses breast tumor progression in a mouse model
    Xiuxiu Wang, Min Jia, Yifei Mao, Zhenzhen Jia, Huilin Liu, Guiwen Yang, Shuo Wang, Baoguo Sun, Hongyan Zhang
    Food & Function.2022; 13(6): 3391.     CrossRef
  • Global, regional, and national cancer deaths and disability‐adjusted life‐years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990‐2019
    Saeid Safiri, Seyed Aria Nejadghaderi, Nahid Karamzad, Kristin Carson‐Chahhoud, Nicola Luigi Bragazzi, Mark J. M. Sullman, Amir Almasi‐Hashiani, Mohammad Ali Mansournia, Gary S. Collins, Jay S. Kaufman, Ali‐Asghar Kolahi
    Cancer.2022; 128(9): 1840.     CrossRef
  • Adherence to the Vegetable-Fruit-Soy Dietary Pattern, a Reference From Mediterranean Diet, Protects Against Postmenopausal Breast Cancer Among Chinese Women
    Shang Cao, Linchen Liu, Qianrang Zhu, Zheng Zhu, Jinyi Zhou, Pingmin Wei, Ming Wu
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • The effects of modest drinking on life expectancy and mortality risks: a population-based cohort study
    Yen-Tze Liu, June Han Lee, Min Kuang Tsai, James Cheng-Chung Wei, Chi-Pang Wen
    Scientific Reports.2022;[Epub]     CrossRef
  • Colon Cancer: From Epidemiology to Prevention
    Kyriaki Katsaounou, Elpiniki Nicolaou, Paris Vogazianos, Cameron Brown, Marios Stavrou, Savvas Teloni, Pantelis Hatzis, Agapios Agapiou, Elisavet Fragkou, Georgios Tsiaoussis, George Potamitis, Apostolos Zaravinos, Chrysafis Andreou, Athos Antoniades, Chr
    Metabolites.2022; 12(6): 499.     CrossRef
  • Associations Between Physical Activity and Alcohol Consumption in Rural Cancer Survivors
    Scherezade K. Mama, Natalia I. Heredia, Hannah Johnston, David E. Conroy
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Epidemiology beyond its limits
    Lauren E. McCullough, Maret L. Maliniak, Avnika B. Amin, Julia M. Baker, Davit Baliashvili, Julie Barberio, Chloe M. Barrera, Carolyn A. Brown, Lindsay J. Collin, Alexa A. Freedman, David C. Gibbs, Maryam B. Haddad, Eric W. Hall, Sarah Hamid, Kristin R. V
    Science Advances.2022;[Epub]     CrossRef
  • Review on recent development of quinoline for anticancer activities
    Mohan Ilakiyalakshmi, Ayyakannu Arumugam Napoleon
    Arabian Journal of Chemistry.2022; 15(11): 104168.     CrossRef
  • Relationship Between Physical Activity Levels and Thyroid Cancer Risk: A Prospective Cohort Study in Korea
    Anh Quynh Bui, Madhawa Gunathilake, Jeonghee Lee, Eun Kyung Lee, Jeongseon Kim
    Thyroid.2022; 32(11): 1402.     CrossRef
  • Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
    Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee, Daehee Kang
    Cancer Biology & Medicine.2022; 19(8): 1224.     CrossRef
  • Bewertung des Rotweinkonsums im Rahmen der mediterranen Ernährung – Eine systematische Literaturanalyse
    Benjamin Seethaler, Mirjam Fuchs, Julia Schumacher, Maryam Basrai, Marion Kiechle, Stephan C. Bischoff
    Aktuelle Ernährungsmedizin.2022; 47(05): 368.     CrossRef
  • What is behind the lifestyle risk factors for head and neck cancer?
    Anem Iftikhar, Mohammad Islam, Simon Shepherd, Sarah Jones, Ian Ellis
    Frontiers in Psychology.2022;[Epub]     CrossRef
  • Association of alcohol use with memory decline in middle-aged and older Chinese: a longitudinal cohort study
    Yu Meng Tian, Wei Sen Zhang, Chao Qiang Jiang, Feng Zhu, Ya Li Jin, Tong Zhu, Kar Keung Cheng, Lin Xu
    BMC Psychiatry.2022;[Epub]     CrossRef
  • Impact of Physical Activity on the Characteristics and Metabolic Consequences of Alcohol Consumption: A Cross-Sectional Population-Based Study
    Onni Niemelä, Aini Bloigu, Risto Bloigu, Anni S. Halkola, Markus Niemelä, Mauri Aalto, Tiina Laatikainen
    International Journal of Environmental Research and Public Health.2022; 19(22): 15048.     CrossRef
  • Current Developments in European Alcohol Policy: An Analysis of Possible Impacts on the German Wine Industry
    Frederik Nikolai Schulz, Barbara Richter, Jon H. Hanf
    Beverages.2022; 8(4): 75.     CrossRef
  • Polymorphisms in IL-17A Gene and Susceptibility of Colorectal Cancer in Bangladeshi Population: A Case-Control Analysis
    Md. Robiul Islam, Md. Abdul Aziz, Mohammad Shahriar, Mohammad Safiqul Islam
    Cancer Control.2022;[Epub]     CrossRef
  • Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses
    Jue‐Sheng Ong, Eske M. Derks, Mikael Eriksson, Jiyuan An, Liang‐Dar Hwang, Douglas F. Easton, Paul P. Pharoah, Andrew Berchuck, Linda E. Kelemen, Keitaro Matsuo, Georgia Chenevix‐Trench, Per Hall, Stig E. Bojesen, Penelope M. Webb, Stuart MacGregor
    International Journal of Cancer.2021; 148(6): 1338.     CrossRef
  • Estimation of cancers caused by light to moderate alcohol consumption in the European Union
    Pol Rovira, Jürgen Rehm
    European Journal of Public Health.2021; 31(3): 591.     CrossRef
  • LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer
    Wei-Ling Yu, Jin-Jian Yao, Zong-Zhou Xie, Yan-Jing Huang, Sha Xiao
    International Journal of General Medicine.2021; Volume 14: 255.     CrossRef
  • Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea
    Hayeong Khil, Sung Min Kim, SungEun Hong, Hyeon Min Gil, Eugene Cheon, Dong Hoon Lee, Young Ae Kim, NaNa Keum
    Scientific Reports.2021;[Epub]     CrossRef
  • Alcohol Consumption, HDL-Cholesterol and Incidence of Colon and Rectal Cancer: A Prospective Cohort Study Including 250,010 Participants
    Aage Tverdal, Gudrun Høiseth, Per Magnus, Øyvind Næss, Randi Selmer, Gun Peggy Knudsen, Jørg Mørland
    Alcohol and Alcoholism.2021; 56(6): 718.     CrossRef
  • Low-level alcohol consumption and cancer mortality
    Hyeonyoung Ko, Yoosoo Chang, Han-Na Kim, Jae-Heon Kang, Hocheol Shin, Eunju Sung, Seungho Ryu
    Scientific Reports.2021;[Epub]     CrossRef
  • Factors Associated with Women’s Unwillingness to Decrease Alcohol Intake to Decrease Breast Cancer Risk
    Jenna Matin, Rachel McFarland Lucia, Krustina Lal, Alyssa Columbus, Deborah Goodman, Kathryn Larsen, Argyrios Ziogas, Hannah Lui Park
    Journal of Primary Care & Community Health.2021;[Epub]     CrossRef
  • Past 6-Year Trends in Current Alcohol Use among Cyberbullied Adolescents
    George E. Higgins, Jason Nicholson, Catherine D. Marcum
    Substance Use & Misuse.2021; 56(6): 831.     CrossRef
  • Meme Kanserinden Korunmada ve Meme Kanseri Tedavisinde Akdeniz Diyetinin Etkisi
    Burcu DENİZ GÜNEŞ, Nilüfer ACAR TEK
    Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2021; 5(2): 442.     CrossRef
  • Global colorectal cancer burden in 2020 and projections to 2040
    Yue Xi, Pengfei Xu
    Translational Oncology.2021; 14(10): 101174.     CrossRef
  • Alcohol abstinence and mortality in a general population sample of adults in Germany: A cohort study
    Ulrich John, Hans-Juergen Rumpf, Monika Hanke, Christian Meyer, Charlotte Hanlon
    PLOS Medicine.2021; 18(11): e1003819.     CrossRef
  • Alcohol Use and Cancer in the European Union
    Jürgen Rehm, Kevin D. Shield
    European Addiction Research.2021; 27(1): 1.     CrossRef
  • Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
    Firas Baidoun, Kholoud Elshiwy, Yasmine Elkeraie, Zahi Merjaneh, George Khoudari, Muhammad Talal Sarmini, Mohamed Gad, Muneer Al-Husseini, Anas Saad
    Current Drug Targets.2021; 22(9): 998.     CrossRef
  • Improving Knowledge that Alcohol Can Cause Cancer is Associated with Consumer Support for Alcohol Policies: Findings from a Real-World Alcohol Labelling Study
    Ashini Weerasinghe, Nour Schoueri-Mychasiw, Kate Vallance, Tim Stockwell, David Hammond, Jonathan McGavock, Thomas K. Greenfield, Catherine Paradis, Erin Hobin
    International Journal of Environmental Research and Public Health.2020; 17(2): 398.     CrossRef
  • Alcohol Consumption by Beverage Type and Risk of Breast Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies
    Qiuyu Sun, Weihong Xie, Yanli Wang, Feifei Chong, Mengmeng Song, Tiandong Li, Linping Xu, Chunhua Song
    Alcohol and Alcoholism.2020; 55(3): 246.     CrossRef
  • The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017
    Peng Ji, Yue Gong, Ming-Liang Jin, Xin Hu, Gen-Hong Di, Zhi-Ming Shao
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • General and particular issues of etiopathogenesis of peptic ulcer and gastric cancer: current status of the problem
    A. M. Osadchuk, I. L. Davydkin, T. A. Gricenko, M. A. Osadchuk
    Terapevticheskii arkhiv.2020; 92(2): 97.     CrossRef
  • Risk Factors of Cardiovascular Disease according to Alcohol Behavioral Change after Cancer Diagnosis
    Eun Mi Bae, In Young Cho, Ji-Hye Jun, Kiheon Lee, Ju Young Kim, Woo Kyung Bae, Hyejin Lee, Jong Soo Han, Se Young Jung, Kee Hyuck Lee, Sarah Kim, Hye Yeon Koo, Sang Jin Cho, Houbuem Lee, Chuelmin Paek
    Korean Journal of Family Medicine.2020; 41(4): 222.     CrossRef
  • Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies
    Aviane Auguste, Jacqueline Deloumeaux, Clarisse Joachim, Stanie Gaete, Leah Michineau, Cécile Herrmann‐Storck, Suzy Duflo, Danièle Luce
    Cancer Medicine.2020; 9(18): 6854.     CrossRef
  • Impacts of Habitual Diets Intake on Gut Microbial Counts in Healthy Japanese Adults
    Takuya Sugimoto, Tatsuichiro Shima, Ryuta Amamoto, Chiaki Kaga, Yukiko Kado, Osamu Watanabe, Junko Shiinoki, Kaoru Iwazaki, Hiroko Shigemura, Hirokazu Tsuji, Satoshi Matsumoto
    Nutrients.2020; 12(8): 2414.     CrossRef
  • Alcohol Consumption in Non-Alcoholic Fatty Liver Disease: Safety and Disease Overlap
    Sheela S. Reddy
    Current Hepatology Reports.2020; 19(4): 382.     CrossRef
  • Qualitative Study of Compliance with Nutritional Management in Colorectal Cancer Patient Undergoing Chemotherapy
    Heejung Park, Hyonson Kil, Wookyoun Cho
    Korean Journal of Community Nutrition.2020; 25(4): 303.     CrossRef
  • Heterogenous Effect of Risk Factors on Breast Cancer across the Breast Density Categories in a Korean Screening Population
    Boyoung Park, Se-Eun Lim, HyoJin Ahn, Junghyun Yoon, Yun Su Choi
    Cancers.2020; 12(6): 1391.     CrossRef
  • The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
    Jong Hwa Choi, Won Sohn, Yong Kyun Cho
    Clinical and Molecular Hepatology.2020; 26(4): 662.     CrossRef
  • Report on Recently (2017–20) Designed Quinoline‐Based Human Cancer Cell Growth Inhibitors
    Atukuri Dorababu
    ChemistrySelect.2020; 5(44): 13902.     CrossRef
  • Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank
    Yon Ho Jee, Chi Gao, Jihye Kim, Seho Park, Sun Ha Jee, Peter Kraft
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1271.     CrossRef
  • Light Alcohol Drinking and the Risk of Cancer Development: A Controversial Relationship
    Giuseppe G. Caprio, Desiree Picascia, Marcello Dallio, Pietro P. Vitiello, Emilio F. Giunta, Vincenzo De Falco, Ludovico Abenavoli, Anna C. Procopio, Vincenzo Famiglietti, Erika Martinelli, Antonietta G. Gravina, Alessandro Federico, Fortunato Ciardiello,
    Reviews on Recent Clinical Trials.2020; 15(3): 164.     CrossRef
  • Laboratory test based assessment of WHO alcohol risk drinking levels
    Onni Niemelä, Ulla Nivukoski, Aini Bloigu, Risto Bloigu, Mauri Aalto, Tiina Laatikainen
    Scandinavian Journal of Clinical and Laboratory Investigation.2019; 79(1-2): 58.     CrossRef
  • Wein und Krebs – was zeigt die epidemiologie?
    N. Worm, Jean-Marie Aurand
    BIO Web of Conferences.2019; 12: 04002.     CrossRef
  • Association of Periodontitis with Oral Cancer: A Case-Control Study
    Y.J. Shin, H.W. Choung, J.H. Lee, I.C. Rhyu, H.D. Kim
    Journal of Dental Research.2019; 98(5): 526.     CrossRef
  • Does Alcohol Use Affect Cancer Risk?
    Jürgen Rehm, Isabelle Soerjomataram, Carina Ferreira-Borges, Kevin D. Shield
    Current Nutrition Reports.2019; 8(3): 222.     CrossRef
  • Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer
    Joshua Petimar, Yong-Moon Mark Park, Stephanie A Smith-Warner, Teresa T Fung, Dale P Sandler
    The American Journal of Clinical Nutrition.2019; 109(5): 1393.     CrossRef
  • Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status
    Ulla Nivukoski, Markus Niemelä, Aini Bloigu, Risto Bloigu, Mauri Aalto, Tiina Laatikainen, Onni Niemelä, Pedro Tauler
    PLOS ONE.2019; 14(6): e0218463.     CrossRef
  • Dietary Intake of Omega-3 fatty acids and Endocrine-related Gynecological Cancer: A Meta-Analysis of Observational Studies
    Tung Hoang, Seung-Kwon Myung, Thu Thi Pham
    Cancer Research and Treatment.2019; 51(3): 1022.     CrossRef
  • Colorectal cancer epidemiology in Korea
    Aesun Shin, Doeun Jang, Sunho Choe, Young-Joo Won, Kyu-Won Jung, Ji Won Park, Seung-Yong Jeong
    Journal of the Korean Medical Association.2019; 62(8): 407.     CrossRef
  • Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
    NaNa Keum, Edward Giovannucci
    Nature Reviews Gastroenterology & Hepatology.2019; 16(12): 713.     CrossRef
  • Alcohol Exposure Impacts the Composition of HeLa-Derived Extracellular Vesicles
    Leandra B. Jones, Sanjay Kumar, Aliyah J. Curry, Jayde S. Price, Alexandre Krendelchtchikov, Brennetta J. Crenshaw, Courtnee’ R. Bell, Sparkle D. Williams, Tambre A. Tolliver, Sabita N. Saldanha, Brian Sims, Qiana L. Matthews
    Biomedicines.2019; 7(4): 78.     CrossRef
  • Joint tobacco smoking and alcohol intake exacerbates cancer risk in women– the Danish nurse cohort
    Jette Heberg, Mette Kildevæld Simonsen, Anne Kjaergaard Danielsen, Tobias Wirenfeldt Klausen, Vibeke Zoffmann, Thordis Thomsen
    European Journal of Oncology Nursing.2019; 43: 101675.     CrossRef
  • Wie hoch ist das Krebs-Risiko bei moderate Weinkonsum im Rahmen einer mediterranen Ernährung?
    N. Worma, P. Roca
    BIO Web of Conferences.2019; 15: 04003.     CrossRef
  • From scientific evidence to media and policy: Wine – part of a balanced diet or a health risk?
    U. Fradera, C. Stein-Hammer, P. Roca
    BIO Web of Conferences.2019; 15: 04004.     CrossRef
  • The individual and combined effects of alcohol consumption and cigarette smoking on site-specific cancer risk in a prospective cohort of 26,607 adults: results from Alberta’s Tomorrow Project
    Benjamin Viner, Amanda M. Barberio, Tiffany R. Haig, Christine M. Friedenreich, Darren R. Brenner
    Cancer Causes & Control.2019; 30(12): 1313.     CrossRef
  • STUDY OF KNOWN RISK FACTORS IN BREAST CANCER PATIENTS IN THE REGIONAL POPULATION
    Ashok Kumar, Abhilash Bipin Kumar Tirkey, Sumitoj Singh, Rajiv Devgan
    Journal of Evolution of Medical and Dental Sciences.2019; 8(18): 1446.     CrossRef
  • High-Risk Drinking in the Elderly
    Seung-Won Oh
    Korean Journal of Family Medicine.2018; 39(4): 209.     CrossRef
  • Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?
    Samir Zakhari, Jan B. Hoek
    Cancers.2018; 10(10): 349.     CrossRef
  • Alcohol and Health
    Giovanni de Gaetano, Simona Costanzo
    Journal of the American College of Cardiology.2017; 70(8): 923.     CrossRef
  • 24,118 View
  • 825 Download
  • 107 Web of Science
  • 102 Crossref
Close layer
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim
Cancer Res Treat. 2018;50(2):488-494.   Published online May 22, 2017
DOI: https://doi.org/10.4143/crt.2016.584
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The optimal treatment strategy for patients with metastatic non-clear cell type renal cell carcinoma (nccRCC) remains unclear. Although several inhibitors of vascular endothelial growth factor have recently shown efficacy against nccRCC, the clinical benefit of pazopanib in nccRCC has not been analyzed. We therefore designed a single-arm, open-label, phase II study to determine the efficacy and safety of pazopanib in patients with nccRCC.
Materials and Methods
Patientswith locally advanced or metastatic nccRCC, exceptfor collecting duct or sarcomatoid type, received 800 mg/day of pazopanib daily until progression of disease or intolerable toxicity. One cyclewas defined as 4weeks and tumorresponsewas evaluated every two cycles. The primary objective was overall response rate (ORR).
Results
A total of 29 eligible patients were enrolled at nine centers in Korea from December 2012 and September 2014. The median age of the patients was 58 years (range, 27 to 76 years) and 21 patients (72%) were male. Regarding histology type, 19 patients had papillary, three had chromophobe, two had unclassified and five had unknown non-clear cell type. Of 28 evaluable patients, eight achieved a confirmed partial response with ORR of 28%. The median progression-free survival was 16.5 months (95% confidence interval, 10.9 to 22.1) and median overall survival was not reached. Sixteen patients (55%) experienced treatment-related toxicity of grade 3 or more, but most adverse events were overcome through dose reduction and delay.
Conclusion
In this prospective phase II study, pazopanib demonstrated promising activity and tolerable safety profile in patients with metastatic nccRCC.

Citations

Citations to this article as recorded by  
  • Systemic therapy for non–clear cell renal cell carcinomas: A systematic review
    Balqees Ara, Anum Babar, Durkho Atif, Bushra Ghafoor, Mustafa Shah, Syed Maaz Abdullah, Danish Safi, Amir Kamran
    Journal of Oncology Pharmacy Practice.2025; 31(1): 128.     CrossRef
  • Liver metastasis from a chromophobe renal cell carcinoma 18 years after initial diagnosis: a case report
    Alexandra Ökrösi, Lothar Ponhold, Simon Turba, Melitta Kitzwögerer, Gertraud Heinz
    Journal of Medical Case Reports.2025;[Epub]     CrossRef
  • Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options
    Nathaniel R. Wilson, Yusuf Acikgoz, Elshad Hasanov
    International Journal of Cancer.2024; 154(6): 947.     CrossRef
  • Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
    Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, Adriano Gonçalves e Silva, Ana Paula Garcia Cardoso, André Deeke Sasse, André P. Fay, André Paternò Castello Dias Carneiro, Antonio Machado Alencar Junior, Augusto César de Andra
    Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
  • Papillary Renal Cell Carcinoma: Current Evidence and Future Directions
    Albert Jang, Charbel S. Hobeika, Shilpa Gupta
    Kidney Cancer.2024; 8(1): 61.     CrossRef
  • Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
    Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, Nargız Majidova, Tugay Avci, Halil Göksel Güzel, Caner Kapar, Mehmet Uzun, Perihan Perkin, Fahri Akgül, Saadet Sim Yildirim, Seda Sali, Anil Yildiz, Seher Nazli Kazaz, Engin Hendem, Murat Arcagok, G
    Journal of Chemotherapy.2024; : 1.     CrossRef
  • Genomic profiling and molecular characterization of non-clear cell renal cell carcinoma: a narrative review from a clinical perspective
    Gaetano Pezzicoli, Vittoria Musci, Federica Ciciriello, Francesco Salonne, Paola Cafforio, Nicoletta Lionetti, Anna Ragno, Mimma Rizzo
    Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
  • Effectiveness of systemic treatments for advanced non-clear cell renal cell carcinoma: a systematic review and meta-analysis
    Yaping Zhang, Jian Chen, Xiaoyan Wang, Hui Wang, Xiaoli Chen, Jianfeng Hong, Hongming Fang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Real World Data of Diagnosis, Survival, and Treatment Outcomes in Patients With Metastatic Non Clear Cell Renal Cell Carcinoma
    Floriane Izarn, Benoît Allignet, Romane Gille, Helen Boyle, Eve-Marie Neidhardt, Sylvie Négrier, Aude Fléchon
    Clinical Genitourinary Cancer.2023; 21(2): e35.     CrossRef
  • SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
    María José Méndez-Vidal, Martin Lázaro Quintela, Nuria Lainez-Milagro, Begoña Perez-Valderrama, Cristina Suárez Rodriguez, José Ángel Arranz Arija, Ignacio Peláez Fernández, Enrique Gallardo Díaz, Julio Lambea Sorrosal, Aránzazu González-del-Alba
    Clinical and Translational Oncology.2023; 25(9): 2732.     CrossRef
  • Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium
    Cihan Erol, Emre Yekedüz, Deniz Tural, Serdar Karakaya, Nihan Şentürk Öztaş, Gökhan Uçar, Saadettin Kılıçkap, İsmail Ertürk, Özlem Nuray Sever, Çağatay Arslan, Ahmet Küçükarda, Orçun Can, Özlem Balvan, Satı Coşkun Yazgan, Mustafa Özgüroğlu, Berna Öksüzoğl
    Urologia Internationalis.2023; 107(6): 595.     CrossRef
  • The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database
    Tomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, Kazuyuki Numakura, Yumina Muto, Renpei Kato, Takahiro Kojima, Yoshihide Kawasaki, Kento Morozumi, Shuya Kandori, Sadafumi Kawamura, Hiroyuki Nishiyama, Akihiro Ito, Tomonori Habuchi, Wataru Obara, Chikara Oh
    Cancer Medicine.2023; 12(22): 20677.     CrossRef
  • Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
    Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I. Carlo, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Yasser Ged, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Pay
    Journal of the National Comprehensive Cancer Network.2022; 20(1): 71.     CrossRef
  • Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Jason R. Brown, Adam Calaway, Erik Castle, Jorge Garcia, Pedro C. Barata
    Kidney Cancer.2022; 6(1): 53.     CrossRef
  • Non-Clear Cell Renal Cell Carcinoma: Molecular Pathogenesis, Innovative Modeling, and Targeted Therapeutic Approaches
    Niloofar Khoshdel Rad, Maryam Vahidyeganeh, Mahsa Mohammadi, Anastasia Shpichka, Peter Timashev, Nikoo Hossein-Khannazer, Massoud Vosough
    International Journal of Translational Medicine.2022; 2(4): 555.     CrossRef
  • Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds
    Panagiotis Zoumpourlis, Giannicola Genovese, Nizar M. Tannir, Pavlos Msaouel
    Clinical Genitourinary Cancer.2021; 19(2): 103.     CrossRef
  • Comprehensive review of chromophobe renal cell carcinoma
    Rohan Garje, Dean Elhag, Hesham A Yasin, Luna Acharya, Daniel Vaena, Laila Dahmoush
    Critical Reviews in Oncology/Hematology.2021; 160: 103287.     CrossRef
  • A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma
    Chelsea K. Osterman, Tracy L. Rose
    Kidney Cancer.2020; 4(1): 15.     CrossRef
  • Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report
    Ivana Puliafito, Alessio Russo, Dorotea Sciacca, Caterina Puglisi, Dario Giuffrida
    Journal of Medical Case Reports.2020;[Epub]     CrossRef
  • On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment—Cytokines, Targeted Therapy, and Immunotherapy
    Janice P. Dutcher, Ronan Flippot, Jaleh Fallah, Bernard Escudier
    American Society of Clinical Oncology Educational Book.2020; (40): 418.     CrossRef
  • Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review
    Melissa Bersanelli, Matteo Brunelli, Letizia Gnetti, Umberto Maestroni, Sebastiano Buti
    Therapeutic Advances in Medical Oncology.2020;[Epub]     CrossRef
  • Management of Metastatic Renal Cell Carcinoma with Variant Histologies
    Ronan Flippot, Vijay Damarla, Bradley A. McGregor
    Urologic Clinics of North America.2020; 47(3): 319.     CrossRef
  • Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase Inhibitors
    Silvia Salerno, Elisabetta Barresi, Aída Nelly García-Argáez, Sabrina Taliani, Francesca Simorini, Giorgio Amendola, Stefano Tomassi, Sandro Cosconati, Ettore Novellino, Federico Da Settimo, Anna Maria Marini, Lisa Dalla Via
    ACS Medicinal Chemistry Letters.2019; 10(4): 457.     CrossRef
  • Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
    Nieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, Hannah Dzimitrowicz, Jarred Burkart, Daniel M Geynisman, Archana Balakrishnan, I Alex Bowman, Rohit Jain, Walter Stadler, Yousef Zakharia, Vivek Narayan, Benoit Beuselinck, Rana R McKay, Abhishek Tri
    The Lancet Oncology.2019; 20(4): 581.     CrossRef
  • Recent advances in the systemic treatment of metastatic non‐clear cell renal cell carcinomas
    Keiichi Ito
    International Journal of Urology.2019; 26(9): 868.     CrossRef
  • Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
    Inkeun Park, Young Sup Shim, Heounjeong Go, Bum Sik Hong, Jae Lyun Lee
    BMC Urology.2019;[Epub]     CrossRef
  • Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
    Jii Bum Lee, Hyung Soon Park, Sejung Park, Hyo Jin Lee, Kyung A Kwon, Young Jin Choi, Yu Jung Kim, Chung Mo Nam, Nam Hoon Cho, Beodeul Kang, Hyun Cheol Chung, Sun Young Rha
    Cancer Research and Treatment.2019; 51(4): 1578.     CrossRef
  • The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review
    Gregory T. Sneed, Sukdong Lee, Jamie N. Brown, Julia M. Hammond
    Clinical Genitourinary Cancer.2019; 17(6): 419.     CrossRef
  • A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non–clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus
    Inkeun Park, Se Hoon Lee, Jae Lyun Lee
    Clinical Genitourinary Cancer.2018; 16(5): e997.     CrossRef
  • Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan
    Keiichi Ito, Shuji Mikami, Katsunori Tatsugami, Naoya Masumori, Nobuo Shinohara, Tsunenori Kondo, Shotaro Nakanishi, Yoji Nagashima, Masatoshi Eto, Tomomi Kamba, Naoto Kuroda, Yoshihiko Tomita, Hideyasu Matsuyama, Tetsuro Onishi, Tomoyasu Tsushima, Hayaka
    Clinical Genitourinary Cancer.2018; 16(6): e1201.     CrossRef
  • 11,049 View
  • 494 Download
  • 38 Web of Science
  • 30 Crossref
Close layer
ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
Ji Won Lee, Sung Hye Park, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn
Cancer Res Treat. 2018;50(2):495-505.   Published online May 22, 2017
DOI: https://doi.org/10.4143/crt.2016.577
AbstractAbstract PDFPubReaderePub
Purpose
In this study, anaplastic lymphoma kinase (ALK) mutation and amplification, ALK protein expression, loss of the nuclear alpha thalassemia/mental retardation syndrome X-linked (ATRX) protein, and telomerase reverse transcriptase (TERT) protein expressionwere studied to investigate potential correlations between these molecular characteristics and clinical features or outcomes in neuroblastoma.
Materials and Methods
Seventy-two patients were enrolled in this study. Polymerase chain reaction amplification and direct sequencing were used for mutation analysis. ALK and MYCN amplifications were detected by fluorescence in situ hybridization. Protein expressionwas evaluated by immunohistochemical (IHC) staining.
Results
ALK mutation was found in only two patients (4.1%); ALK amplification was not detected. ALK positivity, loss of nuclear ATRX protein, TERT positivity by IHC were detected in 40 (55.6%), nine (13.0%), and 42 (59.2%) patients, respectively. The incidence of ALK expression increased in accordance with increasing tumor stage (p=0.001) and risk group (p < 0.001). The relapse rate was significantly higher in ALK+ patients compared to that of other patients (47.5% vs. 11.3%, p=0.007). However, there was no significant difference in relapse rate when the survival analysis was confined to the high-risk patients.
Conclusion
Although ALK mutation was rare and no amplification was observed, ALK protein expression was found in a significant number of patients and was correlated with advanced stage and high-risk neuroblastoma. ALK protein expression could be considered as a marker related to the aggressive neuroblastoma, but it was not the independent prognostic factor for the outcome.

Citations

Citations to this article as recorded by  
  • Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features
    Thu Dang Anh Phan, Thao Quyen Nguyen, Nhi Thuy To, Thien Ly Thanh, Dat Quoc Ngo
    Journal of Pathology and Translational Medicine.2024; 58(1): 29.     CrossRef
  • Multi-omics revealed that ELAVL3 regulates MYCN in neuroblastoma via immunogenic cell death: Risk stratification and experimental research
    Peng Hong, Zaihong Hu, Jie Lin, Kongkong Cui, Zhiqiang Gao, Xiaomao Tian, Qinlin Shi, Tao Lin, Guanghui Wei
    International Journal of Biological Macromolecules.2024; 282: 137045.     CrossRef
  • Prominent Staining of MYCN Immunohistochemistry Predicts a Poor Prognosis in MYCN Non-Amplified Neuroblastoma
    Manli Zhao, Weizhong Gu, Fei Liu, Lihua Yu, Yan Shu, Lei Liu, Jiahui Hu, Yang Liu, Hongfeng Tang, Jianhua Mao
    Pediatric and Developmental Pathology.2023; 26(2): 124.     CrossRef
  • ALKGene Mutation and ALK Protein Expression in Advanced Neuroblastoma and the Potential Value in Risk Stratification in Fine-Needle Aspiration Biopsy Samples
    Neha Bhardwaj, Manish Rohilla, Upasana Gautam, Amita Trehan, Deepak Bansal, Nandita Kakkar, Radhika Srinivasan
    American Journal of Clinical Pathology.2023;[Epub]     CrossRef
  • Rapid detection of telomerase expression of neuroblastoma in paraffin-embedded tissue: combination of in situ hybridisation and quantitative PCR
    Manli Zhao, Zhonghai Guan, Liang Gong, Fei Liu, Weizhong Gu, Lei Liu, Kewen Jiang, Jiabin Cai, Chunyue Feng, Chik Hong Kuick, Kenneth Tou En Chang, Jinhu Wang, Hongfeng Tang, Minzhi Yin, Jianhua Mao
    Pathology.2023; 55(7): 958.     CrossRef
  • Interactions of Butyrylcholinesterase with Neuroblastoma-associated Oncoproteins
    Janina Baranowska-Kortylewicz, Zbigniew P. Kortylewicz, Erin M. McIntyre, John G. Sharp, Don W. Coulter
    Current Enzyme Inhibition.2023; 19(2): 109.     CrossRef
  • Combined Detection of Copy Number Variations of MYCN and ALK using Droplet Digital Polymerase Chain Reaction to Identify High-Risk Patients with Neuroblastoma
    Trupti Trivedi, Kinjal Panchal, Neha Bhalala, Priti Trivedi, Harsha Panchal
    World Neurosurgery.2022; 159: e48.     CrossRef
  • ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma
    Dinesh Babu Somasundaram, Sheeja Aravindan, Nandita Gupta, Zhongxin Yu, Ashley Baker, Natarajan Aravindan
    World Journal of Pediatrics.2022; 18(4): 285.     CrossRef
  • Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo
    Janina Baranowska-Kortylewicz, Zbigniew P. Kortylewicz, Erin M. McIntyre, John G. Sharp, Don W. Coulter
    Journal of Pediatric Hematology/Oncology.2022; 44(6): 293.     CrossRef
  • Differential Impact of ALK Mutations in Neuroblastoma
    Tara O'Donohue, Nitya Gulati, Audrey Mauguen, Brian H. Kushner, Neerav Shukla, M. I. Rodriguez-Sanchez, Nancy Bouvier, Stephen Roberts, Ellen Basu, Nai-Kong Cheung, Shakeel Modak
    JCO Precision Oncology.2021; (5): 492.     CrossRef
  • The challenge of defining “ultra‐high‐risk” neuroblastoma
    Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau‐Couanet, Wendy B. London, Meredith S. Irwin
    Pediatric Blood & Cancer.2019;[Epub]     CrossRef
  • ALK in Neuroblastoma: Biological and Therapeutic Implications
    Ricky Trigg, Suzanne Turner
    Cancers.2018; 10(4): 113.     CrossRef
  • 10,118 View
  • 364 Download
  • 10 Web of Science
  • 12 Crossref
Close layer
Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study
Joo Ho Lee, Eui Kyu Chie, Seung-Yong Jeong, Tae-You Kim, Dae Yong Kim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Hee Jin Chang, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Sung Hwan Kim, Jong Hoon Lee, Doo Ho Choi, Hee Chul Park, Sung-Bum Kang, Jae-Sung Kim
Cancer Res Treat. 2018;50(2):506-517.   Published online May 24, 2017
DOI: https://doi.org/10.4143/crt.2016.607
AbstractAbstract PDFPubReaderePub
Purpose
This study was conducted to validate the prognostic influence of treatment response among patients with positive circumferential resection margin for locally advanced rectal cancer.
Materials and Methods
Clinical data of 197 patientswith positive circumferentialresection margin defined as ≤ 2 mm after preoperative chemoradiotherapy followed by total mesorectal excision between 2004 and 2009were collected forthis multicenter validation study. All patients underwent median 50.4Gy radiationwith concurrentfluoropyrimidine based chemotherapy. Treatmentresponse was dichotomized to good response, including treatmentresponse of grade 2 or 3, and poor response, including grade 0 or 1.
Results
After 52 months median follow-up, 5-year overall survival (OS) for good responders and poor responders was 79.1% and 48.4%, respectively (p < 0.001). In multivariate analysis, circumferential resection margin involvement and treatment response were a prognosticator for OS and locoregional recurrence-free survival. In subgroup analysis, good responders with close margin showed significantly better survival outcomes for survival. Good responders with involved margin and poor responders with close margin shared similar results, whereas poorresponderswith involved margin hadworst survival (5-year OS, 81.2%, 57.0%, 50.0%, and 32.4%, respectively; p < 0.001).
Conclusion
Among patients with positive circumferential resection margin after preoperative chemoradiotherapy, survival of the good responders was significantly better than poor responders. Subgroup analysis revealed that definition of positive circumferential resection margin may be individualized as involvement for good responders, whereas ≤ 2 mm for poor responders.

Citations

Citations to this article as recorded by  
  • Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial
    Philippe Rouanet, Eric Rullier, Bernard Lelong, Philippe Maingon, Jean-Jacques Tuech, Denis Pezet, Florence Castan, Stephanie Nougaret
    Diseases of the Colon & Rectum.2022; 65(8): 986.     CrossRef
  • Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis
    Iresha Ratnayake, Jason Park, Natalie Biswanger, Allison Feely, Grace Musto, Kathleen Decker
    Current Oncology.2021; 28(3): 2239.     CrossRef
  • 11,301 View
  • 266 Download
  • 4 Web of Science
  • 2 Crossref
Close layer
Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
Jwa Hoon Kim, Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Kyu-pyo Kim, Beom Su Kim, Moon-Won Yoo, Jeong Hwan Yook, Byung Sik Kim, Jihun Kim, Sun-Ju Byeon, Yoon-Koo Kang
Cancer Res Treat. 2018;50(2):518-529.   Published online May 24, 2017
DOI: https://doi.org/10.4143/crt.2017.005
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to evaluate the efficacy and safety of induction chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) plus bevacizumab (BEV) on initially unresectable locally advanced gastric cancer (LAGC) or paraaortic lymph node (PAN) metastatic gastric cancer (GC).
Materials and Methods
Patients with LAGC or unresectable PAN metastatic GC received six induction chemotherapy cycles (60 mg/m2 docetaxel intravenously on day 1, 937.5 mg/m2 capecitabine orally twice daily on days 1-14, 60 mg/m2 cisplatin intravenously on day 1, and 7.5 mg/kg BEV intravenously on day 1 every 3 weeks), followed by conversion surgery. The primary endpoint was R0 resection rate.
Results
Thirty-one patients with invasion to adjacent organs but without PAN metastasis (n=14, LAGC group) or with PAN metastasis regardless of invasion (n=17, PAN group) were enrolled between July 2010 and December 2014. Twenty-seven patients (87.1%) completed six chemotherapy cycles. The most common grade ≥ 3 toxicities were neutropenia (71%), neutropenia with fever/infection (22.6%/3.2%), and stomatitis (16.1%). The clinical response and R0 resection rates were 64.3% (95% confidence interval [CI], 46.6 to 82.0) and 64.5% (LAGC group, 71.4%; PAN group, 58.8%), respectively. The pathological complete regression rate was 12.9%. After a median follow-up of 44.5 months (range, 39.4 to 49.7 months), the median progression-free survival and overall survival were 13.1 months (95% CI, 8.9 to 17.3) and 38.6 months (95% CI, 22.0 to 55.1), respectively.
Conclusion
Induction chemotherapy with DXP+BEV displayed antitumor activities with encouraging R0 resection rate and manageable toxicity profiles on patients with LAGC or PAN metastatic GC.

Citations

Citations to this article as recorded by  
  • Clinical Efficacy and Safety of Bevacizumab, Apatinib, and Recombinant Human Endothelial Inhibitor in the Treatment of Advanced Gastric Cancer
    Liang Wang, Wei Li, Ya-Gang Liu, Cui Zhang, Wei-Na Gao, Li-Fei Gao, Wei long Zhong
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
    Deguo Yu, Zhenfeng Wang, Tingbang He, Lijun Yang
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Research progress in targeted therapy and immunotherapy for gastric cancer
    Xuewei Li, Jun Xu, Jun Xie, Wenhui Yang
    Chinese Medical Journal.2022; 135(11): 1299.     CrossRef
  • Novel Drug Delivery Method Targeting Para-Aortic Lymph Nodes by Retrograde Infusion of Paclitaxel into Pigs’ Thoracic Duct
    Akira Saito, Natsuka Kimura, Yuji Kaneda, Hideyuki Ohzawa, Hideyo Miyato, Hironori Yamaguchi, Alan Kawarai Lefor, Ryozo Nagai, Naohiro Sata, Joji Kitayama, Kenichi Aizawa
    Cancers.2022; 14(15): 3753.     CrossRef
  • New therapeutic options opened by the molecular classification of gastric cancer
    Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu, Carmen C Diaconu
    World Journal of Gastroenterology.2018; 24(18): 1942.     CrossRef
  • Gastric cancer: Basic aspects
    Henrique O. Duarte, Joana Gomes, José C. Machado, Celso A. Reis
    Helicobacter.2018;[Epub]     CrossRef
  • 9,403 View
  • 320 Download
  • 11 Web of Science
  • 6 Crossref
Close layer
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat. 2018;50(2):530-537.   Published online June 1, 2017
DOI: https://doi.org/10.4143/crt.2017.156
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is often uncertain. We aimed to utilize analytic morphomics, a high-throughput imaging analysis, to assess if body composition is predictive of post-TACE survival.
Materials and Methods
We included patients from a single center (Ann Arbor VA)who had TACE as the primary treatment forHCC and had a pre-treatment computed tomography scans. Univariate analysis and multivariate conditional inference tree analysis were utilized to identify the morphomic characteristics predictive of 1-year survival. Resultswere validated in an external cohort(University of MichiganHealth System) ofHCC patientswho underwent TACE as their primary treatment.
Results
In the 75 patients in the derivation cohort, median survival was 439 (interquartile range, 377 to 685) days from receipt of TACE, with 1-year survival of 61%. Visceral fat density (VFD) was the only morphomic factor predictive of overall and 1-year survival (p < 0.001). Patients with VFD above the 56th percentile had a 1-year survival of 39% versus 78% for those below the 56th percentile. VFD also correlated with 1-year survival in the external validation cohort (44% vs. 72%, p < 0.001). In a secondary analysis, patients with higher VFD were significantly more likely to experience hepatic decompensation after TACE (p < 0.001).
Conclusion
VFD served as an objective predictor of mortality in patients undergoing TACE, possibly through its ability to predict hepatic decompensation. VFD may serve as a radiographic biomarker in predicting TACE outcomes.

Citations

Citations to this article as recorded by  
  • Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review
    Elina En Li Cho, Michelle Law, Zhenning Yu, Jie Ning Yong, Claire Shiying Tan, En Ying Tan, Hirokazu Takahashi, Pojsakorn Danpanichkul, Benjamin Nah, Gwyneth Shook Ting Soon, Cheng Han Ng, Darren Jun Hao Tan, Yuya Seko, Toru Nakamura, Asahiro Morishita, S
    Digestive Diseases and Sciences.2025; 70(2): 533.     CrossRef
  • Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis
    Anrong Wang, Junfeng Li, Changfeng Li, Hui Zhang, Yingfang Fan, Kuansheng Ma, Qiang Wang
    Heliyon.2024; 10(3): e25237.     CrossRef
  • Incorporation of quantitative imaging data using artificial intelligence improves risk prediction in veterans with liver disease
    Grace L. Su, Peng Zhang, Patrick X. Belancourt, Bradley Youles, Binu Enchakalody, Ponni Perumalswami, Akbar Waljee, Sameer Saini
    Hepatology.2024; 80(4): 928.     CrossRef
  • Morphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer
    Valerie Gunchick, Edward Brown, Juan Liu, Jason W. Locasale, Philip A. Philip, Stewart C. Wang, Grace L. Su, Vaibhav Sahai
    JAMA Network Open.2024; 7(10): e2440047.     CrossRef
  • Role of tumor-specific and whole-body imaging biomarkers for prediction of recurrence in patients with stage III colorectal cancer
    Amir A. Borhani, Peng Zhang, Brenda Diergaarde, Sophie Darwiche, Kalina Chuperlovska, Stewart C. Wang, Robert E. Schoen, Grace L. Su
    Abdominal Radiology.2024; 50(5): 1907.     CrossRef
  • Impact of sarcopenia on clinical outcomes for patients with resected hepatocellular carcinoma: a retrospective comparison of Eastern and Western cohorts
    Berend R. Beumer, Kosei Takagi, Stefan Buettner, Yuzo Umeda, Takahito Yagi, Toshiyoshi Fujiwara, Jeroen L.A. van Vugt, Jan N.M. IJzermans
    International Journal of Surgery.2023; 109(8): 2258.     CrossRef
  • Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Dan-Dan Wang, Jin-Feng Zhang, Lin-Han Zhang, Meng Niu, Hui-Jie Jiang, Fu-Cang Jia, Shi-Ting Feng
    Hepatobiliary & Pancreatic Diseases International.2023; 22(6): 594.     CrossRef
  • Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
    Alexey Surov, Maximilian Thormann, Mattes Hinnerichs, Max Seidensticker, Ricarda Seidensticker, Osman Öcal, Kerstin Schütte, Christoph J. Zech, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Chris Verslype, Bernhard Gebauer, Christian Sengel, Iren
    Hepatology Communications.2023;[Epub]     CrossRef
  • Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis
    Shuo Shi, Haiyan Yi, Yi Zheng, Yuxuan Zhao, Dexin Yu
    European Journal of Radiology.2023; 167: 111025.     CrossRef
  • Preoperative Pectoralis Muscle Index Predicts Distant Metastasis-Free Survival in Breast Cancer Patients
    Wen-juan Huang, Meng-lin Zhang, Wen Wang, Qing-chun Jia, Jia-rui Yuan, Xin Zhang, Shuang Fu, Yu-xi Liu, Shi-di Miao, Rui-tao Wang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease
    Wei Zhang, Grace L Su, Kaza Sravanthi, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Anna S Lok
    JGH Open.2022; 6(8): 519.     CrossRef
  • Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
    Berend R. Beumer, Jeroen L.A. van Vugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Malgorzata Nowosad, William Bennet, Emmanouil Tsochatzis, Evangelia Koutli, Fariba Abbassi, Marco P.A.W
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(5): 2373.     CrossRef
  • Bone Densities Assessed by Hounsfield Units at L5 in Computed Tomography Image Independently Predict Hepatocellular Carcinoma Development in Cirrhotic Patients
    Christopher Yeh, Ming-Wei Lai, Chau-Ting Yeh, Yang-Hsiang Lin, Jeng-Hwei Tseng
    Journal of Clinical Medicine.2022; 11(19): 5562.     CrossRef
  • What Is the Role of Body Composition Assessment in HCC Management?
    Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour
    Cancers.2022; 14(21): 5290.     CrossRef
  • High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma
    Leona von Hessen, Marie Roumet, Martin Helmut Maurer, Naomi Lange, Helen Reeves, Jean‐François Dufour, Pompilia Radu
    Liver International.2021; 41(4): 828.     CrossRef
  • Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis
    Winnie Y. Zou, Binu E. Enchakalody, Peng Zhang, Nidhi Shah, Sameer D. Saini, Nicholas C. Wang, Stewart C. Wang, Grace L. Su
    Hepatology Communications.2021; 5(11): 1901.     CrossRef
  • The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE
    Jihye Lim, Kyung Won Kim, Yousun Ko, Il-Young Jang, Yung Sang Lee, Young-Hwa Chung, Han Chu Lee, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jonggi Choi, Danbi Lee
    BMC Cancer.2021;[Epub]     CrossRef
  • Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients
    Kung-Hao Liang, Peng Zhang, Chih-Lang Lin, Stewart C. Wang, Tsung-Hui Hu, Chau-Ting Yeh, Grace L. Su
    Digestive Diseases and Sciences.2020; 65(7): 2130.     CrossRef
  • Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy
    Maryam Ebadi, Carlos Moctezuma-Velazquez, Judith Meza-Junco, Vickie E. Baracos, Abha R. DunichandHoedl, Sunita Ghosh, Philippe Sarlieve, Richard J. Owen, Norman Kneteman, Aldo J. Montano-Loza
    Cancers.2020; 12(2): 356.     CrossRef
  • Review article: prognostic significance of body composition abnormalities in patients with cirrhosis
    Maryam Ebadi, Rahima A. Bhanji, Puneeta Tandon, Vera Mazurak, Vickie E. Baracos, Aldo J. Montano‐Loza
    Alimentary Pharmacology & Therapeutics.2020; 52(4): 600.     CrossRef
  • Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis
    Maryam Ebadi, Rahima A. Bhanji, Abha R. Dunichand-Hoedl, Vera C. Mazurak, Vickie E. Baracos, Aldo J. Montano-Loza
    Nutrients.2020; 12(11): 3463.     CrossRef
  • Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis
    Wei Zhang, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Grace L. Su, Anna S. Lok
    Hepatology Communications.2019; 3(12): 1585.     CrossRef
  • Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics
    Jonghoon Kim, Seung Joon Choi, Seung-Hak Lee, Ho Yun Lee, Hyunjin Park
    American Journal of Roentgenology.2018; 211(5): 1026.     CrossRef
  • Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
    Joanne Marie O’Rourke, Vandana Mridhu Sagar, Tahir Shah, Shishir Shetty
    World Journal of Gastroenterology.2018; 24(39): 4436.     CrossRef
  • The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions
    Adam McCulloch, Hardip Malhi, Amritpal Dhaliwal, Sheldon Cooper, Tahir Shah
    European Medical Journal.2018; : 126.     CrossRef
  • 10,863 View
  • 224 Download
  • 26 Web of Science
  • 25 Crossref
Close layer
Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy
Lingyun Liu, Wei Wang, Yi Zhang, Jianting Long, Zhaohui Zhang, Qiao Li, Bin Chen, Shaoqiang Li, Yunpeng Hua, Shunli Shen, Baogang Peng
Cancer Res Treat. 2018;50(2):538-550.   Published online June 1, 2017
DOI: https://doi.org/10.4143/crt.2017.106
AbstractAbstract PDFPubReaderePub
Purpose
Various inflammation-based prognostic biomarkers such as the platelet to lymphocyte ratio and neutrophil to lymphocyte ratio, are related to poor survival in patients with intrahepatic cholangiocarcinoma (ICC). This study aims to investigate the prognostic value of the aspartate aminotransferase to neutrophil ratio index (ANRI) in ICC after hepatic resection.
Materials and Methods
Data of 184 patients with ICC after hepatectomy were retrospectively reviewed. The cut-off value of ANRIwas determined by a receiver operating characteristic curve. Preoperative ANRI and clinicopathological variables were analyzed. The predictive value of preoperative ANRI for prognosis of ICC was identified by univariate and multivariate analyses.
Results
The optimal cut-off value of ANRI was 6.7. ANRI was associated with tumor size, tumor recurrence, white blood cell, neutrophil count, aspartate aminotransferase, and alanine transaminase. Univariate analysis showed that ANRI, sex, tumor number, tumor size, tumor differentiation, lymph node metastasis, resection margin, clinical TNM stage, neutrophil count, and carcinoembryonic antigen were markedly correlated with overall survival (OS) and disease-free survival (DFS) in patients with ICC. Multivariable analyses revealed that ANRI, a tumor size > 6 cm, poor tumor differentiation, and an R1 resection margin were independent prognostic factors for both OS and DFS. Additionally, preoperative ANRI also had a significant value to predict prognosis in various subgroups of ICC, including serum hepatitis B surface antigen‒negative and preoperative elevated carbohydrate antigen 19-9 patients.
Conclusion
Preoperative declined ANRI is a noninvasive, simple, and effective predictor of poor prognosis in patients with ICC after hepatectomy.

Citations

Citations to this article as recorded by  
  • Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers
    Guo-Le Nie, Jun Yan, Ying Li, Hong-Long Zhang, Dan-Na Xie, Xing-Wang Zhu, Xun Li
    World Journal of Gastrointestinal Oncology.2024; 16(4): 1213.     CrossRef
  • An Analysis of the Factors Influencing Disease-Free and Overall Survival Time after Curative Resection for Hepatocellular Carcinoma
    琪栋 陈
    Advances in Clinical Medicine.2024; 14(04): 2267.     CrossRef
  • The preoperative scoring system combining neutrophil/lymphocyte ratio and CA19-9 predicts the long-term prognosis of intrahepatic cholangiocarcinoma patients undergoing curative liver resection
    Shilei Bai, Xiaodong Shi, Yizhe Dai, Huifeng Wang, Yong Xia, Jian Liu, Kui Wang
    BMC Cancer.2024;[Epub]     CrossRef
  • Multifaceted roles of neutrophils in tumor microenvironment
    Xueyin Pan, Qiang Wang, Beicheng Sun
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2024; 1879(6): 189231.     CrossRef
  • Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
    Jinming Fu, Fenqi Du, Tian Tian, Hao Huang, Lei Zhang, Dapeng Li, Yupeng Liu, Ding Zhang, Lijing Gao, Ting Zheng, Yanlong Liu, Yashuang Zhao
    BMC Cancer.2023;[Epub]     CrossRef
  • Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
    Zimin Song, Shuirong Lin, Xiwen Wu, Xiaoxue Ren, Yifan Wu, Haoxiang Wen, Baifeng Qian, Haozhong Lin, Yihao Huang, Chenfeng Zhao, Nian Wang, Yan Huang, Baogang Peng, Xiaoxing Li, Hong Peng, Shunli Shen
    Hepatology International.2023; 17(5): 1300.     CrossRef
  • A novel nomogram based on preoperative parameters to predict posthepatectomy liver failure in patients with hepatocellular carcinoma
    Shuirong Lin, Zimin Song, Hong Peng, Baifeng Qian, Haozhong Lin, Xiwen Wu, Huilong Li, Yunpeng Hua, Baogang Peng, Changzhen Shang, Ming Kuang, Shunli Shen
    Surgery.2023; 174(4): 865.     CrossRef
  • The Prognostic Value of Multiple Systemic Inflammatory Biomarkers in Preoperative Patients With Non-small Cell Lung Cancer
    Kai Wang, Qidi Zhao, Tao Yan, Deyu Guo, Jichang Liu, Guanghui Wang, Jiajun Du
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Prognostic significance of gamma‐glutamyl transpeptidase to albumin ratio in patients with intrahepatic cholangiocarcinoma after hepatectomy
    Hui Li, Rongqiang Liu, Jiawang Li, Jiaxin Li, Hong Wu, Genshu Wang, Zhenhua Li, Dewei Li
    Journal of Cellular and Molecular Medicine.2022; 26(11): 3196.     CrossRef
  • AST·MLR index and operation injury condition are novel prognostic predictor for the prediction of survival in patients with colorectal cancer liver metastases undergoing surgical resection
    Qichen Chen, Mingxia Li, Jinghua Chen, Zhen Huang, Xiao Chen, Hong Zhao, Jianqiang Cai
    BMC Cancer.2022;[Epub]     CrossRef
  • Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience
    Zehao Zheng, Renguo Guan, Yiping Zou, Zhixiang Jian, Ye Lin, Rongping Guo, Haosheng Jin
    Journal of Inflammation Research.2022; Volume 15: 5089.     CrossRef
  • Can the De Ritis Ratio (AST/ALT) be used to predict colon cancer stages?
    Saygın ALTINER, Enes CEBECİ, Bedri Burak SUCU, Mert ÇÖL, Ender ERGÜDER, Yılmaz ÜNAL, Salih TUNCAL, Mevlüt Recep PEKCİCİ
    Ahi Evran Medical Journal.2022;[Epub]     CrossRef
  • Diagnostic Value of Hematological and Biochemical Parameters Combinations for Predicting Coronavirus Disease 2019 (COVID-19) in Suspected Patients
    Dong Huang, Huan Yang, He Yu, Ting Wang, Zhu Chen, Rong Yao, Zongan Liang
    The American Journal of the Medical Sciences.2021; 362(4): 387.     CrossRef
  • Is Aspartate Aminotransferase to Alanine Aminotransferase (De Ritis Ratio) Helpful in Predicting Breast Cancer?
    Abdullah DURHAN, Abdullah ŞENLİKCİ, Ender ERGÜDER, Marlen SÜLEYMAN, Koray KOŞMAZ, Ümit MERCAN, Mevlüt Recep PEKCİCİ, Serap EREL
    Archives of Clinical and Experimental Medicine.2021; 6(1): 13.     CrossRef
  • Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis
    Junjie Kong, Shu Shen, Zifei Zhang, Wentao Wang
    Cancer Biomarkers.2020; 27(4): 505.     CrossRef
  • High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma
    Hisao Kano, Yutaka Midorikawa, Peipei Song, Hisashi Nakayama, Masamichi Moriguchi, Tokio Higaki, Shingo Tsuji, Tadatoshi Takayama
    BioScience Trends.2020; 14(4): 304.     CrossRef
  • Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
    Fengming Ji, Qiang Kang, Lianmin Wang, Lixin Liu, Yang Ke, Ya Zhu, Naiqiang Zhang, Shifeng Xiong, Yuehua Li, Hao Zou
    Medicine.2020; 99(43): e22827.     CrossRef
  • Prognostic biomarkers for cholangiocarcinoma and their clinical implications
    Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, Sopit Wongkham
    Expert Review of Anticancer Therapy.2018; 18(6): 579.     CrossRef
  • Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
    Lingyun Liu, Jian Wu, Yu Guo, Wenxuan Xie, Bin Chen, Yi Zhang, Shaoqiang Li, Yunpeng Hua, Baogang Peng, Shunli Shen
    Aging.2018; 10(12): 4120.     CrossRef
  • 9,569 View
  • 238 Download
  • 18 Web of Science
  • 19 Crossref
Close layer
Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database
Byoung Hyuck Kim, Jeanny Kwon, Kyubo Kim
Cancer Res Treat. 2018;50(2):551-561.   Published online June 1, 2017
DOI: https://doi.org/10.4143/crt.2017.189
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Few studies for occult breast cancer (OBC) have evaluated the effect of radiotherapy (RT) after mastectomy or axillary lymph node dissection (ALND) with/without breast surgery. Therefore, we investigated clinicopathologic factors of OBC with the impact of postoperative RT to determine its prognostic significance using large population-based data.
Materials and Methods
We performed a retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database from 1983 to 2013. A total of 1,045 eligible patients with OBC were identified. We compared overall survival (OS) using Cox proportional hazards regression with propensity score matching after verifying an imbalance of prognosticators between RT group (n=518) and non-RT group (n=479).
Results
Patients with age < 70 (p=0.033), married marital status (p < 0.001), undergoing ALND (p < 0.001), more examined lymph nodes (LNs) (p < 0.001), and more metastatic LNs (p < 0.001) were more likely to receive RT. Multivariate analysis after propensity score matching (n=798) showed that patients treated with RT survived significantly longer than those without RT (5-year OS, 81.5% vs. 78.3%; p=0.014). A significantly prolonged OS was observed when RT was given to patients treated with mastectomy (p=0.033), those treated with ALND (p=0.036), or those with more than seven metastatic LNs (p=0.016).
Conclusion
RT may offer survival benefit in OBC even after mastectomy or ALND, especially in patients with more than seven metastatic LNs. Further prospective studies are needed to validate these findings.

Citations

Citations to this article as recorded by  
  • Occult breast cancer in an older woman: A case report
    Cong Liu, Hua Xing
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping
    Xin Ye, Li Yang, Qi He, Xiaoyan Lin, Jie Wang, Rongrong Cui, Cheng Xu
    Women & Health.2023; 63(2): 105.     CrossRef
  • Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients
    Jingkun Qu, Chaofan Li, Mengjie Liu, Yusheng Wang, Zeyao Feng, Jia Li, Weiwei Wang, Fei Wu, Shuqun Zhang, Xixi Zhao
    Journal of Clinical Medicine.2023; 12(9): 3097.     CrossRef
  • Best treatment options for occult breast cancer: A meta-analysis
    Rong Wang, Hong-xin Yang, Jie Chen, Jian-jun Huang, Qing Lv
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Occult Breast Cancer Patients with Mastectomy have Better Prognosis than those with Breast-Conserving Therapy
    Jiayi Li, Gang Liu, Ziqi Jia, Fei Ren, Dawei Dong, Menglu Zhang, Xiang Wang, Yipeng Wang
    Future Oncology.2023; 19(36): 2405.     CrossRef
  • Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry
    Mitsuo Terada, Minoru Miyashita, Hiraku Kumamaru, Hiroaki Miyata, Kenji Tamura, Masayuki Yoshida, Etsuyo Ogo, Masayuki Nagahashi, Sota Asaga, Yasuyuki Kojima, Takayuki Kadoya, Kenjiro Aogi, Naoki Niikura, Kotaro Iijima, Naoki Hayashi, Makoto Kubo, Yutaka
    Breast Cancer.2022; 29(4): 698.     CrossRef
  • Occult Breast Cancer Presented with Axillary Lymph Node Metastases: A Small Case Series to a Frustrating Medical Issue
    D. Mantas, Z. Garoufalia, C. Kontzoglou
    Indian Journal of Surgery.2021; 83(S2): 364.     CrossRef
  • Treatment for occult breast cancer: A propensity score analysis of the National Cancer Database
    Catherine Tsai, Beiqun Zhao, Theresa Chan, Sarah L. Blair
    The American Journal of Surgery.2020; 220(1): 153.     CrossRef
  • Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI
    Haeyoung Kim, Won Park, Su Ssan Kim, Sung Ja Ahn, Yong Bae Kim, Tae Hyun Kim, Jin Hee Kim, Jin-Hwa Choi, Hae Jin Park, Jee Suk Chang, Doo Ho Choi
    The Breast.2020; 49: 63.     CrossRef
  • Breast-Conserving Surgery in Patients With Mammary Paget's Disease
    Yufeng Yao, Li Sun, Yan Meng, Yan Zhuang, Lin Zhao, Qiao Yu, Chengshuai Si
    Journal of Surgical Research.2019; 241: 178.     CrossRef
  • Evaluation of the benefit of post‑mastectomy radiotherapy in patients with early‑stage breast cancer: A propensity score matching study
    Wenjie Shi, Youhong Luo, Dongkang Zhao, Hao Huang, Weiyi Pang
    Oncology Letters.2019;[Epub]     CrossRef
  • 10,825 View
  • 365 Download
  • 13 Web of Science
  • 11 Crossref
Close layer
The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis
Jeffrey S. Chang, Yen-Feng Chiu, Jih-Chang Yu, Li-Tzong Chen, Hui-Ju Ch’ang
Cancer Res Treat. 2018;50(2):562-574.   Published online June 9, 2017
DOI: https://doi.org/10.4143/crt.2017.105
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The role of consolidation chemoradiation (CCRT) after systemic chemotherapy in locally advanced pancreatic cancer (LAPC) is still controversial. We aim to evaluate the effectiveness of CCRT in LAPC using systematic review and meta-analysis of prospective studies.
Materials and Methods
Prospective clinical trials of LAPC receiving chemotherapy with or without subsequent CCRT were included in the analysis. We systematically searched in PubMed, MEDLINE, Embase, and Web of Science. The primary outcome of interest was 1-year survival. Secondary endpoints were median overall survival, progression-free survival, toxicity, and resection rate.
Results
Forty-one studies with 49 study arms were included with a total of 1,018 patients receiving CCRT after induction chemotherapy (ICT) and 954 patients receiving chemotherapy alone. CCRT after ICT did not improve 1-year survival significantly in LAPC patients compared with chemotherapy alone (58% vs. 52%). ICT lasted for at least 3 months revealed significantly improved survival of additional CCRT to LAPC patients compared to chemotherapy alone (65% vs. 52%). A marginal survival benefit of consolidation CCRT was noted in studies using maintenance chemotherapy (59% vs. 52%), and fluorouracil-based CCRT (64% vs. 52%), as well as in studies conducted after the 2010 (64% vs. 55%).
Conclusion
The survival benefit of ICT+CCRT over chemotherapy alone in treating LAPC was noted when ICT lasted for at least 3 months. Fluorouracil-based CCRT, and maintenance chemotherapy were associated with improved clinical outcomes.

Citations

Citations to this article as recorded by  
  • Effect of Radiotherapy in Neoadjuvant Treatment of Borderline Resectable and Locally Advanced Pancreatic Cancer
    Peng Tang, Junfeng Zhang, Qiang Zhou, Wenmin Yi, Huaizhi Wang
    Pancreas.2025; 54(3): e246.     CrossRef
  • Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?
    Rita Saúde-Conde, Benjelloun El Ghali, Julie Navez, Christelle Bouchart, Jean-Luc Van Laethem
    Cancers.2024; 16(13): 2423.     CrossRef
  • Issues in the 2022 revision of the Clinical Practice Guidelines for Pancreatic Cancer -Radiotherapy-
    Yoshinori ITO, Satoaki NAKAMURA, Takayuki OHGURI, Masanori SOMEYA, Makoto SHINOTO
    Suizo.2023; 38(2): 121.     CrossRef
  • Can Concurrent Chemoradiotherapy Add Meaningful Benefit in Addition to Induction Chemotherapy in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer?
    Animesh Saha, Jonathan Wadsley, Bhawna Sirohi, Rebecca Goody, Alan Anthony, Karthikeyan Perumal, Danny Ulahanan, Fiona Collinson
    Pancreas.2023; 52(1): e7.     CrossRef
  • Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
    Rishi Das, Madeline R. Abbott, Scott W. Hadley, Vaibhav Sahai, Filip Bednar, Joseph R. Evans, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo
    Advances in Radiation Oncology.2023; 8(6): 101266.     CrossRef
  • A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
    Yung-Yeh Su, Yen-Feng Chiu, Chung-Pin Li, Shih-Hung Yang, Johnson Lin, Shyh-Jer Lin, Ping-Ying Chang, Nai-Jung Chiang, Yan-Shen Shan, Hui-Ju Ch’ang, Li-Tzong Chen
    British Journal of Cancer.2022; 126(7): 1018.     CrossRef
  • Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
    P.J. Ross, H.S. Wasan, D. Croagh, M. Nikfarjam, N. Nguyen, M. Aghmesheh, A.M. Nagrial, D. Bartholomeusz, A. Hendlisz, T. Ajithkumar, C. Iwuji, N.E. Wilson, D.M. Turner, D.C. James, E. Young, M.T. Harris
    ESMO Open.2022; 7(1): 100356.     CrossRef
  • Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches

    Pancreatology.2021; 21(7): 1326.     CrossRef
  • Current status of non-surgical treatment of locally advanced pancreatic cancer
    Stavros Spiliopoulos, Maria Teresa Zurlo, Annachiara Casella, Letizia Laera, Giammarco Surico, Alessia Surgo, Alba Fiorentino, Nicola de'Angelis, Roberto Calbi, Riccardo Memeo, Riccardo Inchingolo
    World Journal of Gastrointestinal Oncology.2021; 13(12): 2064.     CrossRef
  • Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes
    Euna Cho, S M Bakhtiar Ul Islam, Fen Jiang, Ju-Eun Park, Bora Lee, Nam Deuk Kim, Tae-Ho Hwang
    Cancer Research and Treatment.2020; 52(1): 309.     CrossRef
  • ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer
    Felipe A. Calvo, Marco Krengli, Jose M. Asencio, Javier Serrano, Philip Poortmans, Falk Roeder, Robert Krempien, Frank W. Hensley
    Radiotherapy and Oncology.2020; 148: 57.     CrossRef
  • Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
    Christelle Bouchart, Julie Navez, Jean Closset, Alain Hendlisz, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem
    Therapeutic Advances in Medical Oncology.2020;[Epub]     CrossRef
  • Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines
    Laura Hartmann, Philipp Schröter, Wolfram Osen, Daniel Baumann, Rienk Offringa, Mahmoud Moustafa, Rainer Will, Jürgen Debus, Stephan Brons, Stefan Rieken, Stefan B. Eichmüller
    Scientific Reports.2020;[Epub]     CrossRef
  • Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
    Kyriaki Lekka, Evanthia Tzitzi, Alexander Giakoustidis, Vassilios Papadopoulos, Dimitrios Giakoustidis
    Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(2): 97.     CrossRef
  • Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
    Sung J. Ma, Austin J. Iovoli, Gregory M. Hermann, Kavitha M. Prezzano, Anurag K. Singh
    Cancer Medicine.2019; 8(9): 4110.     CrossRef
  • Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
    Maximilian Brunner, Zhiyuan Wu, Christian Krautz, Christian Pilarsky, Robert Grützmann, Georg F. Weber
    International Journal of Molecular Sciences.2019; 20(18): 4543.     CrossRef
  • 13,243 View
  • 412 Download
  • 18 Web of Science
  • 16 Crossref
Close layer
Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma
Ga-In Lee, Dongryul Oh, Won Seog Kim, Seok Jin Kim, Young Hyeh Ko, Kyung In Woo, Yoon-Duck Kim, Yong Chan Ahn
Cancer Res Treat. 2018;50(2):575-581.   Published online June 16, 2017
DOI: https://doi.org/10.4143/crt.2017.182
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to evaluate the clinical features and the long-term outcomes of primary conjunctival marginal zone B-cell lymphoma (MZBCL) patients who were treated with radiation therapy (RT).
Materials and Methods
Retrospective data of 79 patients with 121 primary conjunctival MZBCL lesions were collected from January 1, 2001 till June 30, 2014. All lesions were treated by local RT (26 Gy) with patient-specific customized lens-shielding device.
Results
The current Korean patients’ cohort showed younger median age at diagnosis (38 years), great female preponderance (78.5%) and more frequent bilateral involvement (53.2%) than the previous studies. Following 26 Gy’s RT, excellent clinical outcomes were achieved: 5-year rates of overall survival, local relapse-free survival, and contralateral relapse-free survival were 100%, 98.1%, and 91.5%, respectively. Two patients (2.5%) developed local relapse and five (6.3%) developed relapse at initially uninvolved contralateral conjunctiva with median interval of 52.9 months, and late adverse events of grade 2 and 3 occurred in seven (8.8%) and two (2.5%) patients, respectively.
Conclusion
26 Gy’s RT was highly effective and safe, with the use of lens-shielding device, in treating patients with primary conjunctival MZBCL.

Citations

Citations to this article as recorded by  
  • Deintensification of radiation dose to 20 Gy for conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma
    Jaeha Lee, Si Yeol Song, Young Seob Shin, Sung-Woo Kim, Ye Jin Yoo, Ji Hyeon Joo, Ho-Seok Sa, Dok Hyun Yoon, Sang-wook Lee
    Leukemia & Lymphoma.2025; : 1.     CrossRef
  • Clinicopathologic features of conjunctival MALT lymphomas refractory to radiation therapy
    Yuka Suimon, Satoru Kase, Rumiko Kinoshita, Susumu Ishida
    Canadian Journal of Ophthalmology.2024; 59(5): e501.     CrossRef
  • Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma
    Eduardo Edelman Saul, Juan Pablo Alderuccio, Isildinha M. Reis, Wei Zhao, Sunil G. Iyer, Gregor Rodriguez, Amrita Desai, Jennifer R. Chapman, David T. Tse, Arnold M. Markoe, Derek M. Isrow, Izidore S. Lossos
    American Journal of Hematology.2023; 98(1): 148.     CrossRef
  • Conjunctival Lymphoma
    Lindsay A. McGrath, David A. Ryan, Sunil K. Warrier, Sarah E. Coupland, William J. Glasson
    Eye.2023; 37(5): 837.     CrossRef
  • Long‐term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single‐center cohort study
    Yuanzheng Liang, Rui‐ying Fu, Xue‐lin Liu, Xin‐di Liu, Ying‐shi Piao, Jian‐min Ma, Liang Wang
    Cancer Medicine.2023; 12(3): 2514.     CrossRef
  • Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study
    Kentaro Mizuhara, Tsutomu Kobayashi, Mitsushige Nakao, Ryoichi Takahashi, Hiroto Kaneko, Kazuho Shimura, Koichi Hirakawa, Nobuhiko Uoshima, Katsuya Wada, Eri Kawata, Reiko Isa, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Akiko Yoneda
    Cancer Medicine.2023; 12(3): 3134.     CrossRef
  • Apigenin and Exposure to Low Dose Gamma Radiation Ameliorate Acetic Acid-Induced Ulcerative Colitis in Rats
    Eman E. Shibrya, Rasha R. Rashed, Mai A. Abd El Fattah, Mona A. El-Ghazaly, Sanaa A. Kenawy
    Dose-Response.2023;[Epub]     CrossRef
  • Ultra-low-dose radiation treatment for early-stage ocular adnexal MALT lymphoma
    Min Joung Lee, Me Yeon Lee, Ji-Young Choe, Se Hyun Choi, Hyo Jung Kim
    European Journal of Ophthalmology.2022; 32(5): 3092.     CrossRef
  • Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report
    Jeremy P. M. Flanagan, Michael Ng, Awet Z. Kibrom, Robin J. A. Filshie, Richard J. Stawell, Roderick F. O’Day
    Journal of Ophthalmic Inflammation and Infection.2022;[Epub]     CrossRef
  • One Case of Conjunctival MALT Lymphoma and Literature Review
    旭霞 李
    Advances in Clinical Medicine.2022; 12(08): 7586.     CrossRef
  • Ocular surface complications of local anticancer drugs for treatment of ocular tumors
    Jayoon Moon, Se Hyun Choi, Min Joung Lee, Dong Hyun Jo, Un Chul Park, Sun-Ok Yoon, Se Joon Woo, Joo Youn Oh
    The Ocular Surface.2021; 19: 16.     CrossRef
  • Ocular Oncology—Primary and Metastatic Malignancies
    Basil K. Williams, Maura Di Nicola
    Medical Clinics of North America.2021; 105(3): 531.     CrossRef
  • Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours
    Giuseppe Giannaccare, Federico Bernabei, Martina Angi, Marco Pellegrini, Antonio Maestri, Vito Romano, Vincenzo Scorcia, Pierre-Räphael Rothschild
    Cancers.2021; 13(8): 1933.     CrossRef
  • Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients
    Khaled Elsayad, Gabriele Reinartz, Michael Oertel, Stephan Rehn, Jens Eismann, Sergiu Scobioala, Hendrik Berssenbrügge, Nicole Eter, Carsten Weishaupt, Hartmut H. Schmidt, Birte Friedrichs, Inga Grünewald, Wolfgang Hartmann, Georg Lenz, Eva Wardelmann, No
    Strahlentherapie und Onkologie.2020; 196(2): 117.     CrossRef
  • Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum
    Andrés J. M. Ferreri, Marianna Sassone, Elisabetta Miserocchi, Silvia Govi, Caterina Cecchetti, Matteo E. Corti, Silvia Mappa, Luca Arcaini, Francesco Zaja, Giuseppe Todeschini, Donato Mannina, Teresa Calimeri, Salvatore Perrone, Maurilio Ponzoni, Giulio
    Blood Advances.2020; 4(6): 1013.     CrossRef
  • Patterns of care for orbital marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross‐sectional cohort study (KROG 16–19)
    Jeongshim Lee, Dongryul Oh, Byung Ock Choi, Keun‐Yong Eom, Jong Hoon Lee, Jung Hoon Kim, Sang Wook Lee, Yang Kwon Suh, Chang‐Ok Suh
    Asia-Pacific Journal of Clinical Oncology.2019; 15(6): 358.     CrossRef
  • Classification, diagnosis, and management of conjunctival lymphoma
    Rebecca E. Tanenbaum, Anat Galor, Sander R. Dubovy, Carol L. Karp
    Eye and Vision.2019;[Epub]     CrossRef
  • Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct Treatment
    Gaurav Dhawan, Rachna Kapoor, Asha Dhamija, Ravinder Singh, Bharat Monga, Edward J. Calabrese
    Dose-Response.2019; 17(3): 155932581987175.     CrossRef
  • Health Impacts of Low-Dose Ionizing Radiation: Current Scientific Debates and Regulatory Issues
    Alexander Vaiserman, Alexander Koliada, Oksana Zabuga, Yehoshua Socol
    Dose-Response.2018;[Epub]     CrossRef
  • 15,489 View
  • 249 Download
  • 18 Web of Science
  • 19 Crossref
Close layer
Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort
Heewon Kim, Yunji Hwang, Hokyung Sung, Jieun Jang, Choonghyun Ahn, Sang Gyun Kim, Keun-Young Yoo, Sue K. Park
Cancer Res Treat. 2018;50(2):582-589.   Published online June 9, 2017
DOI: https://doi.org/10.4143/crt.2017.048
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study was performed to investigate the effectiveness of gastric cancer (GC) screening methods in a community-based prospective cohort of the Korean Multi-center Cancer Cohort (KMCC) with over a 10-year follow-up.
Materials and Methods
A total 10,909 and 4,773 subjects from the KMCC with information on gastroendoscopy (GE) and upper gastrointestinal series (UGIS) were included in this study. Cox proportional hazard model adjusted for age, sex, Helicobacter pylori infection, cigarette smoking, and alcohol drinking was used to estimate the hazard ratios (HRs) and 95% confidence interval (CI).
Results
The GE screened subjects had almost half the risk of GC-specific death than that of unscreened subjects (HR, 0.58; 95% CI, 0.36 to 0.94). Among the GC patients, GE screenees had a 2.24-fold higher survival rate than that of the non-screenees (95% CI, 1.61 to 3.11). In particular, GE screenees who underwent two or more screening episodes had a higher survival rate than that of the non-screenees (HR, 13.11; 95% CI, 7.38 to 23.30). The effectiveness of GE screening on reduced GC mortality and increased survival rate of GC patients was better in elderly subjects (≥ 65 years old) (HR, 0.47; 95% CI, 0.24 to 0.95 and HR, 8.84; 95% CI, 3.63 to 21.57, respectively) than that in younger subjects (< 65 years old) (HR, 0.66; 95% CI, 0.34 to 1.29 and HR, 1.83; 95% CI, 1.24 to 2.68, respectively). In contrast, UGIS screening had no significant relation to GC mortality and survival.
Conclusion
The findings of this study suggest that a decreased GC-specific mortality and improved survival rate in GC patients can be achieved through GE screening.

Citations

Citations to this article as recorded by  
  • Sedated and unsedated gastroscopy has no influence on the outcomes of patients with gastric cancer: a retrospective study
    Chengke Yin, Yiwu Sun, Jie Liang, Xin Sui, Zhaoyi He, Ailing Song, Wenjia Xu, Lei Zhang, Yufei Sun, Jingshun Zhao, Fei Han
    BMC Cancer.2025;[Epub]     CrossRef
  • Assessing cross-country inequalities in global burden of gastrointestinal cancers: slope and concentration index approach
    Haoyun Zhou, Yongbo Wang, Fang Wang, Runtang Meng, Yong Yu, Su Han, Yu Zhang, Yu Wu, Xiaoxue Liu
    Discover Oncology.2025;[Epub]     CrossRef
  • RORα inhibits proliferation and chemoresistance through AKR1A1-induced glucose and lipid reprogramming in gastric cancer
    Xiaoshan Wang, Mengding Chen, Yuwei Wu, Feixu Chen, Tong Shen, Zhengguang Wang
    Cellular Signalling.2025; 131: 111741.     CrossRef
  • The artificial intelligence revolution in gastric cancer management: clinical applications
    Runze Li, Jingfan Li, Yuman Wang, Xiaoyu Liu, Weichao Xu, Runxue Sun, Binqing Xue, Xinqian Zhang, Yikun Ai, Yanru Du, Jianming Jiang
    Cancer Cell International.2025;[Epub]     CrossRef
  • PET/CT with 68Ga-FAPI and 18F-FDG in the Detection of Metastases in Regional Lymph Nodes in Gastric Cancer
    E. V. Belkin, P. E. Tulin, O. B. Abu-Khaydar, I. A. Skripachev, A. V. Filimonov
    Journal of oncology: diagnostic radiology and radiotherapy.2025; 8(1): 29.     CrossRef
  • Inhibition of TAF1B impairs ribosome biosynthesis and suppresses cell proliferation in stomach adenocarcinoma through promoting c-MYC mRNA degradation
    Hang-fei Chen, Zhang-ping Li, Qi Wu, Chun Yu, Jing-Yi Yan, Yong-feng Bai, Sheng-mei Zhu, Mao-xiang Qian, Ming Liu, Li-feng Xu, Zheng Peng, Feng Zhang
    Heliyon.2024; 10(1): e23167.     CrossRef
  • Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study
    Byeong Yun Ahn, Bokyung Kim, Sanghyun Park, Sang Gyun Kim, Kyungdo Han, Soo‐Jeong Cho
    Cancer.2024; 130(10): 1807.     CrossRef
  • Gastric cancer screening in Western countries: A call to action
    Fabio Farinati, Filippo Pelizzaro
    Digestive and Liver Disease.2024; 56(10): 1653.     CrossRef
  • The Role of Screening and Early Detection in Upper Gastrointestinal Cancers
    Jin Woo Yoo, Monika Laszkowska, Robin B. Mendelsohn
    Hematology/Oncology Clinics of North America.2024; 38(3): 693.     CrossRef
  • Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer
    Chong-Mei Zhou, Shao-Hua Zhao
    World Journal of Gastrointestinal Oncology.2024; 16(5): 1737.     CrossRef
  • Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035
    Ju-Li Lin, Jian-Xian Lin, Guang-Tan Lin, Chang-Ming Huang, Chao-Hui Zheng, Jian-Wei Xie, Jia-bin Wang, Jun Lu, Qi-Yue Chen, Ping Li
    BMC Public Health.2024;[Epub]     CrossRef
  • Gastric intestinal metaplasia regression in United States population: A retrospective longitudinal study
    Akram I Ahmed, Ahmed El Sabagh, Claire Caplan, Arielle Lee, Won K Cho
    JGH Open.2024;[Epub]     CrossRef
  • Performance of the National Cancer Screening Program for Gastric Cancer in Korea
    Young-Il Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 231.     CrossRef
  • MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle
    Jinbao Guo, Li Zhong, Mohammad Reza Momeni
    Cell Biology and Toxicology.2024;[Epub]     CrossRef
  • Clinicopathological and prognostic significance of TIMP1 expression in gastric cancer: a systematic review and meta-analysis
    Mingcan Zheng, Puxu Wang, Yuhang Wang, Zirui Jia, Jiacheng Gao, Xiaodong Tan, Hailong Chen, Guo Zu
    Expert Review of Anticancer Therapy.2024; 24(11): 1169.     CrossRef
  • Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
    M. Constanza Camargo
    JAMA.2024; 332(19): 1621.     CrossRef
  • Knowledge and practice of early gastric cancer screening among adults aged ≥ 45 years in China: a cross-sectional study
    Xiaoci He, Wei Qi, Qian Wang, Shuping Zhao
    BMC Public Health.2024;[Epub]     CrossRef
  • Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy
    Qing-Zhou Kong, Cheng Peng, Zhen Li, Bao-Ling Tian, Yue-Yue Li, Fei-Xue Chen, Xiu-Li Zuo, Yan-Qing Li
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Clinicopathologic significance of Her-2 and P53 expressions in gastric cancer
    Xiaoyu Zhang, Mingchuan Wang, Yizhuo Wang, Xianbin Cheng, Yang Jiang, Huijie Xiao
    Asian Journal of Surgery.2023; 46(1): 526.     CrossRef
  • Trend of gastric cancer incidence and death rate in adolescents and young adults: A retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database
    Jie Wen, Huiqin Shen
    Journal of Gastroenterology and Hepatology.2023; 38(3): 393.     CrossRef
  • Metachronous gastric neoplasm beyond 5 years after endoscopic resection for early gastric cancer
    Eunwoo Lee, Sang Gyun Kim, Bokyung Kim, Jue Lie Kim, Jung Kim, Hyunsoo Chung, Soo-Jeong Cho
    Surgical Endoscopy.2023; 37(5): 3901.     CrossRef
  • Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years
    Hongfa Wei, Xiao-Yong Zhan, Xianying Liao, Wenchao Li, Hui Chen, Cuncan Deng, Xinghan Jin, Zhangsen Huang, Mo Yang, Changhua Zhang, Yulong He
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Controlling Gastric Cancer in a World of Heterogeneous Risk
    Robert J. Huang, Monika Laszkowska, Haejin In, Joo Ha Hwang, Meira Epplein
    Gastroenterology.2023; 164(5): 736.     CrossRef
  • Willingness to Undergo Gastroscopy for Early Gastric Cancer Screening and Its Associated Factors During the COVID-19 Pandemic – A Nationwide Cross-Sectional Study in China
    Kejia Ma, Xuejie Chen, Xin Xiang, Xueyi Mao, Ningxin Zhu, Tianyu Wang, Shuyu Ye, Xiaoyan Wang, Minzi Deng
    Patient Preference and Adherence.2023; Volume 17: 505.     CrossRef
  • Radiographic and endoscopic screening to reduce gastric cancer mortality: a systematic review and meta-analysis
    Masaya Hibino, Chisato Hamashima, Mitsunaga Iwata, Teruhiko Terasawa
    The Lancet Regional Health - Western Pacific.2023; 35: 100741.     CrossRef
  • Screening behaviors and related factors among the first-degree relatives of Chinese patients with gastric cancer
    Min Zhao, Hui Li, Hui Ren, Jie Zhang, Hong Yang, Yuhan Lu
    Asia-Pacific Journal of Oncology Nursing.2023; 10(5): 100220.     CrossRef
  • ALDOC regulated the biological function and immune infiltration of gastric cancer cells
    Liqiao Chen, Yi Zeng, Baoqing Ren, Xinyu Wang, Fucheng Zhao, Jitao Du, Rupeng Zhang, Jingyu Deng
    The International Journal of Biochemistry & Cell Biology.2023; 158: 106407.     CrossRef
  • Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine
    Vigneshwar Suriya Prakash Sinnarasan, Dahrii Paul, Rajesh Das, Amouda Venkatesan
    OMICS: A Journal of Integrative Biology.2023; 27(6): 260.     CrossRef
  • Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program
    Ryosuke Hirai, Mami Hirai, Motoyuki Otsuka, Toshiharu Mitsuhashi, Yuichi Shimodate, Hirokazu Mouri, Kazuhiro Matsueda, Hiroshi Yamamoto, Motowo Mizuno
    Journal of Gastroenterology.2023; 58(9): 848.     CrossRef
  • Determinants of gastric cancer screening attendance in Southeastern China: a cross-sectional study
    Zhiwen Huang, Zhijian Hu, Li Ping Wong, Yulan Lin
    BMJ Open.2023; 13(7): e073925.     CrossRef
  • LINC00665 activating Wnt3a/β-catenin signaling by bond with YBX1 promotes gastric cancer proliferation and metastasis
    Jie Wang, Dongxiao Shen, Shichao Li, Qiuying Li, Qingsong Zuo, Jiahao Lu, Donghao Tang, Yuejiao Feng, Peihao Yin, Chao Chen, Teng Chen
    Cancer Gene Therapy.2023; 30(11): 1530.     CrossRef
  • FIS1 Overexpression Is Correlated with Tumor Metastasis in Gastric Adenocarcinoma
    Dariush Karimi, Negar Pedram, Farzad Kakaei, Milad Asadi, Elham Poursaei, Touraj Asvadi Kermani
    Journal of Gastrointestinal Cancer.2022; 53(2): 466.     CrossRef
  • An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States
    Robert J. Huang, Meira Epplein, Chisato Hamashima, Il Ju Choi, Eunjung Lee, Dennis Deapen, Yanghee Woo, Thuy Tran, Shailja C. Shah, John M. Inadomi, David A. Greenwald, Joo Ha Hwang
    Clinical Gastroenterology and Hepatology.2022; 20(10): 2218.     CrossRef
  • Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer
    Xiao-dong Chu, Zheng-bin Lin, Ting Huang, Hui Ding, Yi-ran Zhang, Zhan Zhao, Shu-chen Huangfu, Sheng-hui Qiu, Yan-guan Guo, Xiao-li Chu, Jing-hua Pan, Yun-long Pan
    BMC Cancer.2022;[Epub]     CrossRef
  • Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study
    Wen-Qing Li, Xiang-Xiang Qin, Zhe-Xuan Li, Le-Hua Wang, Zong-Chao Liu, Xiao-Han Fan, Li-Hui Zhang, Yi Li, Xiu-Zhen Wu, Jun-Ling Ma, Yang Zhang, Lan-Fu Zhang, Ming Li, Tong Zhou, Jing-Ying Zhang, Jian-Xi Wang, Wei-Dong Liu, Wei-Cheng You, Kai-Feng Pan
    Endoscopy.2022; 54(09): 848.     CrossRef
  • Current status of the gastric cancer screening program in Korea
    Young-Il Kim, Il Ju Choi
    Journal of the Korean Medical Association.2022; 65(5): 250.     CrossRef
  • Gastric hydrodistension CT versus CT without gastric distension in preoperative TN staging of gastric carcinoma: analysis of single-center cancer registry
    Yu-Hsien Lee, Wen-Hui Chan, Ying-Chieh Lai, An-Hsin Chen, Chien-Ming Chen
    Scientific Reports.2022;[Epub]     CrossRef
  • Small molecules as potential biomarkers of early gastric cancer: A mass spectrometry imaging approach
    Long Zou, Luolin Wang, Lei Guo, Weixun Zhou, Zhizhen Lai, Cheng Zhu, Xi Wu, Zhili Li, Aiming Yang
    Clinica Chimica Acta.2022; 534: 35.     CrossRef
  • Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA
    Si Lin Wu, Yao Zhang, Yi Fu, Jian Li, Ji Sheng Wang
    BMJ Open.2022; 12(7): e061038.     CrossRef
  • Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
    Young-Il Kim, Il Ju Choi
    Journal of Gastric Cancer.2022; 22(3): 169.     CrossRef
  • Effectiveness of endoscopic screening for gastric cancer: The Japan Public Health Center‐based Prospective Study
    Nobuhiro Narii, Tomotaka Sobue, Ling Zha, Tetsuhisa Kitamura, Motoki Iwasaki, Manami Inoue, Taiki Yamaji, Shoichiro Tsugane, Norie Sawada
    Cancer Science.2022; 113(11): 3922.     CrossRef
  • The Novel Protein ADAMTS16 Promotes Gastric Carcinogenesis by Targeting IFI27 through the NF-κb Signaling Pathway
    Tuoyang Li, Junyi Zhou, Yingming Jiang, Yandong Zhao, Jintuan Huang, Weiyao Li, Zhenze Huang, Zijian Chen, Xiaocheng Tang, Hao Chen, Zuli Yang
    International Journal of Molecular Sciences.2022; 23(19): 11022.     CrossRef
  • Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer
    Hua Fan, Xue Li, Zhong-Wu Li, Nai-Ren Zheng, Li-Hua Cao, Zong-Chao Liu, Ming-Wei Liu, Kai Li, Wen-Hui Wu, Zhe-Xuan Li, Tong Zhou, Yang Zhang, Wei-Dong Liu, Lan-Fu Zhang, Wei-Cheng You, Yi Wang, Jianmin Wu, Kai-Feng Pan, Jun Qin, Wen-Qing Li
    eBioMedicine.2022; 86: 104340.     CrossRef
  • Forthcoming Step in Gastric Cancer Prevention: How Can Risk Stratification Be Combined with Endoscopic Screening for Gastric Cancer?
    Chisato Hamashima
    Gut and Liver.2022; 16(6): 811.     CrossRef
  • Survival of gastric cancer in China from 2000 to 2022: A nationwide systematic review of hospital-based studies
    Houqiang Li, Han Zhang, Hujia Zhang, Youxin Wang, Xiaobing Wang, Haifeng Hou
    Journal of Global Health.2022;[Epub]     CrossRef
  • Optimal extent of lymph node dissection in gastric cancer
    Zsolt Varga, Péter Kolozsi, Kitti Nagy, Dezső Tóth
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Urine Proteomic Signatures Predicting the Progression from Premalignancy to Malignant Gastric Cancer
    Hua Fan, Xue Li, Zhong-Wu Li, Nai-Ren Zheng, Li-Hua Cao, Zong-Chao Liu, Yi Wang, Ming-Wei Liu, Kai Li, Wen-Hui Wu, Zhe-Xuan Li, Tong Zhou, Yang Zhang, Wei-Dong Liu, Lan-Fu Zhang, Wei-Cheng You, Jianmin Wu, Kai-Feng Pan, Jun Qin, Wen-Qing Li
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Disaggregated mortality from gastrointestinal cancers in Asian Americans: Analysis of United States death records
    Robert J. Huang, Nora Sharp, Ruth Talamoa, Kristopher Kapphahn, Vedant Sathye, Bryant Lin, Malathi Srinivasan, Latha P. Palaniappan
    International Journal of Cancer.2021; 148(12): 2954.     CrossRef
  • Gastrointestinal cancers in China, the USA, and Europe
    Yumo Xie, Lishuo Shi, Xiaosheng He, Yanxin Luo
    Gastroenterology Report.2021; 9(2): 91.     CrossRef
  • Endoscopic Screening and Surveillance for Gastric Cancer
    Bokyung Kim, Soo-Jeong Cho
    Gastrointestinal Endoscopy Clinics of North America.2021; 31(3): 489.     CrossRef
  • Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
    Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Extended Gastrectomy for T4b Gastric Adenocarcinoma: Single-Surgeon Experience
    Mushegh А. Sahakyan, Artak Gabrielyan, Hmayak Petrosyan, Shushan Yesayan, Sevak S. Shahbazyan, Arthur M. Sahakyan
    Journal of Gastrointestinal Cancer.2020; 51(1): 135.     CrossRef
  • Laparoscopic management of gastric remnant ischemia after laparoscopic distal gastrectomy with Billroth-I anastomosis—A case report
    Abdulaziz Alshehri, Hee-sung Kim, Byung Sik Kim
    International Journal of Surgery Case Reports.2020; 66: 265.     CrossRef
  • Modeling the Surface Field From an Ingested Radio Transmitter With an Approximate Attenuation Model for Gastroenterology Investigations
    Yana A. Salchak, Hugo G. Espinosa, David V. Thiel
    IEEE Transactions on Biomedical Engineering.2020; 67(2): 504.     CrossRef
  • The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study
    Mingwang Shen, Ruyi Xia, Zheng Luo, Hongmei Zeng, Wenqiang Wei, Guihua Zhuang, Lei Zhang, Wanqing Chen
    Journal of Theoretical Biology.2020; 484: 109996.     CrossRef
  • CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker
    Mohammad Amini, Khodayar Ghorban, Ahad Mokhtarzadeh, Maryam Dadmanesh, Behzad Baradaran
    Life Sciences.2020; 254: 117774.     CrossRef
  • Bio-assay of the non-amidated progastrin-derived peptide (G17-Gly) using the tailor-made recombinant antibody fragment and phage display method: a biomedical analysis
    Deniz Sadighbayan, Mohammad Reza Tohidkia, Tayebeh Mehdipour, Mohammad Hasanzadeh, Ahmad Yari Khosroushahi
    Analytical Methods.2020; 12(21): 2735.     CrossRef
  • A protocol of systematic review and meta-analysis of narrow band imaging endoscopy in detection of early gastric cancer
    Li Zhang, Xiao-yu Liu, Gang Zhong, Zhi Xin, Xiang-Yu Sun, Zhen-Yu Wang
    Medicine.2020; 99(33): e21420.     CrossRef
  • Gastric cancer
    Elizabeth C Smyth, Magnus Nilsson, Heike I Grabsch, Nicole CT van Grieken, Florian Lordick
    The Lancet.2020; 396(10251): 635.     CrossRef
  • Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non‐high‐incidence area
    Hai‐Fan Xiao, Shi‐Peng Yan, Ji‐Gang Li, Zhao‐Hui Shi, Yan‐Hua Zou, Ke‐Kui Xu, Xian‐Zhen Liao
    Cancer Medicine.2020; 9(22): 8722.     CrossRef
  • The Clinicopathological Features and Staging at Presentation of Gastric Cancer: A Single-Center Retrospective Study
    Syn Yi Chong, Soo Fan Ang
    Asian Journal of Oncology.2020; 06: 120.     CrossRef
  • Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China
    Hongmei Zeng, Kexin Sun, Maomao Cao, Rongshou Zheng, Xibin Sun, Shuzheng Liu, Zhiyi Zhang, Yuqin Liu, Guizhou Guo, Guohui Song, Yigong Zhu, Xianghong Wu, Bingbing Song, Xianzhen Liao, Yanfang Chen, Mingyang Song, Edward Giovannucci, Guihua Zhuang, Wenqian
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Gastric Mucosal Atrophy Impedes Housekeeping Gene Methylation in Gastric Cancer Patients
    Jung-Hwan Oh, Mun-Gan Rhyu, Suk-Il Kim, Mi-Ri Yun, Jung-Ha Shin, Seung-Jin Hong
    Cancer Research and Treatment.2019; 51(1): 267.     CrossRef
  • Gastric Cancer – From Aetiology to Management: Differences Between the East and the West
    W.L. Chan, K.O. Lam, V.H.F. Lee, M. Davidson, T.H. So, J.S. Li, I. Chau, D.L.W. Kwong
    Clinical Oncology.2019; 31(8): 570.     CrossRef
  • Using big data to see the forest and the trees: endoscopic submucosal dissection of early gastric cancer in Korea
    Chang Seok Bang, Gwang Ho Baik
    The Korean Journal of Internal Medicine.2019; 34(4): 772.     CrossRef
  • Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways
    Carmen Bax, Beatrice Julia Lotesoriere, Selena Sironi, Laura Capelli
    Cancers.2019; 11(9): 1244.     CrossRef
  • Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study
    Qi Liu, Xi Zeng, Wen Wang, Ruo-lin Huang, Yan-jin Huang, Shan Liu, Ying-hui Huang, Ying-xin Wang, Qing-hong Fang, Guoping He, Ying Zeng
    BMJ Open.2019; 9(7): e029638.     CrossRef
  • Preoperative gastric lavage in gastric cancer patients undergoing surgical, endoscopic or minimally invasive treatment: An oncological measure preventing peritoneal spillage of intragastric cancer cells and development of related metastases
    Edoardo Virgilio, Genoveffa Balducci, Paolo Mercantini, Enrico Giarnieri, Maria Rosaria Giovagnoli, Monica Montagnini, Antonella Proietti, Rosaria D'Urso, Marco Cavallini
    Medical Hypotheses.2018; 114: 30.     CrossRef
  • Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review
    Xing Zhang, Meng Li, Shuntai Chen, Jiaqi Hu, Qiujun Guo, Rui Liu, Honggang Zheng, Zhichao Jin, Yuan Yuan, Yupeng Xi, Baojin Hua
    Gastroenterology.2018; 155(2): 347.     CrossRef
  • Screening for gastric cancer with magnetically controlled capsule gastroscopy in asymptomatic individuals
    An-Jing Zhao, Yang-Yang Qian, Hui Sun, Xi Hou, Jun Pan, Xiao Liu, Wei Zhou, Yi-Zhi Chen, Xi Jiang, Zhao-Shen Li, Zhuan Liao
    Gastrointestinal Endoscopy.2018; 88(3): 466.     CrossRef
  • Changing trends in clinico-pathologic characteristics and treatment outcomes in patients with gastric cancer: A single-center, public hospital, retrospective study
    Min-Seung Gwak, Jong-Min Park
    Korean Journal of Clinical Oncology.2018; 14(2): 69.     CrossRef
  • 11,646 View
  • 440 Download
  • 71 Web of Science
  • 71 Crossref
Close layer
Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01
Jung Hye Choi, Tae Min Kim, Hyo Jung Kim, Sung Ae Koh, Yeung-Chul Mun, Hye Jin Kang, Yun Hwa Jung, Hyeok Shim, So Young Chong, Der-Sheng Sun, Soonil Lee, Byeong Bae Park, Jung Hye Kwon, Seung-Hyun Nam, Jun Ho Yi, Young Jin Yuh, Jong-Youl Jin, Jae Joon Han, Seok-Hyun Kim
Cancer Res Treat. 2018;50(2):590-598.   Published online June 9, 2017
DOI: https://doi.org/10.4143/crt.2017.172
AbstractAbstract PDFPubReaderePub
Purpose
The treatment strategy for elderly patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) has not been established because of poor treatment tolerability and lack of data.
Materials and Methods
This multicenter retrospective study was conducted to investigate clinical characteristics, treatment patterns and outcomes of patients older than 80 years who were diagnosed with DLBCL at 19 institutions in Korea between 2005 and 2016.
Results
A total of 194 patients were identified (median age, 83.3 years). Of these, 114 patients had an age-adjusted International Prognostic Index (aaIPI) score of 2-3 and 48 had a Charlson index score of 4 or more. R-CHOP was given in 124 cases, R-CVP in 13 cases, other chemotherapy in 17 cases, radiation alone in nine cases, and surgery alone in two cases. Twenty-nine patients did not undergo any treatment. The median number of chemotherapy cycles was three. Only 37 patients completed the planned treatment cycles. The overall response rate from 105 evaluable patientswas 90.5% (complete response, 41.9%). Twentynine patients died due to treatment-related toxicities (TRT). Thirteen patients died due to TRT after the first cycle. Median overall survival was 14.0 months. The main causes of death were disease progression (30.8%) and TRT (27.1%). In multivariate analysis, overall survival was affected by aaIPI, hypoalbuminemia, elevated creatinine, and treatment.
Conclusion
Age itself should not be a contraindication to treatment. However, since elderly patients show higher rates of TRT due to infection, careful monitoring and dose modification of chemotherapeutic agents is needed.

Citations

Citations to this article as recorded by  
  • Treatment Patterns and Costs Among US Patients With Diffuse Large B-Cell Lymphoma not Treated With 2L Stem Cell Transplantation
    Teofilia Acheampong, Tao Gu, Trong Kim Le, Scott J Keating
    Future Oncology.2024; 20(10): 623.     CrossRef
  • Identification of independent risk factors for hypoalbuminemia in patients with CKD stages 3 and 4: the construction of a nomogram
    Chong-Hui Wang, Meng-Han Jiang, Ji-Min Ma, Ming-Cong Yuan, Lei Liao, Hao-Zhang Duan, Dan Wang, Lian Duan
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma
    Will Harris, Edward J. Bataillard, Yoonha Choi, Tarec C. El-Galaly, Vaikunth Cuchelkar, Carsten Henneges, Antonia Kwan, Daniel J. Schneider, Joseph N. Paulson, Tina G. Nielsen
    JCO Clinical Cancer Informatics.2022;[Epub]     CrossRef
  • A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China
    Chunli Yang, Qiaoer Li, Ke Xie, Yakun Zhang, Dania Xiang, Yunwei Han, Liqun Zou
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
    Se‐Il Go, Mi Jung Park, Sungwoo Park, Myoung Hee Kang, Hoon‐Gu Kim, Jung Hun Kang, Jung Hoon Kim, Gyeong‐Won Lee
    Journal of Cachexia, Sarcopenia and Muscle.2021; 12(6): 2211.     CrossRef
  • Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma – Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007–2015
    Vicki A. Morrison, Laurie Hamilton, Augustina Ogbonnaya, Aditya Raju, Kristin Hennenfent, Aaron Galaznik
    Journal of Geriatric Oncology.2020; 11(1): 41.     CrossRef
  • Clinical characteristics, treatment patterns and outcomes of patients older than 80 years diagnosed with DLBCL in China over a 10-year period
    Zhan Shi, Xi Tang, Qianwen Shen, Jiayan Chen, Fei Liu, Xi Chen, Jingwen Wang, Jie Zhuang
    Cancer Chemotherapy and Pharmacology.2019; 84(1): 127.     CrossRef
  • Antineoplastics

    Reactions Weekly.2018; 1701(1): 32.     CrossRef
  • 10,970 View
  • 320 Download
  • 8 Web of Science
  • 8 Crossref
Close layer
Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma
Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh, Sung-Soo Yoon
Cancer Res Treat. 2018;50(2):599-613.   Published online June 19, 2017
DOI: https://doi.org/10.4143/crt.2016.357
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Anaplastic large cell lymphoma (ALCL) is a rare aggresive non-Hodgkin lymphoma, of which over 50% of cases have an aberrant nucleophosmin (NPM)‒anaplastic lymphoma kinase (ALK) fusion protein. Both mechanistic target of rapamycin (mTOR) inhibitor everolimus and ALK inhibitor crizotinib have shown promising antitumor activity in ALK-positive cancer cell lines. However, their combined effect has not yet been investigated.
Materials and Methods
We evaluated the anti-proliferative effects of everolimus and/or crizotinib in ALK-positive ALCL cell lines, Karpas 299 and SU-DHL-1, and lung adenocarcinoma cell line, NCI-H2228.
Results
We found that individually, both everolimus and crizotinib potently inhibited cell growth in a dose-dependent manner in both Karpas 299 and SU-DHL-1 cells. A combination of these agents synergistically inhibited proliferation in the two cell lines. Crizotinib down-regulated aberrant AKT and ERK phosphorylation induced by everolimus. Combination treatment also significantly increased G0/G1 cell-cycle arrest, DNA damage, and apoptosis compared with everolimus or crizotinib alone in ALK-positive ALCL cells. In the Karpas 299 xenograft model, the combination treatment exerted a stronger antitumor effect than monotherapies, without significant change in body weight. The synergistic effect of everolimus and crizotinib was also reproduced in the ALK-positive lung adenocarcinoma cell line NCI-H2228. The combination treatment abrogated phosphoinositide 3-kinase/AKT and mTOR signaling pathways with little effect on the Ras/ERK pathway in NCI-H2228 cells.
Conclusion
Crizotinib combinedwith everolimus synergistically inhibits proliferation of ALK-positive ALCL cells. Our results suggest that this novel combination is worthy of further clinical development in patients with ALK-positive ALCL.

Citations

Citations to this article as recorded by  
  • The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies
    Bahareh Kashani, Zahra Zandi, Atieh Pourbagheri‑Sigaroodi, Amir-Mohammad Yousefi, Seyed H. Ghaffari, Davood Bashash
    Expert Review of Anticancer Therapy.2024; 24(7): 493.     CrossRef
  • Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
    Yuan Wang, Jing He, Manyu Xu, Qingfeng Xue, Cindy Zhu, Juan Liu, Yaping Zhang, Wenyu Shi
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC
    Juanjuan Xiao, Lu Zhang, Huijun Yi, Ling Zou, Jianmei Mo, Feng Xue, Jinhua Zheng, Yingze Huang, Hui Lu, Hansheng Wu, Peipei Xue, Xin Zhang, Lifei He, Zhaoxin Li, Shigui Pang, Guibin Qiao, Qiuhong Duan, Feng Zhu
    Cell Death & Disease.2022;[Epub]     CrossRef
  • CORR Insights®: Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma
    Xiaodong Tang
    Clinical Orthopaedics & Related Research.2021; 479(4): 853.     CrossRef
  • Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor
    Nehad M. Ayoub, Amer E. Alkhalifa, Dalia R. Ibrahim, Ahmed Alhusban
    Medical Oncology.2021;[Epub]     CrossRef
  • The Dual Role of Autophagy in Crizotinib-Treated ALK+ ALCL: From the Lymphoma Cells Drug Resistance to Their Demise
    Estelle Espinos, Raymond Lai, Sylvie Giuriato
    Cells.2021; 10(10): 2517.     CrossRef
  • Hexokinases II‐mediated glycolysis governs susceptibility to crizotinib in ALK‐positive non‐small cell lung cancer
    Caiyu Lin, Hengyi Chen, Rui Han, Li Li, Conghua Lu, Shuai Hao, Yubo Wang, Yong He
    Thoracic Cancer.2021; 12(23): 3184.     CrossRef
  • 12,997 View
  • 400 Download
  • 8 Web of Science
  • 7 Crossref
Close layer
Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
Su-Jin Koh, Shinmi Kim, JinShil Kim, Bhumsuk Keam, Dae Seog Heo, Kyung Hee Lee, Bong-Seog Kim, Jee Hyun Kim, Hye Jung Chang, Sun Kyung Baek
Cancer Res Treat. 2018;50(2):614-623.   Published online July 3, 2017
DOI: https://doi.org/10.4143/crt.2016.446
AbstractAbstract PDFPubReaderePub
Purpose
The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.
Materials and Methods
A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.
Results
A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of “terminal state,” and mostrespondents tried to disclose the patient’s condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.
Conclusion
This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.

Citations

Citations to this article as recorded by  
  • Physicians are over optimistic in recognizing inpatients’ survival and palliative care needs: a large-scale multi-center study in Taiwan
    C -M Huang, S -J Huang, T -Y Wu, Y -C Chen, S -H Hsiao, D Chu
    QJM: An International Journal of Medicine.2024; 117(3): 195.     CrossRef
  • The quality of dying and death of patients with cancer from Shanghai in China from the perspective of healthcare providers: A cross-sectional study
    Jiawei Min, Peihao Liu, Kaifeng Xiao, Zhe Huang, Xiaobin Lai
    International Journal of Nursing Sciences.2024; 11(2): 179.     CrossRef
  • Issues and implications of the life-sustaining treatment decision act: comparing the data from the survey and clinical data of inpatients at the end-of-life process
    Eunjeong Song, Dongsoon Shin, Jooseon Lee, Seonyoung Yun, Minjeong Eom, Suhee Oh, Heejung Lee, Jiwan Lee, Rhayun Song
    BMC Medical Ethics.2024;[Epub]     CrossRef
  • Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study
    Hyeon-Su Im, Insook Lee, Shinmi Kim, Jong Soo Lee, Ju-Hee Kim, Jae Young Moon, Byung Kyu Park, Kyung Hee Lee, Myung Ah Lee, Sanghoon Han, Yoonki Hong, Hyeyeoung Kim, Jaekyung Cheon, Su-Jin Koh
    BMC Medical Ethics.2023;[Epub]     CrossRef
  • Barriers and facilitators that hospital clinicians perceive to discuss the personal values, wishes, and needs of patients in palliative care: a mixed-methods systematic review
    Sita de Vries, Mary-Joanne Verhoef, Sigrid Cornelia Johanna Maria Vervoort, Yvette Milene van der Linden, Saskia Cornelia Constantia Maria Teunissen, Everlien de Graaf
    Palliative Care and Social Practice.2023;[Epub]     CrossRef
  • Association Among End-Of-Life Discussions, Cancer Patients’ Quality of Life at End of Life, and Bereaved Families’ Mental Health
    Yoko Hayashi, Kazuki Sato, Masahiro Ogawa, Yoshiro Taguchi, Hisashi Wakayama, Aya Nishioka, Chikako Nakamura, Kaoru Murota, Ayumi Sugimura, Shoko Ando
    American Journal of Hospice and Palliative Medicine®.2022; 39(9): 1071.     CrossRef
  • Difficulties Facing Junior Physicians and Solutions Toward Delivering End-of-Life Care for Patients with Cancer: A Nationwide Survey in Japan
    Soichiro Okamoto, Yu Uneno, Natsuki Kawashima, Shunsuke Oyamada, Yusuke Hiratsuka, Keita Tagami, Manabu Muto, Tatsuya Morita
    Palliative Medicine Reports.2022; 3(1): 255.     CrossRef
  • The silent transition from curative to palliative treatment: a qualitative study about cancer patients’ perceptions of end-of-life discussions with oncologists
    A. Kitta, A. Hagin, M. Unseld, F. Adamidis, T. Diendorfer, E. K. Masel, K. Kirchheiner
    Supportive Care in Cancer.2021; 29(5): 2405.     CrossRef
  • Advance Care Planning in Asia: A Systematic Narrative Review of Healthcare Professionals’ Knowledge, Attitude, and Experience
    Diah Martina, Cheng-Pei Lin, Martina S. Kristanti, Wichor M. Bramer, Masanori Mori, Ida J. Korfage, Agnes van der Heide, Carin C.D. van der Rijt, Judith A.C. Rietjens
    Journal of the American Medical Directors Association.2021; 22(2): 349.e1.     CrossRef
  • Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
    Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2021; 53(2): 584.     CrossRef
  • Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act
    Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon
    BMC Palliative Care.2021;[Epub]     CrossRef
  • Act on Decisions on Life-Sustaining Treatment and Timing of Referral to Hospice
    Han-na Ju, Seung Hun Lee, Yun-Jin Kim, Sang-Yeoup Lee, Jeong-Gyu Lee, Yu-Hyeon Yi, Young-Hye Cho, Young-Jin Tak, Hye-Rim Hwang, Eun-Ju Park, Young-In Lee
    Korean Journal of Family Practice.2021; 11(5): 331.     CrossRef
  • Nature of Discussions about Systemic Therapy Discontinuation or Hospice among Patients, Families, and Palliative Care Clinicians during Care for Incurable Cancer: A Qualitative Study
    Lara Traeger, Chelsea Rapoport, Emily Wright, Areej El-Jawahri, Joseph A. Greer, Elyse R. Park, Vicki A. Jackson, Jennifer S. Temel
    Journal of Palliative Medicine.2020; 23(4): 542.     CrossRef
  • Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
    Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2020; 52(3): 917.     CrossRef
  • Advance care planning in Asian culture
    Shao-Yi Cheng, Cheng-Pei Lin, Helen Yue-lai Chan, Diah Martina, Masanori Mori, Sun-Hyun Kim, Raymond Ng
    Japanese Journal of Clinical Oncology.2020; 50(9): 976.     CrossRef
  • Differences in perspectives of pediatricians on advance care planning: a cross-sectional survey
    In Gyu Song, Sung Han Kang, Min Sun Kim, Cho Hee Kim, Yi Ji Moon, Jung Lee
    BMC Palliative Care.2020;[Epub]     CrossRef
  • Feasibility of a team based prognosis and treatment goal discussion (T-PAT) with women diagnosed with advanced breast cancer
    Mary M. Step, Gretchen A. Ferber, Catherine Downs-Holmes, Paula Silverman
    Patient Education and Counseling.2019; 102(1): 77.     CrossRef
  • Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act
    Hye Yoon Park, Young Ae Kim, Jin-Ah Sim, Jihye Lee, Hyewon Ryu, Jung Lim Lee, Chi Hoon Maeng, Jung Hye Kwon, Yu Jung Kim, Eun Mi Nam, Hyun-Jeong Shim, Eun-Kee Song, Kyung Hae Jung, Eun Joo Kang, Jung Hun Kang, Young Ho Yun
    Journal of Pain and Symptom Management.2019; 57(4): 774.     CrossRef
  • Family-clinician communication in the ICU and its relationship to psychological distress of family members: A cross-sectional study
    Minjeong Jo, Mi-Kyung Song, George J. Knafl, Linda Beeber, Yang-Sook Yoo, Marcia Van Riper
    International Journal of Nursing Studies.2019; 95: 34.     CrossRef
  • Implementation of Antimicrobial Stewardship Programs in End-of-Life Care
    Ki Tae Kwon
    Infection & Chemotherapy.2019; 51(2): 89.     CrossRef
  • Facilitators and Barriers to Oncologists’ Conduct of Goals of Care Conversations
    Dena Schulman-Green, Jenny J. Lin, Cardinale B. Smith, Shelli Feder, Nina A. Bickell
    Journal of Palliative Care.2018; 33(3): 143.     CrossRef
  • Clinical characteristics and survival outcomes of terminally ill patients undergoing withdrawal of mechanical ventilation
    Yu-Shin Hung, Shu-Hui Lee, Chia-Yen Hung, Chao-Hui Wang, Chen-Yi Kao, Hung-Ming Wang, Wen-Chi Chou
    Journal of the Formosan Medical Association.2017;[Epub]     CrossRef
  • 10,096 View
  • 268 Download
  • 22 Web of Science
  • 22 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP